<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><style scope="para-num">para-num {
  display: block;
}</style><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US20040161776A1 - PSMA formulations and uses thereof 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US20040161776A1/en">
    <meta name="description" content="
     The invention includes stable multimeric, particularly dimeric, forms of PSMA protein, compositions and kits containing dimeric PSMA protein as well as methods of producing, purifying and using these compositions. Such methods include methods for eliciting or enhancing an immune reponse to cells expressing PSMA, including methods of producing antibodies to dimeric PSMA, as well as methods of treating cancer, such as prostate cancer.  
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="PSMA formulations and uses thereof 
       ">
    <meta name="DC.date" content="2003-10-27" scheme="dateSubmitted">
    <meta name="DC.description" content="
     The invention includes stable multimeric, particularly dimeric, forms of PSMA protein, compositions and kits containing dimeric PSMA protein as well as methods of producing, purifying and using these compositions. Such methods include methods for eliciting or enhancing an immune reponse to cells expressing PSMA, including methods of producing antibodies to dimeric PSMA, as well as methods of treating cancer, such as prostate cancer.  
   
   ">
    <meta name="citation_patent_application_number" content="US:10/695,667">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/ad/fb/cf/5bf21f9d3e4b4a/US20040161776A1.pdf">
    <meta name="citation_patent_publication_number" content="US:20040161776:A1">
    <meta name="DC.date" content="2004-08-19">
    <meta name="DC.contributor" content="Paul Maddon" scheme="inventor">
    <meta name="DC.contributor" content="Gerald Donovan" scheme="inventor">
    <meta name="DC.contributor" content="William Olson" scheme="inventor">
    <meta name="DC.contributor" content="Norbert Schulke" scheme="inventor">
    <meta name="DC.contributor" content="Jason Gardner" scheme="inventor">
    <meta name="DC.contributor" content="Dangshe Ma" scheme="inventor">
    <meta name="DC.contributor" content="Individual" scheme="assignee">
    <meta name="DC.relation" content="US:215472" scheme="references">
    <meta name="DC.relation" content="US:6107090" scheme="references">
    <meta name="DC.relation" content="US:5804602" scheme="references">
    <meta name="DC.relation" content="US:20040033229:A1" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            PSMA formulations and uses thereof 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA48872768" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div id="A-0001" class="abstract style-scope patent-text">The invention includes stable multimeric, particularly dimeric, forms of PSMA protein, compositions and kits containing dimeric PSMA protein as well as methods of producing, purifying and using these compositions. Such methods include methods for eliciting or enhancing an immune reponse to cells expressing PSMA, including methods of producing antibodies to dimeric PSMA, as well as methods of treating cancer, such as prostate cancer. </div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">55</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/32/e6/d9/50c738bea63b42/US20040161776A1-20040819-D00001.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/93/56/3f/f044b1fa1515b4/US20040161776A1-20040819-D00002.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/99/45/76/00079ae4a18ac4/US20040161776A1-20040819-D00003.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b6/4d/80/d3337f436964ae/US20040161776A1-20040819-D00004.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/62/05/37/2c1bc13369ad0f/US20040161776A1-20040819-D00005.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c2/3b/10/b6fee255f01c55/US20040161776A1-20040819-D00006.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/05/cd/da/192cd6c56d9698/US20040161776A1-20040819-D00007.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ff/57/ef/f212fd2f86dfb6/US20040161776A1-20040819-D00008.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/d0/0d/c4/c786b81067f4e9/US20040161776A1-20040819-D00009.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/38/d9/c7/2fd92bb98e5261/US20040161776A1-20040819-D00010.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b4/01/45/f786051b05520b/US20040161776A1-20040819-D00011.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/53/c7/6d/1a77b8e0ab4b0d/US20040161776A1-20040819-D00012.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b1/4e/7e/2108339bc74b66/US20040161776A1-20040819-D00013.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9b/15/db/f1872c531a2fc2/US20040161776A1-20040819-D00014.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/bc/7d/43/5a5c2aea3b2c61/US20040161776A1-20040819-D00015.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/e6/94/2c/9de76b1bfe0767/US20040161776A1-20040819-D00016.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/9c/56/ca/4f3f9358e36f0b/US20040161776A1-20040819-D00017.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/59/ef/8a/383e758390ee13/US20040161776A1-20040819-D00018.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c8/86/cb/64a9ffb77c7f52/US20040161776A1-20040819-D00019.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/17/a5/22/c1c30ee03afc7d/US20040161776A1-20040819-D00020.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/c9/1a/fd/74cb34e9683a28/US20040161776A1-20040819-D00021.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/94/e1/ae/24eed8fc9e9d6e/US20040161776A1-20040819-D00022.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fb/6a/b4/47be0f3f6d5edd/US20040161776A1-20040819-D00023.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/bc/f4/53/c2400b501ba1dd/US20040161776A1-20040819-D00024.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/44/2f/38/4d7d62c7944051/US20040161776A1-20040819-D00025.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/bd/0b/4a/2c2ad087753dab/US20040161776A1-20040819-D00026.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/af/0d/3f/e8176231eb5f44/US20040161776A1-20040819-D00027.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/f6/c7/46/75c22aa2ce2587/US20040161776A1-20040819-D00028.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/09/58/98/67368c737950f0/US20040161776A1-20040819-D00029.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/de/93/0e/82bc19a66b4a36/US20040161776A1-20040819-D00030.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ae/18/96/97faedd47639a9/US20040161776A1-20040819-D00031.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/12/84/a9/87108dcf45a8c7/US20040161776A1-20040819-D00032.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/03/a8/8d/46fa96aaf46c29/US20040161776A1-20040819-D00033.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fb/f8/e1/3836a97fd80771/US20040161776A1-20040819-D00034.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a3/2d/0e/3b6457644c575b/US20040161776A1-20040819-D00035.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/59/17/97/71ce66d6273bc3/US20040161776A1-20040819-D00036.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/d1/2d/12/0af94123b7980b/US20040161776A1-20040819-D00037.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/30/ac/4f/dd50ee87171b66/US20040161776A1-20040819-D00038.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/8c/b8/06/e26f140d29efcd/US20040161776A1-20040819-D00039.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ba/d0/4e/833c6ec80504b7/US20040161776A1-20040819-D00040.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/5f/a9/7c/6a12d4c8b4e760/US20040161776A1-20040819-D00041.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/ae/e0/79/433f9b7ac25e05/US20040161776A1-20040819-D00042.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/72/cb/71/1844e26c8b0289/US20040161776A1-20040819-D00043.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a0/f5/ca/1e639fa5c584e8/US20040161776A1-20040819-D00044.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/78/2f/bf/d88031f2b57672/US20040161776A1-20040819-D00045.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/84/4a/e8/c2f99f838da7e9/US20040161776A1-20040819-D00046.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/f1/0e/d2/b64710aaf91ed7/US20040161776A1-20040819-D00047.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/fc/96/e2/74fc23db618577/US20040161776A1-20040819-D00048.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/40/63/bd/10dac9e0f0a7e2/US20040161776A1-20040819-D00049.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/8e/84/4c/46626d1767988b/US20040161776A1-20040819-D00050.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/84/6c/2c/5cd8e7fea18ef1/US20040161776A1-20040819-D00051.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/07/b8/74/be9430402e22dc/US20040161776A1-20040819-D00052.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/a0/ca/6e/f867e274723af9/US20040161776A1-20040819-D00053.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/b2/22/7d/22b9b891d6137b/US20040161776A1-20040819-D00054.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/68/24/fb/456b8ba0237aaa/US20040161776A1-20040819-D00055.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G"><a id="link" href="#" class="style-scope state-modifier">G</a></state-modifier>
                  <span class="description style-scope classification-tree">PHYSICS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01"><a id="link" href="#" class="style-scope state-modifier">G01</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING; TESTING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N"><a id="link" href="#" class="style-scope state-modifier">G01N</a></state-modifier>
                  <span class="description style-scope classification-tree">INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/00"><a id="link" href="#" class="style-scope state-modifier">G01N33/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/48"><a id="link" href="#" class="style-scope state-modifier">G01N33/48</a></state-modifier>
                  <span class="description style-scope classification-tree">Biological material, e.g. blood, urine; Haemocytometers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/50"><a id="link" href="#" class="style-scope state-modifier">G01N33/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/53"><a id="link" href="#" class="style-scope state-modifier">G01N33/53</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/574"><a id="link" href="#" class="style-scope state-modifier">G01N33/574</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoassay; Biospecific binding assay; Materials therefor for cancer</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="G01N33/57407"><a id="link" href="#" class="style-scope state-modifier">G01N33/57407</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="G01N33/57434"><a id="link" href="#" class="style-scope state-modifier">G01N33/57434</a></state-modifier>
                  <span class="description style-scope classification-tree">Specifically defined cancers of prostate</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6801"><a id="link" href="#" class="style-scope state-modifier">A61K47/6801</a></state-modifier>
                  <span class="description style-scope classification-tree">Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6803"><a id="link" href="#" class="style-scope state-modifier">A61K47/6803</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6811"><a id="link" href="#" class="style-scope state-modifier">A61K47/6811</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6817"><a id="link" href="#" class="style-scope state-modifier">A61K47/6817</a></state-modifier>
                  <span class="description style-scope classification-tree">Toxins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6819"><a id="link" href="#" class="style-scope state-modifier">A61K47/6819</a></state-modifier>
                  <span class="description style-scope classification-tree">Plant toxins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6825"><a id="link" href="#" class="style-scope state-modifier">A61K47/6825</a></state-modifier>
                  <span class="description style-scope classification-tree">Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6869"><a id="link" href="#" class="style-scope state-modifier">A61K47/6869</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from a cell of the reproductive system: ovaria, uterus, testes, prostate</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/00"><a id="link" href="#" class="style-scope state-modifier">A61K51/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparations containing radioactive substances for use in therapy or testing in vivo</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/02"><a id="link" href="#" class="style-scope state-modifier">A61K51/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/04"><a id="link" href="#" class="style-scope state-modifier">A61K51/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/08"><a id="link" href="#" class="style-scope state-modifier">A61K51/08</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/10"><a id="link" href="#" class="style-scope state-modifier">A61K51/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/1045"><a id="link" href="#" class="style-scope state-modifier">A61K51/1045</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/1072"><a id="link" href="#" class="style-scope state-modifier">A61K51/1072</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/00"><a id="link" href="#" class="style-scope state-modifier">A61K51/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparations containing radioactive substances for use in therapy or testing in vivo</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/02"><a id="link" href="#" class="style-scope state-modifier">A61K51/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/04"><a id="link" href="#" class="style-scope state-modifier">A61K51/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Organic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/08"><a id="link" href="#" class="style-scope state-modifier">A61K51/08</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/10"><a id="link" href="#" class="style-scope state-modifier">A61K51/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/1093"><a id="link" href="#" class="style-scope state-modifier">A61K51/1093</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K51/1096"><a id="link" href="#" class="style-scope state-modifier">A61K51/1096</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/00"><a id="link" href="#" class="style-scope state-modifier">C07K16/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/18"><a id="link" href="#" class="style-scope state-modifier">C07K16/18</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/28"><a id="link" href="#" class="style-scope state-modifier">C07K16/28</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/30"><a id="link" href="#" class="style-scope state-modifier">C07K16/30</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K16/3069"><a id="link" href="#" class="style-scope state-modifier">C07K16/3069</a></state-modifier>
                  <span class="description style-scope classification-tree">Reproductive system, e.g. ovaria, uterus, testes, prostate</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K39/00"><a id="link" href="#" class="style-scope state-modifier">A61K39/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing antigens or antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="A61K2039/505"><a id="link" href="#" class="style-scope state-modifier">A61K2039/505</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing antigens or antibodies comprising antibodies</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/20"><a id="link" href="#" class="style-scope state-modifier">C07K2317/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by taxonomic origin</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/21"><a id="link" href="#" class="style-scope state-modifier">C07K2317/21</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/50"><a id="link" href="#" class="style-scope state-modifier">C07K2317/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by immunoglobulin fragments</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/56"><a id="link" href="#" class="style-scope state-modifier">C07K2317/56</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/565"><a id="link" href="#" class="style-scope state-modifier">C07K2317/565</a></state-modifier>
                  <span class="description style-scope classification-tree">Complementarity determining region [CDR]</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/00"><a id="link" href="#" class="style-scope state-modifier">C07K2317/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/60"><a id="link" href="#" class="style-scope state-modifier">C07K2317/60</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K2317/62"><a id="link" href="#" class="style-scope state-modifier">C07K2317/62</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" additional="true" data-cpc="C07K2317/622"><a id="link" href="#" class="style-scope state-modifier">C07K2317/622</a></state-modifier>
                  <span class="description style-scope classification-tree">Single chain antibody (scFv)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 10 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US20040161776A1</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent application publication</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/ad/fb/cf/5bf21f9d3e4b4a/US20040161776A1.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;psma&quot;,&quot;composition&quot;,&quot;sodium&quot;,&quot;psma protein&quot;,&quot;salt&quot;]" data-before="20011023"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US20040161776A1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Paul Maddon"><a id="link" href="#" class="style-scope state-modifier">Paul Maddon</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Gerald Donovan"><a id="link" href="#" class="style-scope state-modifier">Gerald Donovan</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="William Olson"><a id="link" href="#" class="style-scope state-modifier">William Olson</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Norbert Schulke"><a id="link" href="#" class="style-scope state-modifier">Norbert Schulke</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jason Gardner"><a id="link" href="#" class="style-scope state-modifier">Jason Gardner</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Dangshe Ma"><a id="link" href="#" class="style-scope state-modifier">Dangshe Ma</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    PSMA Development Co LLC
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2003</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US10/695,667</div>
                <div class="style-scope application-timeline">Filing date: 2003-10-27</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2004</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP2007509977A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2006538350A</div>
                <div class="style-scope application-timeline">Filing date: 2004-10-27</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1691840A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP04810137A</div>
                <div class="style-scope application-timeline">Filing date: 2004-10-27</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2005042029A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/US2004/036120</div>
                <div class="style-scope application-timeline">Filing date: 2004-10-27</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2543703A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002543703A</div>
                <div class="style-scope application-timeline">Filing date: 2004-10-27</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2004285543A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2004285543A</div>
                <div class="style-scope application-timeline">Filing date: 2004-10-27</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US10/695,667 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2003-10-27</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Individual"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Individual</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="priority style-scope application-timeline">2003-10-27</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority to US10/695,667</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2004-08-19</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US20040161776A1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Abandoned</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      
        <div class="event layout horizontal expand style-scope application-timeline">
          Show all events <iron-icon style="height: 15px; width: 15px;" icon="expand-more" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M16.59 8.59L12 13.17 7.41 8.59 6 10l6 6 6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope application-timeline"></template>
          <template is="dom-if" class="style-scope application-timeline"></template>
        </div>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (15)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (45)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PG01&amp;s1=20040161776.PGNR.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/10695667">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=20040161776">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=2004161776A1&amp;KC=A1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/US/20040161776/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US20040161776">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><ul mxw-id="PDES68982026" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <heading class="style-scope patent-text">RELATED APPLICATIONS </heading>
    <li class="style-scope patent-text"> <para-num num="[0001]" class="style-scope patent-text">
    
    [0001]
  </para-num> <div id="P-0001" num="0001" class="description-line style-scope patent-text">This application is a continuation-in-part of U.S. nonprovisional application Ser. No. 10/395,894, filed on Mar. 21, 2003, which is a continuation-in-part of International application PCT/US02/33944 designating the United States, filed on Oct. 23, 2002, which claims the benefit under 35 U.S.C.  119 of U.S. <span style="display: none" class="style-scope patent-text">[0001] </span> <figure-callout id="60" label="provisional application" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">provisional application</a></figure-callout> 60/335,215, filed Oct. 23, 2001, U.S. <figure-callout id="60" label="provisional application" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">provisional application</a></figure-callout> 60/362,747, filed Mar. 7, 2002, and U.S. <figure-callout id="60" label="provisional application" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">provisional application</a></figure-callout> 60/412,618, filed Sep. 20, 2002, each of which is incorporated herein by reference.</div>
    
    
    </li> <summary-of-invention class="style-scope patent-text">
      <heading class="style-scope patent-text">FIELD OF THE INVENTION </heading>
      <li class="style-scope patent-text"> <para-num num="[0002]" class="style-scope patent-text">
    
    [0002]
  </para-num> <div id="P-0002" num="0002" class="description-line style-scope patent-text">This invention relates generally to the field of cancer associated polypeptides and formulations of and kits including these polypeptides. In particular, the invention relates, in part, to formulations of multimeric forms of PSMA proteins, particularly dimeric PSMA, and methods of their processing, purification, production and use. <span style="display: none" class="style-scope patent-text">[0002] </span> </div>
      </li> <heading class="style-scope patent-text">BACKGROUND OF THE INVENTION </heading>
      <li class="style-scope patent-text"> <para-num num="[0003]" class="style-scope patent-text">
    
    [0003]
  </para-num> <div id="P-0003" num="0003" class="description-line style-scope patent-text">Prostate cancer is the most prevalent type of cancer and the second leading cause of death from cancer in American men, with an estimated 179,000 cases and 37,000 deaths in 1999, (Landis, S. H. et al. <span style="display: none" class="style-scope patent-text">[0003] </span> <i class="style-scope patent-text">CA Cancer J. Clin. </i>48:6-29 (1998)). The number of men diagnosed with prostate cancer is steadily increasing as a result of the increasing population of older men as well as a greater awareness of the disease leading to its earlier diagnosis (Parker et al., 1997, <i class="style-scope patent-text">CA Cancer J. Clin. </i>47:5-280). The life time risk for men developing prostate cancer is about 1 in 5 for Caucasians, 1 in 6 for African Americans. High risk groups are represented by those with a positive family history of prostate cancer or African Americans. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0004]" class="style-scope patent-text">
    
    [0004]
  </para-num> <div id="P-0004" num="0004" class="description-line style-scope patent-text">Over a lifetime, more than  of the men diagnosed with prostate cancer die of the disease (Wingo et al., 1996, <span style="display: none" class="style-scope patent-text">[0004] </span> <i class="style-scope patent-text">CA Cancer J. Clin. </i>46:113-25). Moreover, many patients who do not succumb to prostate cancer require continuous treatment to ameliorate symptoms such as pain, bleeding and urinary obstruction. Thus, prostate cancer also represents a major cause of suffering and increased health care expenditures. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0005]" class="style-scope patent-text">
    
    [0005]
  </para-num> <div id="P-0005" num="0005" class="description-line style-scope patent-text">Where prostate cancer is localized and the patient's life expectancy is 10 years or more, radical prostatectomy offers the best chance for eradication of the disease. Historically, the drawback of this procedure is that most cancers had spread beyond the bounds of the operation by the time they were detected. Patients with bulky, high-grade tumors are less likely to be successfully treated by radical prostatectomy. <span style="display: none" class="style-scope patent-text">[0005] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0006]" class="style-scope patent-text">
    
    [0006]
  </para-num> <div id="P-0006" num="0006" class="description-line style-scope patent-text">Radiation therapy has also been widely used as an alternative to radical prostatectomy. Patients generally treated by radiation therapy are those who are older and less healthy and those with higher-grade, more clinically advanced tumors. Particularly preferred procedures are external-beam therapy which involves three dimensional, confocal radiation therapy where the field of radiation is designed to conform to the volume of tissue treated; interstitial-radiation therapy where seeds of radioactive compounds are implanted using ultrasound guidance; and a combination of external-beam therapy and interstitial-radiation therapy. <span style="display: none" class="style-scope patent-text">[0006] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0007]" class="style-scope patent-text">
    
    [0007]
  </para-num> <div id="P-0007" num="0007" class="description-line style-scope patent-text">For treatment of patients with locally advanced disease, hormonal therapy before or following radical prostatectomy or radiation therapy has been utilized. Hormonal therapy is the main form of treating men with disseminated prostate cancer. Orchiectomy reduces serum testosterone concentrations, while estrogen treatment is similarly beneficial. Diethylstilbestrol from estrogen is another useful hormonal therapy which has a disadvantage of causing cardiovascular toxicity. When gonadotropin-releasing hormone agonists are administered testosterone concentrations are ultimately reduced. Flutamide and other nonsteroidal, anti-androgen agents block binding of testosterone to its intracellular receptors. As a result, it blocks the effect of testosterone, increasing serum testosterone concentrations and allows patients to remain potenta significant problem after radical prostatectomy and radiation treatments. <span style="display: none" class="style-scope patent-text">[0007] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0008]" class="style-scope patent-text">
    
    [0008]
  </para-num> <div id="P-0008" num="0008" class="description-line style-scope patent-text">Cytotoxic chemotherapy is largely ineffective in treating prostate cancer. Its toxicity makes such therapy unsuitable for elderly patients. In addition, prostate cancer is relatively resistant to cytotoxic agents. <span style="display: none" class="style-scope patent-text">[0008] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0009]" class="style-scope patent-text">
    
    [0009]
  </para-num> <div id="P-0009" num="0009" class="description-line style-scope patent-text">Relapsed or more advanced disease is also treated with anti-androgen therapy. Unfortunately, almost all tumors become hormone-resistant and progress rapidly in the absence of any effective therapy. <span style="display: none" class="style-scope patent-text">[0009] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0010]" class="style-scope patent-text">
    
    [0010]
  </para-num> <div id="P-0010" num="0010" class="description-line style-scope patent-text">Accordingly, there is a need for effective therapeutics for prostate cancer which are not overwhelmingly toxic to normal tissues of a patient, and which are effective in selectively eliminating prostate cancer cells. <span style="display: none" class="style-scope patent-text">[0010] </span> </div>
      </li> <heading class="style-scope patent-text">SUMMARY OF THE INVENTION </heading>
      <li class="style-scope patent-text"> <para-num num="[0011]" class="style-scope patent-text">
    
    [0011]
  </para-num> <div id="P-0011" num="0011" class="description-line style-scope patent-text">The present invention relates, in part, to multimeric, particularly dimeric, forms of PSMA protein, compositions and kits containing dimeric PSMA protein as well as methods of producing, purifying, processing and using these compositions. <span style="display: none" class="style-scope patent-text">[0011] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0012]" class="style-scope patent-text">
    
    [0012]
  </para-num> <div id="P-0012" num="0012" class="description-line style-scope patent-text">In one aspect compositions comprising multimeric forms of PSMA protein are provided. In some embodiments, these compositions contain isolated PSMA protein, at least 5% of which is in the form of PSMA protein multimer. In other embodiments at least 10%, 15%, 20%, 25%, 30%, 35%, 40%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more of the isolates PSMA protein is in the form of a PSMA protein multimer. In other embodiments the PSMA protein multimer is a PSMA protein dimer, wherein the PSMA protein dimer is formed by the covalent or non-covalent association of two PSMA proteins. In some embodiments the PSMA protein dimer is engineered to form a stable PSMA dimer through covalent bonds. In other embodiments the covalent bonds are disulfide bonds. Preferably, the PSMA protein dimer is associated in the same way as that of native PSMA dimer or is associated in such a way as to form at least one antigenic epitope that can be used to generate antibodies that recognize the native PSMA dimer. These antibodies, preferably, recognize the native PSMA dimer and not PSMA monomer or recognize the native PSMA dimer with greater specificity. In some embodiments of the invention the percent dimer can be calculated in terms of the number of PSMA protein molecules in the dimeric form versus the total number of PSMA protein (monomer, dimer or other multimer). In other embodiments the percent dimer can be calculated in terms of the number of PSMA dimers relative to the number of PSMA monomers, PSMA dimers and PSMA multimers. <span style="display: none" class="style-scope patent-text">[0012] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0013]" class="style-scope patent-text">
    
    [0013]
  </para-num> <div id="P-0013" num="0013" class="description-line style-scope patent-text">In some embodiments the PSMA protein multimers comprise the full-length PSMA protein (SEQ ID NO: 1) or a fragment thereof. In other embodiments the PSMA protein multimer comprises the extracellular portion of PSMA (amino acids 44-750 of SEQ ID NO: 1) or a fragment thereof. In still other embodiments the PSMA protein multimer comprises the amino acids 58-750 of SEQ ID NO: 1 or a fragment thereof. In yet other embodiments the PSMA protein multimer comprises the amino acids 610-750 of SEQ ID NO: 1 or a fragment thereof. The fragments are capable of forming a PSMA multimer that can be used to generate antibodies that recognize PSMA, preferably native PSMA dimer. Typically, the PSMA multimers are homomultimers, meaning that the two or more PSMA molecules are the same. In other embodiments, the PSMA multimers are heteromultimers, whereby at least two of the PSMA proteins are not the same. In still other embodiments the PSMA proteins can be functionally equivalent proteins, whereby the PSMA protein is conservatively substituted. <span style="display: none" class="style-scope patent-text">[0013] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0014]" class="style-scope patent-text">
    
    [0014]
  </para-num> <div id="P-0014" num="0014" class="description-line style-scope patent-text">In another aspect of the invention compositions comprising isolated multimeric PSMA protein, wherein the composition comprises less than 35% of a monomeric PSMA protein are provided. In still other embodiments the composition comprises less than 20% of the monomeric PSMA protein. In yet other embodiments the composition comprises less than 15% of the monomeric PSMA protein. In still other embodiments the composition comprises less than 5% of the monomeric PSMA protein. In some preferred embodiments the isolated multimeric PSMA protein is an isolated dimeric PSMA protein. <span style="display: none" class="style-scope patent-text">[0014] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0015]" class="style-scope patent-text">
    
    [0015]
  </para-num> <div id="P-0015" num="0015" class="description-line style-scope patent-text">In some aspects of the invention, agents and compositions thereof that preserve or promote multimeric association of PSMA, particularly dimeric association, are provided. In some embodiments these agents include metal ions, salts, or pH adjusting agents. These agents that preserve or promote multimeric PSMA associations can do so individually or do so in combination. Therefore, in another aspect of the invention, a composition comprising PSMA protein multimers in conjunction with metal ion are provided. In some embodiments these compositions comprise at least 0.25 molar equivalents of metal ion to PSMA protein (total PSMA protein regardless of its form). In other embodiments at least 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.3, 1.5, 1.7, 2, 3, 4, 5, or more molar equivalents of metal ion to PSMA protein are present in the composition. In other embodiments the metal ion is in molar excess to PSMA protein. In some preferred embodiments the compositions provided are free of chelating agents. <span style="display: none" class="style-scope patent-text">[0015] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0016]" class="style-scope patent-text">
    
    [0016]
  </para-num> <div id="P-0016" num="0016" class="description-line style-scope patent-text">In yet another aspect of the invention compositions comprising PSMA protein in a solution that promotes or preserves multimeric association of PSMA protein are provided. In some embodiments the solution that promotes or preserves multimeric association of PSMA protein is a solution that promotes or preserves dimeric association of PSMA protein. In other embodiments the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 4 to 8. In still other embodiments the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 5 to 7. Other embodiments include compositions wherein the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 5.5 to 7. In still other embodiments the solution that promotes or preserves dimeric association of PSMA protein has a pH of 6. <span style="display: none" class="style-scope patent-text">[0016] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0017]" class="style-scope patent-text">
    
    [0017]
  </para-num> <div id="P-0017" num="0017" class="description-line style-scope patent-text">In still another aspect of the invention compositions comprising PSMA protein in a solution that promotes or preserves multimeric association of PSMA protein, wherein the solution comprises a salt, are provided. In some embodiments, the cationic component of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and the anionic component of the salt is chloride, sulfate, acetate or a combination thereof. In preferred embodiments the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. In some embodiments the salt is present at a concentration in the range of 50 mM to 2M. In other embodiments the salt is present at a concentration in the range of 100 mM to 300 mM. In still other embodiments the salt is present at a concentration of 150 mM. <span style="display: none" class="style-scope patent-text">[0017] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0018]" class="style-scope patent-text">
    
    [0018]
  </para-num> <div id="P-0018" num="0018" class="description-line style-scope patent-text">In yet another aspect of the invention a composition comprising PSMA protein in a solution that promotes or preserves dimeric association of PSMA protein, wherein the solution comprises metal ions are provided. In some embodiments the metal ions are zinc ions, calcium ions, magnesium ions, cobalt ions, manganese ions or a combination thereof. In still other embodiments the metal ions are zinc ions and calcium ions. In yet other embodiments the zinc ions and calcium ions are present at a concentration in the range of 0.1 mM to 5 mM. In still other embodiments the zinc ions are present at a concentration that is lower than the concentration of the calcium ions. In some embodiments the zinc ions are present at a concentration of 0.1 mM and the calcium ions are present at a concentration of 1 mM. In other embodiments the metal ions are magnesium ions. In some of these embodiments the magnesium ions are present at a concentration in the range of 0.1 mM to 5 mM. In other embodiments the magnesium ions are present at a concentration of 0.5 mM. In a preferred embodiment the compositions are free of chelating agents. <span style="display: none" class="style-scope patent-text">[0018] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0019]" class="style-scope patent-text">
    
    [0019]
  </para-num> <div id="P-0019" num="0019" class="description-line style-scope patent-text">In still a further aspect of the invention a composition comprising isolated PSMA protein in a solution that promotes or preserves dimeric association of PSMA protein wherein the solution comprises (a) 5 to 20 mM of sodium phosphate, sodium acetate or a combination thereof, (b) 100 to 300 mM sodium chloride or sodium sulfate, and (c) 0.1 to 2 mM of at least one metal ion is provided. In one embodiment the solution has a pH in the range of 4 to 8. In another embodiment the solution has a pH in a range of 5 to 7. In still another embodiment the solution has a pH in a range of 6 to 6.5. The metal ion in some embodiments is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. <span style="display: none" class="style-scope patent-text">[0019] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0020]" class="style-scope patent-text">
    
    [0020]
  </para-num> <div id="P-0020" num="0020" class="description-line style-scope patent-text">In another aspect of the invention a composition comprising PSMA protein which also comprises an agent that promotes or preserves multimeric association, particularly dimeric association of PSMA protein, is provided, wherein the composition is stable when stored at 80 C. In other aspects of the invention the composition is stable when stored at 20 C. In still other aspects the composition is stable when stored at 4 C. In yet another aspect of the invention the composition is stable when stored at room temperature. <span style="display: none" class="style-scope patent-text">[0020] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0021]" class="style-scope patent-text">
    
    [0021]
  </para-num> <div id="P-0021" num="0021" class="description-line style-scope patent-text">Another aspect of the invention provides a method of promoting or preserving dimeric association of PSMA protein in a solution by obtaining a solution of PSMA protein, and adjusting the pH to be in the range of 4 to 8. In some embodiments the pH is adjusted to be in the range of 5 to 7. In other embodiments the pH is adjusted to be in the range of 5.5 to 7. In yet other embodiments the pH is adjusted to be 6. <span style="display: none" class="style-scope patent-text">[0021] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0022]" class="style-scope patent-text">
    
    [0022]
  </para-num> <div id="P-0022" num="0022" class="description-line style-scope patent-text">In another aspect of the invention a method of processing a PSMA protein by contacting the PSMA protein in a solution with a first agent that promotes or preserves dimeric association of PSMA protein in an amount effective to promote or preserve PSMA protein dimer formation is provided. In some embodiments the amount effective to promote or preserve PSMA protein dimer formation is enough to promote or maintain at least 5% of the PSMA protein in the solution in dimer form. In other embodiments at least 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more of the PSMA protein in the solution is in dimer form. The percentage of the dimer form of PSMA is calculated in terms of the total amount of the various forms of PSMA protein. In other words the percentage is calculated according to the number of PSMA dimers relative to the number of PSMA monomers, dimers and other multimers. In some embodiments the first agent that promotes or preserves dimeric association of PSMA protein is a salt, metal ion or a pH adjusting agent. The cationic components of the salt can include sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, while the anionic component of the salt can include chloride, sulfate, acetate or a combination thereof. In some embodiments the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. In other embodiments the salt is present at a concentration in the range of 50 mM to 2M. In still other embodiments the salt is present at a concentration in the range of 100 mM to 30 mM. In yet other embodiments the salt is present at a concentration of 150 mM. In some embodiments of the invention the method further includes combining the PSMA protein solution with an adjuvant or diluent. The adjuvant or diluent can be combined with the PSMA protein in an amount to dilute the salt concentration to 100 mM to 300 mM. In some embodiment the salt concentration is diluted to 150 mM. In certain embodiments this is done prior to administering the solution to a subject. In other embodiments the first agent is a metal ion and the metal ion is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. In some embodiments the metal ion is a combination of zinc ion and calcium ion. In still other embodiments the zinc ion and calcium ion are present at a concentration in the range of 0.1 mM to 5 mM. In yet other embodiments the zinc ion is present at a concentration that is lower than the concentration of the calcium ion. In still further embodiments the zinc ion is present at a concentration of 0.1 mM and the calcium ion is present at a concentration of 1 mM. In other embodiments the metal ion is a magnesium ion. In some of these embodiments the magnesium ion is present at a concentration in the range of 0.1 mM to 5 mM. In still other of these embodiments the magnesium ion is present at a concentration of 0.5 mM. In the embodiments where the first agent is a solution of a certain pH, the pH of the solution can be adjusted to be in the range of 4 to 8. In some embodiments the pH of the solution is adjusted to be in the range of 5 to 7. In still other embodiments the pH of the solution is adjusted to be in the range of 5.5 to 7. In yet other embodiments the pH of the solution is adjusted to be 6. <span style="display: none" class="style-scope patent-text">[0022] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0023]" class="style-scope patent-text">
    
    [0023]
  </para-num> <div id="P-0023" num="0023" class="description-line style-scope patent-text">In some embodiments the method further comprises contacting the PSMA protein with a second agent that promotes or preserves dimeric association of PSMA protein, wherein the second agent is different than the first agent. A second agent that is different than the first agent includes agents that are of a different type or different class. The second agent, therefore, can be a metal ion, salt or pH adjusting agent. In some embodiments where the first agent is a metal ion the second agent can be a salt, pH adjusting agent or a solution with a certain pH. In other embodiments the first agent is a salt, and the second agent is a metal ion, pH adjusting agent or a solution with a certain pH. In still another embodiment the first agent is a pH adjusting agent or a solution with a certain pH and the second agent is a metal ion or a salt. In yet other embodiments the first agent can be a salt, metal ion, pH adjusting agent or a solution with a certain pH and the second agent can be of the same class but a different type within the same class of agents. For instance if the first agent is a salt such as sodium chloride, the second agent can also be a salt but a different type, e.g., ammonium sulfate. <span style="display: none" class="style-scope patent-text">[0023] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0024]" class="style-scope patent-text">
    
    [0024]
  </para-num> <div id="P-0024" num="0024" class="description-line style-scope patent-text">In another aspect of the invention a method of purifying a sample containing PSMA protein by subjecting the sample containing PSMA to chromatography in the presence of an agent that preserves or promotes the dimeric association of PSMA is provided. In some embodiments the agent that promotes or preserves the dimeric association of PSMA is a metal ion, a salt or a solution with a pH in the range of 4 to 8 or a combination thereof. In a preferred embodiment the metal ion is a combination of calcium ion and magnesium ion. In one such embodiment the calcium ion and magnesium ion are each present at a concentration in the range of 0.1 mM to 5 mM. In a further embodiment the calcium ion and magnesium ion are present at a concentration of 1 mM and 0.5 mM, respectively. In other embodiments wherein the agent that promotes or preserves the dimeric association of PSMA is a salt, the salt is present at a concentration in the range of 50 mM to 2M. In some of these embodiments the salt is present at a concentration of 2M. In still other embodiments where the agent that promotes or preserves the dimeric association of PSMA is a solution with a pH in the range of 4 to 8, the pH of the solution is in the range of 5 to 7. In still other embodiments the pH of the solution is in the range of 6 to 7.5. <span style="display: none" class="style-scope patent-text">[0024] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0025]" class="style-scope patent-text">
    
    [0025]
  </para-num> <div id="P-0025" num="0025" class="description-line style-scope patent-text">In other aspects of the invention a method of purifying a sample containing PSMA protein by applying the sample to a first column, washing the first column with a first wash solution containing salt and metal ions, and collecting the PSMA protein that elutes from the first column is provided. In some embodiments the salt is ammonium sulfate at a saturation of no more than 35% in the wash solution. <span style="display: none" class="style-scope patent-text">[0025] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0026]" class="style-scope patent-text">
    
    [0026]
  </para-num> <div id="P-0026" num="0026" class="description-line style-scope patent-text">In embodiments of the invention the method further comprises dialyzing or diafiltering the eluted PSMA protein with a first salt solution at a pH in the range of 6 to 7.5 to yield a dialyzed or diafiltrated solution containing PSMA protein. In some of these embodiments the first salt solution has a salt concentration of at least 5 mM. In still other of these embodiments the first salt solution is a 10 mM sodium phosphate solution with a pH of 7. <span style="display: none" class="style-scope patent-text">[0026] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0027]" class="style-scope patent-text">
    
    [0027]
  </para-num> <div id="P-0027" num="0027" class="description-line style-scope patent-text">In still other embodiments of the invention the method further comprises loading the eluted PSMA protein, dialyzed or diafiltrated solution containing PSMA protein onto a second column, washing the second column with a second salt solution, and collecting the PSMA eluted by the second salt solution. In some embodiments the second salt solution has a salt concentration of 100 mM to 2M. In certain of these embodiments the second salt solution is 2M sodium chloride in 10 mM sodium phosphate. In still other embodiments the second salt solution has a pH in the range of 6 to 7.5. <span style="display: none" class="style-scope patent-text">[0027] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0028]" class="style-scope patent-text">
    
    [0028]
  </para-num> <div id="P-0028" num="0028" class="description-line style-scope patent-text">In yet another embodiment of the invention the method further comprises dialyzing or diafiltrating the PSMA eluted by the second salt solution with a metal ion solution, applying the dialyzed or diafiltrated PSMA eluted by the second salt solution onto a third column, washing the third column with a second wash solution containing salt and metal ions and collecting the PSMA eluted. In some of these embodiments the pH is maintained in the range of 6 to 7.5 through all of the purification steps. <span style="display: none" class="style-scope patent-text">[0028] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0029]" class="style-scope patent-text">
    
    [0029]
  </para-num> <div id="P-0029" num="0029" class="description-line style-scope patent-text">In other embodiments the method further comprises separating the different forms of PSMA protein, wherein the different forms of PSMA protein are monomeric, dimeric or other multimeric forms of PSMA. In some of these embodiments the different forms of PSMA protein are separated by size exclusion chromatography. <span style="display: none" class="style-scope patent-text">[0029] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0030]" class="style-scope patent-text">
    
    [0030]
  </para-num> <div id="P-0030" num="0030" class="description-line style-scope patent-text">In yet another aspect of the invention a method of identifying an agent which promotes or preserves dimeric association of PSMA protein by determining the amount of a form of PSMA protein in a sample prior to exposure to a candidate agent, exposing the sample to the candidate agent, determining the amount of the form of PSMA protein in the sample after the exposure, and comparing the amount of the form of PSMA protein in the sample prior to and after the exposure is provided. In some embodiments the form of PSMA protein is monomer or dimer. In other embodiments the form of PSMA can be another multimer form with three or more associated PSMA proteins. <span style="display: none" class="style-scope patent-text">[0030] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0031]" class="style-scope patent-text">
    
    [0031]
  </para-num> <div id="P-0031" num="0031" class="description-line style-scope patent-text">In another aspect of the invention a method of treating a subject to elicit or enhance an immune response to cells in the subject expressing PSMA, comprising administering to the subject an effective amount of any of the compositions given herein is provided. In some embodiments the expressed PSMA is expressed on the cell surface. In other embodiments the method further comprises administering one or more booster doses of a composition comprising PSMA protein. In some of these embodiments the composition comprising PSMA protein is a composition of PSMA protein dimer. In still other embodiments the booster dose composition further comprises an adjuvant. In yet other embodiments the booster dose composition can be any of the compositions provided herein. In still other embodiments the composition is administered by intravenous, intramuscular, subcutaneous, parenteral, spinal, intradermal or epidermal administration. In this aspect of the invention the subject has cancer or is at risk of having cancer. In some embodiments the subject has also been treated for cancer. In some embodiments the cancer is a primary tumor or is metastatic cancer. In a preferred embodiment the subject has prostate cancer. <span style="display: none" class="style-scope patent-text">[0031] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0032]" class="style-scope patent-text">
    
    [0032]
  </para-num> <div id="P-0032" num="0032" class="description-line style-scope patent-text">In another aspect of the invention a method of eliciting an immune response by administering to a subject an effective amount of any of the compositions provided is given. In some embodiments the method further comprises administering one or more booster doses of a composition comprising PSMA protein. In certain of these embodiments the composition comprising PSMA protein is a composition PSMA protein dimer. In still other embodiments the booster dose composition is any of the compositions given herein. In yet another embodiment the booster does compositions can also include an adjuvant. <span style="display: none" class="style-scope patent-text">[0032] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0033]" class="style-scope patent-text">
    
    [0033]
  </para-num> <div id="P-0033" num="0033" class="description-line style-scope patent-text">In other aspects of the invention kits which contain any of the compositions provided and instructions for use are provided. In some aspects the kit contains a multimeric composition provided herein, an adjuvant and instructions for mixing. In other aspects the kit includes one of the compositions provided herein, a diluent and instructions for mixing. In some embodiments the composition is provided in a vial or ampoule with a septum or a syringe. In other embodiments the composition is in lyophilized form. <span style="display: none" class="style-scope patent-text">[0033] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0034]" class="style-scope patent-text">
    
    [0034]
  </para-num> <div id="P-0034" num="0034" class="description-line style-scope patent-text">The compositions provided herein can further comprise a therapeutic agent (e.g., a cytokine, an anti-cancer agent, an adjuvant, etc.). In some embodiments the adjuvant is alum, monophosphoryl lipid A, a saponin, an immunostimulatory oligonucleotide, incomplete Freund's adjuvant, complete Freund's adjuvant, montanide, vitamin E, a water-in-oil emulsions prepared from a biodegradable oil, Quil A, a MPL and mycobacterial cell wall skeleton combination, ENHANZYN, CRL-1005, L-121, alpha-galactosylceramide or a combination thereof. <span style="display: none" class="style-scope patent-text">[0034] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0035]" class="style-scope patent-text">
    
    [0035]
  </para-num> <div id="P-0035" num="0035" class="description-line style-scope patent-text">In other embodiments the compositions provided can also include at least one buffer. Buffers include PBS (phosphate buffered saline), citric acid, sodium citrate, sodium acetate, acetic acid, sodium phosphate, phosphoric acid, sodium ascorbate, tartartic acid, maleic acid, glycine, sodium lactate, lactic acid, ascorbic acid, imidazole, sodium bicarbonate, carbonic acid, sodium succinate, succinic acid, histidine, sodium benzoate, benzoic acid and combinations thereof. <span style="display: none" class="style-scope patent-text">[0035] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0036]" class="style-scope patent-text">
    
    [0036]
  </para-num> <div id="P-0036" num="0036" class="description-line style-scope patent-text">In some embodiments the compositions provided further include a free amino acid. These free amino acids can be naturally or non-naturally occurring. In some embodiments the free amino acids are non-acidic free amino acids. Examples of non-acidic free amino acids include glycine, proline, isoleucine, leucine, alanine, arginine and combinations thereof. <span style="display: none" class="style-scope patent-text">[0036] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0037]" class="style-scope patent-text">
    
    [0037]
  </para-num> <div id="P-0037" num="0037" class="description-line style-scope patent-text">Compositions of PSMA protein multimers including a surfactant are also provided. Such surfactants include Tween20, Tween80, Triton X-100, dodecylmaltoside, cholic acid, CHAPS and combinations thereof. <span style="display: none" class="style-scope patent-text">[0037] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0038]" class="style-scope patent-text">
    
    [0038]
  </para-num> <div id="P-0038" num="0038" class="description-line style-scope patent-text">Also provided are compositions of PSMA protein multimers that comprise a cryoprotectant, an antioxidant, a preservative or a combination thereof. Examples of cryoprotectants include a sugar, a polyol, an amino acid, a polymer, an inorganic salt, an organic salt, trimethylamine N-oxide, sarcosine, betaine, gamma-aminobutyric acid, octapine, alanopine, strombine, dimethylsulfoxide and ethanol. When the cryoprotectant is a sugar the sugar can be sucrose, lactose, glucose, trehalose or maltose. In other embodiments when the cryoprotectant is a polyol the polyol can be inositol, ethylene glycol, glycerol, sorbitol, xylitol, mannitol or 2-methyl-2,4-pentane-diol. When the cryoprotectant is an amino acid the amino acid can be Na glutamate, proline, alpha-alanine, beta-alanine, glycine, lysine-HCl or 4-hydroxyproline. When the cryoprotectant is a polymer the polymer can be polyethylene glycol, dextran or polyvinylpyrrolidone. When the cryoprotectant is an inorganic salt the cryoprotectant can be sodium sulfate, ammonium sulfate, potassium phosphate, magnesium sulfate or sodium fluoride. Finally, when the cryoprotectant is an organic salt the organic salt can be sodium acetate, sodium polyethylene, sodium caprylate, proprionate, lactate or succinate. Examples of antioxidants that are part of these composition in some embodiments include ascorbic acid, an ascorbic acid derivative, butylated hydroxy anisole, butylated hydroxy toluene, alkylgallate, dithiothreitol (DTT), sodium meta-bisulfite, sodium bisulfite, sodium dithionite, sodium thioglycollic acid, sodium formaldehyde sulfoxylate, tocopherol, a tocopherol derivative, monothioglycerol and sodium sulfite. Ascorbic acid derivatives, in some embodiments, include ascorbylpalmitate, ascorbylstearate, sodium ascorbate and calcium ascorbate, while tocopherol derivatives include d-alpha tocopherol, d-alpha tocopherol acetate, dl-alpha tocopherol acetate, d-alpha tocopherol succinate, beta tocopherol, delta tocopherol, gamma tocopherol and d-alpha <span style="display: none" class="style-scope patent-text">[0038] </span> <figure-callout id="1000" label="tocopherol polyoxyethylene glycol" filenames="US20040161776A1-20040819-D00034.png,US20040161776A1-20040819-D00049.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">tocopherol polyoxyethylene glycol</a></figure-callout> 1000 succinate. Examples of preservatives present in the compositions in some embodiments include benzalkonium chloride, chlorobutanol, parabens, thimerosal, benzyl alcohol and phenol. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0039]" class="style-scope patent-text">
    
    [0039]
  </para-num> <div id="P-0039" num="0039" class="description-line style-scope patent-text">The composition in some embodiments are physiologically acceptable compositions. <span style="display: none" class="style-scope patent-text">[0039] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0040]" class="style-scope patent-text">
    
    [0040]
  </para-num> <div id="P-0040" num="0040" class="description-line style-scope patent-text">The compositions provided are, in some embodiments, in liquid or lyophilized form. <span style="display: none" class="style-scope patent-text">[0040] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0041]" class="style-scope patent-text">
    
    [0041]
  </para-num> <div id="P-0041" num="0041" class="description-line style-scope patent-text">In some other embodiments the compositions provided are sterile. <span style="display: none" class="style-scope patent-text">[0041] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0042]" class="style-scope patent-text">
    
    [0042]
  </para-num> <div id="P-0042" num="0042" class="description-line style-scope patent-text">In other aspects of the invention pharmaceutical compositions are provided which contain any of the compositions provided herein and a pharmaceutically acceptable carrier. <span style="display: none" class="style-scope patent-text">[0042] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0043]" class="style-scope patent-text">
    
    [0043]
  </para-num> <div id="P-0043" num="0043" class="description-line style-scope patent-text">The present invention also relates, in part, to antibodies or antigen-binding fragments thereof which specifically bind the extracellular domain of prostate specific membrane antigen (PSMA), compositions containing one or a combination of such antibodies or antigen-binding fragments thereof, hybridoma cell lines that produce the antibodies, and methods of using the antibodies or antigen-binding fragments thereof for cancer diagnosis and treatment. <span style="display: none" class="style-scope patent-text">[0043] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0044]" class="style-scope patent-text">
    
    [0044]
  </para-num> <div id="P-0044" num="0044" class="description-line style-scope patent-text">According to one aspect of the invention, isolated antibodies or an antigen-binding fragments thereof are provided. The antibodies or fragments thereof specifically bind to an extracellular domain of prostate specific membrane antigen (PSMA), and competitively inhibit the specific binding of a second antibody to its target epitope on PSMA. In a second aspect of the invention, isolated antibodies or antigen-binding fragments thereof are provided which specifically bind to an epitope on prostate specific membrane antigen (PSMA) defined by a second antibody. In each of the forgoing aspects of the invention, the second antibody is selected from the group consisting of PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11, PSMA 5.4, PSMA 7.1, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, Abgenix 4.248.2, Abgenix 4.360.3, Abgenix 4.7.1, Abgenix 4.4.1, Abgenix 4.177.3, Abgenix 4.16.1, Abgenix 4.22.3, Abgenix 4.28.3, Abgenix 4.40.2, Abgenix 4.48.3, Abgenix 4.49.1, Abgenix 4.209.3, Abgenix 4.219.3, Abgenix 4.288.1, Abgenix 4.333.1, Abgenix 4.54.1, Abgenix 4.153.1, Abgenix 4.232.3, Abgenix 4.292.3, Abgenix 4.304.1, Abgenix 4.78.1, Abgenix 4.152.1, and antibodies comprising (a) a heavy chain encoded by a nucleic acid molecule comprising the coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 2-7, and (b) a light chain encoded by a nucleic acid molecule comprising the coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 8-13. <span style="display: none" class="style-scope patent-text">[0044] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0045]" class="style-scope patent-text">
    
    [0045]
  </para-num> <div id="P-0045" num="0045" class="description-line style-scope patent-text">In certain embodiments, the antibody or antigen-binding fragment thereof is selected from the group consisting of PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11 PSMA 5.4, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, Abgenix 4.248.2, Abgenix 4.360.3, Abgenix 4.7.1, Abgenix 4.4.1, Abgenix 4.177.3, Abgenix 4.16.1, Abgenix 4.22.3, Abgenix 4.28.3, Abgenix 4.40.2, Abgenix 4.48.3, Abgenix 4.49.1, Abgenix 4.209.3, Abgenix 4.219.3, Abgenix 4.288.1, Abgenix 4.333.1, Abgenix 4.54.1, Abgenix 4.153.1, Abgenix 4.232.3, Abgenix 4.292.3, Abgenix 4.304.1, Abgenix 4.78.1, and Abgenix 4.152.1. In other embodiments, the antibody or antigen-binding fragment thereof is selected from the group consisting of antibodies comprising (a) a heavy chain encoded by a nucleic acid molecule comprising the coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 2-7, and (b) a light chain encoded by a nucleic acid molecule comprising the coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 8-13, and antigen-binding fragments thereof. <span style="display: none" class="style-scope patent-text">[0045] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0046]" class="style-scope patent-text">
    
    [0046]
  </para-num> <div id="P-0046" num="0046" class="description-line style-scope patent-text">In further embodiments, the antibody or antigen-binding fragments thereof is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least about 90% identical to the nucleotide sequence encoding the foregoing antibodies, preferably at least about 95% identical, more preferably at least about 97% identical, still more preferably at least about 98% identical, and most preferably is at least about 99% identical. <span style="display: none" class="style-scope patent-text">[0046] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0047]" class="style-scope patent-text">
    
    [0047]
  </para-num> <div id="P-0047" num="0047" class="description-line style-scope patent-text">In some embodiments of the foregoing aspects, antigen-binding fragments of the isolated antibodies are provided. The antigen-binding fragments include (a) a heavy chain variable region encoded by a nucleic acid molecule comprising the coding regions or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 14, 18, 22, 26 and 30, and (b) a light chain variable region encoded by a nucleic acid molecule comprising the coding region or region of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 16, 20, 24, 28 and 32. In other embodiments, the antigen-binding fragment includes (a) a heavy chain variable region comprising an amino acid sequence selected from the group consisting of amino acid sequences set forth as: SEQ ID NOs: 15, 19, 23, 27 and 31, and (b) a light chain variable region comprising an amino acid sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 17, 21, 25, 29 and 33. <span style="display: none" class="style-scope patent-text">[0047] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0048]" class="style-scope patent-text">
    
    [0048]
  </para-num> <div id="P-0048" num="0048" class="description-line style-scope patent-text">In a further embodiments of the invention, isolated antigen-binding fragments of antibodies, which include a CDR of the foregoing antigen-binding fragments are provided. Preferably the CDR is CDR3. <span style="display: none" class="style-scope patent-text">[0048] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0049]" class="style-scope patent-text">
    
    [0049]
  </para-num> <div id="P-0049" num="0049" class="description-line style-scope patent-text">According another aspect of the invention, expression vectors including an isolated nucleic acid molecule encoding the foregoing isolated antibodies or antigen-binding fragments is provided. Host cells transformed or transfected by these expression vectors also are provided. <span style="display: none" class="style-scope patent-text">[0049] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0050]" class="style-scope patent-text">
    
    [0050]
  </para-num> <div id="P-0050" num="0050" class="description-line style-scope patent-text">In certain embodiments, the antibody or antigen-binding fragment thereof is selected for its ability to bind live cells, such as a tumor cell or a prostate cell, preferably LNCaP cells. In other embodiments, the antibody or antigen-binding fragment thereof mediates cytolysis of cells expressing PSMA. Preferably cytolysis of cells expressing PSMA is mediated by effector cells or is complement mediated in the presence of effector cells. <span style="display: none" class="style-scope patent-text">[0050] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0051]" class="style-scope patent-text">
    
    [0051]
  </para-num> <div id="P-0051" num="0051" class="description-line style-scope patent-text">In other embodiments, the antibody or antigen-binding fragment thereof inhibits the growth of cells expressing PSMA. Preferably the antibody or antigen-binding fragment thereof does not require cell lysis to bind to the extracellular domain of PSMA. <span style="display: none" class="style-scope patent-text">[0051] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0052]" class="style-scope patent-text">
    
    [0052]
  </para-num> <div id="P-0052" num="0052" class="description-line style-scope patent-text">In further embodiments, the antibody or antigen-binding fragment thereof is selected from the group consisting of IgG1, IgG2, IgG3, IgG4, IgM, IgA1, IgA2, IgAsec, IgD, IgE or has immunoglobulin constant and/or variable domain of IgG1, IgG2, IgG3, IgG4, IgM, IgA1, IgA2, IgAsec, IgD or IgE. In other embodiments, the antibody is a bispecific or multispecific antibody. <span style="display: none" class="style-scope patent-text">[0052] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0053]" class="style-scope patent-text">
    
    [0053]
  </para-num> <div id="P-0053" num="0053" class="description-line style-scope patent-text">In still other embodiments, the antibody is a recombinant antibody, a polyclonal antibody, a monoclonal antibody, a humanized antibody or a chimeric antibody, or a mixture of these. In particularly preferred embodiments, the antibody is a human antibody, e.g., a monoclonal antibody, polyclonal antibody or a mixture of monoclonal and polyclonal antibodies. In still other embodiments, the antibody is a bispecific or multispecific antibody. <span style="display: none" class="style-scope patent-text">[0053] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0054]" class="style-scope patent-text">
    
    [0054]
  </para-num> <div id="P-0054" num="0054" class="description-line style-scope patent-text">Preferred antigen-binding fragments include a Fab fragment, a F(ab)<span style="display: none" class="style-scope patent-text">[0054] </span> <sub class="style-scope patent-text">2 </sub>fragment, and a Fv fragment CDR3. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0055]" class="style-scope patent-text">
    
    [0055]
  </para-num> <div id="P-0055" num="0055" class="description-line style-scope patent-text">In further embodiments, the isolated antibody or antigen-binding fragment is a monoclonal antibody produced by a hybridoma cell line selected from the group consisting of PSMA 3.7 (PTA-3257), PSMA 3.8, PSMA 3.9 (PTA-3258), PSMA 3.11 (PTA-3269), PSMA 5.4 (PTA-3268), PSMA 7.1 (PTA-3292), PSMA 7.3 (PTA-3293), PSMA 10.3 (PTA-3247), PSMA 1.8.3 (PTA-3906), PSMA A3.1.3 (PTA-3904), PSMA A3.3.1 (PTA-3905), Abgenix 4.248.2 (PTA-4427), Abgenix 4.360.3 (PTA-4428), Abgenix 4.7.1 (PTA-4429), Abgenix 4.4.1 (PTA-4556), Abgenix 4.177.3 (PTA-4557), Abgenix 4.16.1 (PTA-4357), Abgenix 4.22.3 (PTA-4358), Abgenix 4.28.3 (PTA-4359), Abgenix 4.40.2 (PTA-4360), Abgenix 4.48.3 (PTA-4361), Abgenix 4.49.1 (PTA-4362), Abgenix 4.209.3 (PTA-4365), Abgenix 4.219.3 (PTA-4366), Abgenix 4.288.1 (PTA-4367), Abgenix 4.333.1 (PTA-4368), Abgenix 4.54.1 (PTA-4363), Abgenix 4.153.1 (PTA-4388), Abgenix 4.232.3 (PTA-4389), Abgenix 4.292.3 (PTA-4390), Abgenix 4.304.1 (PTA-4391), Abgenix 4.78.1 (PTA-4652), and Abgenix 4.152.1(PTA-4653). <span style="display: none" class="style-scope patent-text">[0055] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0056]" class="style-scope patent-text">
    
    [0056]
  </para-num> <div id="P-0056" num="0056" class="description-line style-scope patent-text">In certain other embodiments, the antibody or antigen-binding fragment thereof binds to a conformational epitope and/or is internalized into a cell along with the prostate specific membrane antigen. In other embodiments, the isolated antibody or antigen-binding fragment thereof is bound to a label, preferably one selected from the group consisting of a fluorescent label, an enzyme label, a radioactive label, a nuclear magnetic resonance active label, a luminescent label, and a chromophore label. <span style="display: none" class="style-scope patent-text">[0056] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0057]" class="style-scope patent-text">
    
    [0057]
  </para-num> <div id="P-0057" num="0057" class="description-line style-scope patent-text">In still other embodiments, the isolated antibody or antigen-binding fragment thereof is bound to at least one therapeutic moiety, such as a drug, preferably a cytotoxic drug, a replication-selective virus, a toxin or a fragment thereof, or an enzyme or a fragment thereof. Preferred cytotoxic drug include: calicheamicin, esperamicin, methotrexate, doxorubicin, melphalan, chlorambucil, ARA-C, vindesine, mitomycin C, cis-platinum, etoposide, bleomycin, 5-fluorouracil, estramustine, vincristine, etoposide, doxorubicin, paclitaxel, docetaxel, <span style="display: none" class="style-scope patent-text">[0057] </span> <figure-callout id="10" label="dolastatin" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">dolastatin</a></figure-callout> 10, auristatin E and auristatin PHE. In other embodiments, the therapeutic moiety is an immunostimulatory or immunomodulating agent, preferably one selected from the group consisting of: a cytokine, chemokine and adjuvant. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0058]" class="style-scope patent-text">
    
    [0058]
  </para-num> <div id="P-0058" num="0058" class="description-line style-scope patent-text">In some embodiments, the antibodies or antigen-binding fragments of the invention specifically bind cell-surface PSMA and/or rsPSMA with a binding affinity of about 110<span style="display: none" class="style-scope patent-text">[0058] </span> <sup class="style-scope patent-text">9</sup>M or less. Preferably, the binding affinity is about 110<sup class="style-scope patent-text">10</sup>M or less, more preferably the binding affinity is about 110<sup class="style-scope patent-text">11</sup>M or less. In other embodiments the binding affinity is less than about 510<sup class="style-scope patent-text">10</sup>M. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0059]" class="style-scope patent-text">
    
    [0059]
  </para-num> <div id="P-0059" num="0059" class="description-line style-scope patent-text">In additional embodiments, the antibodies or antigen-binding fragments of the invention mediate specific cell killing of PSMA-expressing cells with an IC<span style="display: none" class="style-scope patent-text">[0059] </span> <sub class="style-scope patent-text">50</sub>s of less than about 110<sup class="style-scope patent-text">10</sup>M. Preferably the IC<sub class="style-scope patent-text">50</sub>s is less than about 110<sup class="style-scope patent-text">11</sup>M. More preferably the IC<sub class="style-scope patent-text">50</sub>s is less than about 110<sup class="style-scope patent-text">12</sup>M. In other embodiments the IC<sub class="style-scope patent-text">50</sub>s is less than about 1.510<sup class="style-scope patent-text">11</sup>M. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0060]" class="style-scope patent-text">
    
    [0060]
  </para-num> <div id="P-0060" num="0060" class="description-line style-scope patent-text">In yet other embodiments, the isolated antibody or antigen-binding fragment thereof is bound to a radioisotope. The radioisotope can emit  radiations,  radiations, or  radiations. Preferably the radioisotope is selected from the group consisting of <span style="display: none" class="style-scope patent-text">[0060] </span> <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">211 </sup>At, <sup class="style-scope patent-text">212</sup>Bi, <sup class="style-scope patent-text">213 </sup>Bi, <sup class="style-scope patent-text">186</sup>Rh, 188 <sup class="style-scope patent-text">177</sup>Lu, <sup class="style-scope patent-text">90</sup>Y, <sup class="style-scope patent-text">131</sup>I, <sup class="style-scope patent-text">67</sup>Cu, <sup class="style-scope patent-text">125</sup>I, <sup class="style-scope patent-text">123</sup>I, <sup class="style-scope patent-text">77</sup>Br, <sup class="style-scope patent-text">153</sup>Sm, <sup class="style-scope patent-text">166</sup>Ho, <sup class="style-scope patent-text">64</sup>Cu, <sup class="style-scope patent-text">212</sup>Pb, <sup class="style-scope patent-text">224</sup>Ra and <sup class="style-scope patent-text">223</sup>Ra. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0061]" class="style-scope patent-text">
    
    [0061]
  </para-num> <div id="P-0061" num="0061" class="description-line style-scope patent-text">According to another aspect of the invention, hybridoma cell lines are provided that produce an antibody selected from the group consisting of PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11, PSMA 5.4, PSMA 7.1, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, Abgenix 4.248.2, Abgenix 4.360.3, Abgenix 4.7.1, Abgenix 4.4.1, Abgenix 4.177.3, Abgenix 4.16.1, Abgenix 4.22.3, Abgenix 4.28.3, Abgenix 4.40.2, Abgenix 4.48.3, Abgenix 4.49.1, Abgenix 4.209.3, Abgenix 4.219.3, Abgenix 4.288.1, Abgenix 4.333.1, Abgenix 4.54.1, Abgenix 4.153.1, Abgenix 4.232.3, Abgenix 4.292.3, Abgenix 4.304.1, Abgenix 4.78.1 and Abgenix 4.152.1. In some embodiments, the hybridoma cell line is selected from the group consisting of PSMA 3.7 (PTA-3257), PSMA 3.8, PSMA 3.9 (PTA-3258), PSMA 3.11 (PTA-3269), PSMA 5.4 (PTA-3268), PSMA 7.1 (PTA-3292), PSMA 7.3 (PTA-3293), PSMA 10.3 (PTA-3247), PSMA 1.8.3 (PTA-3906), PSMA A3.1.3 (PTA-3904), PSMA A3.3.1 (PTA-3905), Abgenix 4.248.2 (PTA-4427), Abgenix 4.360.3 (PTA-4428), Abgenix 4.7.1 (PTA-4429), Abgenix 4.4.1 (PTA-4556), Abgenix 4.177.3 (PTA-4557), Abgenix 4.16.1 (PTA-4357), Abgenix 4.22.3 (PTA-4358), Abgenix 4.28.3 (PTA-4359), Abgenix 4.40.2 (PTA-4360), Abgenix 4.48.3 (PTA-4361), Abgenix 4.49.1 (PTA-4362), Abgenix 4.209.3 (PTA-4365), Abgenix 4.219.3 (PTA-4366), Abgenix 4.288.1 (PTA-4367), Abgenix 4.333.1 (PTA-4368), Abgenix 4.54.1 (PTA-4363), Abgenix 4.153.1 (PTA-4388), Abgenix 4.232.3 (PTA-4389), Abgenix 4.292.3 (PTA-4390), Abgenix 4.304.1 (PTA-4391), Abgenix 4.78.1 (PTA-4652), and Abgenix 4.152.1(PTA-4653). <span style="display: none" class="style-scope patent-text">[0061] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0062]" class="style-scope patent-text">
    
    [0062]
  </para-num> <div id="P-0062" num="0062" class="description-line style-scope patent-text">According to a further aspect of the invention, compositions are provided that include the foregoing antibodies or antigen-binding fragments thereof and a pharmaceutically acceptable carrier, excipient, or stabilizer. Other compositions include a combination of two or more of the foregoing antibodies or antigen-binding fragments thereof and a pharmaceutically acceptable carrier, excipient, or stabilizer. In some embodiments, the compositions also include an antitumor agent, an immunostimulatory agent, an immunomodulator, or a combination thereof. Preferred antitumor agents include a cytotoxic agent, an agent that acts on tumor neovasculature, or a combination thereof. Preferred immunomodulators include -interferon, -interferon, tumor necrosis factor- or a combination thereof. Preferred immunostimulatory agents include interleukin-2, immunostimulatory oligonucleotides, or a combination thereof. <span style="display: none" class="style-scope patent-text">[0062] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0063]" class="style-scope patent-text">
    
    [0063]
  </para-num> <div id="P-0063" num="0063" class="description-line style-scope patent-text">According to another aspect of the invention antibodies or antigen-binding fragments thereof that mediate antibody-dependent cellular cytotoxicity (ADCC) are provided. In some embodiments these antibodies or antigen-binding fragments thereof mediate ADCC of human prostate cancer cells. In other embodiments the antibodies are human antibodies. In still other embodiments the antibodies are capable of causing at least 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 50%, 75% or more cell lysis in vitro with an effector to target ratio of 5:1, 10:1, 15:1, 20:1, 25:1, 30:1, 40:1, 50:1 or more. In other embodiments these antibodies mediate more ADCC than control antibodies. <span style="display: none" class="style-scope patent-text">[0063] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0064]" class="style-scope patent-text">
    
    [0064]
  </para-num> <div id="P-0064" num="0064" class="description-line style-scope patent-text">According to another aspect of the invention, kits for detecting prostate cancer for diagnosis, prognosis or monitoring are provided. The kits include the foregoing isolated labeled antibody or antigen-binding fragment thereof, and one or more compounds for detecting the label. Preferably the label is selected from the group consisting of a fluorescent label, an enzyme label, a radioactive label, a nuclear magnetic resonance active label, a luminescent label, and a chromophore label. <span style="display: none" class="style-scope patent-text">[0064] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0065]" class="style-scope patent-text">
    
    [0065]
  </para-num> <div id="P-0065" num="0065" class="description-line style-scope patent-text">The invention in another aspect provides one or more of the foregoing isolated antibodies or antigen-binding fragments thereof packaged in lyophilized form, or packaged in an aqueous medium. <span style="display: none" class="style-scope patent-text">[0065] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0066]" class="style-scope patent-text">
    
    [0066]
  </para-num> <div id="P-0066" num="0066" class="description-line style-scope patent-text">In another aspect of the invention, methods for detecting the presence of PSMA, or a cell expressing PSMA, in a sample are provided. The methods include contacting the sample with any of the foregoing antibodies or antigen-binding fragments thereof which specifically bind to an extracellular domain of PSMA, for a time sufficient to allow the formation of a complex between the antibody or antigen-binding fragment thereof and PSMA, and detecting the PSMA-antibody complex or PSMA-antigen-binding fragment complex. The presence of a complex in the sample is indicative of the presence in the sample of PSMA or a cell expressing PSMA. <span style="display: none" class="style-scope patent-text">[0066] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0067]" class="style-scope patent-text">
    
    [0067]
  </para-num> <div id="P-0067" num="0067" class="description-line style-scope patent-text">In another aspect, the invention provides other methods for diagnosing a PSMA-mediated disease in a subject. The methods include administering to a subject suspected of having or previously diagnosed with PSMA-mediated disease an amount of any of the foregoing antibodies or antigen-binding fragments thereof which specifically bind to an extracellular domain of prostate specific membrane antigen. The method also includes allowing the formation of a complex between the antibody or antigen-binding fragment thereof and PSMA, and detecting the formation of the PSMA-antibody complex or PSMA-antigen-binding fragment antibody complex to the target epitope. The presence of a complex in the subject suspected of having or previously diagnosed with prostate cancer is indicative of the presence of a PSMA-mediated disease. <span style="display: none" class="style-scope patent-text">[0067] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0068]" class="style-scope patent-text">
    
    [0068]
  </para-num> <div id="P-0068" num="0068" class="description-line style-scope patent-text">In certain embodiments of the methods, the PSMA-mediated disease is prostate cancer. In other embodiments, the PSMA-mediated disease is a non-prostate cancer, such as those selected from the group consisting of bladder cancer including transitional cell carcinoma; pancreatic cancer including pancreatic duct carcinoma; lung cancer including non-small cell lung carcinoma; kidney cancer including conventional renal cell carcinoma; sarcoma including soft tissue sarcoma; breast cancer including breast carcinoma; brain cancer including glioblastoma multiforme; neuroendocrine carcinoma; colon cancer including colonic carcinoma; testicular cancer including testicular embryonal carcinoma; and melanoma including malignant melanoma. <span style="display: none" class="style-scope patent-text">[0068] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0069]" class="style-scope patent-text">
    
    [0069]
  </para-num> <div id="P-0069" num="0069" class="description-line style-scope patent-text">In preferred embodiments of the foregoing methods, the antibody or antigen-binding fragment thereof is labeled. In other embodiments of the foregoing methods, a second antibody is administered to detect the first antibody or antigen-binding fragment thereof. <span style="display: none" class="style-scope patent-text">[0069] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0070]" class="style-scope patent-text">
    
    [0070]
  </para-num> <div id="P-0070" num="0070" class="description-line style-scope patent-text">In a further aspect of the invention, methods for assessing the prognosis of a subject with a PSMA-mediated disease are provided. The methods include administering to a subject suspected of having or previously diagnosed with PSMA-mediated disease an effective amount of an antibody or antigen-binding fragment thereof according to claim A1 or B1, allowing the formation of a complex between the antibody or antigen-binding fragment thereof and PSMA, and detecting the formation of the complex to the target epitope. The amount of the complex in the subject suspected of having or previously diagnosed with PSMA-mediated disease is indicative of the prognosis. <span style="display: none" class="style-scope patent-text">[0070] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0071]" class="style-scope patent-text">
    
    [0071]
  </para-num> <div id="P-0071" num="0071" class="description-line style-scope patent-text">In another aspect of the invention, methods for assessing the effectiveness of a treatment of a subject with a PSMA-mediated disease are provided. The methods include administering to a subject suspected treated for a PSMA-mediated disease an effective amount of the foregoing antibodies or antigen-binding fragments thereof, allowing the formation of a complex between the antibody or antigen-binding fragment thereof and PSMA, and detecting the formation of the complex to the target epitope. The amount of the complex in the subject suspected of having or previously diagnosed with PSMA-mediated disease is indicative of the effectiveness of the treatment. <span style="display: none" class="style-scope patent-text">[0071] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0072]" class="style-scope patent-text">
    
    [0072]
  </para-num> <div id="P-0072" num="0072" class="description-line style-scope patent-text">In certain embodiments of these two aspects of the invention, the PSMA-mediated disease is prostate cancer. In other embodiments, the PSMA-mediated disease is a non-prostate cancer. In those embodiments, the non-prostate cancer preferably is selected from the group consisting of bladder cancer including transitional cell carcinoma; pancreatic cancer including pancreatic duct carcinoma; lung cancer including non-small cell lung carcinoma; kidney cancer including conventional renal cell carcinoma; sarcoma including soft tissue sarcoma; breast cancer including breast carcinoma; brain cancer including glioblastoma multiforme; neuroendocrine carcinoma; colon cancer including colonic carcinoma; testicular cancer including testicular embryonal carcinoma; and melanoma including malignant melanoma. In still other embodiments, the antibody or antigen-binding fragment thereof is labeled. In further embodiments, a second antibody is administered to detect the first antibody or antigen-binding fragment thereof. <span style="display: none" class="style-scope patent-text">[0072] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0073]" class="style-scope patent-text">
    
    [0073]
  </para-num> <div id="P-0073" num="0073" class="description-line style-scope patent-text">According to yet another aspect of the invention, methods for inhibiting the growth of a cell expressing PSMA are provided. The methods include contacting a cell expressing PSMA with an amount of at least one of the foregoing antibodies or antigen-binding fragments thereof which specifically binds to an extracellular domain of PSMA effective to inhibit the growth of the cell expressing PSMA. <span style="display: none" class="style-scope patent-text">[0073] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0074]" class="style-scope patent-text">
    
    [0074]
  </para-num> <div id="P-0074" num="0074" class="description-line style-scope patent-text">According to another aspect of the invention, methods for inducing cytolysis of a cell expressing PSMA are provided. The methods include contacting a cell expressing PSMA with an amount of at least one of the foregoing antibodies or antigen-binding fragments thereof which specifically binds to an extracellular domain of PSMA effective to induce cytolysis of the cell expressing PSMA. In certain embodiments, the cytolysis occurs in the presence of an effector cell. In other embodiments, the cytolysis is complement mediated. <span style="display: none" class="style-scope patent-text">[0074] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0075]" class="style-scope patent-text">
    
    [0075]
  </para-num> <div id="P-0075" num="0075" class="description-line style-scope patent-text">According to still another aspect of the invention, methods for treating or preventing a PSMA-mediated disease are provided. The methods include administering to a subject having a PSMA-mediated disease an effective amount of at least one of the forgoing antibodies or antigen-binding fragments thereof to treat or prevent the PSMA-mediated disease. In some embodiments, the PSMA-mediated disease is a cancer, such as prostate cancer or a non-prostate cancer (including the nonprostate cancers described elsewhere herein). <span style="display: none" class="style-scope patent-text">[0075] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0076]" class="style-scope patent-text">
    
    [0076]
  </para-num> <div id="P-0076" num="0076" class="description-line style-scope patent-text">In yet a further aspect of the invention, methods for treating or preventing a PSMA-mediated disease are provided. The methods include administering to a subject having a PSMA-mediated disease or at risk of having a PSMA-mediated disease an amount of at least one of the foregoing antibodies or antigen-binding fragments thereof effective to treat or prevent the PSMA-mediated disease. <span style="display: none" class="style-scope patent-text">[0076] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0077]" class="style-scope patent-text">
    
    [0077]
  </para-num> <div id="P-0077" num="0077" class="description-line style-scope patent-text">In some embodiments, the PSMA-mediated disease is a cancer, such as prostate cancer or a non-prostate cancer (including the nonprostate cancers described elsewhere herein). <span style="display: none" class="style-scope patent-text">[0077] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0078]" class="style-scope patent-text">
    
    [0078]
  </para-num> <div id="P-0078" num="0078" class="description-line style-scope patent-text">In other embodiments, the method also includes administering another therapeutic agent to treat or prevent the PSMA-mediated disease at any time before, during or after the administration of the antibody or antigen-binding fragment thereof. In some of these embodiments, the therapeutic agent is a vaccine, and preferably the vaccine immunizes the subject against PSMA. <span style="display: none" class="style-scope patent-text">[0078] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0079]" class="style-scope patent-text">
    
    [0079]
  </para-num> <div id="P-0079" num="0079" class="description-line style-scope patent-text">In still other embodiments, the antibody or antigen-binding fragment thereof is bound to at least one therapeutic moiety, preferably a cytotoxic drug, a drug which acts on the tumor neovasculature and combinations thereof. Preferred cytotoxic drugs are selected from the group consisting of: calicheamicin, esperamicin, methotrexate, doxorubicin, melphalan, chlorambucil, ARA-C, vindesine, mitomycin C, cis-platinum, etoposide, bleomycin, 5-fluorouracil, estramustine, vincristine, etoposide, doxorubicin, paclitaxel, docetaxel, <span style="display: none" class="style-scope patent-text">[0079] </span> <figure-callout id="10" label="dolastatin" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">dolastatin</a></figure-callout> 10, auristatin E and auristatin PHE. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0080]" class="style-scope patent-text">
    
    [0080]
  </para-num> <div id="P-0080" num="0080" class="description-line style-scope patent-text">In other embodiments, the antibody or antigen-binding fragment thereof is bound to a radioisotope and the radiations emitted by the radioisotope is selected from the group consisting of ,  and  radiations. Preferably, the radioisotope is selected from the group consisting of <span style="display: none" class="style-scope patent-text">[0080] </span> <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">211</sup>At, <sup class="style-scope patent-text">212</sup>Bi, <sup class="style-scope patent-text">213</sup>Bi, <sup class="style-scope patent-text">186</sup>Rh, <sup class="style-scope patent-text">188</sup>Rh, <sup class="style-scope patent-text">177</sup>Lu, <sup class="style-scope patent-text">90</sup>Y, <sup class="style-scope patent-text">131</sup>I, <sup class="style-scope patent-text">67</sup>Cu, <sup class="style-scope patent-text">125</sup>I, <sup class="style-scope patent-text">123</sup>I, <sup class="style-scope patent-text">77</sup>Br, <sup class="style-scope patent-text">153</sup>Sm, <sup class="style-scope patent-text">166</sup>Ho, <sup class="style-scope patent-text">64</sup>Cu, <sup class="style-scope patent-text">212</sup>Pb, <sup class="style-scope patent-text">224</sup>Ra and <sup class="style-scope patent-text">223</sup>Ra. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0081]" class="style-scope patent-text">
    
    [0081]
  </para-num> <div id="P-0081" num="0081" class="description-line style-scope patent-text">The present invention provides methods for modulating at least one enzymatic activity of PSMA. As used in preferred embodiments of the methods, modulating an enzymatic activity of PSMA means enhancing or inhibiting the enzymatic activity. Thus in certain aspects of the invention, methods for inhibiting an enzymatic activity of PSMA are provided, and in other aspects of the invention, methods for enhancing an enzymatic activity of PSMA are provided. The terms enhancing and inhibiting in this context indicate that the enzymatic activity of PSMA is enhanced or inhibited in the presence of an antibody that specifically binds PSMA, or antigen-binding fragment thereof, relative to the level of activity in the absence of such an antibody or antigen-binding fragment thereof. Enzymatic activities of PSMA include folate hydrolase activity, N-acetylated -linked acidic dipeptidase (NAALADase) activity, dipeptidyl dipeptidase IV activity and -glutamyl hydrolase activity. <span style="display: none" class="style-scope patent-text">[0081] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0082]" class="style-scope patent-text">
    
    [0082]
  </para-num> <div id="P-0082" num="0082" class="description-line style-scope patent-text">Thus the invention in another aspect provides methods for modulating folate hydrolase activity. In certain embodiments of these methods, the activity is inhibited and in other embodiments, the activity is enhanced. The methods include contacting a folate hydrolase polypeptide with an amount of the foregoing isolated antibody or antigen-binding fragment thereof, under conditions wherein the isolated antibody or antigen-binding fragment thereof modulates the folate hydrolase activity. The folate hydrolase polypeptide can be isolated, contained in a sample such as a cell, a cell homogenate, a tissue, or a tissue homogenate, or contained in an organism. The organism preferably is an animal, particularly preferably a mammal. <span style="display: none" class="style-scope patent-text">[0082] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0083]" class="style-scope patent-text">
    
    [0083]
  </para-num> <div id="P-0083" num="0083" class="description-line style-scope patent-text">In another aspect of the invention, methods for modulating N-acetylated -linked acidic dipeptidase (NAALADase) activity are provided. In certain embodiments of these methods, the activity is inhibited and in other embodiments, the activity is enhanced. The methods include contacting a NAALADase polypeptide with an amount of the foregoing isolated antibody or antigen-binding fragment thereof under conditions wherein the isolated antibody or antigen-binding fragment thereof modulates NAALADase activity. The NAALADase polypeptide can be isolated, contained in a sample such as a cell, a cell homogenate, a tissue, or a tissue homogenate, or contained in an organism. The organism preferably is an animal, particularly preferably a mammal. <span style="display: none" class="style-scope patent-text">[0083] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0084]" class="style-scope patent-text">
    
    [0084]
  </para-num> <div id="P-0084" num="0084" class="description-line style-scope patent-text">In yet another aspect of the invention, methods for modulating dipeptidyl dipeptidase IV activity are provided. In certain embodiments of these methods, the activity is inhibited and in other embodiments, the activity is enhanced. The methods include contacting a dipeptidyl dipeptidase IV polypeptide with an amount of the foregoing isolated antibody or antigen-binding fragment thereof under conditions wherein the isolated antibody or antigen-binding fragment thereof modulates dipeptidyl dipeptidase IV activity. The dipeptidyl dipeptidase IV polypeptide can be isolated, contained in a sample such as a cell, a cell homogenate, a tissue, or a tissue homogenate, or contained in an organism. The organism preferably is an animal, particularly preferably a mammal. <span style="display: none" class="style-scope patent-text">[0084] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0085]" class="style-scope patent-text">
    
    [0085]
  </para-num> <div id="P-0085" num="0085" class="description-line style-scope patent-text">In yet another aspect of the invention, methods for modulating -glutamyl hydrolase activity are provided. In certain embodiments of these methods, the activity is inhibited and in other embodiments, the activity is enhanced. The methods include contacting a -glutamyl hydrolase polypeptide with an amount of the foregoing isolated antibody or antigen-binding fragment thereof under conditions wherein the isolated antibody or antigen-binding fragment thereof modulates -glutamyl hydrolase activity. The -glutamyl hydrolase polypeptide can be isolated, contained in a sample such as a cell, a cell homogenate, a tissue, or a tissue homogenate, or contained in an organism. The organism preferably is an animal, particularly preferably a mammal. <span style="display: none" class="style-scope patent-text">[0085] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0086]" class="style-scope patent-text">
    
    [0086]
  </para-num> <div id="P-0086" num="0086" class="description-line style-scope patent-text">Methods of specific delivery of at least one therapeutic agent to PSMA-expressing cells are provided according to another aspect of the invention. The methods include administering an effective amount of at least one of the foregoing antibodies or antigen-binding fragments thereof conjugated to the at least one therapeutic agent. In some embodiments, the therapeutic agent is a nucleic acid molecule, an antitumor drug, a toxin or a fragment thereof, an enzyme or a fragment thereof, a replication-selective virus, or an immunostimulatory or immunomodulating agent. Preferred antitumor drugs include cytotoxic drugs, drugs which act on the tumor neovasculature and combinations thereof. Preferred cytotoxic drugs include calicheamicin, esperamicin, methotrexate, doxorubicin, melphalan, chlorambucil, ARA-C, vindesine, mitomycin C, cis-platinum, etoposide, bleomycin, 5-fluorouracil, estramustine, vincristine, etoposide, doxorubicin, paclitaxel, docetaxel, <span style="display: none" class="style-scope patent-text">[0086] </span> <figure-callout id="10" label="dolastatin" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">dolastatin</a></figure-callout> 10, auristatin E and auristatin PHE. Preferred immunostimulatory or immunomodulating agent included cytokines, chemokines and adjuvants. </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0087]" class="style-scope patent-text">
    
    [0087]
  </para-num> <div id="P-0087" num="0087" class="description-line style-scope patent-text">In still another aspect of the invention, isolated antibodies that selectively bind a PSMA protein multimer are provided. In preferred embodiments, the PSMA protein multimer is a dimer, and preferably at least one of the PSMA proteins forming the multimer is a recombinant, soluble PSMA (rsPSMA) polypeptide. Preferably the rsPSMA polypeptide consists essentially of amino acids 44-750 of SEQ ID NO: 1. <span style="display: none" class="style-scope patent-text">[0087] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0088]" class="style-scope patent-text">
    
    [0088]
  </para-num> <div id="P-0088" num="0088" class="description-line style-scope patent-text">In a further aspect of the invention, isolated antibodies are provided that selectively bind a PSMA protein multimer and modulate one or more enzymatic activities of the PSMA protein multimer. As used in preferred embodiments of this aspect of the invention, modulating an enzymatic activity of a PSMA multimer means enhancing or inhibiting the enzymatic activity. Thus in certain aspects of the invention, antibodies that inhibit an enzymatic activity of PSMA multimers are provided, and in other aspects of the invention, antibodies that inhibit an enzymatic activity of PSMA multimers are provided. The terms enhancing and inhibiting in this context indicate that the enzymatic activity of a PSMA multimer is enhanced or inhibited in the presence of an antibody that specifically binds the PSMA multimers, or antigen-binding fragment thereof, relative to the level of activity in the absence of such an antibody or antigen-binding fragment thereof. In some embodiments, the enzymatic activity is selected from the group consisting of folate hydrolase activity, NAALADase activity, dipeptidyl dipeptidase IV activity and -glutamyl hydrolase activity. In other embodiments, the enzymatic activity is in the extracellular domain of the PSMA molecule. In still other embodiments, the antibody or antigen-binding fragment thereof specifically binds to an extracellular domain of PSMA. <span style="display: none" class="style-scope patent-text">[0088] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0089]" class="style-scope patent-text">
    
    [0089]
  </para-num> <div id="P-0089" num="0089" class="description-line style-scope patent-text">In a further aspect, an isolated antibody or antigen-binding fragment thereof is provided that selectively binds a PSMA protein multimer. In this aspect, the isolated antibody is raised by immunizing an animal with a preparation comprising a PSMA protein multimer. Preferred preparations used in raising the antibody include those having at least about 10%, 20%, 30%, 40%, 50%, 75%, 90%, or 95% PSMA protein multimer. Preferably the PSMA protein multimer is a dimer. <span style="display: none" class="style-scope patent-text">[0089] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0090]" class="style-scope patent-text">
    
    [0090]
  </para-num> <div id="P-0090" num="0090" class="description-line style-scope patent-text">In yet another aspect of the invention, compositions are provided that include one or more of the foregoing isolated antibodies, and an immunostimulatory molecule, such as an adjuvant and/or and a cytokine. Preferably the immunostimulatory molecule is IL-2 or an immunostimulatory oligonucleotide. In certain embodiments, the foregoing compositions also include a pharmaceutically-acceptable carrier. <span style="display: none" class="style-scope patent-text">[0090] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0091]" class="style-scope patent-text">
    
    [0091]
  </para-num> <div id="P-0091" num="0091" class="description-line style-scope patent-text">The invention also includes methods for inducing an immune response, including administering to a subject in need of such treatment an effective amount of the foregoing isolated antibodies or compositions. <span style="display: none" class="style-scope patent-text">[0091] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0092]" class="style-scope patent-text">
    
    [0092]
  </para-num> <div id="P-0092" num="0092" class="description-line style-scope patent-text">The invention provides, in another aspect, isolated antibodies or antigen-binding fragments thereof that selectively bind a PSMA protein multimer and modulate at least one enzymatic activity of PSMA. As used in preferred embodiments of this aspect of the invention, modulating an enzymatic activity of a PSMA means enhancing or inhibiting the enzymatic activity. Thus in certain aspects of the invention, antibodies that inhibit an enzymatic activity of PSMA are provided, and in other aspects of the invention, antibodies that inhibit an enzymatic activity of PSMA are provided. The terms enhancing and inhibiting in this context indicate that the enzymatic activity of PSMA is enhanced or inhibited in the presence of an antibody that specifically binds PSMA, or antigen-binding fragment thereof, relative to the level of activity in the absence of such an antibody or antigen-binding fragment thereof. The enzyme, in certain embodiments, is selected from the group consisting of hydrolases and peptidases. Preferred hydrolases include folate hydrolase and -glutamyl hydrolase. In a particularly preferred embodiment of PSMA inhibition, the hydrolase is folate hydrolase and the antibody is mAb 5.4 or mAb 3.9. Preferred peptidases include NAALADase and dipeptidyl dipeptidase IV. In some embodiments, the enzyme is active in cancer cells and has lesser activity in normal cells than in cancer cells or, preferably, no activity in normal cells. In preferred embodiments, the cancer cells in which the enzyme is active are prostate cancer cells. Compositions including the foregoing isolated antibodies or antigen-binding fragments thereof, and a pharmaceutically acceptable carrier, also are provided by the invention. <span style="display: none" class="style-scope patent-text">[0092] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0093]" class="style-scope patent-text">
    
    [0093]
  </para-num> <div id="P-0093" num="0093" class="description-line style-scope patent-text">In another aspect of the invention, compositions are provided that include an isolated PSMA protein multimer. Preferably the PSMA protein multimer is a dimer. In certain embodiments, the compositions include at least about 10%, 20%, 30%, 40%, 50%, 75%, 90%, or 95% PSMA protein multimer. In other embodiments, the PSMA protein multimer comprises noncovalently associated PSMA proteins. The PSMA proteins preferably are noncovalently associated under nondenaturing conditions. <span style="display: none" class="style-scope patent-text">[0093] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0094]" class="style-scope patent-text">
    
    [0094]
  </para-num> <div id="P-0094" num="0094" class="description-line style-scope patent-text">In certain embodiments of the foregoing compositions, at least one of the PSMA proteins forming the multimer is a recombinant, soluble PSMA (rsPSMA) polypeptide. In other embodiments, the PSMA protein multimer is reactive with a conformation-specific antibody that specifically recognizes PSMA. Preferably, the PSMA protein multimer comprises PSMA proteins in a native conformation and/or the PSMA multimer is enzymatically active. In preferred embodiments, the enzymatic activity is folate hydrolase activity, NAALADase activity, dipeptidyl dipeptidase IV activity and/or -glutamyl hydrolase activity. <span style="display: none" class="style-scope patent-text">[0094] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0095]" class="style-scope patent-text">
    
    [0095]
  </para-num> <div id="P-0095" num="0095" class="description-line style-scope patent-text">In still other embodiments, the foregoing compositions also include an adjuvant and/or a cytokine or other immunostimulatory molecule. Preferred cytokines include IL-2, IL-12, IL-18 and GM-CSF. In further embodiments, the foregoing compositions also include a pharmaceutically acceptable carrier. <span style="display: none" class="style-scope patent-text">[0095] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0096]" class="style-scope patent-text">
    
    [0096]
  </para-num> <div id="P-0096" num="0096" class="description-line style-scope patent-text">According to yet another aspect of the invention, methods for inducing an immune response are provided. The methods include administering to a subject in need of such treatment an effective amount of one or more of the foregoing compositions. <span style="display: none" class="style-scope patent-text">[0096] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0097]" class="style-scope patent-text">
    
    [0097]
  </para-num> <div id="P-0097" num="0097" class="description-line style-scope patent-text">In a further aspect, the invention includes isolated recombinant soluble PSMA (rsPSMA) protein multimers, and isolated rsPSMA protein dimers. In some embodiments, the dimer includes noncovalently associated rsPSMA proteins, and preferably the rsPSMA proteins are noncovalently associated under nondenaturing conditions. In other embodiments, the isolated rsPSMA dimer is reactive with a conformation-specific antibody that specifically recognizes PSMA. <span style="display: none" class="style-scope patent-text">[0097] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0098]" class="style-scope patent-text">
    
    [0098]
  </para-num> <div id="P-0098" num="0098" class="description-line style-scope patent-text">In a certain preferred embodiment, the isolated rsPSMA dimer is enzymatically active, with the enzymatic activity selected from the group consisting of folate hydrolase activity, NAALADase activity, dipeptidyl dipeptidase IV activity and -glutamyl hydrolase activity. <span style="display: none" class="style-scope patent-text">[0098] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0099]" class="style-scope patent-text">
    
    [0099]
  </para-num> <div id="P-0099" num="0099" class="description-line style-scope patent-text">In still another aspect of the invention, methods of screening for a candidate agent that modulates at least one enzymatic activity of a PSMA enzyme are provided. As used in preferred embodiments of the methods, modulating an enzymatic activity of PSMA means enhancing or inhibiting the enzymatic activity. Thus in certain aspects of the invention, methods for screening for a candidate agent that inhibits an enzymatic activity of PSMA are provided, and in other aspects of the invention, methods for screening for a candidate agent that enhances an enzymatic activity of PSMA are provided. The terms enhancing and inhibiting in this context indicate that the enzymatic activity of PSMA is enhanced or inhibited in the presence of a candidate agent relative to the level of activity in the absence of such an agent. The methods include mixing the candidate agent with an isolated PSMA protein multimer to form a reaction mixture, followed by adding a substrate for the PSMA enzyme to the reaction mixture, and determining the amount of a product formed from the substrate by the PSMA enzyme. A change in the amount of product formed in comparison to a control is indicative of an agent capable of modulating at least one enzymatic activity of the PSMA enzyme. A decrease in the amount of product formed in comparison to a control is indicative of an agent capable of inhibiting at least one enzymatic activity of the PSMA enzyme. An increase in the amount of product formed in comparison to a control is indicative of an agent capable of enhancing at least one enzymatic activity of the PSMA enzyme. In some embodiments the PSMA enzyme is selected from the group consisting of NAALADase, folate hydrolase, dipeptidyl dipeptidase IV and -glutamyl hydrolase. In other embodiments the PSMA multimer comprises recombinant, soluble PSMA. In yet other embodiments the candidate agent is selected from the group consisting of an antibody, a small organic compound, or a peptide. <span style="display: none" class="style-scope patent-text">[0099] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0100]" class="style-scope patent-text">
    
    [0100]
  </para-num> <div id="P-0100" num="0100" class="description-line style-scope patent-text">In another aspect of the invention, candidate agents that modulate at least one enzymatic activity of PSMA are provided. The candidate agents are identified according to the foregoing methods. Thus in certain aspects of the invention, candidate agents that inhibit an enzymatic activity of PSMA are provided, and in other aspects of the invention, candidate agents that enhance an enzymatic activity of PSMA are provided. In certain embodiments, the agent is selected from a combinatorial antibody library, a combinatorial protein library, or a small organic molecule library. <span style="display: none" class="style-scope patent-text">[0100] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0101]" class="style-scope patent-text">
    
    [0101]
  </para-num> <div id="P-0101" num="0101" class="description-line style-scope patent-text">The invention also provides methods for identifying compounds that promote dissociation of PSMA dimers. The methods include contacting a PSMA dimer with a compound under conditions that do not promote dissociation of the PSMA dimer in the absence of the compound, measuring the amount of PSMA monomer and/or dimer; and comparing the amount of PSMA monomer and/or dimer measured in the presence of the compound with that observed in the absence of the compound. An increase in the amount of PSMA monomer measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. A decrease in the amount of PSMA dimer measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. When the amounts of PSMA monomer and PSMA dimer are measured, the methods can include calculating a ratio of PSMA monomer to PSMA dimer and comparing the ratio obtained in the presence of the compound with that obtained in the absence of the compound. In such methods, an increase in the ratio measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. <span style="display: none" class="style-scope patent-text">[0101] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0102]" class="style-scope patent-text">
    
    [0102]
  </para-num> <div id="P-0102" num="0102" class="description-line style-scope patent-text">The use of the foregoing compositions, molecules and agents in the preparation of medicaments also is provided. In preferred embodiments, the medicaments are useful in the treatment of conditions related to hyperproliferative diseases including cancer, and diseases of inappropriate NAALADase activity, folate hydrolase activity, dipeptidyl dipeptidase IV activity and/or -glutamyl hydrolase activity. <span style="display: none" class="style-scope patent-text">[0102] </span> </div>
      </li> <li class="style-scope patent-text"> <para-num num="[0103]" class="style-scope patent-text">
    
    [0103]
  </para-num> <div id="P-0103" num="0103" class="description-line style-scope patent-text">These and other aspects of the invention will be described in further detail in connection with the detailed description of the invention.<span style="display: none" class="style-scope patent-text">[0103] </span> </div>
    </li> </summary-of-invention>
    
    
    <heading class="style-scope patent-text">BRIEF DESCRIPTION OF THE DRAWINGS </heading>
    <li class="style-scope patent-text"> <para-num num="[0104]" class="style-scope patent-text">
    
    [0104]
  </para-num> <div id="P-0104" num="0104" class="description-line style-scope patent-text">FIG. 1 depicts PSMA reactivity of mAbs as determined by flow cytometry. Anti-PSMA mAbs (3.7, 3.9, 3.11, 3.12, 5.4, and 10.3) incubated with either parental 3T3 cells (denoted by black lines) or 3T3 cells engineered to express cell-surface PSMA (3T3-PSMA; gray lines). <span style="display: none" class="style-scope patent-text">[0104]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0105]" class="style-scope patent-text">
    
    [0105]
  </para-num> <div id="P-0105" num="0105" class="description-line style-scope patent-text">FIG. 2 shows a digitized image of immunoprecipitation of PSMA by mAbs. Lysates from 3T3-PSMA cells or parental 3T3 cells were incubated with each mAb and then precipitated using Protein A/G agarose beads. After washing, proteins were resolved on a polyacrylamide gel, blotted onto nitrocellulose membranes and visualized using the MAB544 anti-PSMA mAb. <span style="display: none" class="style-scope patent-text">[0105]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0106]" class="style-scope patent-text">
    
    [0106]
  </para-num> <div id="P-0106" num="0106" class="description-line style-scope patent-text">FIG. 3 shows the recognition of non-denatured PSMA by several PSMA antibodies that recognize PSMA conformation. <span style="display: none" class="style-scope patent-text">[0106]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0107]" class="style-scope patent-text">
    
    [0107]
  </para-num> <div id="P-0107" num="0107" class="description-line style-scope patent-text">FIG. 4 is a digitized image of a Western blot that shows the recognition of denatured PSMA by two PSMA antibodies and shows that antibodies that recognize PSMA conformation do not recognize denatured PSMA. <span style="display: none" class="style-scope patent-text">[0107]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0108]" class="style-scope patent-text">
    
    [0108]
  </para-num> <div id="P-0108" num="0108" class="description-line style-scope patent-text">FIG. 5 is a digitized image of a polyacrylamide gel that shows an analysis of purified recombinant, soluble PSMA (rsPSMA) and of full-length PSMA from 3T3 cells (3T3 PSMA) or LNCaP cells (LNCaP PSMA) by reduced and non-reduced SDS-PAGE. <span style="display: none" class="style-scope patent-text">[0108]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0109]" class="style-scope patent-text">
    
    [0109]
  </para-num> <div id="P-0109" num="0109" class="description-line style-scope patent-text">FIG. 6 provides the results for the determination of the dimeric structure of PSMA. FIG. 6A is a digitized image of a polyacrylamide gel that depicts a Blue Native PAGE analysis of purified recombinant, soluble PSMA (Purified rsPSMA) and of full-length PSMA extracted from 3T3 cells (3T3 PSMA) or LNCaP cells (LNCaP PSMA). FIG. 6B shows the results of the analytical size exclusion chromatography (SEC) of purified rsPSMA in neutral PBS buffer. The arrows indicate the retention times of protein standards. The retention time of 260 kDa for rsPSMA is consistent with that of a homodimer. <span style="display: none" class="style-scope patent-text">[0109]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0110]" class="style-scope patent-text">
    
    [0110]
  </para-num> <div id="P-0110" num="0110" class="description-line style-scope patent-text">FIG. 7 illustrates that the dimeric but not monomeric rsPSMA (also referred to as PSMA<span style="display: none" class="style-scope patent-text">[0110]</span> <sub class="style-scope patent-text">ECTO</sub>) is enzymatically active. Dimeric and monomeric PSMA were tested for folate hydrolase activity (FIG. 7A) and NAALADase activity (FIG. 7B). The background activity observed for PSMA monomer is consistent with residual amount (approximately 4%) of dimer present in the preparation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0111]" class="style-scope patent-text">
    
    [0111]
  </para-num> <div id="P-0111" num="0111" class="description-line style-scope patent-text">FIG. 8 shows the effect of four antibodies (mAb 3.9, mAb 5.4, mAb 7.3 and mAb J591) on the enzymatic activity of folate hydrolase through measuring the rate of cleavage of glutamate from methotrexate di-gamma glutamate by folate hydrolase present in 0.0002 <span style="display: none" class="style-scope patent-text">[0111]</span> <figure-callout id="7" label="g rsPSMA #" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">g rsPSMA #</a></figure-callout>7. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0112]" class="style-scope patent-text">
    
    [0112]
  </para-num> <div id="P-0112" num="0112" class="description-line style-scope patent-text">FIG. 9 shows the effect of four antibodies (mAb 3.9, mAb 5.4, mAb 7.3 and mAb J591) on the enzymatic activity of folate hydrolase through measuring the rate of cleavage of glutamate from methotrexate di-gamma glutamate by folate hydrolase present in 0.0002 <span style="display: none" class="style-scope patent-text">[0112]</span> <figure-callout id="8" label="g rsPSMA #" filenames="US20040161776A1-20040819-D00026.png,US20040161776A1-20040819-D00036.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">g rsPSMA #</a></figure-callout>8. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0113]" class="style-scope patent-text">
    
    [0113]
  </para-num> <div id="P-0113" num="0113" class="description-line style-scope patent-text">FIG. 10 shows the effect of four antibodies (mAb 3.9, mAb 5.4, mAb 7.3 and mAb J591) on the enzymatic activity of folate hydrolase through measuring the rate of cleavage of glutamate from methotrexate di-gamma glutamate by folate hydrolase present in lysates of C4-2 cells. <span style="display: none" class="style-scope patent-text">[0113]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0114]" class="style-scope patent-text">
    
    [0114]
  </para-num> <div id="P-0114" num="0114" class="description-line style-scope patent-text">FIG. 11 shows the impact of four antibodies (<span style="display: none" class="style-scope patent-text">[0114]</span> <figure-callout id="006" label="human mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="human mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">human mAbs</a></figure-callout> </a></figure-callout> 006, 026 and 4.40.2 as well as murine mAb 5.4) on PSMA folate hydrolase activity. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0115]" class="style-scope patent-text">
    
    [0115]
  </para-num> <div id="P-0115" num="0115" class="description-line style-scope patent-text">FIG. 12 illustrates the rapid and efficient internalization of <span style="display: none" class="style-scope patent-text">[0115]</span> <sup class="style-scope patent-text">111</sup>In labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 incubated with C4-2 cells. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0116]" class="style-scope patent-text">
    
    [0116]
  </para-num> <div id="P-0116" num="0116" class="description-line style-scope patent-text">FIG. 13 depicts the cloning protocol for IgG1 antibody cloning into pcDNA. <span style="display: none" class="style-scope patent-text">[0116]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0117]" class="style-scope patent-text">
    
    [0117]
  </para-num> <div id="P-0117" num="0117" class="description-line style-scope patent-text">FIG. 14 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody AB-PG1-XG1-006. <span style="display: none" class="style-scope patent-text">[0117]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0118]" class="style-scope patent-text">
    
    [0118]
  </para-num> <div id="P-0118" num="0118" class="description-line style-scope patent-text">FIG. 15 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody AB-PG1-XG1-026. <span style="display: none" class="style-scope patent-text">[0118]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0119]" class="style-scope patent-text">
    
    [0119]
  </para-num> <div id="P-0119" num="0119" class="description-line style-scope patent-text">FIG. 16 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody AB-PG1-XG1-051. <span style="display: none" class="style-scope patent-text">[0119]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0120]" class="style-scope patent-text">
    
    [0120]
  </para-num> <div id="P-0120" num="0120" class="description-line style-scope patent-text">FIG. 17 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody AB-PG1-XG1-069. <span style="display: none" class="style-scope patent-text">[0120]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0121]" class="style-scope patent-text">
    
    [0121]
  </para-num> <div id="P-0121" num="0121" class="description-line style-scope patent-text">FIG. 18 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody AB-PG1-XG1-077. <span style="display: none" class="style-scope patent-text">[0121]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0122]" class="style-scope patent-text">
    
    [0122]
  </para-num> <div id="P-0122" num="0122" class="description-line style-scope patent-text">FIG. 19 provides the plasmid map of a nucleic acid molecule encoding the heavy chain of antibody PSMA 10.3. <span style="display: none" class="style-scope patent-text">[0122]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0123]" class="style-scope patent-text">
    
    [0123]
  </para-num> <div id="P-0123" num="0123" class="description-line style-scope patent-text">FIG. 20 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody AB-PG1-XG1-006. <span style="display: none" class="style-scope patent-text">[0123]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0124]" class="style-scope patent-text">
    
    [0124]
  </para-num> <div id="P-0124" num="0124" class="description-line style-scope patent-text">FIG. 21 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody AB-PG1-XG1-026. <span style="display: none" class="style-scope patent-text">[0124]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0125]" class="style-scope patent-text">
    
    [0125]
  </para-num> <div id="P-0125" num="0125" class="description-line style-scope patent-text">FIG. 22 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody AB-PG1-XG1-051. <span style="display: none" class="style-scope patent-text">[0125]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0126]" class="style-scope patent-text">
    
    [0126]
  </para-num> <div id="P-0126" num="0126" class="description-line style-scope patent-text">FIG. 23 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody AB-PG1-XG1-069. <span style="display: none" class="style-scope patent-text">[0126]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0127]" class="style-scope patent-text">
    
    [0127]
  </para-num> <div id="P-0127" num="0127" class="description-line style-scope patent-text">FIG. 24 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody AB-PG1-XG1-077. <span style="display: none" class="style-scope patent-text">[0127]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0128]" class="style-scope patent-text">
    
    [0128]
  </para-num> <div id="P-0128" num="0128" class="description-line style-scope patent-text">FIG. 25 provides the plasmid map of a nucleic acid molecule encoding the light chain of antibody PSMA 10.3. <span style="display: none" class="style-scope patent-text">[0128]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0129]" class="style-scope patent-text">
    
    [0129]
  </para-num> <div id="P-0129" num="0129" class="description-line style-scope patent-text">FIG. 26 depicts the cytotoxicity of <span style="display: none" class="style-scope patent-text">[0129]</span> <sup class="style-scope patent-text">225</sup>Ac-3.9 on LNCaP target cells. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0130]" class="style-scope patent-text">
    
    [0130]
  </para-num> <div id="P-0130" num="0130" class="description-line style-scope patent-text">FIG. 27 illustrates the reactivity of anti-PSMA monoclonal antibodies XG-006, XG-051, 4.40.1, 4.49.1, 4.292.1 and 4.304.1 incubated with either parent 3T3 cells (black histogram) or 3T3 cells engineered to express cell-surface human PSMA (red histogram) and analyzed by flow cytometry. <span style="display: none" class="style-scope patent-text">[0130]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0131]" class="style-scope patent-text">
    
    [0131]
  </para-num> <div id="P-0131" num="0131" class="description-line style-scope patent-text">FIG. 28 illustrates the binding of the anti-PSMA Abs. FIG. 28A shows that anti-PSMA mAbs bind to 3T3-PSMA cells and not 3T3 cells. One representative experiment from at least ten determinations is shown. FIG. 28B illustrates that binding to cell-surface PSMA using serial dilutions of anti-PSMA mAb-containing culture supernatants occurred. One representative experiment from five is shown. FIG. 28C shows binding to cell-surface PSMA using serial dilutions of purified anti-PSMA mAbs, XG-006 and 10.3 One representative experiment is shown. <span style="display: none" class="style-scope patent-text">[0131]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0132]" class="style-scope patent-text">
    
    [0132]
  </para-num> <div id="P-0132" num="0132" class="description-line style-scope patent-text">FIG. 29 illustrates the immunotoxin cytotoxicity of murine anti-PSMA antibodies on C4-2 prostate cancer cells. SJ25C-1 as a control antibody is a murine anti-CD19 IgG. The LD 50 s (M) for 5.4, 3.9, and mJ591 antibodies were 2.2710<span style="display: none" class="style-scope patent-text">[0132]</span> <sup class="style-scope patent-text">11</sup>, 2.2910<sup class="style-scope patent-text">11 </sup>and 8.8210<sup class="style-scope patent-text">11</sup>, respectively. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0133]" class="style-scope patent-text">
    
    [0133]
  </para-num> <div id="P-0133" num="0133" class="description-line style-scope patent-text">FIG. 30 illustrates the immunotoxin cytotoxicity of murine anti-PSMA antibodies on PSMA-3T3 cells. SJ25C-1 as a control antibody is a murine anti-CD19 IgG. The LD 50s (M) for 5.4, 3.9, and mJ591 antibodies were 1.6410<span style="display: none" class="style-scope patent-text">[0133]</span> <sup class="style-scope patent-text">11</sup>, 1.9610<sup class="style-scope patent-text">11 </sup>and 8.9010<sup class="style-scope patent-text">11</sup>, respectively. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0134]" class="style-scope patent-text">
    
    [0134]
  </para-num> <div id="P-0134" num="0134" class="description-line style-scope patent-text">FIG. 31 provides the cytotoxicity of direct conjugated human 4.304 anti-PSMA antibodies with saporin on PSMA-3T3. The LD50 was 1.4810<span style="display: none" class="style-scope patent-text">[0134]</span> <sup class="style-scope patent-text">11 </sup>M for direct conjugated 4.304 anti-PSMA antibodies with saporin. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0135]" class="style-scope patent-text">
    
    [0135]
  </para-num> <div id="P-0135" num="0135" class="description-line style-scope patent-text">FIG. 32 illustrates the results of the competition assay of unmodified 4.304, 4.40, mJ591 anti-PSMA antibodies used to compete with In-111 radiolabeled 4.40 and 4.304 anti-PSMA antibodies. <span style="display: none" class="style-scope patent-text">[0135]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0136]" class="style-scope patent-text">
    
    [0136]
  </para-num> <div id="P-0136" num="0136" class="description-line style-scope patent-text">FIG. 33 illustrates the results of the competition assay of unmodified 4.304, mJ591 anti-PSMA antibodies used to compete with In-111 radiolabeled mJ591 anti-PSMA antibodies. <span style="display: none" class="style-scope patent-text">[0136]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0137]" class="style-scope patent-text">
    
    [0137]
  </para-num> <div id="P-0137" num="0137" class="description-line style-scope patent-text">FIG. 34 shows an analysis of antibody PRGX1-XG-006 in association phase and dissociation phase at different concentrations of rsPSMA from 100 nM to 6.25 nM. <span style="display: none" class="style-scope patent-text">[0137]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0138]" class="style-scope patent-text">
    
    [0138]
  </para-num> <div id="P-0138" num="0138" class="description-line style-scope patent-text">FIG. 35 shows the results of the comparison of the fully human anti-PSMA antibodies 4.40.1, 4.49.1, 051 and 006 and the murine anti-PSMA antibody 3.9 performed using Biacore analysis. <span style="display: none" class="style-scope patent-text">[0138]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0139]" class="style-scope patent-text">
    
    [0139]
  </para-num> <div id="P-0139" num="0139" class="description-line style-scope patent-text">FIG. 36 provides results from the Scatchard analysis using In-111 labeled anti-PSMA antibody 3.9 of the PSMA-3T3, LNCaP and C4-2 cell lines. <span style="display: none" class="style-scope patent-text">[0139]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0140]" class="style-scope patent-text">
    
    [0140]
  </para-num> <div id="P-0140" num="0140" class="description-line style-scope patent-text">FIG. 37 shows in vitro cytotoxicity of Ac-225 labeled human anti-PSMA antibody 4.40 on prostate cancer cells. <span style="display: none" class="style-scope patent-text">[0140]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0141]" class="style-scope patent-text">
    
    [0141]
  </para-num> <div id="P-0141" num="0141" class="description-line style-scope patent-text">FIG. 38 shows the specific killing of PSMA expressing cells (C4-2) vs. PSMA non-expressing cells (PC-3) treated with <span style="display: none" class="style-scope patent-text">[0141]</span> <sup class="style-scope patent-text">225</sup>Ac labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0142]" class="style-scope patent-text">
    
    [0142]
  </para-num> <div id="P-0142" num="0142" class="description-line style-scope patent-text">FIG. 39 shows the in vitro cytotoxicity of <span style="display: none" class="style-scope patent-text">[0142]</span> <sup class="style-scope patent-text">225</sup>Ac labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 on human prostate cancer cell lines (C4-2 and LNCaP). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0143]" class="style-scope patent-text">
    
    [0143]
  </para-num> <div id="P-0143" num="0143" class="description-line style-scope patent-text">FIG. 40 shows the in vitro cytotoxicity of <span style="display: none" class="style-scope patent-text">[0143]</span> <sup class="style-scope patent-text">225</sup>Ac labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 on human prostate cancer cell line, C4-2, evaluated by <sup class="style-scope patent-text">3</sup>H thymidine incorporation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0144]" class="style-scope patent-text">
    
    [0144]
  </para-num> <div id="P-0144" num="0144" class="description-line style-scope patent-text">FIG. 41 shows the results of in vivo radioimmunotherapy with Lu-177 labeled human anti-PSMA antibodies. <span style="display: none" class="style-scope patent-text">[0144]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0145]" class="style-scope patent-text">
    
    [0145]
  </para-num> <div id="P-0145" num="0145" class="description-line style-scope patent-text">FIG. 42 provides the radio-HPLC profile and cell-based immunoreactivity of <span style="display: none" class="style-scope patent-text">[0145]</span> <sup class="style-scope patent-text">177</sup>Lu labeled antibodies (006, 026, mJ591 and HuIgG (control)). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0146]" class="style-scope patent-text">
    
    [0146]
  </para-num> <div id="P-0146" num="0146" class="description-line style-scope patent-text">FIG. 43 shows the specific binding of <span style="display: none" class="style-scope patent-text">[0146]</span> <sup class="style-scope patent-text">177</sup>Lu labeled antibodies (006, 026, mJ591 and IgG (control)) to PSMA positive tumors in vivo. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0147]" class="style-scope patent-text">
    
    [0147]
  </para-num> <div id="P-0147" num="0147" class="description-line style-scope patent-text">FIG. 44 shows the preferential retention of radiolabeled antibodies (006, 026, mJ591 and HuIgG) in PSMA+ tumors vs. PSMA tumors as assessed by the percent activity in the tumors. <span style="display: none" class="style-scope patent-text">[0147]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0148]" class="style-scope patent-text">
    
    [0148]
  </para-num> <div id="P-0148" num="0148" class="description-line style-scope patent-text">FIG. 45 provides data for normal organ (blood, liver, spleen, lungs, bone, heart and muscle) uptake (injected dose per gram of tissue, % ID/g) for the antibodies (006, 026, mJ591 and HuIgG). <span style="display: none" class="style-scope patent-text">[0148]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0149]" class="style-scope patent-text">
    
    [0149]
  </para-num> <div id="P-0149" num="0149" class="description-line style-scope patent-text">FIG. 46 illustrates the therapeutic efficacy of <span style="display: none" class="style-scope patent-text">[0149]</span> <sup class="style-scope patent-text">177</sup>Lu labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 in PSMA-3T3 and 3T3 tumor-bearing mice. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0150]" class="style-scope patent-text">
    
    [0150]
  </para-num> <div id="P-0150" num="0150" class="description-line style-scope patent-text">FIG. 47 shows the preferential binding of <span style="display: none" class="style-scope patent-text">[0150]</span> <figure-callout id="006" label="mAb" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 006 to rsPSMA dimer. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0151]" class="style-scope patent-text">
    
    [0151]
  </para-num> <div id="P-0151" num="0151" class="description-line style-scope patent-text">FIG. 48 shows the preferential binding of <span style="display: none" class="style-scope patent-text">[0151]</span> <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 to rsPSMA dimer. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0152]" class="style-scope patent-text">
    
    [0152]
  </para-num> <div id="P-0152" num="0152" class="description-line style-scope patent-text">FIG. 49 shows the binding of mAb 4.40 to rsPSMA dimer and monomer. <span style="display: none" class="style-scope patent-text">[0152]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0153]" class="style-scope patent-text">
    
    [0153]
  </para-num> <div id="P-0153" num="0153" class="description-line style-scope patent-text">FIG. 50 shows the binding of mAb mJ591 to rsPSMA dimer and monomer. <span style="display: none" class="style-scope patent-text">[0153]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0154]" class="style-scope patent-text">
    
    [0154]
  </para-num> <div id="P-0154" num="0154" class="description-line style-scope patent-text">FIG. 51 is a series of graphs that show flow cytometry data for the binding of anti-PSMA antisera to PSMA-3T3 cells. Antisera from mice immunized with a rsPSMA dimer preparation (ABIM151, ABIM152, ABIM153, ABIM154 and ABIM155) exhibited strong binding to PSMA-expressing cells. Antisera from mice immunized with a rsPSMA monomer preparation (ABIM156, ABIM157, ABIM158, ABIM159 and ABIM160) exhibited little or no binding to PSMA-expressing cells. <span style="display: none" class="style-scope patent-text">[0154]</span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0155]" class="style-scope patent-text">
    
    [0155]
  </para-num> <div id="P-0155" num="0155" class="description-line style-scope patent-text">FIG. 52 provides the results showing antibody dependent cell-mediated cytotoxicity (ADCC) of human prostate cancer cells mediated by <span style="display: none" class="style-scope patent-text">[0155]</span> <figure-callout id="006" label="mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAbs</a></figure-callout> </a></figure-callout> 006 and 026. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0156]" class="style-scope patent-text">
    
    [0156]
  </para-num> <div id="P-0156" num="0156" class="description-line style-scope patent-text">FIG. 53 shows the results of PSMA monomer-dimer equilibrium analysis. Purified dimeric (FIG. 53A) and monomeric (FIG. 53B) rsPSMA were subjected to various buffer conditions and analyzed for size by analytical size exclusion chromatography (SEC). The percentages of monomer (M) and dimer (D) are indicated. The monomer and dimer were initially contained in PBS+ buffer at a concentration of 0.2 mg/ml. The buffer conditions were adjusted as indicated, and the proteins were incubated at ambient temperature for the indicated time periods before SEC analysis.<span style="display: none" class="style-scope patent-text">[0156]</span> </div>
    
    
    </li> <heading class="style-scope patent-text">DETAILED DESCRIPTION OF THE INVENTION </heading>
    <li class="style-scope patent-text"> <para-num num="[0157]" class="style-scope patent-text">
    
    [0157]
  </para-num> <div id="P-0157" num="0157" class="description-line style-scope patent-text">The present invention provides, in part, multimeric, particularly dimeric, forms of PSMA protein, compositions and kits containing dimeric PSMA protein as well as methods of producing, purifying, processing and using these compositions. Such methods include methods for eliciting or enhancing an immune response to PSMA and/or cells expressing PSMA. Such methods include methods of producing antibodies to dimeric PSMA as well as methods of treating cancer, such as prostate cancer. <span style="display: none" class="style-scope patent-text">[0157] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0158]" class="style-scope patent-text">
    
    [0158]
  </para-num> <div id="P-0158" num="0158" class="description-line style-scope patent-text">Prostate specific membrane antigen (PSMA) is a 100 kD Type II membrane glycoprotein expressed in prostate tissues and was originally identified by reactivity with a monoclonal antibody designated 7E11-C5 (Horoszewicz et al., 1987<span style="display: none" class="style-scope patent-text">[0158] </span> <i class="style-scope patent-text">, Anticancer Res. </i>7:927-935; U.S. Pat. No. 5,162,504). PSMA was obtained in purified form (Wright et al., 1990, Antibody Immunoconjugates and Radio Pharmaceuticals 3:Abstract 193) and characterized as a type II transmembrane protein having sequence identity with the transferrin receptor (Israeli et al., 1994<i class="style-scope patent-text">, Cancer Res. </i>54:1807-1811) and with NAALADase activity (Carter et al., 1996<i class="style-scope patent-text">, Proc. Natl. Acad. Sci. U.S.A. </i>93:749-753). More importantly, PSMA is expressed in increased amounts in prostate cancer, and elevated levels of PSMA are also detectable in the sera of these patients (Horoszewicz et al., 1987; Rochon et al., 1994<i class="style-scope patent-text">, Prostate </i>25:219-223; Murphy et al., 1995<i class="style-scope patent-text">, Prostate </i>26:164-168; and Murphy et al., 1995<i class="style-scope patent-text">, Anticancer Res. </i>15:1473-1479). PSMA expression increases with disease progression, becoming highest in metastatic, hormone-refractory disease for which there is no present therapy. Provocative recent data indicates that PSMA is also abundantly expressed on the neovasculature of a variety of other important tumors, including bladder, pancreas, sarcoma, melanoma, lung, and kidney tumor cells, but not on normal vasculature. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0159]" class="style-scope patent-text">
    
    [0159]
  </para-num> <div id="P-0159" num="0159" class="description-line style-scope patent-text">It has been discovered that PSMA in its native form is a homodimer. When ordinary isolation techniques are followed, however, the native form of PSMA is not typically maintained. Compositions of isolated PSMA protein that include isolated multimeric PSMA, particularly dimeric PSMA, therefore, are provided. These compositions include isolated PSMA protein, wherein at least about 5% of the isolated PSMA protein is in multimeric form. Other compositions are provided where at least about 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more of the isolated PSMA protein is in multimeric form. It has further been discovered that certain agents preserve or promote the multimeric, particularly the dimeric, association of isolated PSMA. Compositions of isolated PSMA protein that include these agents as well as methods of purifying and processing isolated PSMA protein compositions are, therefore, also provided. <span style="display: none" class="style-scope patent-text">[0159] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0160]" class="style-scope patent-text">
    
    [0160]
  </para-num> <div id="P-0160" num="0160" class="description-line style-scope patent-text">As used herein PSMA protein includes the full-length PSMA protein (provided as SEQ ID NO: 1) or a portion thereof. These proteins are capable of forming multimers or aggregates of PSMA protein. As used herein, a multimer or aggregate of PSMA protein refers to the association of two or more PSMA proteins. Preferably, the PSMA proteins described herein are those that are capable of forming a dimer like that of native PSMA by non-covalent interactions or engineered to form a stable native-like dimer through covalent bonds, such as disulfide bonds. A dimer like that of native PSMA includes two PSMA proteins that are associated in the same way as the protein as found in nature or in such a way as to allow for the generation of antibodies that recognize at least one antigenic epitope of the native dimer (i.e., associate in a way such as to form an antigenic region as found in the native PSMA dimer or one capable of generating cross-reacting antibodies). The antibodies generated to the dimers provided herein are, therefore, capable of recognizing the native dimer. Preferably, the antibodies generated recognize native PSMA dimer but not PSMA monomer or have greater specificity for the native PSMA dimer than the monomer. In some embodiments, the PSMA proteins provided herein are larger aggregates of PSMA (i.e., three or more PSMA protein that are associated). These aggregates are likewise capable of generating antibodies that recognize PSMA. In some embodiments, these antibodies do not recognize PSMA monomer but do recognize native PSMA dimer. In other embodiments, these antibodies have greater specificity for the native PSMA dimer rather than PSMA monomer. <span style="display: none" class="style-scope patent-text">[0160] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0161]" class="style-scope patent-text">
    
    [0161]
  </para-num> <div id="P-0161" num="0161" class="description-line style-scope patent-text">PSMA multimers are typically homomultimers (i.e., the associated PSMA proteins are the same). However, in some embodiments the PSMA multimers can be heteromultimers, particularly heterodimers. As used herein a PSMA heteromultimer is a multimer of PSMA proteins that is composed of at least two different PSMA proteins. Examples include two PSMA fragments, where one is slightly longer than the other or when one has a conservative amino acid substitution and the other does not. The heteromultimers provided herein, like homomultimers, are capable of generating antibodies that recognize native PSMA dimer. In preferred embodiments the antibodies raised against the PSMA heteromultimers recognize native PSMA dimer but not PSMA monomer. In still other preferred embodiments these antibodies have greater specificity for native PSMA dimer rather than PSMA monomer. <span style="display: none" class="style-scope patent-text">[0161] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0162]" class="style-scope patent-text">
    
    [0162]
  </para-num> <div id="P-0162" num="0162" class="description-line style-scope patent-text">PMSA protein capable of forming multimers, particularly dimers, include the full-length protein (SEQ ID NO: 1). In some embodiments the PSMA protein capable of forming a multimer is the extracellular portion of PSMA (amino acids 44-750 of SEQ ID NO: 1). In other embodiments the PSMA protein capable of forming a multimer is PSM (amino acids 58-750 of SEQ ID NO: 1), an alternatively spliced form of PSMA. In yet other embodiments fragments of the full-length protein, the extracellular portion or PSM are capable of forming multimers. For example, these fragments include truncated PSMA proteins that begin at <span style="display: none" class="style-scope patent-text">[0162] </span> <figure-callout id="48" label="amino acid" filenames="US20040161776A1-20040819-D00047.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="50" label="amino acid" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="54" label="amino acid" filenames="US20040161776A1-20040819-D00047.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="55" label="amino acid" filenames="US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="60" label="amino acid" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="64" label="amino acid" filenames="US20040161776A1-20040819-D00005.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="65" label="amino acid" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">amino acid</a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, etc. of SEQ ID NO: 1 and end at amino acid 750 of SEQ ID NO: 1. Other such truncated proteins begin at amino acid 44 of SEQ ID NO: 1 and end at amino acid 749, 748, 747, 746, 745, 744, 743, 742, 741, 740, etc. of SEQ ID NO: 1. Still other truncated proteins include those that begin at <figure-callout id="48" label="amino acid" filenames="US20040161776A1-20040819-D00047.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="50" label="amino acid" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="54" label="amino acid" filenames="US20040161776A1-20040819-D00047.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="55" label="amino acid" filenames="US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="60" label="amino acid" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="64" label="amino acid" filenames="US20040161776A1-20040819-D00005.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="65" label="amino acid" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">amino acid</a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, etc. of SEQ ID NO: 1 and end at amino acid 749, 748, 747, 746, 745, 744, 743, 742, 741, 740, etc. of SEQ ID NO: 1. In some embodiments the truncated PSMA protein includes the amino acids 601-750 of SEQ ID NO: 1 or a functional portion thereof capable of forming dimers. As provided herein, the PSMA proteins are intended to encompass any fragment of the PSMA protein that is capable of forming a multimer as provided herein. Therefore, any portion of SEQ ID NO: 1 is included in this definition as well as its functional variant. Functional variants are described further herein below. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0163]" class="style-scope patent-text">
    
    [0163]
  </para-num> <div id="P-0163" num="0163" class="description-line style-scope patent-text">In some embodiments the isolated PSMA protein is not full-length PSM (amino acids 58-750 of SEQ ID NO: 1) or the full-length extracellular portion of PSMA (amino acids 44-750 of SEQ ID NO: 1). In other instances, the isolated PSMA protein is not full-length PSMA (SEQ ID NO: 1). The fragment can have a size of at least about 25, 50, 100, 125, 150, 175, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, or 749 amino acids and every integer length therebetween. In some embodiments, these fragments include amino acids 63-68, 132-137 or 482-487 of SEQ ID NO:1. In some other preferred instances, the PSMA protein is not membrane-bound. <span style="display: none" class="style-scope patent-text">[0163] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0164]" class="style-scope patent-text">
    
    [0164]
  </para-num> <div id="P-0164" num="0164" class="description-line style-scope patent-text">Compositions of PSMA protein with agents and/or solutions that preserve or promote the multimeric association, particularly the dimeric association, of PSMA also are provided. In some instances the agents are in a solution along with the PSMA protein but are not necessarily so. An agent or solution that preserves or promotes the dimeric assocation of PSMA is one that either maintains the dimeric association (dimerization) of PSMA over time or facilitates the the dimeric association of monomeric forms of the PSMA protein. For example, any solution that increases the amount of PSMA dimers, maintains the amount of PSMA dimers or retards the disassociation of PSMA dimers is encompassed by the above definition. Although the dimeric state is specifically recited, these terms are also intended to encompass other multimeric states of PSMA, and therefore, compositions, kits and methods of production and use of other multimers of PSMA. <span style="display: none" class="style-scope patent-text">[0164] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0165]" class="style-scope patent-text">
    
    [0165]
  </para-num> <div id="P-0165" num="0165" class="description-line style-scope patent-text">Preferably, the preservation or promotion of dimeric PSMA refers to the maintenance of the dimeric state of PSMA protein for at least about 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95% or more of the PSMA dimers initially present in a composition. Preferred compositions comprising the dimeric form of PSMA have less than about 35% of the monomeric form of PSMA, preferably less than about 20%, more preferably less than about 15% of the monomeric form. In one embodiment the composition has less than about 5% of the monomeric PSMA protein. The preservation or promotion of dimeric PSMA also refers to the conversion of about 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95% or more of the initially monomeric PSMA to dimeric form. <span style="display: none" class="style-scope patent-text">[0165] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0166]" class="style-scope patent-text">
    
    [0166]
  </para-num> <div id="P-0166" num="0166" class="description-line style-scope patent-text">The promotion of dimerization or maintenance of the dimeric state can occur at any of a number of experimental or storage temperatures. In some instances the promotion or preservation of dimeric PSMA occurs at a temperature of about 45 C. or lower. In other instances the promotion or preservation of dimeric PSMA is at a temperature of about 37 C. The promotion or preservation can also be at a temperature range of about 20 C. to about 30 C. or about or below room temperature. In other instances the promotion or preservation is at a range of about 4 C. to about 20 C. In still other instances the promotion or preservation is at about 20 C. to about 4 C. or about 80 C. to about 20 C. The promotion or preservation of the dimeric state of PSMA can also occur in a composition of PSMA protein that is in solution or in a freeze-dried form, e.g., lyophilized form. The dimeric state can also be promoted or preserved over any period of time. In some instances the period of time is at least about 1, 2, 3, 4, 5, 6, 10, 15, 20, 24, 48, 72 or more hours. In other instances the period of time is at least about 1, 2, 3, 4, 5, 10, 15, 20, 25, 30 or more days. In still other instances the period of time is at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 15, 20, 25, 30 or more weeks. In yet other instances, the period of time is at least about 1, 2, 3, 6, 9, 12 or more months or as long as 2 years or more. The formulations provided herein are stable during long-term storage, i.e., the formulations preserve or promote the dimeric PSMA state. <span style="display: none" class="style-scope patent-text">[0166] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0167]" class="style-scope patent-text">
    
    [0167]
  </para-num> <div id="P-0167" num="0167" class="description-line style-scope patent-text">It was surprisingly discovered that pH alone can influence the dimeric state of PSMA. As described below in the Examples section, the pH at which a PSMA solution is incubated can influence the multimeric form of PSMA as well as its recovery. Incubation at various pHs for 4 days at a temperature of about 45 C. influenced the dimerization or aggregation of PSMA protein as well as the recovery of PSMA protein by analytical TSK gel filtration chromatography. The benefits of pH on the preservation of dimeric rsPSMA (2 mg/ml in PBS+) are retained when the protein solution is diluted 10-fold in a variety of buffer solutions, each containing 2 mM glycine, 2 mM citric acid, 2 mM Hepes, 2 mM MES and 2 mM Tris Base. <span style="display: none" class="style-scope patent-text">[0167] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0168]" class="style-scope patent-text">
    
    [0168]
  </para-num> <div id="P-0168" num="0168" class="description-line style-scope patent-text">The dimeric structure of PSMA according to the invention is preserved at a pH in the range of about 4 to about 8. Therefore, a solution that preserves or promotes the dimerization of PSMA is one with a pH of about 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, or 8. Recovery of dimeric PSMA from a column was better at a pH in the range of about 5 to about 7, and these pH values are preferred. In some instances, a pH of about 6 is preferred. Thus, the invention provides formulations of PSMA in solution, wherein the pH is in the range from about 4 to about 8, preferably in the range from about 5 to about 7, more preferably in the range from about 5.5 to about 7, and most preferably in the range from about 6 to about 7. <span style="display: none" class="style-scope patent-text">[0168] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0169]" class="style-scope patent-text">
    
    [0169]
  </para-num> <div id="P-0169" num="0169" class="description-line style-scope patent-text">An agent that preserves or promotes the dimeric association of PSMA is meant to encompass an agent that promotes or maintains the dimerization of PSMA. Such agents have been found to include pH adjusting agents (as discussed above), metal ions and salts. It has been discovered that these agents, individually or in combination, are able to preserve or promote dimeric association of PSMA. In some embodiments it is the combination of the metal ion, salt or pH adjusting agent that can promote or preserve dimeric association of PSMA, while the individual metal ion, salt or pH adjusting agent cannot. As provided in the Examples, the use of chelating agents, such as EDTA, converted dimeric PSMA into the monomer. This result indicated that the presence of metal ions can positively affect the stability of the dimer. Additionally, PSMA shares modest sequence and structural homology with human transferrin receptor (TfR), which contains additional metal-binding sites within its helical domains (Lawrence, C. M., et al. (1999) Science 286, 779-782). Therefore, metal ions are considered to be agents which promote or preserve the dimeric state of PSMA protein. Such metals ions include, but are not limited to, zinc ions (e.g., Zn<span style="display: none" class="style-scope patent-text">[0169] </span> <sup class="style-scope patent-text">2+</sup>), calcium ions (e.g., Ca<sup class="style-scope patent-text">2+</sup>), magnesium ions (e.g., Mg<sup class="style-scope patent-text">2+</sup>). cobalt ions (e.g., Co<sup class="style-scope patent-text">2+</sup>), manganese ions (e.g., Mn<sup class="style-scope patent-text">2+</sup>) or combinations thereof. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0170]" class="style-scope patent-text">
    
    [0170]
  </para-num> <div id="P-0170" num="0170" class="description-line style-scope patent-text">In some instances these metal ions can be added to a composition of PSMA protein in the form of a salt. Such salts include zinc chloride, calcium chloride, magnesium chloride, cobalt chloride or manganese chloride. It has been further determined that compositions of PSMA protein, wherein the dimeric state is promoted or preserved, include at least about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5 or more molar equivalents of metal ion to PSMA protein (total PSMA protein, i.e., total amount of PSMA protein molecules). In some instances, the molar equivalent of metal ions should be in molar excess to PSMA protein. In some specific solutions of PSMA protein (2 mg/ml in PBS+; diluted 10-fold), as provided in the Examples, it has further been found, that the metal ions are preferably present at a concentration in the range of about 0.1 mM to about 5 mM. The metal ions in some instances are present at a concentration in the range of about 0.1 mM to about 1 mM. In other embodiments the metal ions are present at a concentration in the range of about 0.1 mM to about 0.5 mM. In solutions where there is a combination of one or more types of metal ions, the one or more metal ions can be at the same concentration or at a different concentration. For example, one such solution can contain a concentration of calcium ions of about 0.5 mM and a concentration of zinc ions of a concentration that is greater than 0.1 mM but less than 0.5 mM. Because of the importance of metal ions in the dimerization of PSMA in some compositions, in some instances, it is preferred that the compositions do not contain a chelating agent. <span style="display: none" class="style-scope patent-text">[0170] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0171]" class="style-scope patent-text">
    
    [0171]
  </para-num> <div id="P-0171" num="0171" class="description-line style-scope patent-text">It has also been found that salts preserve or promote PSMA dimerization. As shown below in the Examples, a dimer preparation that contained approximately 5% monomer initially was converted to 100% dimer upon incubation for 72 hours at ambient temperature in PBS+ (phosphate-buffered saline containing 1 mM Ca<span style="display: none" class="style-scope patent-text">[0171] </span> <sup class="style-scope patent-text">2+</sup> and 0.5 mM Mg<sup class="style-scope patent-text">2+</sup>, pH 7.2) supplemented with 2M sodium chloride. For a preparation that initially comprised &gt;95% monomer, high salt similarly drove the equilibrium to mostly (81%) dimer within 72 hours. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0172]" class="style-scope patent-text">
    
    [0172]
  </para-num> <div id="P-0172" num="0172" class="description-line style-scope patent-text">Salts that preserve or promote PSMA dimerization can include those with a cationic component selected from the group consisting of sodium, potassium, ammonium, magnesium, calcium, zinc and combinations thereof, and those with an anionic component selected from the group consisting of chloride, sulfate, acetate and combinations thereof. In preferred embodiments the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. The salt can be present in a PSMA-containing composition at any concentration that preserves or promotes the dimerization of PSMA. In some instances the salt is present at a concentration in the range of about 50 mM to about 2M. The salt preferably is present at a concentration of about 100 mM to 300 mM. The salt more preferably is present at a concentration of about 150 mM. <span style="display: none" class="style-scope patent-text">[0172] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0173]" class="style-scope patent-text">
    
    [0173]
  </para-num> <div id="P-0173" num="0173" class="description-line style-scope patent-text">In some cases where a high salt concentration is used to promote or preserve PSMA dimerization, the salt concentration can be diluted to within a physiologically acceptable range suitable for parenteral use prior to administration. As an example, the salt concentration can be diluted with an adjuvant or a diluent. Diluents and adjuvants are both well known in the art. An adjuvant is a substance which potentiates the immune response. Specific examples of adjuvants include monophosphoryl lipid A (MPL, SmithKline Beecham); saponins including QS21 (SmithKline Beecham); immunostimulatory oligonucleotides (e.g., CpG oligonucleotides described by Kreig et al., <span style="display: none" class="style-scope patent-text">[0173] </span> <i class="style-scope patent-text">Nature </i>374:546-9, 1995); incomplete Freund's adjuvant; complete Freund's adjuvant; montanide; vitamin E and various water-in-oil emulsions prepared from biodegradable oils such as squalene and/or tocopherol, Quil A, MPL and cell wall skeleton from mycobacterium combinations such as ENHANZYN (Corixa Corporation, Hamilton, Mont.), CRL-1005, L-121, alpha-galactosylceramide (Fujii et al., <i class="style-scope patent-text">J. Exp. Med., </i>2003, Jul. 21; 198(2): 267-79) and combinations thereof. A preferred adjuvant is alum. Other diluents include water suitable for injection, saline, PBS, solubilizing agents and emulsifiers such as ethyl alcohol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol, dimethyl formamide, oils (in particular, cottonseed, groundnut, corn, germ, olive, castor and sesame oils), glycerol, tetrahydrofurfuryl alcohol, polyethylene glycols and fatty acid esters of sorbitan and mixtures thereof. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0174]" class="style-scope patent-text">
    
    [0174]
  </para-num> <div id="P-0174" num="0174" class="description-line style-scope patent-text">Therefore, in some aspects of the invention a preferred composition comprising isolated PSMA protein is a solution that promotes or preserves multimeric, particularly dimeric, association of PSMA protein comprising 5 to 20 mM sodium phosphate, sodium acetate or a combination thereof; 100 to 300 mM sodium chloride or sodium sulfate; and 0.1 to 2 mM of at least one metal ion. The metal ions can be chosen from zinc ions, calcium ions, magnesium ions, cobalt ions, manganese ions or a combination thereof. The pH of such a solution can also be adjusted to be in a range of about 4 to 8, preferable 5 to 7 and most preferable 6 to 6.5. Such a solution can also, optionally, include an adjuvant such as alum. <span style="display: none" class="style-scope patent-text">[0174] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0175]" class="style-scope patent-text">
    
    [0175]
  </para-num> <div id="P-0175" num="0175" class="description-line style-scope patent-text">Agents that preserve or promote PSMA dimerization can be used in compositions of PSMA protein or methods of processing such compositions. Furthermore, a method for identifying such agents is provided herein. Such a method includes the following steps: determining the amount of form of PSMA in a sample prior to exposure to a candidate agent; exposing the sample to the candidate agent; determining the amount of the form of PSMA in the sample after the exposure; and comparing the amount of the form of PSMA in the sample prior to and after the exposure to the candidate agent. The form of PSMA can be a monomer or multimer, prederably the dimer. An agent which preserves and/or promotes dimer formation of PSMA protein is suitable for use in the compositions comprising PSMA protein dimers. <span style="display: none" class="style-scope patent-text">[0175] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0176]" class="style-scope patent-text">
    
    [0176]
  </para-num> <div id="P-0176" num="0176" class="description-line style-scope patent-text">As described below the effect of buffering agent on the ability of PSMA to dimerize or maintain its dimerization was also tested. It was found that many can be used in a solution of PSMA without negatively impacting the dimeric state of PSMA. The sole exception for solutions of PSMA protein with 150 mM NaCl at a pH of 6 was citrate buffer. Interestingly, citrate buffer is known to function as a chelating agent. Therefore the formulations of PSMA described herein can include any buffer so long as the buffer is not one with a chelating effect that outweighs the preservation or promoting effect of the other properties of the formulation. Preferably optimal buffers include those with buffering capacity at a pH in the range of about 4 to about 8. More preferably, buffers are those with buffering capacity at a pH in the range of about 5 to about 7. Most preferably the buffers are those that have buffering capacity at a pH in the range of about 5.5 to about 7. Buffers in general are well known to those of ordinary skill in the art. Buffer systems include citrate buffers, acetate buffers, borate buffers, and phosphate buffers. Specific examples of buffers include citric acid, sodium citrate, sodium acetate, acetic acid, sodium phosphate and phosphoric acid, sodium ascorbate, tartartic acid, maleic acid, glycine, sodium lactate, lactic acid, ascorbic acid, imidazole, sodium bicarbonate and carbonic acid, sodium succinate and succinic acid, histidine, and sodium benzoate and benzoic acid. Buffers also include PBS and Hepes. <span style="display: none" class="style-scope patent-text">[0176] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0177]" class="style-scope patent-text">
    
    [0177]
  </para-num> <div id="P-0177" num="0177" class="description-line style-scope patent-text">The effect of free amino acids on the dimeric state of rsPSMA (2 mg/ml in PBS+) dialyzed into 20 mM sodium acetate and 150 mM NaCl at a pH of about 6 was also tested. In general it was found that free amino acids did not have a strong negative effect on dimer association of PSMA and/or column recovery, with the exception of histidine, glutamic acid and aspartic acid used individually at the specific experimental conditions. Therefore, the formulations provided herein can also include a free amino acid or combination of free amino acids, provided that the free amino acid does not have a negative effect that outweighs the dimeric association promoting or preserving nature of the specific formulation. Such free amino acids can be naturally occurring, modified or non-naturally occurring free amino acids (i.e., compounds that do not occur in nature but that can be incorporated into a polypeptide chain; see, for example, http://www.cco.caltech.edu/dadgrp/Unnatstruct.gif, which displays structures of non-natural amino acids that have been successfully incorporated into functional ion channels). Modified or non-naturally occurring free amino acids also include but are not limited to 2-aminoadipic acid; 3-aminoadipic acid; beta-alanine, beta-aminopropionic acid; 2-aminobutyric acid; 4-aminobutyric acid, piperidinic acid; 6-aminocaproic acid; 2-aminoheptanoic acid; 2-aminoisobutyric acid; 3-aminoisobutyric acid; 2-aminopimelic acid; 2, 4-diaminobutyric acid; desmosine; 2,2-diaminopimelic acid; 2,3-diaminopropionic acid; N-ethylglycine; N-ethylasparagine; hydroxylysine; allo-hydroxylysine; 3-hydroxyproline; 4-hydroxyproline; isodesmosine; allo-isoleucine; N-methylglycine, sarcosine; N-methylisoleucine; 6-N-methyllysine; N-methylvaline; norvaline; norleucine and ornithine. In particular, free amino acids that do not have a negative effect on dimeric association of PSMA and/or column recovery include those that are non-acidic. Examples of these non-acidic free amino acids include glycine, proline, isoleucine, leucine, alanine and arginine. <span style="display: none" class="style-scope patent-text">[0177] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0178]" class="style-scope patent-text">
    
    [0178]
  </para-num> <div id="P-0178" num="0178" class="description-line style-scope patent-text">In addition to free amino acids, surfactants and other excipients were also found not to have a negative impact on the dimeric state of PSMA. Therefore, surfactants as well as other excipients can be included in the compositions provided herein. Examples of surfactants include those known in the art and described herein. For example, surfactants include Triton X-100, dodecylmaltoside, cholic acid and CHAPS. <span style="display: none" class="style-scope patent-text">[0178] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0179]" class="style-scope patent-text">
    
    [0179]
  </para-num> <div id="P-0179" num="0179" class="description-line style-scope patent-text">Examples of excipients include binders, coatings, compression/encapsulation aids, disintegrants, creams and lotions, lubricants, materials for chewable tablets, parenterals, plasticizers, powder lubricants, soft gelatin capsules, spheres for coating, spheronization agents, suspending/gelling agents, sweeteners and wet granulation agents. Specific examples of such excipients include acetyltriethyl citrate (ATEC); acetyltri-n-butyl citrate (ATBC); aspartame; aspartame and lactose; alginates; calcium carbonate; carbopol; carrageenan; cellulose acetate phthalate-based coatings; cellulose-based coatings; cellulose and lactose combinations; colorants for film coating systems; croscarmellose sodium; crospovidone; dextrose; dibutyl sebacate; ethylcellulose-based coatings; fructose; gellan gum; glyceryl behenate; honey; lactose; anhydrous; lactose; monohydrate; lactose and aspartame; lactose and cellulose; lactose and microcrystalline cellulose; L-HPC (Low-substituted HydroxyPryopl Cellulose); magnesium stearate; maltodextrin; maltose DC; mannitol DC; methylcellulose-based coatings; microcrystalline cellulose; methacrylate-based coatings; microcrystalline cellulose and carrageenan; microcrystalline cellulose and guar gum; microcrystalline cellulose and lactose; microcrystalline cellulose and sodium carboxymethylcellulose; molasses DC; polyvinyl acetate phathalate (PVAP); povidone; shellac; sodium starch glycolate; sorbitol, crystalline; sorbitol, special solution; starch DC; sucrose DC; sugar spheres; triacetin; triethylcitrate and xanthan gum. Other excipients include antioxidants and cryoprotectants. <span style="display: none" class="style-scope patent-text">[0179] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0180]" class="style-scope patent-text">
    
    [0180]
  </para-num> <div id="P-0180" num="0180" class="description-line style-scope patent-text">Antioxidants are substances capable of inhibiting oxidation by removing free radicals from solution. Antioxidants are well known to those of ordinary skill in the art and include materials such as ascorbic acid, ascorbic acid derivatives (e.g., ascorbylpalmitate, ascorbylstearate, sodium ascorbate, calcium ascorbate, etc.), butylated hydroxy anisole, butylated hydroxy toluene, alkylgallate, dithiothreitol (DTT), sodium meta-bisulfite, sodium bisulfite, sodium dithionite, sodium thioglycollic acid, sodium formaldehyde sulfoxylate, tocopherol and derivatives thereof (e.g., d-alpha tocopherol, d-alpha tocopherol acetate, dl-alpha tocopherol acetate, d-alpha tocopherol succinate, beta tocopherol, delta tocopherol, gamma tocopherol, and d-alpha <span style="display: none" class="style-scope patent-text">[0180] </span> <figure-callout id="1000" label="tocopherol polyoxyethylene glycol" filenames="US20040161776A1-20040819-D00034.png,US20040161776A1-20040819-D00049.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">tocopherol polyoxyethylene glycol</a></figure-callout> 1000 succinate) monothioglycerol, and sodium sulfite. Such materials are typically added in ranges from about 0.01 to about 2%. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0181]" class="style-scope patent-text">
    
    [0181]
  </para-num> <div id="P-0181" num="0181" class="description-line style-scope patent-text">For a lyophilized product or a product stored in the cold, one or more cryoprotectants can be added. Typical cryoprotectants for proteins include but are not limited to: sugars such as sucrose, lactose, glucose, trehalose, maltose, and the like; polyols such as inositol, ethylene glycol, glycerol, sorbitol, xylitol, mannitol, 2-methyl-2,4-pentane-diol and the like; amino acids such as Na glutamate, proline, alpha-alanine, beta-alanine, glycine, lysine-HCl, 4-hydroxyproline; polymers such as polyethylene glycol, dextran, polyvinylpyrrolidone and the like; inorganics salts such as sodium sulfate, ammonium sulfate, potassium phosphate, magnesium sulfate, and sodium fluoride and the like; organics salts such as sodium acetate, sodium polyethylene, sodium caprylate, proprionate, lactate, succinate and the like; as well as agents such as trimethylamine N-oxide, sarcosine, betaine, gamma-aminobutyric acid, octapine, alanopine, strombine, dimethylsulfoxide, and ethanol. <span style="display: none" class="style-scope patent-text">[0181] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0182]" class="style-scope patent-text">
    
    [0182]
  </para-num> <div id="P-0182" num="0182" class="description-line style-scope patent-text">The invention also involves methods for preparing or processing compositions of PSMA protein. Aqueous solutions of PSMA protein are included in these methods. Some of these methods include the step of adjusting the pH so that it is in the range of about 4 to about 8. In some methods the pH is adjusted to be in the range of about about 5 to 7, and more preferably the pH is adjusted to be in the range of about 5.5 to 7. Most preferably the pH is adjusted to be about 6. The compositions can also contain any one or combination of an isotonicity agent, a buffering agent, a surfactant, an antioxidant, a cryoprotectant or other excipients. Preferably the compositions do not include a chelating agent. <span style="display: none" class="style-scope patent-text">[0182] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0183]" class="style-scope patent-text">
    
    [0183]
  </para-num> <div id="P-0183" num="0183" class="description-line style-scope patent-text">According to another aspect of the invention, a composition of PSMA protein is processed by contacting the composition of PSMA protein with an agent that promotes or preserves the dimeric association of PSMA such as pH adjusting agents, metal ions and/or salts as provided above. Compositions that include these agents can also include agents selected from an isotonicity agent, a buffering agent, a surfactant, an antioxidant, a cryoprotectant and other excipients, but preferably, not a chelating agent. Such methods can also include futher steps of contacting the composition of PSMA protein with other dimer promoting or preserving agents and/or pH adjusting steps when the PSMA protein is in a solution. <span style="display: none" class="style-scope patent-text">[0183] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0184]" class="style-scope patent-text">
    
    [0184]
  </para-num> <div id="P-0184" num="0184" class="description-line style-scope patent-text">Additionally, in another aspect of the invention, a method of purifying PSMA protein is also provided. The methods of purifying PSMA include the use of any of the agents and/or solutions described herein that preserve or promote the multimeric, particularly dimeric, association of PSMA in conjunction with any of the separation techniques that are known to those in the art. Such separation techniques include chromatography (e.g., TSK gel filtration chromatography) and are described in more detail in the Examples below. For instance, a separation technique encompassed within this aspect of the invention can include the steps of loading a sample onto a column, eluting or washing the sample from the column and collecting the eluted fractions. Such steps can be repeated any of a number of times to produce the desired PSMA protein composition. These steps can, optionally, also include steps whereby the sample containing PSMA protein is dialyzed. Preferably, the sample containing PSMA protein is dialyzed into a solution that preserves or promotes the multimeric association of PSMA. In one embodiment, the solutions used in these methods contain a metal ion or a salt. In other embodiments, the solution is at a pH that preserves or promotes PSMA multimerization. The metal ion and salts, including concentration ranges, as well as pH ranges that can be used in these purification methods have been provided above. In some preferred embodiments, the pH of the solution can be at about 7 or 7.5. In other preferred embodiments, the metals are calcium ions, magnesium ions or combinations thereof. The calcium and magnesium ions are present, for instance, at a concentration of about 1 mM and of about 0.5 mM, respectively. In other preferred embodiments the salt is present at a concentration of about 2M. <span style="display: none" class="style-scope patent-text">[0184] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0185]" class="style-scope patent-text">
    
    [0185]
  </para-num> <div id="P-0185" num="0185" class="description-line style-scope patent-text">The amount of dimeric PSMA in the compositions provided herein is effective to elicit or enhance an immune response to cells expressing PSMA. The compositions can, therefore, be used to immunize an animal for the purpose of raising antibodies to dimeric PSMA. The compositions provided herein can also be used to treat a subject suffering from a cancer, wherein the cancer cells or proximate neovasculature express PSMA. Such cancers can include prostate, bladder, pancreas, lung, colon, kidney, melanomas and sarcomas. In a preferred embodiment the cancer cell is a prostate cancer cell. The cancer cells can be cells of a primary tumor or can be those of a metastatic tumor. <span style="display: none" class="style-scope patent-text">[0185] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0186]" class="style-scope patent-text">
    
    [0186]
  </para-num> <div id="P-0186" num="0186" class="description-line style-scope patent-text">Another aspect of the invention provides an isolated antibody or an antigen-binding fragment thereof which specifically binds to an extracellular domain of PSMA wherein the antibody or the antigen-binding fragment thereof competitively inhibits the specific binding of a second antibody to its target epitope on PSMA, and wherein the second antibody is selected from the group consisting of PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11, PSMA 5.4, PSMA 7.1, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, 4.248.2, 4.360.3, 4.7.1, 4.4.1, 4.177.3, 4.16.1, 4.22.3, 4.28.3, 4.40.2, 4.48.3, 4.49.1, 4.209.3, 4.219.3, 4.288.1, 4.333.1, 4.54.1, 4.153.1, 4.232.3, 4.292.3, 4.304.1, 4.78.1, and 4.152.1. <span style="display: none" class="style-scope patent-text">[0186] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0187]" class="style-scope patent-text">
    
    [0187]
  </para-num> <div id="P-0187" num="0187" class="description-line style-scope patent-text">Another aspect of the invention provides an isolated antibody or an antigen-binding fragment thereof that specifically binds to an epitope on PSMA defined by an antibody selected from the group consisting of PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11, PSMA 5.4, PSMA 7.1, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, 4.248.2, 4.360.3, 4.7.1, 4.4.1, 4.177.3, 4.16.1, 4.22.3, 4.28.3, 4.40.2, 4.48.3, 4.49.1, 4.209.3, 4.219.3, 4.288.1, 4.333.1, 4.54.1, 4.153.1, 4.232.3, 4.292.3, 4.304.1, 4.78.1, and 4.152.1. <span style="display: none" class="style-scope patent-text">[0187] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0188]" class="style-scope patent-text">
    
    [0188]
  </para-num> <div id="P-0188" num="0188" class="description-line style-scope patent-text">In particular embodiments, these antibodies are produced by hybridomas referred to herein as PSMA 3.7, PSMA 3.8, PSMA 3.9, PSMA 3.11, PSMA 5.4, PSMA 7.1, PSMA 7.3, PSMA 10.3, PSMA 1.8.3, PSMA A3.1.3, PSMA A3.3.1, Abgenix 4.248.2, Abgenix 4.360.3, Abgenix 4.7.1, Abgenix 4.4.1, Abgenix 4.177.3, Abgenix 4.16.1, Abgenix 4.22.3, Abgenix 4.28.3, Abgenix 4.40.2, Abgenix 4.48.3, Abgenix 4.49.1, Abgenix 4.209.3, Abgenix 4.219.3, Abgenix 4.288.1, Abgenix 4.333.1, Abgenix 4.54.1, Abgenix 4.153.1, Abgenix 4.232.3, Abgenix 4.292.3, Abgenix 4.304.1, Abgenix 4.78.1, and Abgenix 4.152.1, respectively. These hybridomas were deposited with ATCC as an International Depository Authority and given the following Patent Deposit Designations (Table 1):  
<span style="display: none" class="style-scope patent-text">[0188] </span> <tables id="TABLE-US-00001" num="1" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" class="description-td style-scope patent-text" colspan="4">TABLE 1</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Patent</td> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Hybridoma/</td> <td class="description-td style-scope patent-text">Deposit</td> <td class="description-td style-scope patent-text">Date of</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Antibody</td> <td class="description-td style-scope patent-text">Plasmid</td> <td class="description-td style-scope patent-text">Designation</td> <td class="description-td style-scope patent-text">Deposit</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 3.7</td> <td class="description-td style-scope patent-text">PSMA 3.7</td> <td class="description-td style-scope patent-text">PTA-3257</td> <td class="description-td style-scope patent-text">Apr. 5, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 3.9</td> <td class="description-td style-scope patent-text">PSMA 3.9</td> <td class="description-td style-scope patent-text">PTA-3258</td> <td class="description-td style-scope patent-text">Apr. 5, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 3.11</td> <td class="description-td style-scope patent-text">PSMA 3.11</td> <td class="description-td style-scope patent-text">PTA-3269</td> <td class="description-td style-scope patent-text">Apr. 10, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 5.4</td> <td class="description-td style-scope patent-text">PSMA 5.4</td> <td class="description-td style-scope patent-text">PTA-3268</td> <td class="description-td style-scope patent-text">Apr. 10, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 7.1</td> <td class="description-td style-scope patent-text">PSMA 7.1</td> <td class="description-td style-scope patent-text">PTA-3292</td> <td class="description-td style-scope patent-text">Apr. 18, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 7.3</td> <td class="description-td style-scope patent-text">PSMA 7.3</td> <td class="description-td style-scope patent-text">PTA-3293</td> <td class="description-td style-scope patent-text">Apr. 18, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 10.3</td> <td class="description-td style-scope patent-text">PSMA 10.3</td> <td class="description-td style-scope patent-text">PTA-3347</td> <td class="description-td style-scope patent-text">May 1, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">PSMA 10.3</td> <td class="description-td style-scope patent-text">PTA-4413</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">HC in</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">pcDNA</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 7)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">PSMA 10.3</td> <td class="description-td style-scope patent-text">PTA-4414</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Kappa in</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">pcDNA</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 13)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA 1.8.3</td> <td class="description-td style-scope patent-text">PSMA 1.8.3</td> <td class="description-td style-scope patent-text">PTA-3906</td> <td class="description-td style-scope patent-text">Dec. 5, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA A3.1.3</td> <td class="description-td style-scope patent-text">PSMA A3.1.3</td> <td class="description-td style-scope patent-text">PTA-3904</td> <td class="description-td style-scope patent-text">Dec. 5, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PSMA A3.3.1</td> <td class="description-td style-scope patent-text">PSMA A3.3.1</td> <td class="description-td style-scope patent-text">PTA-3905</td> <td class="description-td style-scope patent-text">Dec. 5, 2001</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.248.2</td> <td class="description-td style-scope patent-text">Abgenix 4.248.2</td> <td class="description-td style-scope patent-text">PTA-4427</td> <td class="description-td style-scope patent-text">Jun. 4, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.360.3</td> <td class="description-td style-scope patent-text">Abgenix 4.360.3</td> <td class="description-td style-scope patent-text">PTA-4428</td> <td class="description-td style-scope patent-text">Jun. 4, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.7.1</td> <td class="description-td style-scope patent-text">Abgenix 4.7.1</td> <td class="description-td style-scope patent-text">PTA-4429</td> <td class="description-td style-scope patent-text">Jun. 4, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.4.1</td> <td class="description-td style-scope patent-text">Abgenix 4.4.1</td> <td class="description-td style-scope patent-text">PTA-4556</td> <td class="description-td style-scope patent-text">Jul. 18, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.177.3</td> <td class="description-td style-scope patent-text">Abgenix 4.177.3</td> <td class="description-td style-scope patent-text">PTA-4557</td> <td class="description-td style-scope patent-text">Jul. 18, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.16.1</td> <td class="description-td style-scope patent-text">Abgenix 4.16.1</td> <td class="description-td style-scope patent-text">PTA-4357</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.22.3</td> <td class="description-td style-scope patent-text">Abgenix 4.22.3</td> <td class="description-td style-scope patent-text">PTA-4358</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.28.3</td> <td class="description-td style-scope patent-text">Abgenix 4.28.3</td> <td class="description-td style-scope patent-text">PTA-4359</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.40.2</td> <td class="description-td style-scope patent-text">Abgenix 4.40.2</td> <td class="description-td style-scope patent-text">PTA-4360</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.48.3</td> <td class="description-td style-scope patent-text">Abgenix 4.48.3</td> <td class="description-td style-scope patent-text">PTA-4361</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.49.1</td> <td class="description-td style-scope patent-text">Abgenix 4.49.1</td> <td class="description-td style-scope patent-text">PTA-4362</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.209.3</td> <td class="description-td style-scope patent-text">Abgenix 4.209.3</td> <td class="description-td style-scope patent-text">PTA-4365</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.219.3</td> <td class="description-td style-scope patent-text">Abgenix 4.219.3</td> <td class="description-td style-scope patent-text">PTA-4366</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.288.1</td> <td class="description-td style-scope patent-text">Abgenix 4.288.1</td> <td class="description-td style-scope patent-text">PTA-4367</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.333.1</td> <td class="description-td style-scope patent-text">Abgenix 4.333.1</td> <td class="description-td style-scope patent-text">PTA-4368</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.54.1</td> <td class="description-td style-scope patent-text">Abgenix 4.54.1</td> <td class="description-td style-scope patent-text">PTA-4363</td> <td class="description-td style-scope patent-text">May 16, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.153.1</td> <td class="description-td style-scope patent-text">Abgenix 4.153.1</td> <td class="description-td style-scope patent-text">PTA-4388</td> <td class="description-td style-scope patent-text">May 23, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.232.3</td> <td class="description-td style-scope patent-text">Abgenix 4.232.3</td> <td class="description-td style-scope patent-text">PTA-4389</td> <td class="description-td style-scope patent-text">May 23, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.292.3</td> <td class="description-td style-scope patent-text">Abgenix 4.292.3</td> <td class="description-td style-scope patent-text">PTA-4390</td> <td class="description-td style-scope patent-text">May 23, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Abgenix 4.304.1</td> <td class="description-td style-scope patent-text">Abgenix 4.304.1</td> <td class="description-td style-scope patent-text">PTA-4391</td> <td class="description-td style-scope patent-text">May 23, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">AB-PG1-XG1-006</td> <td class="description-td style-scope patent-text">AB-PG1-XG1-006</td> <td class="description-td style-scope patent-text">PTA-4403</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Heavy Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 2)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AB-PG1-XG1-006</td> <td class="description-td style-scope patent-text">PTA-4404</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Light Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 8)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">AB-PG1-XG1-026</td> <td class="description-td style-scope patent-text">AB-PG1-XG1-026</td> <td class="description-td style-scope patent-text">PTA-4405</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Heavy Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AB-PG1-XG1-026</td> <td class="description-td style-scope patent-text">PTA-4406</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Light Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 9)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">AB-PG1-XG1-051</td> <td class="description-td style-scope patent-text">AB-PG1-XG1-051</td> <td class="description-td style-scope patent-text">PTA-4407</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Heavy Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 4)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AB-PG1-XG1-051</td> <td class="description-td style-scope patent-text">PTA-4408</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Light Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 10)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">AB-PG1-XG1-069</td> <td class="description-td style-scope patent-text">AB-PG1-XG1-069</td> <td class="description-td style-scope patent-text">PTA-4409</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Heavy Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 5)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AB-PG1-XG1-069</td> <td class="description-td style-scope patent-text">PTA-4410</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Light Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 11)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">AB-PG1-XG1-077</td> <td class="description-td style-scope patent-text">AB-PG1-XG1-077</td> <td class="description-td style-scope patent-text">PTA-4411</td> <td class="description-td style-scope patent-text">May 29, 2002</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Heavy Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 6)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AB-PG1-XG1-077</td> <td class="description-td style-scope patent-text">PTA-4412</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Light Chain</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(SEQ ID NO: 12)</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0189]" class="style-scope patent-text">
    
    [0189]
  </para-num> <div id="P-0189" num="0189" class="description-line style-scope patent-text">In another aspect of the invention, antibodies having particular sequences are provided. Specifically, the antibodies are selected from the group consisting of antibodies comprising: a heavy chain encoded by a nucleic acid molecule comprising the heavy chain coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 2-7, and a light chain encoded by a nucleic acid molecule comprising the light chain coding region or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as SEQ ID NOs: 8-13. Also provided are antigen-binding fragments of the foregoing antibodies. <span style="display: none" class="style-scope patent-text">[0189] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0190]" class="style-scope patent-text">
    
    [0190]
  </para-num> <div id="P-0190" num="0190" class="description-line style-scope patent-text">The plasmids encoding the heavy and light chains of antibodies PSMA 10.3, AB-PG1-XG1-006, AB-PG1-XG1-026, AB-PG1-XG1-051, AB-PG1-XG1-069, AB-PG1-XG1-077 were also deposited with ATCC and are shown in Table 1 above. As used herein, the names of the deposited hybridomas or plasmids may be used interchangeably with the names of the antibodies. It would be clear to one of skill in the art when the name is intended to refer to the antibody or when it refers to the plasmids or hybridomas that encode or produce the antibodies, respectively. Additionally, the antibody names may be an abbreviated form of the name shown in Table 1. For instance antibody AB-PG1-XG1-006 may be referred to as AB-PG1-XG1-006, PG1-XG1-006, XG1-006, 006, etc. In another example, the antibody name PSMA 4.232.3 may be referred to as PSMA 4.232.1, 4.232.3, 4.232.1, 4.232, etc. It is intended that all of the variations in the name of the antibody refer to the same antibody and not a different one. <span style="display: none" class="style-scope patent-text">[0190] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0191]" class="style-scope patent-text">
    
    [0191]
  </para-num> <div id="P-0191" num="0191" class="description-line style-scope patent-text">Antibodies are also provided that are encoded by particular sets of heavy and light chain sequences. In one embodiment an antibody (AB-PG1-XG1-006) encoded by a nucleic acid molecule which comprises the coding region or regions of the nucleic acid sequences set forth as :SEQ ID NOs: 2 and 8 is provided. In another embodiment the antibody (AB-PG1-XG1-026) is encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 3 and 9. In still another embodiment the antibody (AB-PG1-XG1-051) is encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 4 and 10. In yet another embodiment the antibody (AB-PG1-XG1-069) is encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 5 and 11. In another embodiment the antibody (AB-PG1-XG1-077) is encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 6 and 12. In yet another embodiment the antibody (PSMA 10.3) is encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 7 and 13. <span style="display: none" class="style-scope patent-text">[0191] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0192]" class="style-scope patent-text">
    
    [0192]
  </para-num> <div id="P-0192" num="0192" class="description-line style-scope patent-text">In particularly preferred embodiments, the antibodies include a heavy chain variable region encoded by a nucleic acid molecule comprising the coding regions or regions of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 14, 18, 22, 26 and 30, and a light chain variable region encoded by a nucleic 10 acid molecule comprising the coding region or region of a nucleotide sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 16, 20, 24, 28 and 32. As used herein, a coding region refers to a region of a nucleotide sequence that encodes a polypeptide sequence; the coding region can include a region coding for a portion of a protein that is later cleaved off, such as a signal peptide. <span style="display: none" class="style-scope patent-text">[0192] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0193]" class="style-scope patent-text">
    
    [0193]
  </para-num> <div id="P-0193" num="0193" class="description-line style-scope patent-text">Those of skill in the art will appreciate that the invention includes nucleic acids and polypeptides that include nucleotide and amino acid sequences presented herein. In some instances, the nucleotide and amino acid sequences may include sequences that encode or that are signal peptides. The invention embraces each of these sequences with, or without, the portion of the sequence that encodes or is a signal peptide. <span style="display: none" class="style-scope patent-text">[0193] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0194]" class="style-scope patent-text">
    
    [0194]
  </para-num> <div id="P-0194" num="0194" class="description-line style-scope patent-text">Antibodies also are provided that include particular sets of heavy and light chain variable sequences. In one embodiment an antibody (AB-PG1-XG1-006) includes an immunoglobulin variable sequence encoded by nucleic acid molecules which included the coding region or regions of the nucleic acid sequences set forth as :SEQ ID NOs: 14 and 16 is provided. Likewise the antibody may include an immunoglobulin variable sequence which comprises the amino acid sequences set forth as SEQ ID NOs: 15 and 17. In another embodiment the antibody (AB-PG1-XG1-026) includes an immunoglobulin variable sequence encoded by nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 18 and 20 or includes an immunoglobulin variable sequence which comprises the amino acid sequences set forth as SEQ ID NOs: 19 and 21. In still another embodiment the antibody (AB-PG1-XG1-051) includes an immunoglobulin variable sequence encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 22 and 24 or includes an immunoglobulin variable sequence which comprises the amino acid sequences set forth as SEQ ID NOs: 23 and 25. In yet another embodiment the antibody (AB-PG1-XG1-069) includes an immunoglobulin variable sequence encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 26 and 28 or includes an immunoglobulin variable sequence which comprises the amino acid sequences set forth as SEQ ID NOs: 27 and 29. In another embodiment the antibody (AB-PG1-XG1-077) includes an immunoglobulin variable sequence encoded by the nucleic acid molecules comprising the coding region or regions of nucleotide sequences set forth as: SEQ ID NOs: 30 and 32 or includes an immunoglobulin variable sequence which comprises the amino acid sequences set forth as SEQ ID NOs: 31 and 33. <span style="display: none" class="style-scope patent-text">[0194] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0195]" class="style-scope patent-text">
    
    [0195]
  </para-num> <div id="P-0195" num="0195" class="description-line style-scope patent-text">In certain embodiments, the antibody is encoded by a nucleic acid molecule that is highly homologous to the foregoing nucleic acid molecules. Preferably the homologous nucleic acid molecule comprises a nucleotide sequence that is at least about 90% identical to the nucleotide sequence provided herein. More preferably, the nucleotide sequence is at least about 95% identical, at least about 97% identical, at least about 98% identical, or at least about 99% identical to the nucleotide sequence provided herein. The homology can be calculated using various, publicly available software tools well known to one of ordinary skill in the art. Exemplary tools include the BLAST system available from the website of the National Center for Biotechnology Information (NCBI) at the National Institutes of Health. <span style="display: none" class="style-scope patent-text">[0195] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0196]" class="style-scope patent-text">
    
    [0196]
  </para-num> <div id="P-0196" num="0196" class="description-line style-scope patent-text">One method of identifying highly homologous nucleotide sequences is via nucleic acid hybridization. Thus the invention also includes antibodies having the PSMA-binding properties and other functional properties described herein, which are encoded by nucleic acid molecules that hybridize under high stringency conditions to the foregoing nucleic acid molecules. Identification of related sequences can also be achieved using polymerase chain reaction (PCR) and other amplification techniques suitable for cloning related nucleic acid sequences. Preferably, PCR primers are selected to amplify portions of a nucleic acid sequence of interest, such as a CDR. <span style="display: none" class="style-scope patent-text">[0196] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0197]" class="style-scope patent-text">
    
    [0197]
  </para-num> <div id="P-0197" num="0197" class="description-line style-scope patent-text">The term high stringency conditions as used herein refers to parameters with which the art is familiar. Nucleic acid hybridization parameters may be found in references that compile such methods, e.g. <span style="display: none" class="style-scope patent-text">[0197] </span> <i class="style-scope patent-text">Molecular Cloning: A Laboratory Manual</i>, J. Sambrook, et al., eds., Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989, or <i class="style-scope patent-text">Current Protocols in Molecular Biology</i>, F. M. Ausubel, et al., eds., John Wiley &amp; Sons, Inc., New York. One example of high-stringency conditions is hybridization at 65 C. in hybridization buffer (3.5SSC, 0.02% Ficoll, 0.02% polyvinyl pyrrolidone, 0.02% Bovine Serum Albumin, 2.5 mM NaH<sub class="style-scope patent-text">2</sub>PO<sub class="style-scope patent-text">4</sub>(pH7), 0.5% SDS, 2 mM EDTA). SSC is 0.15M sodium chloride/0.015M sodium citrate, pH7; SDS is sodium dodecyl sulphate; and EDTA is ethylenediaminetetracetic acid. After hybridization, a membrane upon which the nucleic acid is transferred is washed, for example, in 2SSC at room temperature and then at 0.1-0.5SSC/0.1SDS at temperatures up to 68 C. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0198]" class="style-scope patent-text">
    
    [0198]
  </para-num> <div id="P-0198" num="0198" class="description-line style-scope patent-text">In other preferred embodiments, the antibodies include a heavy chain variable region comprising an amino acid sequence selected from the group consisting of amino acid sequences set forth as: SEQ ID NOs: 15, 19, 23, 27 and 31, and a light chain variable region comprising an amino acid sequence selected from the group consisting of nucleotide sequences set forth as: SEQ ID NOs: 17, 21, 25, 29 and 33. Antigen-binding fragments of the foregoing also are provided, as described elsewhere herein. <span style="display: none" class="style-scope patent-text">[0198] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0199]" class="style-scope patent-text">
    
    [0199]
  </para-num> <div id="P-0199" num="0199" class="description-line style-scope patent-text">As used herein, the term antibody refers to a glycoprotein comprising at least two heavy (H) chains and two light (L) chains inter-connected by disulfide bonds. Each heavy chain is comprised of a heavy chain variable region (abbreviated herein as HCVR or V<span style="display: none" class="style-scope patent-text">[0199] </span> <sub class="style-scope patent-text">H</sub>) and a heavy chain constant region. The heavy chain constant region is comprised of three domains, <figure-callout id="1" label="C" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C<sub class="style-scope patent-text"> </sub> </a></figure-callout> <sub class="style-scope patent-text">H</sub>1, <figure-callout id="2" label="C" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C<sub class="style-scope patent-text"> </sub> </a></figure-callout> <sub class="style-scope patent-text">H</sub>2 and <figure-callout id="3" label="C" filenames="US20040161776A1-20040819-D00004.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C<sub class="style-scope patent-text"> </sub> </a></figure-callout> <sub class="style-scope patent-text">H</sub>3. Each light chain is comprised of a light chain variable region (abbreviated herein as LCVR or V<sub class="style-scope patent-text">L</sub>) and a light chain constant region. The light chain constant region is comprised of one domain, CL. The V<sub class="style-scope patent-text">H </sub>and V<sub class="style-scope patent-text">L </sub>regions can be further subdivided into regions of hypervariability, termed complementarity determining regions (CDR), interspersed with regions that are more conserved, termed framework regions (FR). Each V<sub class="style-scope patent-text">H </sub>and V<sub class="style-scope patent-text">L </sub>is composed of three CDRs and four FRs, arranged from amino-terminus to carboxy-terminus in the following order: FR1, CDR1, FR2, CDR2, FR3, CDR3, FR4. The variable regions of the heavy and light chains contain a binding domain that interacts with an antigen. The constant regions of the antibodies may mediate the binding of the immunoglobulin to host tissues or factors, including various cells of the immune system (e.g., effector cells) and the first component (C1q) of the classical complement system. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0200]" class="style-scope patent-text">
    
    [0200]
  </para-num> <div id="P-0200" num="0200" class="description-line style-scope patent-text">The term antigen-binding fragment of an antibody as used herein, refers to one or more portions of an antibody that retain the ability to specifically bind to an antigen (e.g., PSMA). It has been shown that the antigen-binding function of an antibody can be performed by fragments of a full-length antibody. Examples of binding fragments encompassed within the term antigen-binding fragment of an antibody include (i) a Fab fragment, a monovalent fragment consisting of the V<span style="display: none" class="style-scope patent-text">[0200] </span> <sub class="style-scope patent-text">L</sub>, V<sub class="style-scope patent-text">H</sub>, C<sub class="style-scope patent-text">L </sub>and <figure-callout id="1" label="C" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C<sub class="style-scope patent-text"> </sub> </a></figure-callout> <sub class="style-scope patent-text">H</sub>1 domains; (ii) a F(ab)<sub class="style-scope patent-text">2 </sub>fragment, a bivalent fragment comprising two Fab fragments linked by a disulfide bridge at the hinge region; (iii) a Fd fragment consisting of the V<sub class="style-scope patent-text">H </sub>and <figure-callout id="1" label="C" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C<sub class="style-scope patent-text"> </sub> </a></figure-callout> <sub class="style-scope patent-text">H</sub>1 domains; (iv) a Fv fragment consisting of the V<sub class="style-scope patent-text">L </sub>and V<sub class="style-scope patent-text">H </sub>domains of a single arm of an antibody, (v) a dAb fragment (Ward et al., (1989) <i class="style-scope patent-text">Nature </i>341:544-546) which consists of a V<sub class="style-scope patent-text">H </sub>domain; and (vi) an isolated complementarity determining region (CDR). Furthermore, although the two domains of the Fv fragment, V and V<sub class="style-scope patent-text">H</sub>, are coded for by separate genes, they can be joined, using recombinant methods, by a synthetic linker that enables them to be made as a single protein chain in which the V<sub class="style-scope patent-text">L </sub>and V<sub class="style-scope patent-text">H </sub>regions pair to form monovalent molecules (known as single chain Fv (scFv); see e.g., Bird et al. (1988) <i class="style-scope patent-text">Science </i>242:423-426; and Huston et al. (1988) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. USA </i>85:5879-5883). Such single chain antibodies are also intended to be encompassed within the term antigen-binding portion of an antibody. These antibody fragments are obtained using conventional procedures, such as proteolytic fragmentation procedures, as described in J. Goding, Monoclonal Antibodies: Principles and Practice, pp 98-118 (N.Y. Academic Press 1983), which is hereby incorporated by reference as well as by other techniques known to those with skill in the art. The fragments are screened for utility in the same manner as are intact antibodies. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0201]" class="style-scope patent-text">
    
    [0201]
  </para-num> <div id="P-0201" num="0201" class="description-line style-scope patent-text">An isolated antibody, as used herein, is intended to refer to an antibody which is substantially free of other antibodies having different antigenic specificities (e.g., an isolated antibody that specifically binds to PSMA is substantially free of antibodies that specifically bind antigens other than PSMA). An isolated antibody that specifically binds to an epitope, isoform or variant of PSMA may, however, have cross-reactivity to other related antigens, e.g., from other species (e.g., PSMA species homologs). Moreover, an isolated antibody may be substantially free of other cellular material and/or chemicals. As used herein, specific binding refers to antibody binding to a predetermined antigen. Typically, the antibody binds with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen. <span style="display: none" class="style-scope patent-text">[0201] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0202]" class="style-scope patent-text">
    
    [0202]
  </para-num> <div id="P-0202" num="0202" class="description-line style-scope patent-text">The isolated antibodies of the invention encompass various antibody isotypes, such as IgG1, IgG2, IgG3, IgG4, IgM, IgA1, IgA2, IgAsec, IgD, IgE. As used herein, isotype refers to the antibody class (e.g. IgM or IgG1) that is encoded by heavy chain constant region genes. The antibodies can be full length or can include only an antigen-binding fragment such as the antibody constant and/or variable domain of IgG1, IgG2, IgG3, IgG4, IgM, IgA1, IgA2, IgAsec, IgD or IgE or could consist of a Fab fragment, a F(ab)<span style="display: none" class="style-scope patent-text">[0202] </span> <sub class="style-scope patent-text">2 </sub>fragment, and a Fv fragment. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0203]" class="style-scope patent-text">
    
    [0203]
  </para-num> <div id="P-0203" num="0203" class="description-line style-scope patent-text">The antibodies of the present invention can be polyclonal, monoclonal, or a mixture of polyclonal and monoclonal antibodies. The antibodies can be produced by a variety of techniques well known in the art. Procedures for raising polyclonal antibodies are well known. For example anti-PSMA polyclonal antibodies are raised by administering PSMA protein subcutaneously to New Zealand white rabbits which have first been bled to obtain pre-immune serum. The PSMA can be injected at a total volume of 100 l per site at six different sites, typically with one or more adjustments. The rabbits are then bled two weeks after the first injection and periodically boosted with the same antigen three times every six weeks. A sample of serum is collected 10 days after each boost. Polyclonal antibodies are recovered from the serum, preferably by affinity chromatography using PSMA to capture the antibody. This and other procedures for raising polyclonal antibodies are disclosed in E. Harlow, et. al., editors, Antibodies: A Laboratory Manual (1988), which is hereby incorporated by reference. <span style="display: none" class="style-scope patent-text">[0203] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0204]" class="style-scope patent-text">
    
    [0204]
  </para-num> <div id="P-0204" num="0204" class="description-line style-scope patent-text">Monoclonal antibody production may be effected by techniques which are also well known in the art. The term monoclonal antibody, as used herein, refers to a preparation of antibody molecules of single molecular composition. A monoclonal antibody displays a single binding specificity and affinity for a particular epitope. The process of monoclonal antibody production involves obtaining immune somatic cells with the potential for producing antibody, in particular B lymphocytes, which have been previously immunized with the antigen of interest either in vivo or in vitro and that are suitable for fusion with a B-cell myeloma line. <span style="display: none" class="style-scope patent-text">[0204] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0205]" class="style-scope patent-text">
    
    [0205]
  </para-num> <div id="P-0205" num="0205" class="description-line style-scope patent-text">Mammalian lymphocytes typically are immunized by in vivo immunization of the animal (e.g., a mouse) with the desired protein or polypeptide, e.g., with PSMA in the present invention. Such immunizations are repeated as necessary at intervals of up to several weeks to obtain a sufficient titer of antibodies. Once immunized, animals can be used as a source of antibody-producing lymphocytes. Following the last antigen boost, the animals are sacrificed and spleen cells removed. Mouse lymphocytes give a higher percentage of stable fusions with the mouse myeloma lines described herein. Of these, the BALB/c mouse is preferred. However, other mouse strains, rabbit, hamster, sheep and frog may also be used as hosts for preparing antibody-producing cells. See; Goding (in Monoclonal Antibodies: Principles and Practice, 2d ed., pp. 60-61, Orlando, Fla., Academic Press, 1986). In particular, mouse strains that have human immunoglobulin genes inserted in the genome (and which cannot produce mouse immunoglobulins) are preferred. Examples include the HuMAb mouse strains produced by Medarex/GenPharm International, and the XenoMouse strains produced by Abgenix. Such mice produce fully human immunoglobulin molecules in response to immunization. <span style="display: none" class="style-scope patent-text">[0205] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0206]" class="style-scope patent-text">
    
    [0206]
  </para-num> <div id="P-0206" num="0206" class="description-line style-scope patent-text">Those antibody-producing cells that are in the dividing plasmablast stage fuse preferentially. Somatic cells may be obtained from the lymph nodes, spleens and peripheral blood of antigen-primed animals, and the lymphatic cells of choice depend to a large extent on their empirical usefulness in the particular fusion system. The antibody-secreting lymphocytes are then fused with (mouse) B cell myeloma cells or transformed cells, which are capable of replicating indefinitely in cell culture, thereby producing an immortal, immunoglobulin-secreting cell line. The resulting fused cells, or hybridomas, are cultured, and the resulting colonies screened for the production of the desired monoclonal antibodies. Colonies producing such antibodies are cloned, and grown either in vivo or in vitro to produce large quantities of antibody. A description of the theoretical basis and practical methodology of fusing such cells is set forth in Kohler and Milstein, <span style="display: none" class="style-scope patent-text">[0206] </span> <i class="style-scope patent-text">Nature </i>256:495 (1975), which is hereby incorporated by reference. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0207]" class="style-scope patent-text">
    
    [0207]
  </para-num> <div id="P-0207" num="0207" class="description-line style-scope patent-text">Alternatively, human somatic cells capable of producing antibody, specifically B lymphocytes, are suitable for fusion with myeloma cell lines. While B lymphocytes from biopsied spleens, tonsils or lymph nodes of an individual may be used, the more easily accessible peripheral blood B lymphocytes are preferred. The lymphocytes may be derived from patients with diagnosed prostate carcinomas or another PSMA-expressing cancer. In addition, human B cells may be directly immortalized by the Epstein-Barr virus (Cole et al., 1995, Monoclonal Antibodies and Cancer Therapy, Alan R. Liss, Inc., pp. 77-96). Although somatic cell hybridization procedures are preferred, in principle, other techniques for producing monoclonal antibodies can be employed such as viral or oncogenic transformation of B lymphocytes. <span style="display: none" class="style-scope patent-text">[0207] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0208]" class="style-scope patent-text">
    
    [0208]
  </para-num> <div id="P-0208" num="0208" class="description-line style-scope patent-text">Myeloma cell lines suited for use in hybridoma-producing fusion procedures preferably are non-antibody-producing, have high fusion efficiency, and enzyme deficiencies that render them incapable of growing in certain selective media which support the growth of the desired hybridomas. Examples of such myeloma cell lines that may be used for the production of fused cell lines include P3-X63/Ag8, X63-Ag8.653, NS1/1.Ag 4.1, Sp2/0-Ag14, FO, NSO/U, MPC-11, MPC11-X45-GTG 1.7, S194/5XX0 Bul, all derived from mice; R210.RCY3, Y3-Ag 1.2.3, IR983F and 4B210 derived from rats and U-266, GM1500-GRG2, LICR-LON-HMy2, UC729-6, all derived from humans (Goding, in Monoclonal Antibodies: Principles and Practice, 2d ed., pp. 65-66, Orlando, Fla., Academic Press, 1986; Campbell, in Monoclonal Antibody Technology, Laboratory Techniques in Biochemistry and Molecular Biology Vol. 13, Burden and Von Knippenberg, eds. pp. 75-83, Amsterdam, Elseview, 1984). <span style="display: none" class="style-scope patent-text">[0208] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0209]" class="style-scope patent-text">
    
    [0209]
  </para-num> <div id="P-0209" num="0209" class="description-line style-scope patent-text">Fusion with mammalian myeloma cells or other fusion partners capable of replicating indefinitely in cell culture is effected by standard and well-known techniques, for example, by using polyethylene glycol (PEG) or other fusing agents (See Milstein and Kohler, <span style="display: none" class="style-scope patent-text">[0209] </span> <i class="style-scope patent-text">Eur. J. Immunol. </i>6:511 (1976), which is hereby incorporated by reference). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0210]" class="style-scope patent-text">
    
    [0210]
  </para-num> <div id="P-0210" num="0210" class="description-line style-scope patent-text">In other embodiments, the antibodies can be recombinant antibodies. The term recombinant antibody, as used herein, is intended to include antibodies that are prepared, expressed, created or isolated by recombinant means, such as antibodies isolated from an animal (e.g., a mouse) that is transgenic for another species' immunoglobulin genes, antibodies expressed using a recombinant expression vector transfected into a host cell, antibodies isolated from a recombinant, combinatorial antibody library, or antibodies prepared, expressed, created or isolated by any other means that involves splicing of immunoglobulin gene sequences to other DNA sequences. <span style="display: none" class="style-scope patent-text">[0210] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0211]" class="style-scope patent-text">
    
    [0211]
  </para-num> <div id="P-0211" num="0211" class="description-line style-scope patent-text">In yet other embodiments, the antibodies can be chimeric or humanized antibodies. As used herein, the term chimeric antibody refers to an antibody, that combines the murine variable or hypervariable regions with the human constant region or constant and variable framework regions. As used herein, the term humanized antibody refers to an antibody that retains only the antigen-binding CDRs from the parent antibody in association with human framework regions (see, Waldmann, 1991, <span style="display: none" class="style-scope patent-text">[0211] </span> <i class="style-scope patent-text">Science </i>252:1657). Such chimeric or humanized antibodies retaining binding specificity of the murine antibody are expected to have reduced immunogenicity when administered in vivo for diagnostic, prophylactic or therapeutic applications according to the invention. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0212]" class="style-scope patent-text">
    
    [0212]
  </para-num> <div id="P-0212" num="0212" class="description-line style-scope patent-text">According to an alternative embodiment, the monoclonal antibodies of the present invention can be modified to be in the form of a bispecific antibody, or a multispecific antibody. The term bispecific antibody is intended to include any agent, e.g., a protein, peptide, or protein or peptide complex, which has two different binding specificities which bind to, or interact with (a) a cell surface antigen and (b) an Fc receptor on the surface of an effector cell. The term multispecific antibody is intended to include any agent, e.g., a protein, peptide, or protein or peptide complex, which has more than two different binding specificities which bind to, or interact with (a) a cell surface antigen, (b) an Fc receptor on the surface of an effector cell, and (c) at least one other component. Accordingly, the invention includes, but is not limited to, bispecific, trispecific, tetraspecific, and other multispecific antibodies which are directed to cell surface antigens, such as PSMA, and to Fc receptors on effector cells. The term bispecific antibodies further includes diabodies. Diabodies are bivalent, bispecific antibodies in which the V<span style="display: none" class="style-scope patent-text">[0212] </span> <sub class="style-scope patent-text">H </sub>and V<sub class="style-scope patent-text">L </sub>domains are expressed on a single polypeptide chain, but using a linker that is too short to allow for pairing between the two domains on the same chain, thereby forcing the domains to pair with complementary domains of another chain and creating two antigen-binding sites (see e.g., Holliger, P., et al. (1993) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. USA </i>90:6444-6448; Poijak, R. J., et al. (1994) <i class="style-scope patent-text">Structure </i>2:1121-1123). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0213]" class="style-scope patent-text">
    
    [0213]
  </para-num> <div id="P-0213" num="0213" class="description-line style-scope patent-text">A bispecific antibody can be formed of an antigen-binding region specific for the extracellular domain of PSMA and an antigen-binding region specific for an effector cell which has tumoricidal or tumor inhibitory activity. The two antigen-binding regions of the bispecific antibody are either chemically linked or can be expressed by a cell genetically engineered to produce the bispecific antibody. (See generally, Fanger et al., 1995 <span style="display: none" class="style-scope patent-text">[0213] </span> <i class="style-scope patent-text">Drug News </i>&amp; <i class="style-scope patent-text">Perspec. </i>8(3):133-137). Suitable effector cells having tumoricidal activity include but are not limited to cytotoxic T-cells (primarily CD8<sup class="style-scope patent-text">+</sup> cells), natural killer cells, etc. An effective amount of a bispecific antibody according to the invention is administered to a prostrate cancer patient and the bispecific antibody kills and/or inhibits proliferation of the malignant cells after localization at sites of primary or metastatic tumors bearing PSMA. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0214]" class="style-scope patent-text">
    
    [0214]
  </para-num> <div id="P-0214" num="0214" class="description-line style-scope patent-text">In certain embodiments, the antibodies are human antibodies. The term human antibody, as used herein, is intended to include antibodies having variable and constant regions derived from human germline immunoglobulin sequences. The human antibodies of the invention may include amino acid residues not encoded by human germline immunoglobulin sequences (e.g., mutations introduced by random or site-specific mutagenesis in vitro or by somatic mutation in vivo). However, the term human antibody, as used herein, is not intended to include antibodies in which CDR sequences derived from the germline of another mammalian species, such as a mouse have been grafted onto human framework sequences (referred to herein as humanized antibodies). Human antibodies directed against PSMA are generated using transgenic mice carrying parts of the human immune system rather than the mouse system. <span style="display: none" class="style-scope patent-text">[0214] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0215]" class="style-scope patent-text">
    
    [0215]
  </para-num> <div id="P-0215" num="0215" class="description-line style-scope patent-text">Fully human monoclonal antibodies also can be prepared by immunizing mice transgenic for large portions of human immunoglobulin heavy and light chain loci. See, e.g., U.S. Pat. Nos. 5,591,669, 5,598,369, 5,545,806, 5,545,807, 6,150,584, and references cited therein, the contents of which are incorporated herein by reference. These animals have been genetically modified such that there is a functional deletion in the production of endogenous (e.g., murine) antibodies. The animals are further modified to contain all or a portion of the human germ-line immunoglobulin gene locus such that immunization of these animals results in the production of fully human antibodies to the antigen of interest. Following immunization of these mice (e.g., XenoMouse (Abgenix), HuMAb mice (Medarex/GenPharm)), monoclonal antibodies are prepared according to standard hybridoma technology. These monoclonal antibodies have human immunoglobulin amino acid sequences and therefore will not provoke human anti-mouse antibody (HAMA) responses when administered to humans. <span style="display: none" class="style-scope patent-text">[0215] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0216]" class="style-scope patent-text">
    
    [0216]
  </para-num> <div id="P-0216" num="0216" class="description-line style-scope patent-text">Preferably, the mice are 6-16 weeks of age upon the first immunization. For example, a purified or enriched preparation of PSMA antigen (e.g., recombinant PSMA, PSMA-expressing cells, dimeric PSMA) is used to immunize the mice intraperitoneally (IP), although other routes of immunization known to one of ordinary skill in the art are also possible. PSMA antigen is injected in combination with an adjuvant, such as complete Freund's adjuvant, and preferably the initial injection is followed by booster immunizations with antigen in an adjuvant, such as incomplete Freund's adjuvant. The immune response is monitored over the course of the immunization protocol with plasma samples obtained by, for example, retroorbital bleeds. The plasma is screened by ELISA (as described below), and mice with sufficient titers of anti-PSMA human immunoglobulin are used for fusions. Mice are boosted intravenously with <span style="display: none" class="style-scope patent-text">[0216] </span> <figure-callout id="3" label="antigen" filenames="US20040161776A1-20040819-D00004.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">antigen</a></figure-callout> 3 days before sacrifice and removal of the spleen. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0217]" class="style-scope patent-text">
    
    [0217]
  </para-num> <div id="P-0217" num="0217" class="description-line style-scope patent-text">In particular embodiments, the antibodies are produced by hybridomas referred to herein as PSMA 3.7 (PTA-3257), PSMA 3.8, PSMA 3.9 (PTA-3258), PSMA 3.11 (PTA-3269), PSMA 5.4 (PTA-3268), PSMA 7.1 (PTA-3292), PSMA 7.3 (PTA-3293), PSMA 10.3 (PTA-3247), PSMA 1.8.3 (PTA-3906), PSMA A3.1.3 (PTA-3904), PSMA A3.3.1 (PTA-3905), Abgenix 4.248.2 (PTA-4427), Abgenix 4.360.3 (PTA-4428), Abgenix 4.7.1 (PTA-4429), Abgenix 4.4.1 (PTA-4556), Abgenix 4.177.3 (PTA-4557), Abgenix 4.16.1 (PTA-4357), Abgenix 4.22.3 (PTA-4358), Abgenix 4.28.3 (PTA-4359), Abgenix 4.40.2 (PTA-4360), Abgenix 4.48.3 (PTA-4361), Abgenix 4.49.1 (PTA-4362), Abgenix 4.209.3 (PTA-4365), Abgenix 4.219.3 (PTA-4366), Abgenix 4.288.1 (PTA-4367), Abgenix 4.333.1 (PTA-4368), Abgenix 4.54.1 (PTA-4363), Abgenix 4.153.1 (PTA-4388), Abgenix 4.232.3 (PTA-4389), Abgenix 4.292.3 (PTA-4390), Abgenix 4.304.1 (PTA-4391), Abgenix 4.78.1 (PTA-4652), and Abgenix 4.152.1 (PTA-4653). These hybridomas were deposited pursuant to, and in satisfaction of, the requirements of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure with the American Type Culture Collection (ATCC) as an International Depository Authority and given the Patent Deposit Designations shown above and in Table 1. <span style="display: none" class="style-scope patent-text">[0217] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0218]" class="style-scope patent-text">
    
    [0218]
  </para-num> <div id="P-0218" num="0218" class="description-line style-scope patent-text">The present invention further provides nucleic acid molecules encoding anti-PSMA antibodies and vectors comprising the nucleic acid molecules as described herein. The vectors provided can be used to transform or transfect host cells for producing anti-PSMA antibodies with the specificity of antibodies described herein. In a preferred embodiment the antibodies produced will have the specificity of the antibodies AB-PG1-XG1-006, AB-PG1-XG1-026, AB-PG1-XG1-051, AB-PG1, XG1-069, AB-PG1-XG1-077 and PSMA 10.3. In one embodiment the vectors can comprise an isolated nucleic acid molecule encoding the heavy chain of the antibodies listed above encoded by a nucleic acid molecules comprising the coding region or regions of the nucleic acid sequences set forth as SEQ ID NO: 2-7. In another embodiment, the vectors can comprise the nucleic acid sequences encoding the light chain of the antibodies set forth as SEQ ID NOs: 8-13. In a further embodiment the vectors of the invention may comprise a heavy chain and a light chain sequence. In a further embodiment, plasmids are given which produce the antibodies or antigen binding fragments described herein. Plasmids of the invention include plasmids selected from the group consisting of: AB-PG1-XG1-006 Heavy Chain (SEQ ID NO: 2), AB-PG1-XG1-006 Light Chain (SEQ ID NO: 8), AB-PG1-XG1-026 Heavy Chain (SEQ ID NO: 3), AB-PG1-XG1-026 Light Chain (SEQ ID NO: 9), AB-PG1-XG1-051 Heavy Chain (SEQ ID NO: 4), AB-PG1-XG1-051 Light Chain (SEQ ID NO: 10), AB-PG1-XG1-069 Heavy Chain (SEQ ID NO: 5), AB-PG1-XG1-069 Light Chain (SEQ ID NO: 11), AB-PG1-XG1-077 Heavy Chain (SEQ ID NO: 6), AB-PG1-XG1-077 Light Chain (SEQ ID NO: 12), PSMA 10.3 Heavy Chain (SEQ ID NO: 7), and PSMA 10.3 Kappa (SEQ ID NO: 13). <span style="display: none" class="style-scope patent-text">[0218] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0219]" class="style-scope patent-text">
    
    [0219]
  </para-num> <div id="P-0219" num="0219" class="description-line style-scope patent-text">The isolated antibody or antigen-binding fragment thereof preferably is selected for its ability to bind live cells expressing PSMA. In order to demonstrate binding of monoclonal antibodies to live cells expressing the PSMA, flow cytometry can be used. For example, cell lines expressing PSMA (grown under standard growth conditions) or prostate cancer cells that express PSMA are mixed with various concentrations of monoclonal antibodies in PBS containing 0.1<span style="display: none" class="style-scope patent-text">[0219] </span> <figure-callout id="80" label="% Tween" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00010.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="20" label="% Tween" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% Tween</a></figure-callout> </a></figure-callout> 80 and 20% mouse serum, and incubated at 37 C. for 1 hour. After washing, the cells are reacted with fluorescein-labeled anti-human IgG secondary antibody (if human anti-PSMA antibodies were used) under the same conditions as the primary antibody staining. The samples can be analyzed by a fluorescence activated cell sorter (FACS) instrument using light and side scatter properties to gate on single cells. An alternative assay using fluorescence microscopy may be used (in addition to or instead of) the flow cytometry assay. Cells can be stained exactly as described above and examined by fluorescence microscopy. This method allows visualization of individual cells, but may have diminished sensitivity depending on the density of the antigen. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0220]" class="style-scope patent-text">
    
    [0220]
  </para-num> <div id="P-0220" num="0220" class="description-line style-scope patent-text">Binding of the antibody or antigen-binding fragment thereof to live cells expressing PSMA can inhibit the growth of the cells or mediate cytolysis of the cells. Cytolysis can be complement mediated or can be mediated by effector cells. In a preferred embodiment, the cytolysis is carried out in a living organism, preferably a mammal, and the live cell is a tumor cell. Examples of tumors which can be targeted by the antibodies of the invention include, any tumor that expresses PSMA, such as, prostate, bladder, pancreas, lung, colon, kidney, melanomas and sarcomas. In a preferred embodiment the tumor cell is a prostate cancer cell. <span style="display: none" class="style-scope patent-text">[0220] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0221]" class="style-scope patent-text">
    
    [0221]
  </para-num> <div id="P-0221" num="0221" class="description-line style-scope patent-text">The testing of antibody cytolytic activity in vitro by chromium release assay can provide an initial screening prior to testing in vivo models. This testing can be carried out using standard chromium release assays. Briefly, polymorphonuclear cells (PMN), or other effector cells, from healthy donors can be purified by Ficoll Hypaque density centrifugation, followed by lysis of contaminating erythrocytes. Washed PMNs can be suspended in RPMI supplemented with 10% heat-inactivated fetal calf serum and mixed with <span style="display: none" class="style-scope patent-text">[0221] </span> <sup class="style-scope patent-text">51</sup>Cr labeled cells expressing PSMA, at various ratios of effector cells to tumor cells (effector cells:tumor cells). Purified anti-PSMA IgGs can then be added at various concentrations. Irrelevant IgG can be used as negative control. Assays can be carried out for 0-120 minutes at 37 C. Samples can be assayed for cytolysis by measuring <sup class="style-scope patent-text">51</sup>Cr release into the culture supernatant. Anti-PSMA monoclonal antibodies can also be tested in combinations with each other to determine whether cytolysis is enhanced with multiple monoclonal antibodies. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0222]" class="style-scope patent-text">
    
    [0222]
  </para-num> <div id="P-0222" num="0222" class="description-line style-scope patent-text">Antibodies which bind to PSMA also can be tested in an in vivo model (e.g., in mice) to determine their efficacy in mediating cytolysis and killing of cells expressing PSMA, e.g., tumor cells. These antibodies can be selected, for example, based on the following criteria, which are not intended to be exclusive: <span style="display: none" class="style-scope patent-text">[0222] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0223]" class="style-scope patent-text">
    
    [0223]
  </para-num> <div id="P-0223" num="0223" class="description-line style-scope patent-text">1) binding to live cells expressing PSMA; <span style="display: none" class="style-scope patent-text">[0223] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0224]" class="style-scope patent-text">
    
    [0224]
  </para-num> <div id="P-0224" num="0224" class="description-line style-scope patent-text">2) high affinity of binding to PSMA; <span style="display: none" class="style-scope patent-text">[0224] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0225]" class="style-scope patent-text">
    
    [0225]
  </para-num> <div id="P-0225" num="0225" class="description-line style-scope patent-text">3) binding to a unique epitope on PSMA (to eliminate the possibility that antibodies with complimentary activities when used in combination would compete for binding to the same epitope); <span style="display: none" class="style-scope patent-text">[0225] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0226]" class="style-scope patent-text">
    
    [0226]
  </para-num> <div id="P-0226" num="0226" class="description-line style-scope patent-text">4) opsonization of cells expressing PSMA; <span style="display: none" class="style-scope patent-text">[0226] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0227]" class="style-scope patent-text">
    
    [0227]
  </para-num> <div id="P-0227" num="0227" class="description-line style-scope patent-text">5) mediation of growth inhibition, phagocytosis and/or killing of cells expressing PSMA in the presence of effector cells; <span style="display: none" class="style-scope patent-text">[0227] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0228]" class="style-scope patent-text">
    
    [0228]
  </para-num> <div id="P-0228" num="0228" class="description-line style-scope patent-text">6) modulation (inhibition or enhancement) of NAALADase, folate hydrolase, dipeptidyl peptidase IV and/or -glutamyl hydrolase activities; <span style="display: none" class="style-scope patent-text">[0228] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0229]" class="style-scope patent-text">
    
    [0229]
  </para-num> <div id="P-0229" num="0229" class="description-line style-scope patent-text">7) growth inhibition, cell cycle arrest and/or cytotoxicity in the absence of effector cells; <span style="display: none" class="style-scope patent-text">[0229] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0230]" class="style-scope patent-text">
    
    [0230]
  </para-num> <div id="P-0230" num="0230" class="description-line style-scope patent-text">8) internalization of PSMA; <span style="display: none" class="style-scope patent-text">[0230] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0231]" class="style-scope patent-text">
    
    [0231]
  </para-num> <div id="P-0231" num="0231" class="description-line style-scope patent-text">9) binding to a conformational epitope on PSMA; <span style="display: none" class="style-scope patent-text">[0231] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0232]" class="style-scope patent-text">
    
    [0232]
  </para-num> <div id="P-0232" num="0232" class="description-line style-scope patent-text">10) minimal cross-reactivity with cells or tissues that do not express PSMA; and <span style="display: none" class="style-scope patent-text">[0232] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0233]" class="style-scope patent-text">
    
    [0233]
  </para-num> <div id="P-0233" num="0233" class="description-line style-scope patent-text">11) preferential binding to dimeric forms of PSMA rather than monomeric forms of PSMA. <span style="display: none" class="style-scope patent-text">[0233] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0234]" class="style-scope patent-text">
    
    [0234]
  </para-num> <div id="P-0234" num="0234" class="description-line style-scope patent-text">Preferred antibodies of the invention meet one or more, and preferably all, of these criteria. In a particular embodiment, the antibodies are used in combination, e.g., as a pharmaceutical composition comprising two or more different anti-PSMA antibodies or binding fragments thereof. For example, anti-PSMA antibodies having different, but complementary activities can be combined in a single therapy to achieve a desired therapeutic or diagnostic effect. An illustration of this would be a composition containing an anti-PSMA antibody that mediates highly effective killing of target cells in the presence of effector cells, combined with another anti-PSMA antibody that inhibits the growth of cells expressing PSMA. <span style="display: none" class="style-scope patent-text">[0234] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0235]" class="style-scope patent-text">
    
    [0235]
  </para-num> <div id="P-0235" num="0235" class="description-line style-scope patent-text">In a preferred aspect of the invention, the antibody or antigen-binding fragment thereof binds to a conformational epitope within the extracellular domain of the PSMA molecule. To determine if the selected human anti-PSMA antibodies bind to conformational epitopes, each antibody can be tested in assays using native protein (e.g., non-denaturing immunoprecipitation, flow cytometric analysis of cell surface binding) and denatured protein (e.g., Western blot, immunoprecipitation of denatured proteins). A comparison of the results will indicate whether the antibodies bind conformational epitopes. Antibodies that bind to native protein but not denatured protein are those antibodies that bind conformational epitopes, and are preferred antibodies. <span style="display: none" class="style-scope patent-text">[0235] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0236]" class="style-scope patent-text">
    
    [0236]
  </para-num> <div id="P-0236" num="0236" class="description-line style-scope patent-text">In another preferred aspect of the invention, the antibody or antigen-binding fragment thereof binds to a dimer-specific epitope on PSMA. Generally, antibodies or antigen-binding fragments thereof which bind to a dimer-specific epitope preferentially bind the PSMA dimer rather than the PSMA monomer. To determine if the selected human anti-PSMA antibodies bind preferentially (i.e., selectively and/or specifically) to a PSMA dimer, each antibody can be tested in assays (e.g., immunoprecipitation followed by Western blotting) using native dimeric PSMA protein and dissociated monomeric PSMA protein. A comparison of the results will indicate whether the antibodies bind preferentially to the dimer or to the monomer. Antibodies that bind to the PSMA dimer but not to the monomeric PSMA protein are preferred antibodies. <span style="display: none" class="style-scope patent-text">[0236] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0237]" class="style-scope patent-text">
    
    [0237]
  </para-num> <div id="P-0237" num="0237" class="description-line style-scope patent-text">Preferred antibodies include antibodies that competitively inhibit the specific binding of a second antibody to its target epitope on PSMA. To determine competitive inhibition, a variety of assays known to one of ordinary skill in the art can be employed. For example, the cross-competition assays set forth in Examples 4 and 21 can be used to determine if an antibody competitively inhibits binding to PSMA by another antibody. These examples provide cell-based methods employing flow cytometry or solid phase binding analysis. Other assays that evaluate the ability of antibodies to cross-compete for PSMA molecules that are not expressed on the surface of cells, in solid phase or in solution phase, also can be used. These assays preferably use the PSMA multimers described herein. <span style="display: none" class="style-scope patent-text">[0237] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0238]" class="style-scope patent-text">
    
    [0238]
  </para-num> <div id="P-0238" num="0238" class="description-line style-scope patent-text">Certain preferred antibodies competitively inhibit the specific binding of a second antibody to its target epitope on PSMA by at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 95%, or 99%. Inhibition can be assessed at various molar ratios or mass ratios; for example competitive binding experiments can be conducted with a 2-fold, 3-fold, 4-fold, 5-fold, 7-fold, 10-fold or more molar excess of the first antibody over the second antibody. <span style="display: none" class="style-scope patent-text">[0238] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0239]" class="style-scope patent-text">
    
    [0239]
  </para-num> <div id="P-0239" num="0239" class="description-line style-scope patent-text">Other preferred antibodies include antibodies that specifically (i.e., selectively) bind to an epitope on PSMA defined by a second antibody. To determine the epitope, one can use standard epitope mapping methods known in the art. For example, fragments (peptides) of PSMA antigen (preferably synthetic peptides) that bind the second antibody can be used to determine whether a candidate antibody binds the same epitope. For linear epitopes, overlapping peptides of a defined length (e.g., 8 or more amino acids) are synthesized. The peptides preferably are offset by 1 amino acid, such that a series of peptides covering every 8 amino acid fragment of the PSMA protein sequence are prepared. Fewer peptides can be prepared by using larger offsets, e.g., 2 or 3 amino acids. In addition, longer peptides (e.g., 9-, 10- or 11-mers) can be synthesized. Binding of peptides to antibodies can be determined using standard methodologies including surface plasmon resonance (BIACORE; see Example 22) and ELISA assays. For examination of conformational epitopes, larger PSMA fragments can be used. Other methods that use mass spectrometry to define conformational epitopes have been described and can be used (see, e.g., Baerga-Ortiz et al., <span style="display: none" class="style-scope patent-text">[0239] </span> <i class="style-scope patent-text">Protein Science </i>11: 1300-1308, 2002 and references cited therein). Still other methods for epitope determination are provided in standard laboratory reference works, such as Unit 6.8 (Phage Display Selection and Analysis of B-cell Epitopes) and Unit 9.8 (Identification of Antigenic Determinants Using Synthetic Peptide Combinatorial Libraries) of <i class="style-scope patent-text">Current Protocols in Immunology</i>, Coligan et al., eds., John Wiley &amp; Sons. Epitopes can be confirmed by introducing point mutations or deletions into a known epitope, and then testing binding with one or more antibodies to determine which mutations reduce binding of the antibodies. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0240]" class="style-scope patent-text">
    
    [0240]
  </para-num> <div id="P-0240" num="0240" class="description-line style-scope patent-text">In one embodiment of the invention the antibody or antigen-binding fragment thereof binds to and is internalized with PSMA expressed on cells. The mechanism by which the antibody or antigen-binding fragment thereof is internalized with the prostate specific membrane antigen is not critical to the practice of the present invention. For example, the antibody or antigen-binding fragment thereof can induce internalization of PSMA. Alternatively, internalization of the antibody or antigen-binding fragment thereof can be the result of routine internalization of PSMA. The antibody or antigen-binding fragment thereof can be used in an unmodified form, alone or in combination with other compositions. Alternatively, the antibody or antigen-binding fragment thereof can be bound to a substance effective to kill the cells upon binding of the antibody or antigen-binding fragment thereof to prostate specific membrane antigen and upon internalization of the biological agent with the prostate specific membrane antigen. <span style="display: none" class="style-scope patent-text">[0240] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0241]" class="style-scope patent-text">
    
    [0241]
  </para-num> <div id="P-0241" num="0241" class="description-line style-scope patent-text">The human PSMA antibodies of the present invention specifically bind cell-surface PSMA and/or rsPSMA with sub-nanomolar affinity. The human PSMA antibodies of the present invention have binding affinities of about 110<span style="display: none" class="style-scope patent-text">[0241] </span> <sup class="style-scope patent-text">9</sup>M or less, preferably about 110<sup class="style-scope patent-text">10</sup>M or less, more preferably 110<sup class="style-scope patent-text">11</sup>M or less. In a particular embodiment the binding affinity is less than about 510<sup class="style-scope patent-text">10</sup>M. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0242]" class="style-scope patent-text">
    
    [0242]
  </para-num> <div id="P-0242" num="0242" class="description-line style-scope patent-text">An antibody can be linked to a detectable marker, an antitumor agent or an immunomodulator. Antitumor agents can include cytotoxic agents and agents that act on tumor neovasculature. Detectable markers include, for example, radioactive or fluorescent markers. Cytotoxic agents include cytotoxic radionuclides, chemical toxins and protein toxins. <span style="display: none" class="style-scope patent-text">[0242] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0243]" class="style-scope patent-text">
    
    [0243]
  </para-num> <div id="P-0243" num="0243" class="description-line style-scope patent-text">The cytotoxic radionuclide or radiotherapeutic isotope preferably is an alpha-emitting isotope such as <span style="display: none" class="style-scope patent-text">[0243] </span> <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">211</sup>At, <sup class="style-scope patent-text">212</sup>Bi, <sup class="style-scope patent-text">213</sup>Bi, <sup class="style-scope patent-text">212</sup>Pb, <sup class="style-scope patent-text">224</sup>Ra or <sup class="style-scope patent-text">223</sup>Ra. Alternatively, the cytotoxic radionuclide may a beta-emitting isotope such as <sup class="style-scope patent-text">186</sup>Rh, <sup class="style-scope patent-text">188</sup>Rh, <sup class="style-scope patent-text">177</sup>Lu, <sup class="style-scope patent-text">90</sup>Y, <sup class="style-scope patent-text">131</sup>I, <sup class="style-scope patent-text">67</sup>Cu, <sup class="style-scope patent-text">64</sup>Cu, <sup class="style-scope patent-text">153</sup>Sm or <sup class="style-scope patent-text">166</sup>Ho. Further, the cytotoxic radionuclide may emit Auger and low energy electrons and include the isotopes <sup class="style-scope patent-text">125</sup>I, <sup class="style-scope patent-text">123</sup>I or <sup class="style-scope patent-text">77</sup>Br. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0244]" class="style-scope patent-text">
    
    [0244]
  </para-num> <div id="P-0244" num="0244" class="description-line style-scope patent-text">Suitable chemical toxins or chemotherapeutic agents include members of the enediyne family of molecules, such as calicheamicin and esperamicin. Chemical toxins can also be taken from the group consisting of methotrexate, doxorubicin, melphalan, chlorambucil, ARA-C, vindesine, mitomycin C, cis-platinum, etoposide, bleomycin and 5-fluorouracil. Other antineoplastic agents that may be conjugated to the anti-PSMA antibodies of the present invention include dolastatins (U.S. Pat. Nos. 6,034,065 and 6,239,104) and derivatives thereof. Of particular interest is dolastatin 10 (dolavaline-valine-dolaisoleuine-dolaproine-dolaphenine) and the derivatives auristatin PHE (dolavaline-valine-dolaisoleuine-dolaproine-phenylalanine-methyl ester) (Pettit, G. R. et al., <span style="display: none" class="style-scope patent-text">[0244] </span> <i class="style-scope patent-text">Anticancer Drug Des. </i>13(4):243-277, 1998; Woyke, T. et al., <i class="style-scope patent-text">Antimicrob. Agents Chemother. </i>45(12):3580-3584, 2001), and aurastatin E and the like. Toxins that are less preferred in the compositions and methods of the invention include poisonous lectins, plant toxins such as ricin, abrin, modeccin, botulina and diphtheria toxins. Of course, combinations of the various toxins could also be coupled to one antibody molecule thereby accommodating variable cytotoxicity. Other chemotherapeutic agents are known to those skilled in the art. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0245]" class="style-scope patent-text">
    
    [0245]
  </para-num> <div id="P-0245" num="0245" class="description-line style-scope patent-text">Toxin-conjugated forms of the PSMA antibodies of the present invention mediate specific cell killing of PSMA-expressing cells at picomolar concentrations. The toxin-conjugated PSMA antibodies of the present invention exhibit IC<span style="display: none" class="style-scope patent-text">[0245] </span> <sub class="style-scope patent-text">50</sub>s at concentrations of less than about 110<sup class="style-scope patent-text">10</sup>M, preferably less than about 110<sup class="style-scope patent-text">11</sup>M, more preferably less than about 110<sup class="style-scope patent-text">12</sup>M. In a particular embodiment an IC<sub class="style-scope patent-text">50 </sub>is achieved at a concetration of less than about 1.510<sup class="style-scope patent-text">11</sup>M. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0246]" class="style-scope patent-text">
    
    [0246]
  </para-num> <div id="P-0246" num="0246" class="description-line style-scope patent-text">Agents that act on the tumor vasculature can include tubulin-binding agents such as combrestatin A4 (Griggs et al., <span style="display: none" class="style-scope patent-text">[0246] </span> <i class="style-scope patent-text">Lancet Oncol. </i>2:82, 2001), angiostatin and endostatin (reviewed in Rosen, <i class="style-scope patent-text">Oncologist </i>5:20, 2000, incorporated by reference herein) and interferon inducible protein 10 (U.S. Pat. No. 5,994,292). A number of antiangiogenic agents currently in clinical trials are also contemplated. Agents currently in clinical trials include: 2ME2, Angiostatin, Angiozyme, Anti-VEGF RhuMAb, Apra (CT-2584), Avicine, Benefin, BMS275291, Carboxyamidotriazole, CC4047, CC5013, CC7085, CDC801, CGP-41251 (PKC 412), CM11, Combretastatin A-4 Prodrug, EMD 121974, Endostatin, Flavopiridol, Genistein (GCP), Green Tea Extract, IM-862, ImmTher, Interferon alpha, Interleukin-12, Iressa (ZD1839), Marimastat, Metastat (Col-3), Neovastat, Octreotide, Paclitaxel, Penicillamine, Photofrin, Photopoint, PI-88, Prinomastat (AG-3340), PTK787 (ZK22584), RO317453, Solimastat, Squalamine, <figure-callout id="101" label="SU" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00047.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">SU</a></figure-callout> 101, SU 5416, SU-6668, Suradista (FCE 26644), Suramin (Metaret), Tetrathiomolybdate, Thalidomide, TNP-470 and Vitaxin. additional antiangiogenic agents are described by Kerbel, J. Clin. Oncol. 19(18s):45s-51s, 2001, which is incorporated by reference herein. Immunomodulators suitable for conjugation to anti-PSMA antibodies include -interferon, -interferon, and tumor necrosis factor alpha (TNF). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0247]" class="style-scope patent-text">
    
    [0247]
  </para-num> <div id="P-0247" num="0247" class="description-line style-scope patent-text">The coupling of one or more toxin molecules to the anti-PSMA antibody is envisioned to include many chemical mechanisms, for instance covalent binding, affinity binding, intercalation, coordinate binding, and complexation. The toxic compounds used to prepare the anti-PSMA immunotoxins are attached to the antibodies or PSMA-binding fragments thereof by standard protocols known in the art. <span style="display: none" class="style-scope patent-text">[0247] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0248]" class="style-scope patent-text">
    
    [0248]
  </para-num> <div id="P-0248" num="0248" class="description-line style-scope patent-text">The covalent binding can be achieved either by direct condensation of existing side chains or by the incorporation of external bridging molecules. Many bivalent or polyvalent agents are useful in coupling protein molecules to other proteins, peptides or amine functions, etc. For example, the literature is replete with coupling agents such as carbodiimides, diisocyanates, glutaraldehyde, diazobenzenes, and hexamethylene diamines. This list is not intended to be exhaustive of the various coupling agents known in the art but, rather, is exemplary of the more common coupling agents. <span style="display: none" class="style-scope patent-text">[0248] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0249]" class="style-scope patent-text">
    
    [0249]
  </para-num> <div id="P-0249" num="0249" class="description-line style-scope patent-text">In preferred embodiments, it is contemplated that one may wish to first derivatize the antibody, and then attach the toxin component to the derivatized product. Suitable cross-linking agents for use in this manner include, for example, SPDP (N-succinimidyl-3-(2-pyridyldithio)propionate), and SMPT, 4-succinimidyl-oxycarbonyl-methyl-(2-pyridyldithio)toluene. <span style="display: none" class="style-scope patent-text">[0249] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0250]" class="style-scope patent-text">
    
    [0250]
  </para-num> <div id="P-0250" num="0250" class="description-line style-scope patent-text">In addition, protein toxins can be fused to the anti-PSMA antibody or PSMA binding fragment by genetic methods to form a hybrid immunotoxin fusion protein. To make a fusion immunotoxin protein in accordance with the invention, a nucleic acid molecule is generated that encodes an anti-PSMA antibody, a fragment of an anti-PSMA antibody, a single chain anti-PSMA antibody, or a subunit of an anti-PSMA antibody linked to a protein toxin. Such fusion proteins contain at least a targeting agent (e.g., anti-PSMA antibody subunit) and a toxin of the invention, operatively attached. The fusion proteins may also include additional peptide sequences, such as peptide spacers which operatively attach the targeting agent and toxin compound, as long as such additional sequences do not appreciably affect the targeting or toxin activities of the fusion protein. The two proteins can be attached by a peptide linker or spacer, such as a glycine-serine spacer peptide, or a peptide hinge, as is well known in the art. Thus, for example, the C-terminus of an anti-PSMA antibody or fragment thereof can be fused to the N-terminus of the protein toxin molecule to form an immunotoxin that retains the binding properties of the anti-PSMA antibody. Other fusion arrangements will be known to one of ordinary skill in the art. <span style="display: none" class="style-scope patent-text">[0250] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0251]" class="style-scope patent-text">
    
    [0251]
  </para-num> <div id="P-0251" num="0251" class="description-line style-scope patent-text">To express the fusion immunotoxin, the nucleic acid encoding the fusion protein is inserted into an expression vector in accordance with standard methods, for stable expression of the fusion protein, preferably in mammalian cells, such as CHO cells. The fusion protein can be isolated and purified from the cells or culture supernatant using standard methodology, such as a PSMA affinity column. <span style="display: none" class="style-scope patent-text">[0251] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0252]" class="style-scope patent-text">
    
    [0252]
  </para-num> <div id="P-0252" num="0252" class="description-line style-scope patent-text">Radionuclides typically are coupled to an antibody by chelation. For example, in the case of metallic radionuclides, a bifunctional chelator is commonly used to link the isotope to the antibody or other protein of interest. Typically, the chelator is first attached to the antibody, and the chelator-antibody conjugate is contacted with the metallic radioisotope. A number of bifunctional chelators have been developed for this purpose, including the diethylenetriamine pentaacetic acid (DTPA) series of amino acids described in U.S. Pat. Nos. 5,124,471, 5,286,850 and 5,434,287, which are incorporated herein by reference. As another example, hydroxamic acid-based bifunctional chelating agents are described in U.S. Pat. No. 5,756,825, the contents of which are incorporated herein. Another example is the chelating agent termed p-SCN-Bz-HEHA (1,4,7,10,13,16-hexaazacyclo-octadecane-N,N,N,N,N,N-hexaacetic acid) (Deal et al., <span style="display: none" class="style-scope patent-text">[0252] </span> <i class="style-scope patent-text">J. Med. Chem. </i>42:2988, 1999), which is an effective chelator of radiometals such as <sup class="style-scope patent-text">225</sup>Ac. Yet another example is DOTA (1,4,7,10-tetraazacyclododecane N,N,N,N-tetraacetic acid), which is a bifunctional chelating agent (see McDevitt et al., Science 294:1537-1540, 2001) that can be used in a two-step method for labeling followed by conjugation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0253]" class="style-scope patent-text">
    
    [0253]
  </para-num> <div id="P-0253" num="0253" class="description-line style-scope patent-text">In another aspect, the invention provides compositions comprising a multimeric (e.g., dimeric) PSMA protein, an isolated antibody, an antibody derivatized or linked to other functional moieties, or an antigen-binding fragment thereof or a combination of one or more of the aforementioned multimeric PSMA proteins, antibodies or antigen-binding fragments thereof. The compositions include a physiologically or pharmaceutically acceptable carrier, excipient, or stabilizer mixed with the isolated multimeric PSMA protein, antibody or antigen-binding fragment thereof. In a preferred embodiment, the compositions include a combination of multiple (e.g., two or more) isolated multimeric PSMA proteins, antibodies or antigen-binding portions thereof of the invention. Preferably, each of the antibodies or antigen-binding portions thereof of the composition binds to a distinct conformational epitope of PSMA. In one embodiment, anti-PSMA antibodies having complementary activities are used in combination, e.g., as a pharmaceutical composition, comprising two or more anti-PSMA antibodies. For example, an antibody that mediates highly effective cytolysis of target cells in the presence of effector cells can be combined with another antibody that inhibits the growth of cells expressing PSMA. As used herein, target cell shall mean any undesirable cell in a subject (e.g., a human or animal) that can be targeted by a composition of the invention. In preferred embodiments, the target cell is a cell expressing or overexpressing PSMA. Cells expressing PSMA typically include tumor cells, such as prostate, bladder, pancreas, lung, kidney, colon tumor cells, melanomas, and sarcomas. <span style="display: none" class="style-scope patent-text">[0253] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0254]" class="style-scope patent-text">
    
    [0254]
  </para-num> <div id="P-0254" num="0254" class="description-line style-scope patent-text">Pharmaceutical compositions of the invention also can be administered in combination therapy, i.e., combined with other agents. For example, the combination therapy can include a composition of the present invention with at least one anti-tumor agent, immunomodulator, immunostimulatory agent, or other conventional therapy. The agent may be bound or conjugated to or formed as a recombinant fusion molecule with the PSMA antibodies of the present invention for directed targeting of the agent to PSMA-expressing cells. <span style="display: none" class="style-scope patent-text">[0254] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0255]" class="style-scope patent-text">
    
    [0255]
  </para-num> <div id="P-0255" num="0255" class="description-line style-scope patent-text">The PSMA antibodies of the present invention may be used as a targeting moiety for delivery of replication-selective virus to PSMA-expressing cells for tumor therapy. Replication-competent virus such as the p53 pathway targeting adenovirus mutant dll520, ONYX-015, kill tumor cells selectively (Biederer, C. et al., J. Mol. Med. 80(3):163-175, 2002). <span style="display: none" class="style-scope patent-text">[0255] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0256]" class="style-scope patent-text">
    
    [0256]
  </para-num> <div id="P-0256" num="0256" class="description-line style-scope patent-text">The compositions of the present invention may include or be diluted into a pharmaceutically-acceptable carrier. As used herein, pharmaceutically acceptable carrier or physiologically acceptable carrier means one or more compatible solid or liquid fillers, diluents or encapsulating substances which are suitable for administration to a human or other mammal such as a primate, dog, cat, horse, cow, sheep, or goat. Such carriers include any and all salts, solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents, and the like that are physiologically compatible. The term carrier denotes an organic or inorganic ingredient, natural or synthetic, with which the active ingredient is combined to facilitate the application. The carriers are capable of being commingled with the preparations of the present invention, and with each other, in a manner such that there is no interaction which would substantially impair the desired pharmaceutical efficacy or stability. Preferably, the carrier is suitable for oral, intranasal, intravenous, intramuscular, subcutaneous, parenteral, spinal, intradermal or epidermal administration (e.g., by injection or infusion). Suitable carriers can be found in Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, Pa. Depending on the route of administration, the active compound, i.e., antibody or PSMA multimer may be coated in a material to protect the compound from the action of acids and other natural conditions that may inactivate the compound. <span style="display: none" class="style-scope patent-text">[0256] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0257]" class="style-scope patent-text">
    
    [0257]
  </para-num> <div id="P-0257" num="0257" class="description-line style-scope patent-text">When administered, the pharmaceutical preparations of the invention are applied in pharmaceutically-acceptable amounts and in pharmaceutically-acceptable compositions. The term pharmaceutically acceptable means a non-toxic material that does not interfere with the effectiveness of the biological activity of the active ingredients. The components of the pharmaceutical compositions also are capable of being co-mingled with the molecules of the present invention, and with each other, in a manner such that there is no interaction which would substantially impair the desired pharmaceutical efficacy. Such preparations may routinely contain salts, buffering agents, preservatives, compatible carriers, and optionally other therapeutic agents, such as supplementary immune potentiating agents including adjuvants, chemokines and cytokines. When used in medicine, the salts should be pharmaceutically acceptable, but non-pharmaceutically acceptable salts may conveniently be used to prepare pharmaceutically-acceptable salts thereof and are not excluded from the scope of the invention. <span style="display: none" class="style-scope patent-text">[0257] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0258]" class="style-scope patent-text">
    
    [0258]
  </para-num> <div id="P-0258" num="0258" class="description-line style-scope patent-text">A salt retains the desired biological activity of the parent compound and does not impart any undesired toxicological effects (see e.g., Berge, S. M., et al. (1977) <span style="display: none" class="style-scope patent-text">[0258] </span> <i class="style-scope patent-text">J. Pharm. Sci. </i>66: 1-19). Examples of such salts include acid addition salts and base addition salts. Acid addition salts include those derived from nontoxic inorganic acids, such as hydrochloric, nitric, phosphoric, sulfuric, hydrobromic, hydroiodic, phosphorous and the like, as well as from nontoxic organic acids such as aliphatic mono- and dicarboxylic acids, phenyl substituted alkanoic acids, hydroxy alkanoic acids, aromatic acids, aliphatic and aromatic sulfonic acids and the like. Base addition salts include those derived from alkaline earth metals, such as sodium, potassium, magnesium, calcium and the like, as well as from nontoxic organic amines, such as N,N-dibenzylethylenediamine, N-methylglucamine, chloroprocaine, choline, diethanolamine, ethylenediamine, procaine and the like. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0259]" class="style-scope patent-text">
    
    [0259]
  </para-num> <div id="P-0259" num="0259" class="description-line style-scope patent-text">The pharmaceutical preparations of the invention also may include isotonicity agents. This term is used in the art interchangeably with iso-osmotic agent, and is known as a compound which is added to the pharmaceutical preparation to increase the osmotic pressure to that of 0.9% sodium chloride solution, which is iso-osmotic with human extracellular fluids, such as plasma. Preferred isotonicity agents are sodium chloride, mannitol, sorbitol, lactose, dextrose and glycerol. <span style="display: none" class="style-scope patent-text">[0259] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0260]" class="style-scope patent-text">
    
    [0260]
  </para-num> <div id="P-0260" num="0260" class="description-line style-scope patent-text">Optionally, the pharmaceutical preparations of the invention may further comprise a preservative, such as benzalkonium chloride. Suitable preservatives also include but are not limited to: chlorobutanol (0.3-0.9% W/V), parabens (0.01-5.0%), thimerosal (0.004-0.2%), benzyl alcohol (0.5-5%), phenol (0.1-1.0%), and the like. <span style="display: none" class="style-scope patent-text">[0260] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0261]" class="style-scope patent-text">
    
    [0261]
  </para-num> <div id="P-0261" num="0261" class="description-line style-scope patent-text">The formulations provided herein also include those that are sterile. Sterilization processes or techniques as used herein include aseptic techniques such as one or more filtration (0.45 or 0.22 micron filters) steps. <span style="display: none" class="style-scope patent-text">[0261] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0262]" class="style-scope patent-text">
    
    [0262]
  </para-num> <div id="P-0262" num="0262" class="description-line style-scope patent-text">An anti-PSMA antibody composition may be combined, if desired, with a pharmaceutically-acceptable carrier. <span style="display: none" class="style-scope patent-text">[0262] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0263]" class="style-scope patent-text">
    
    [0263]
  </para-num> <div id="P-0263" num="0263" class="description-line style-scope patent-text">The pharmaceutical compositions may contain suitable buffering agents, including: acetic acid in a salt; citric acid in a salt; boric acid in a salt; and phosphoric acid in a salt. <span style="display: none" class="style-scope patent-text">[0263] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0264]" class="style-scope patent-text">
    
    [0264]
  </para-num> <div id="P-0264" num="0264" class="description-line style-scope patent-text">The pharmaceutical compositions may conveniently be presented in unit dosage form and may be prepared by any of the methods well-known in the art of pharmacy. All methods include the step of bringing the active agent into association with a carrier which constitutes one or more accessory ingredients. In general, the compositions are prepared by uniformly and intimately bringing the active compound into association with a liquid carrier, a finely divided solid carrier, or both, and then, if necessary, shaping the product. <span style="display: none" class="style-scope patent-text">[0264] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0265]" class="style-scope patent-text">
    
    [0265]
  </para-num> <div id="P-0265" num="0265" class="description-line style-scope patent-text">Compositions suitable for parenteral administration conveniently comprise a sterile aqueous or non-aqueous preparation of PSMA multimers and/or anti-PSMA antibodies, which is preferably isotonic with the blood of the recipient. This preparation may be formulated according to known methods using suitable dispersing or wetting agents and suspending agents. The sterile injectable preparation also may be a sterile injectable solution or suspension in a non-toxic parenterally-acceptable diluent or solvent, for example, as a solution in 1,3-butane diol. Among the acceptable vehicles and solvents that may be employed are water, Ringer's solution, and isotonic sodium chloride solution. In addition, sterile, fixed oils are conventionally employed as a solvent or suspending medium. For this purpose any bland fixed oil may be employed including synthetic mono-or di-glycerides. In addition, fatty acids such as oleic acid may be used in the preparation of injectables. Carrier formulations suitable for oral, subcutaneous, intravenous, intramuscular, etc. administration can be found in <span style="display: none" class="style-scope patent-text">[0265] </span> <i class="style-scope patent-text">Remington 's Pharmaceutical Sciences</i>, Mack Publishing Co., Easton, Pa. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0266]" class="style-scope patent-text">
    
    [0266]
  </para-num> <div id="P-0266" num="0266" class="description-line style-scope patent-text">The active compounds can be prepared with carriers that will protect the compound against rapid release, such as a controlled release formulation, including implants, transdermal patches, and microencapsulated delivery systems. Biodegradable, biocompatible polymers can be used, such as ethylene vinyl acetate, polyanhydrides, polyglycolic acid, collagen, polyorthoesters, and polylactic acid. Many methods for the preparation of such formulations are patented or generally known to those skilled in the art. See, e.g., <span style="display: none" class="style-scope patent-text">[0266] </span> <i class="style-scope patent-text">Sustained and Controlled Release Drug Delivery Systems</i>, J. R. Robinson, ed., Marcel Dekker, Inc., New York, 1978. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0267]" class="style-scope patent-text">
    
    [0267]
  </para-num> <div id="P-0267" num="0267" class="description-line style-scope patent-text">The therapeutics of the invention can be administered by any conventional route, including injection or by gradual infusion over time. The administration may, for example, be oral, intravenous, intraperitoneal, intramuscular, intracavity, intratumor, or transdermal. When antibodies are used therapeutically, preferred routes of administration include intravenous and by pulmonary aerosol. Techniques for preparing aerosol delivery systems containing antibodies are well known to those of skill in the art. Generally, such systems should utilize components which will not significantly impair the biological properties of the antibodies, such as the paratope binding capacity (see, for example, Sciarra and Cutie, Aerosols, in <span style="display: none" class="style-scope patent-text">[0267] </span> <i class="style-scope patent-text">Remington's Pharmaceutical Sciences, </i>18th edition, 1990, pp. 1694-1712; incorporated by reference). Those of skill in the art can readily determine the various parameters and conditions for producing antibody aerosols without resorting to undue experimentation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0268]" class="style-scope patent-text">
    
    [0268]
  </para-num> <div id="P-0268" num="0268" class="description-line style-scope patent-text">The pharmaceutical preparations of the invention, when used in alone or in cocktails, are administered in therapeutically effective amounts. Effective amounts are well known to those of ordinary skill in the art and are described in the literature. A therapeutically effective amount will be determined by the parameters discussed below; but, in any event, is that amount which establishes a level of the drug(s) effective for treating a subject, such as a human subject, having one of the conditions described herein. An effective amount means that amount alone or with multiple doses, necessary to delay the onset of, inhibit completely or lessen the progression of or halt altogether the onset or progression of the condition being treated. When administered to a subject, effective amounts will depend, of course, on the particular condition being treated; the severity of the condition; individual patient parameters including age, physical condition, size and weight; concurrent treatment; frequency of treatment; and the mode of administration. These factors are well known to those of ordinary skill in the art and can be addressed with no more than routine experimentation. It is preferred generally that a maximum dose be used, that is, the highest safe dose according to sound medical judgment. <span style="display: none" class="style-scope patent-text">[0268] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0269]" class="style-scope patent-text">
    
    [0269]
  </para-num> <div id="P-0269" num="0269" class="description-line style-scope patent-text">An effective amount is that amount of an anti-PSMA antibody or PSMA multimer that alone, or together with further doses, produces the desired response, e.g. treats a malignancy in a subject. This may involve only slowing the progression of the disease temporarily, although more preferably, it involves halting the progression of the disease permanently. This can be monitored by routine methods. The desired response to treatment of the disease or condition also can be delaying the onset or even preventing the onset of the disease or condition. <span style="display: none" class="style-scope patent-text">[0269] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0270]" class="style-scope patent-text">
    
    [0270]
  </para-num> <div id="P-0270" num="0270" class="description-line style-scope patent-text">Such amounts will depend, of course, on the particular condition being treated, the severity of the condition, the individual patient parameters including age, physical condition, size and weight, the duration of the treatment, the nature of concurrent therapy (if any), the specific route of administration and like factors within the knowledge and expertise of the health practitioner. These factors are well known to those of ordinary skill in the art and can be addressed with no more than routine experimentation. It is generally preferred that a maximum dose of the individual components or combinations thereof be used, that is, the highest safe dose according to sound medical judgment. It will be understood by those of ordinary skill in the art, however, that a patient may insist upon a lower dose or tolerable dose for medical reasons, psychological reasons or for virtually any other reasons. <span style="display: none" class="style-scope patent-text">[0270] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0271]" class="style-scope patent-text">
    
    [0271]
  </para-num> <div id="P-0271" num="0271" class="description-line style-scope patent-text">The pharmaceutical compositions used in the foregoing methods preferably are sterile and contain an effective amount of anti-PSMA antibodies or PSMA multimers for producing the desired response in a unit of weight or volume suitable for administration to a patient. The response can, for example, be measured by determining the physiological effects of the anti-PSMA antibody or PSMA multimer, such as regression of a tumor or decrease of disease symptoms. Other assays will be known to one of ordinary skill in the art and can be employed for measuring the level of the response. <span style="display: none" class="style-scope patent-text">[0271] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0272]" class="style-scope patent-text">
    
    [0272]
  </para-num> <div id="P-0272" num="0272" class="description-line style-scope patent-text">The doses of anti-PSMA antibodies or PSMA multimers administered to a subject can be chosen in accordance with different parameters, in particular in accordance with the mode of administration used and the state of the subject. Other factors include the desired period of treatment. In the event that a response in a subject is insufficient at the initial doses applied, higher doses (or effectively higher doses by a different, more localized delivery route) may be employed to the extent that patient tolerance permits. <span style="display: none" class="style-scope patent-text">[0272] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0273]" class="style-scope patent-text">
    
    [0273]
  </para-num> <div id="P-0273" num="0273" class="description-line style-scope patent-text">A variety of administration routes are available. The particular mode selected will depend of course, upon the particular drug selected, the severity of the disease state being treated and the dosage required for therapeutic efficacy. The methods of this invention, generally speaking, may be practiced using any mode of administration that is medically acceptable, meaning any mode that produces effective levels of the active compounds without causing clinically unacceptable adverse effects. Such modes of administration include oral, rectal, sublingual, topical, nasal, transdermal or parenteral routes. The term parenteral includes subcutaneous, intravenous, intramuscular, or infusion. <span style="display: none" class="style-scope patent-text">[0273] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0274]" class="style-scope patent-text">
    
    [0274]
  </para-num> <div id="P-0274" num="0274" class="description-line style-scope patent-text">In general, doses can range from about 10 g/kg to about 100,000 g/kg. Based upon the composition, the dose can be delivered continuously, such as by continuous pump, or at periodic intervals. Desired time intervals of multiple doses of a particular composition can be determined without undue experimentation by one skilled in the art. Other protocols for the administration of anti-PSMA antibody or PSMA multimers will be known to one of ordinary skill in the art, in which the dose amount, schedule of administration, sites of administration, mode of administration and the like vary from the foregoing. <span style="display: none" class="style-scope patent-text">[0274] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0275]" class="style-scope patent-text">
    
    [0275]
  </para-num> <div id="P-0275" num="0275" class="description-line style-scope patent-text">Dosage may be adjusted appropriately to achieve desired drug levels, locally or systemically. Generally, daily oral doses of active compounds will be from about 0.1 mg/kg per day to 30 mg/kg per day. It is expected that IV doses in the range of 0.01-1.00 mg/kg will be effective. In the event that the response in a subject is insufficient at such doses, even higher doses (or effective higher doses by a different, more localized delivery route) may be employed to the extent that patient tolerance permits. Continuous IV dosing over, for example, 24 hours or multiple doses per day also are contemplated to achieve appropriate systemic levels of compounds. <span style="display: none" class="style-scope patent-text">[0275] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0276]" class="style-scope patent-text">
    
    [0276]
  </para-num> <div id="P-0276" num="0276" class="description-line style-scope patent-text">In general, doses of radionuclide delivered by the anti-PSMA antibodies of the invention can range from about 0.01 mCi/Kg to about 10 mCi/kg. Preferably the dose of radionuclide ranges from about 0.1 mCi/Kg to about 1.0 mCi/kg. The optimal dose of a given isotope can be determined empirically by simple routine titration experiments well known to one of ordinary skill in the art. <span style="display: none" class="style-scope patent-text">[0276] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0277]" class="style-scope patent-text">
    
    [0277]
  </para-num> <div id="P-0277" num="0277" class="description-line style-scope patent-text">Administration of anti-PSMA antibody or PSMA multimer compositions to mammals other than humans, e.g. for testing purposes or veterinary therapeutic purposes, is carried out under substantially the same conditions as described above. <span style="display: none" class="style-scope patent-text">[0277] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0278]" class="style-scope patent-text">
    
    [0278]
  </para-num> <div id="P-0278" num="0278" class="description-line style-scope patent-text">The compositions (antibodies to PSMA and derivatives/conjugates thereof and PSMA multimers) of the present invention have in vitro and in vivo diagnostic and therapeutic utilities. For example, these molecules can be administered to cells in culture, e.g. in vitro or ex vivo, or in a subject, e.g., in vivo, to treat, prevent or diagnose a variety of disorders. As used herein, the term subject is intended to include humans and non-human animals. Preferred subjects include a human patient having a disorder characterized by expression, typically aberrant expression (e.g., overexpression) of PSMA. Other preferred subjects include subjects that are treatable with the compositions of the invention. This includes those who have or are at risk of having a cancer or who would otherwise would benefit from an enhanced or elicited immune response to cells expressing PSMA. In preferred embodiments these cells express PSMA on their surface. <span style="display: none" class="style-scope patent-text">[0278] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0279]" class="style-scope patent-text">
    
    [0279]
  </para-num> <div id="P-0279" num="0279" class="description-line style-scope patent-text">One aspect of the present invention relates to a method of detecting cancerous cells or portions thereof in a biological sample (e.g., histological or cytological specimens, biopsies and the like), and, in particular, to distinguish malignant tumors from normal tissues and non-malignant tumors. This method involves providing an antibody or an antigen-binding binding fragment thereof, probe, or ligand, which binds to an extracellular domain of PSMA of such cells, e.g., an anti-PSMA antibody. The anti-PSMA antibody is bound to a label that permits the detection of the cells or portions thereof (e.g., PSMA or fragments thereof liberated from such cancerous cells) upon binding of the anti-PSMA antibody to the cells or portions thereof. The biological sample is contacted with the labeled anti-PSMA antibody under conditions effective to permit binding of the anti-PSMA antibody to the extracellular domain of PSMA of any of the cells or portions thereof in the biological sample. The presence of any cells or portions thereof in the biological sample is detected by detection of the label. In one preferred form, the contact between the anti-PSMA antibody and the biological sample is carried out in a living mammal and involves administering the anti-PSMA antibody to the mammal under conditions that permit binding of the anti-PSMA antibody to PSMA of any of the cells or portions thereof in the biological sample. Again, such administration can be carried out by any suitable method known to one of ordinary skill in the art. <span style="display: none" class="style-scope patent-text">[0279] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0280]" class="style-scope patent-text">
    
    [0280]
  </para-num> <div id="P-0280" num="0280" class="description-line style-scope patent-text">In addition, the anti-PSMA antibodies of the present invention can be used in immunofluorescence techniques to examine human tissue, cell and bodily fluid specimens. In a typical protocol, slides containing cryostat sections of frozen, unfixed tissue biopsy samples or cytological smears are air dried, formalin or acetone fixed, and incubated with the monoclonal antibody preparation in a humidified chamber at room temperature. The slides are then washed and further incubated with a preparation of a secondary antibody directed against the monoclonal antibody, usually some type of anti-mouse immunoglobulin if the monoclonal antibodies used are derived from the fusion of a mouse spleen lymphocyte and a mouse myeloma cell line. This secondary antibody is tagged with a compound, for instance rhodamine or fluorescein isothiocyanate, that fluoresces at a particular wavelength. The staining pattern and intensities within the sample are then determined by fluorescent light microscopy and optionally photographically recorded. <span style="display: none" class="style-scope patent-text">[0280] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0281]" class="style-scope patent-text">
    
    [0281]
  </para-num> <div id="P-0281" num="0281" class="description-line style-scope patent-text">As yet another alternative, computer enhanced fluorescence image analysis or flow cytometry can be used to examine tissue specimens or exfoliated cells, i.e., single cell preparations from aspiration biopsies of tumors using the anti-PSMA antibodies of this invention. The anti-PSMA antibodies of the invention are particularly useful in quantitation of live tumor cells, i.e., single cell preparations from aspiration biopsies of prostate tumors by computer enhanced fluorescence image analyzer or with a flow cytometer. The antibodies of the invention are particularly useful in such assays to differentiate benign from malignant prostate tumors since the PSMA protein to which the anti-PSMA antibodies bind is expressed in increased amounts by malignant tumors as compared to benign prostate tumors. The percent PSMA positive cell population, alone or in conjunction with determination of other attributes of the cells (e.g., DNA ploidy of these cells), may, additionally, provide very useful prognostic information by providing an early indicator of disease progression. <span style="display: none" class="style-scope patent-text">[0281] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0282]" class="style-scope patent-text">
    
    [0282]
  </para-num> <div id="P-0282" num="0282" class="description-line style-scope patent-text">In yet another alternative embodiment, the antibodies of the present invention can be used in combination with other known antibodies to provide additional information regarding the malignant phenotype of a cancer. <span style="display: none" class="style-scope patent-text">[0282] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0283]" class="style-scope patent-text">
    
    [0283]
  </para-num> <div id="P-0283" num="0283" class="description-line style-scope patent-text">The method of the present invention can be used to screen patients for diseases associated with the presence of cancerous cells or portions thereof. Alternatively, it can be used to identify the recurrence of such diseases, particularly when the disease is localized in a particular biological material of the patient. For example, recurrence of prostatic disease in the prostatic fossa may be encountered following radical prostatectomy. Using the method of the present invention, this recurrence can be detected by administering a short range radiolabeled antibody to the mammal and then detecting the label rectally, such as with a transrectal detector probe. <span style="display: none" class="style-scope patent-text">[0283] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0284]" class="style-scope patent-text">
    
    [0284]
  </para-num> <div id="P-0284" num="0284" class="description-line style-scope patent-text">Alternatively, the contacting step can be carried out in a sample of serum or urine or other body fluids, including but not limited to seminal fluid, prostatic fluid, ejaculate, and the like, such as to detect the presence of PSMA in the body fluid. When the contacting is carried out in a serum or urine sample, it is preferred that the biological agent recognize substantially no antigens circulating in the blood other than PSMA. Since intact cells do not excrete or secrete PSMA into the extracellular environment, detecting PSMA in serum, urine, or other body fluids generally indicates that cells are being lysed or shed. Thus, the biological agents and methods of the present invention can be used to determine the effectiveness of a cancer treatment protocol by monitoring the level of PSMA in serum, urine or other body fluids. <span style="display: none" class="style-scope patent-text">[0284] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0285]" class="style-scope patent-text">
    
    [0285]
  </para-num> <div id="P-0285" num="0285" class="description-line style-scope patent-text">In a particularly preferred embodiment of the method of detecting cancerous cells in accordance with the present invention, the anti-PSMA antibodies or an antigen-binding fragment thereof, binds to and is internalized with the prostate specific membrane antigen of such cells. Again, the biological agent is bound to a label effective to permit detection of the cells or portions thereof upon binding of the biological agent to and internalization of the biological agent with the prostate specific membrane antigen. <span style="display: none" class="style-scope patent-text">[0285] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0286]" class="style-scope patent-text">
    
    [0286]
  </para-num> <div id="P-0286" num="0286" class="description-line style-scope patent-text">Biological agents suitable for detecting cancerous cells include anti-PSMA antibodies, such as monoclonal or polyclonal antibodies. In addition, antibody fragments, half-antibodies, hybrid derivatives, probes, and other molecular constructs may be utilized. These biological agents, such as antibodies, antigen-binding fragments thereof, probes, or ligands, bind to extracellular domains of prostate specific membrane antigens or portions thereof in cancerous cells. As a result, the biological agents bind not only to cells which are fixed or cells whose intracellular antigenic domains are otherwise exposed to the extracellular environment. Consequently, binding of the biological agents is concentrated in areas where there are prostate cells, irrespective of whether these cells are fixed or unfixed, viable or necrotic. Additionally or alternatively, these biological agents bind to and are internalized with prostate specific membrane antigens or portions thereof in normal, benign hyperplastic, and to a greater degree in cancerous cells. <span style="display: none" class="style-scope patent-text">[0286] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0287]" class="style-scope patent-text">
    
    [0287]
  </para-num> <div id="P-0287" num="0287" class="description-line style-scope patent-text">The PSMA multimers and antibodies or antigen-binding fragments thereof can also be utilized in in vivo therapy of cancer. The PSMA multimers and antibodies or antigen-binding fragments thereof can be used with a compound which kills and/or inhibits proliferation of malignant cells or tissues. For instance, the antibodies can be covalently attached, either directly or via linker, to such a compound following administration and localization of the conjugates. When the antibody is used by itself, it may mediate tumor destruction by complement fixation or antibody-dependent cellular cytotoxicity. Alternatively, the PSMA multimer or antibody may be administered in combination with a chemotherapeutic drug to result in synergistic therapeutic effects (Baslya and Mendelsohn, 1994 <span style="display: none" class="style-scope patent-text">[0287] </span> <i class="style-scope patent-text">Breast Cancer Res. and Treatment </i>29:127-138). A variety of different types of substances can be directly conjugated for therapeutic uses, including radioactive metal and non-metal isotopes, chemotherapeutic drugs, toxins, etc. as described above and known in the art (see, e.g., Vitetta and Uhr, 1985, <i class="style-scope patent-text">Annu. Rev. Immunol. </i>3:197). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0288]" class="style-scope patent-text">
    
    [0288]
  </para-num> <div id="P-0288" num="0288" class="description-line style-scope patent-text">The antibodies or antigen-binding fragments thereof of the invention can also be administered together with complement. Accordingly, within the scope of the invention are compositions comprising antibodies or antigen-binding fragments thereof and serum or complement. These compositions are advantageous in that the complement is located in close proximity to the human antibodies or antigen-binding fragments thereof. Alternatively, the antibodies or antigen-binding fragments thereof of the invention and the complement or serum can be administered separately. <span style="display: none" class="style-scope patent-text">[0288] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0289]" class="style-scope patent-text">
    
    [0289]
  </para-num> <div id="P-0289" num="0289" class="description-line style-scope patent-text">The PSMA multimers or antibodies can be administered with one or more immunostimulatory agents to induce or enhance an immune response, such as IL-2 and immunostimulatory oligonucleotides (e.g., those containing CpG motifs). Preferred immunostimulatory agents stimulate specific arms of the immune system, such as natural killer (NK) cells that mediate antibody-dependent cell cytotoxicity (ADCC). <span style="display: none" class="style-scope patent-text">[0289] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0290]" class="style-scope patent-text">
    
    [0290]
  </para-num> <div id="P-0290" num="0290" class="description-line style-scope patent-text">Antigens, such as the PSMA dimers described herein, can be administered with one or more adjuvants to induce or enhance an immune response. An adjuvant is a substance which potentiates the immune response. Adjuvants of many kinds are well known in the art. Specific examples of adjuvants include monophosphoryl lipid A (MPL, SmithKline Beecham); saponins including QS21 (SmithKline Beecham); immunostimulatory oligonucleotides (e.g., CpG oligonucleotides described by Kreig et al., <span style="display: none" class="style-scope patent-text">[0290] </span> <i class="style-scope patent-text">Nature </i>374:546-9, 1995); incomplete Freund's adjuvant; complete Freund's adjuvant; montanide; vitamin E and various water-in-oil emulsions prepared from biodegradable oils such as squalene and/or tocopherol, Quil A, Ribi Detox, CRL-1005, L-121, and combinations thereof. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0291]" class="style-scope patent-text">
    
    [0291]
  </para-num> <div id="P-0291" num="0291" class="description-line style-scope patent-text">Other agents which stimulate the immune response of the subject to PSMA multimer antigens can also be administered to the subject. For example, cytokines are also useful in vaccination protocols as a result of their lymphocyte regulatory properties. Many cytokines useful for such purposes will be known to one of ordinary skill in the art, including interleukin-2 (IL-2); IL-4; IL-5; IL-12, which has been shown to enhance the protective effects of vaccines (see, e.g., <span style="display: none" class="style-scope patent-text">[0291] </span> <i class="style-scope patent-text">Science </i>268: 1432-1434, 1995); GM-CSF; IL-15; IL-18; combinations thereof, and the like. Thus cytokines can be administered in conjunction with antibodies, antigens, chemokines and/or adjuvants to increase an immune response. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0292]" class="style-scope patent-text">
    
    [0292]
  </para-num> <div id="P-0292" num="0292" class="description-line style-scope patent-text">Chemokines useful in increasing immune responses include but are not limited to SLC, ELC, MIP3, MIP3, IP-10, MIG, and combinations thereof. <span style="display: none" class="style-scope patent-text">[0292] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0293]" class="style-scope patent-text">
    
    [0293]
  </para-num> <div id="P-0293" num="0293" class="description-line style-scope patent-text">The PSMA multimers or antibodies or antigen-binding fragments thereof of the present invention can be used in conjunction with other therapeutic treatment modalities. Such other treatments include surgery, radiation, cryosurgery, thermotherapy, hormone treatment, chemotherapy, vaccines, and other immunotherapies. <span style="display: none" class="style-scope patent-text">[0293] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0294]" class="style-scope patent-text">
    
    [0294]
  </para-num> <div id="P-0294" num="0294" class="description-line style-scope patent-text">Also encompassed by the present invention is a method which involves using the PSMA multimers or antibodies or antigen-binding fragments thereof for prophylaxis. For example, these materials can be used to prevent or delay development or progression of cancer. <span style="display: none" class="style-scope patent-text">[0294] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0295]" class="style-scope patent-text">
    
    [0295]
  </para-num> <div id="P-0295" num="0295" class="description-line style-scope patent-text">Use of the cancer therapy of the present invention has a number of benefits. Since the anti-PSMA antibodies or antigen-binding fragments thereof according to the present invention preferentially target prostate cancer cells, other tissue is spared. As a result, treatment with such biological agents is safer, particularly for elderly patients. Treatment according to the present invention is expected to be particularly effective, because it directs high levels of anti-PSMA antibodies or antigen-binding fragments thereof to the bone marrow and lymph nodes where prostate cancer metastases predominate. Moreover, tumor sites for prostate cancer tend to be small in size and, therefore, easily destroyed by cytotoxic agents. Treatment in accordance with the present invention can be effectively monitored with clinical parameters such as serum prostate specific antigen and/or pathological features of a patient's cancer, including stage, Gleason score, extracapsular, seminal, vesicle or perineural invasion, positive margins, involved lymph nodes, etc. Alternatively, these parameters can be used to indicate when such treatment should be employed. <span style="display: none" class="style-scope patent-text">[0295] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0296]" class="style-scope patent-text">
    
    [0296]
  </para-num> <div id="P-0296" num="0296" class="description-line style-scope patent-text">Because the antibodies or antigen-binding fragments thereof of the present invention bind to living cells, therapeutic methods using these biological agents are much more effective than those which target lysed cells. For the same reasons, diagnostic and imaging methods which determine the location of living normal, benign hyperplastic, or cancerous cells are much improved by employing the antibodies or antigen-binding fragments thereof of the present invention. In addition, the ability to differentiate between living and dead cells can be advantageous, especially to monitor the effectiveness of a particular treatment regimen. <span style="display: none" class="style-scope patent-text">[0296] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0297]" class="style-scope patent-text">
    
    [0297]
  </para-num> <div id="P-0297" num="0297" class="description-line style-scope patent-text">Also within the scope of the invention are kits comprising the compositions of the invention and instructions for use. The kits can further contain at least one additional reagent, such as complement, or one or more additional antibodies of the invention (e.g., an antibody having a complementary activity which binds to an epitope in PSMA antigen distinct from the first antibody). Other kits can include the PSMA multimers described herein below. <span style="display: none" class="style-scope patent-text">[0297] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0298]" class="style-scope patent-text">
    
    [0298]
  </para-num> <div id="P-0298" num="0298" class="description-line style-scope patent-text">The kits provided herein include any of the compositions described and instructions for the use of these compositions. The instructions can include instructions for mixing a particular amount of a diluent with a particular amount of a PSMA dimeric composition, whereby a final formulation for injection or infusion is prepared. Therefore, kits are also provided, which include the compositions of the invention and an adjuvant (e.g., alum) or diluent and instructions for mixing. Kits are also provided wherein the compositions of the inventions are provided in a vial or ampoule with a septum or a syringe. Other kits where the composition is in lyophilized form are also provided. The instructions, therefore, would take a variety of forms depending on the presence or absence of diluent or other agents (e.g., therapeutic agents). The instructions can include instructions for treating a patient with an effective amount of dimeric PSMA. It also will be understood that the containers containing the pharmaceutical preparation, whether the container is a bottle, a vial with a septum, an ampoule with a septum, an infusion bag, and the like, can contain indicia such as conventional markings which change color when the pharmaceutical preparation has been autoclaved or otherwise sterilized. <span style="display: none" class="style-scope patent-text">[0298] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0299]" class="style-scope patent-text">
    
    [0299]
  </para-num> <div id="P-0299" num="0299" class="description-line style-scope patent-text">Kits containing the antibodies or antigen-binding fragments thereof of the invention can be prepared for in vitro diagnosis, prognosis and/or monitoring cancer by the immunohistological, immunocytological and immunoserological methods described above. The components of the kits can be packaged either in aqueous medium or in lyophilized form. When the antibodies or antigen-binding fragments thereof are used in the kits in the form of conjugates in which a label moiety is attached, such as an enzyme or a radioactive metal ion, the components of such conjugates can be supplied either in fully conjugated form, in the form of intermediates or as separate moieties to be conjugated by the user or the kit. <span style="display: none" class="style-scope patent-text">[0299] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0300]" class="style-scope patent-text">
    
    [0300]
  </para-num> <div id="P-0300" num="0300" class="description-line style-scope patent-text">A kit may comprise a carrier being compartmentalized to receive in close confinement therein one or more container means or series of container means such as test tubes, vials, flasks, bottles, syringes, or the like. A first of said container means or series of container means may contain one or more anti-PSMA antibodies or antigen-binding fragments thereof or PSMA. A second container means or series of container means may contain a label or linker-label intermediate capable of binding to the primary anti-PSMA antibodies (or fragment thereof. <span style="display: none" class="style-scope patent-text">[0300] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0301]" class="style-scope patent-text">
    
    [0301]
  </para-num> <div id="P-0301" num="0301" class="description-line style-scope patent-text">It should be understood that the pharmaceutical preparations of the invention will typically be held in bottles, vials, ampoules, infusion bags, and the like, any one of which may be sparged to eliminate oxygen or purged with nitrogen. In some embodiments, the bottles vials and ampoules are opaque, such as when amber in color. Such sparging and purging protocols are well known to those of ordinary skill in the art and should contribute to maintaining the stability of the pharmaceutical preparations. The pharmaceutical preparations also, in certain embodiments, are expected to be contained within syringes. <span style="display: none" class="style-scope patent-text">[0301] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0302]" class="style-scope patent-text">
    
    [0302]
  </para-num> <div id="P-0302" num="0302" class="description-line style-scope patent-text">Kits for use in in vivo tumor localization and therapy method containing the anti-PSMA antibodies or antigen-binding fragments thereof conjugated to other compounds or substances can be prepared. The components of the kits can be packaged either in aqueous medium or in lyophilized form. When the antibodies or antigen-binding fragments thereof are used in the kits in the form of conjugates in which a label or a therapeutic moiety is attached, such as a radioactive metal ion or a therapeutic drug moiety, the components of such conjugates can be supplied either in fully conjugated form, in the form of intermediates or as separate moieties to be conjugated by the user of the kit. <span style="display: none" class="style-scope patent-text">[0302] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0303]" class="style-scope patent-text">
    
    [0303]
  </para-num> <div id="P-0303" num="0303" class="description-line style-scope patent-text">In one aspect of the invention, a method for modulating at least one enzymatic activity of PSMA, the activity selected from the group consisting of N-acetylated -linked acidic dipeptidase (NAALADase), folate hydrolase, dipeptidyl dipeptidase IV and --glutamyl hydrolase activity or combination thereof in vitro or in vivo. The modulation may be enhancement or inhibition of at least one enzymatic activity of PSMA. <span style="display: none" class="style-scope patent-text">[0303] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0304]" class="style-scope patent-text">
    
    [0304]
  </para-num> <div id="P-0304" num="0304" class="description-line style-scope patent-text">In a preferred embodiment, the invention provides methods for inhibiting at least one enzymatic activity of PSMA, the activity selected from the group consisting of N-acetylated -linked acidic dipeptidase (NAALADase), folate hydrolase, dipeptidyl dipeptidase IV and -glutamyl hydrolase activity or combination thereof in vitro or in vivo. The method comprises contacting a NAALADase, a folate hydrolase, a dipeptidyl dipeptidase IV and/or a -glutamyl hydrolase with an amount of an isolated antibody or antigen-binding fragment thereof of the invention under conditions wherein the isolated monoclonal antibody or antigen-binding fragment thereof inhibits NAALADase, folate hydrolase, dipeptidyl dipeptidase IV or -glutamyl hydrolase activity. <span style="display: none" class="style-scope patent-text">[0304] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0305]" class="style-scope patent-text">
    
    [0305]
  </para-num> <div id="P-0305" num="0305" class="description-line style-scope patent-text">Tissue levels of NAALADase can be determined by detergent solubilizing homogenizing tissues, pelleting the insoluble material by centrifugation and measuring the NAALADase activity in the remaining supernatant. Likewise, the NAALADase activity in bodily fluids can also be measured by first pelleting the cellular material by centrifugation and performing a typical enzyme assay for NAALADase activity on the supernatant. NAALADase enzyme assays have been described by Frieden, 1959, <span style="display: none" class="style-scope patent-text">[0305] </span> <i class="style-scope patent-text">J. Biol, Chem., </i>234:2891. In this assay, the reaction product of the NAALADase enzyme is glutamic acid. This is derived from the enzyme catalyzed cleavage of N-acetylaspartylglutamate to yield N-acetylaspartic acid and glutamic acid. Glutamic acid, in a NAD(P)<sup class="style-scope patent-text">+</sup> requiring step, yields 2-oxoglutarate plus NAD(P)H in a reaction catalyzed by glutamate dehydrogenase. Progress of the reaction can easily and conveniently be measured by the change in absorbance at 340 nm due to the conversion of NAD(P)<sup class="style-scope patent-text">+</sup> to NAD(P)H. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0306]" class="style-scope patent-text">
    
    [0306]
  </para-num> <div id="P-0306" num="0306" class="description-line style-scope patent-text">Folate hydrolase activity of PSMA can be measured by performing enzyme assays as described by Heston and others (e.g., <span style="display: none" class="style-scope patent-text">[0306] </span> <i class="style-scope patent-text">Clin. Cancer Res. </i>2(9):1445-51, 1996; <i class="style-scope patent-text">Urology </i>49(3A Suppl):104-12,1997). Folate hydrolases such as PSMA remove the gamma-linked glutamates from polyglutamated folates. Folate hydrolase activity can be measured using substrates such as methotrexate tri-gamma glutamate (MTXGlu3), methotrexate di-gamma glutamate (MTXGlu2) and pteroylpentaglutamate (PteGlu5), for example using capillary electrophoresis (see <i class="style-scope patent-text">Clin. Cancer Res. </i>2(9):1445-51, 1996). Timed incubations of PSMA with polyglutamated substrates is followed by separation and detection of hydrolysis products. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0307]" class="style-scope patent-text">
    
    [0307]
  </para-num> <div id="P-0307" num="0307" class="description-line style-scope patent-text">The invention also includes isolated antibodies and binding fragments thereof that selectively bind PSMA multimers. As used herein, particularly with respect to the binding of PSMA multimers by the anti-PSMA antibodies and binding fragments, selectively binds means that an antibody preferentially binds to a PSMA protein multimer (e.g., with greater avidity, greater binding affinity) rather than to a PSMA protein monomer. In preferred embodiments, the antibodies of the invention bind to a PSMA protein multimer with an avidity and/or binding affinity that is 1.1-fold, 1.2-fold, 1.3-fold, 1.4-fold, 1.5-fold, 1.6-fold, 1.7-fold, 1.8-fold, 1.9-fold, 2-fold, 3-fold, 4-fold, 5-fold, 7-fold, 10-fold, 20-fold, 30-fold, 40-fold, 50-fold, 70-fold, 100-fold, 200-fold, 300-fold, 500-fold, 1000-fold or more than that exhibited by the antibody for a PSMA protein monomer. Preferably, the antibody selectively binds a PSMA protein multimer, and not a PSMA protein monomer, i.e., substantially exclusively binds to a PSMA protein multimer. Most preferably, the antibody selectively binds a PSMA protein dimer. <span style="display: none" class="style-scope patent-text">[0307] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0308]" class="style-scope patent-text">
    
    [0308]
  </para-num> <div id="P-0308" num="0308" class="description-line style-scope patent-text">The isolated antibody or binding fragment that selectively binds a PSMA protein multimer can, in some embodiments, modulate enzymatic activity of the PSMA protein multimer. In one such embodiment, the antibody inhibits at least one enzymatic activity such as NAALADase activity, folate hydrolase activity, dipeptidyl dipeptidase IV activity, -glutamyl hydrolase activity, or combinations thereof. In another embodiment, the antibody enhances at least one enzymatic activity such as NAALADase activity, folate hydrolase activity, dipeptidyl dipeptidase IV activity, -glutamyl hydrolase activity, or combinations thereof. <span style="display: none" class="style-scope patent-text">[0308] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0309]" class="style-scope patent-text">
    
    [0309]
  </para-num> <div id="P-0309" num="0309" class="description-line style-scope patent-text">A PSMA protein multimer, as used herein, is a protein complex of at least two PSMA proteins or fragments thereof. The PSMA protein multimers can be composed of various combinations of full-length PSMA proteins (e.g., SEQ ID NO: 1), recombinant soluble PSMA (rsPSMA, e.g., amino acids 44-750 of SEQ ID NO: 1) and fragments of the foregoing that form multimers (i.e., that retain the protein domain required for forming dimers and/or higher order multimers of PSMA). In preferred embodiments, at least one of the PSMA proteins forming the multimer is a recombinant, soluble PSMA (rsPSMA) polypeptide. Preferred PSMA protein multimers are dimers, particularly those formed from recombinant soluble PSMA protein. A particularly preferred embodiment is a rsPSMA homodimer. <span style="display: none" class="style-scope patent-text">[0309] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0310]" class="style-scope patent-text">
    
    [0310]
  </para-num> <div id="P-0310" num="0310" class="description-line style-scope patent-text">The PSMA protein multimers referred to herein are believed to assume a native conformation and preferably have such a conformation. The PSMA proteins in certain embodiments are noncovalently bound together to form the PSMA protein multimer. For example, it has been discovered that PSMA protein noncovalently associates to form dimers under non-denaturing conditions, as described in the Examples below. <span style="display: none" class="style-scope patent-text">[0310] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0311]" class="style-scope patent-text">
    
    [0311]
  </para-num> <div id="P-0311" num="0311" class="description-line style-scope patent-text">The PSMA protein multimers can, and preferably do, retain the activities of PSMA. The PSMA activity may be an enzymatic activity, such as folate hydrolase activity, NAALADase activity, dipeptidyl peptidase IV activity and -glutamyl hydrolase activity. Methods for testing the PSMA activity of multimers are well known in the art (reviewed by O'Keefe et al. in: <span style="display: none" class="style-scope patent-text">[0311] </span> <i class="style-scope patent-text">Prostate Cancer: Biology, Genetics, and the New Therapeutics</i>, L. W. K. Chung, W. B. Isaacs and J. W. Simons (eds.) Humana Press, Totowa, N.J., 2000, pp. 307-326), some of which are described in the Examples herein below. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0312]" class="style-scope patent-text">
    
    [0312]
  </para-num> <div id="P-0312" num="0312" class="description-line style-scope patent-text">In certain aspects, the invention also includes compositions including one or more of the isolated PSMA protein multimers described herein, such as the PSMA protein dimer. In preferred embodiments, a PSMA protein multimer composition contains at least about 10% PSMA protein multimer. In other embodiments, the PSMA protein multimer composition contains at least about 20%, 30%, 40%, 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, 99% or 99.5% PSMA protein multimer. In a preferred embodiment, the PSMA protein multimer composition contains substantially pure PSMA protein multimer, with substantially no PSMA protein monomer. It is understood that the list of specific percentages includes by inference all of the unnamed percentages between the recited percentages. <span style="display: none" class="style-scope patent-text">[0312] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0313]" class="style-scope patent-text">
    
    [0313]
  </para-num> <div id="P-0313" num="0313" class="description-line style-scope patent-text">As used herein with respect to polypeptides, proteins or fragments thereof, isolated means separated from its native environment and present in sufficient quantity to permit its identification or use. Isolated, when referring to a protein or polypeptide, means, for example: (i) selectively produced by expression cloning or (ii) purified as by chromatography or electrophoresis. Isolated proteins or polypeptides may be, but need not be, substantially pure. The term substantially pure means that the proteins or polypeptides are essentially free of other substances with which they may be found in nature or in vivo systems to an extent practical and appropriate for their intended use. Substantially pure polypeptides may be produced by techniques well known in the art. Because an isolated protein may be admixed with a pharmaceutically acceptable carrier in a pharmaceutical preparation, the protein may comprise only a small percentage by weight of the preparation. The protein is nonetheless isolated in that it has been separated from the substances with which it may be associated in living systems, i.e. isolated from other proteins. <span style="display: none" class="style-scope patent-text">[0313] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0314]" class="style-scope patent-text">
    
    [0314]
  </para-num> <div id="P-0314" num="0314" class="description-line style-scope patent-text">Fragments of a PSMA protein preferably are those fragments which retain a distinct functional capability of the PSMA protein. Functional capabilities which can be retained in a fragment include binding of other PSMA molecules to form dimers and higher order multimers, interaction with antibodies, interaction with other polypeptides or fragments thereof, and enzymatic activity. Other PSMA protein fragments, e.g., other recombinant soluble fragments of SEQ ID NO: 1, can be selected according to their functional properties. For example, one of ordinary skill in the art can prepare PSMA fragments recombinantly and test those fragments according to the methods exemplified below. <span style="display: none" class="style-scope patent-text">[0314] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0315]" class="style-scope patent-text">
    
    [0315]
  </para-num> <div id="P-0315" num="0315" class="description-line style-scope patent-text">Modifications to a PSMA polypeptide are typically made to the nucleic acid which encodes the PSMA polypeptide, and can include deletions, point mutations, truncations, amino acid substitutions and additions of amino acids or non-amino acid moieties. Alternatively, modifications can be made directly to the polypeptide, such as by cleavage, addition of a linker molecule, addition of a detectable moiety, such as biotin, addition of a fatty acid, and the like. Modifications also embrace fusion proteins comprising all or part of the PSMA amino acid sequence. <span style="display: none" class="style-scope patent-text">[0315] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0316]" class="style-scope patent-text">
    
    [0316]
  </para-num> <div id="P-0316" num="0316" class="description-line style-scope patent-text">In general, modified PSMA polypeptides include polypeptides which are modified specifically to alter a feature of the polypeptide unrelated to its physiological activity. For example, cysteine residues can be substituted or deleted to prevent unwanted disulfide linkages. Similarly, certain amino acids can be changed to enhance expression of a PSMA polypeptide by eliminating proteolysis by proteases in an expression system (e.g., dibasic amino acid residues in yeast expression systems in which KEX2 protease activity is present). <span style="display: none" class="style-scope patent-text">[0316] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0317]" class="style-scope patent-text">
    
    [0317]
  </para-num> <div id="P-0317" num="0317" class="description-line style-scope patent-text">Modifications conveniently are prepared by altering a nucleic acid molecule that encodes the PSMA polypeptide. Mutations of a nucleic acid which encode a PSMA polypeptide preferably preserve the amino acid reading frame of the coding sequence, and preferably do not create regions in the nucleic acid which are likely to hybridize to form secondary structures, such a hairpins or loops, which can be deleterious to expression of the modified polypeptide. <span style="display: none" class="style-scope patent-text">[0317] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0318]" class="style-scope patent-text">
    
    [0318]
  </para-num> <div id="P-0318" num="0318" class="description-line style-scope patent-text">Modifications can be made by selecting an amino acid substitution, or by random mutagenesis of a selected site in a nucleic acid which encodes the PSMA polypeptide. Modified PSMA polypeptides then can be expressed and tested for one or more activities (e.g., antibody binding, enzymatic activity, multimeric stability) to determine which mutation provides a modified polypeptide with the desired properties. Further mutations can be made to modified PSMA polypeptides (or to non-modified PSMA polypeptides) which are silent as to the amino acid sequence of the polypeptide, but which provide preferred codons for translation in a particular host. The preferred codons for translation of a nucleic acid in, e.g., <span style="display: none" class="style-scope patent-text">[0318] </span> <i class="style-scope patent-text">E. coli</i>, are well known to those of ordinary skill in the art. Still other mutations can be made to the noncoding sequences of a PSMA coding sequence or cDNA clone to enhance expression of the polypeptide. The activity of modified PSMA polypeptides can be tested by cloning the gene encoding the modified PSMA polypeptide into a bacterial or mammalian expression vector, introducing the vector into an appropriate host cell, expressing the modified PSMA polypeptide, and testing for a functional capability of the PSMA polypeptides as disclosed herein. The foregoing procedures are well known to one of ordinary skill in the art. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0319]" class="style-scope patent-text">
    
    [0319]
  </para-num> <div id="P-0319" num="0319" class="description-line style-scope patent-text">The skilled artisan will also realize that conservative amino acid substitutions may be made in PSMA polypeptides to provide functionally equivalent PSMA polypeptides, i.e., modified PSMA polypeptides that retain the functional capabilities of PSMA polypeptides. These functionally equivalent PSMA polypeptides include those PSMA polypeptides or proteins that are capable of associating to form multimers, particularly dimers. As used herein, a conservative amino acid substitution refers to an amino acid substitution which does not alter the relative charge or size characteristics of the protein in which the amino acid substitution is made. Modified PSMA polypeptides can be prepared according to methods for altering polypeptide sequence known to one of ordinary skill in the art such as are found in references which compile such methods, e.g. <span style="display: none" class="style-scope patent-text">[0319] </span> <i class="style-scope patent-text">Molecular Cloning: A Laboratory Manual</i>, J. Sambrook, et al., eds., Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989, or <i class="style-scope patent-text">Current Protocols in Molecular Biology</i>, F. M. Ausubel, et al., eds., John Wiley &amp; Sons, Inc., New York. Exemplary functionally equivalent PSMA polypeptides include conservative amino acid substitutions of SEQ ID NO: 1, or fragments thereof, such as the recombinant soluble PSMA polypeptide (amino acids 44-750 of SEQ ID NO: 1). Conservative substitutions of amino acids include substitutions made amongst amino acids within the following groups: (a) M, I, L, V; (b) F, Y, W; (c) K, R, H; (d) A, G; (e) S, T; (f) Q, N; and (g) E, D. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0320]" class="style-scope patent-text">
    
    [0320]
  </para-num> <div id="P-0320" num="0320" class="description-line style-scope patent-text">Conservative amino-acid substitutions in PSMA polypeptides typically are made by alteration of a nucleic acid encoding a PSMA polypeptide. Conservatively substituted PSMA polypeptides include those with 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, or more substitutions. Such substitutions can be made by a variety of methods known to one of ordinary skill in the art. For example, amino acid substitutions may be made by PCR-directed mutation, site-directed mutagenesis, or by chemical synthesis of a gene encoding a PSMA polypeptide. Where amino acid substitutions are made to a small fragment of a PSMA polypeptide, the substitutions can be made by directly synthesizing the peptide. The activity of functionally equivalent fragments of PSMA polypeptides can be tested by cloning the gene encoding the altered PSMA polypeptide into a bacterial or mammalian expression vector, introducing the vector into an appropriate host cell, expressing the altered PSMA polypeptide, and testing for a functional capability of the PSMA polypeptides as disclosed herein. <span style="display: none" class="style-scope patent-text">[0320] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0321]" class="style-scope patent-text">
    
    [0321]
  </para-num> <div id="P-0321" num="0321" class="description-line style-scope patent-text">The PSMA protein multimers as described herein have a number of uses, some of which are described elsewhere herein. The multimers are useful for testing of compounds that modulate PSMA enzymatic activity or PSMA multimerization. The multimers can be used to isolate antibodies that selectively bind PSMA, including those selective for conformational epitopes, those selective for binding PSMA multimers and not PSMA monomers, and those that selectively modulate an enzymatic activity of PSMA. The multimers, particularly dimeric PSMA, also can be used to induce or increase immune responses to PSMA, as vaccine compositions. <span style="display: none" class="style-scope patent-text">[0321] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0322]" class="style-scope patent-text">
    
    [0322]
  </para-num> <div id="P-0322" num="0322" class="description-line style-scope patent-text">Agents that selectively modulate an enzymatic activity of PSMA include agents that inhibit or enhance at least one enzymatic activity of PSMA, such as NAALADase activity, folate hydrolase activity, dipeptidyl dipeptidase IV activity, -glutamyl hydrolase activity, or combinations thereof. <span style="display: none" class="style-scope patent-text">[0322] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0323]" class="style-scope patent-text">
    
    [0323]
  </para-num> <div id="P-0323" num="0323" class="description-line style-scope patent-text">Thus methods of screening for candidate agents that modulate at least one enzymatic activity of a PSMA enzyme are provided in accordance with the invention. The methods can include mixing the candidate agent with an isolated PSMA protein multimer to form a reaction mixture, thereby contacting the PSMA enzyme with the candidate agent. The methods also include adding a substrate for the PSMA enzyme to the reaction mixture, and determining the amount of a product formed from the substrate by the PSMA enzyme. Such methods are adaptable to automated, high-throughput screening of compounds. A decrease in the amount of product formed in comparison to a control is indicative of an agent capable of inhibiting at least one enzymatic activity of the PSMA enzyme. An increase in the amount of product formed in comparison to a control is indicative of an agent capable of enhancing at least one enzymatic activity of the PSMA enzyme. The PSMA enzyme can be NAALADase, folate hydrolase, dipeptidyl dipeptidase IV and/or -glutamyl hydrolase. The PSMA enzyme preferably is a PSMA multimer that includes recombinant soluble PSMA, most preferably a noncovalently associated dimer of PSMA in a native conformation. <span style="display: none" class="style-scope patent-text">[0323] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0324]" class="style-scope patent-text">
    
    [0324]
  </para-num> <div id="P-0324" num="0324" class="description-line style-scope patent-text">The reaction mixture comprises a candidate agent. The candidate agent is preferably an antibody, a small organic compound, or a peptide, and accordingly can be selected from combinatorial antibody libraries, combinatorial protein libraries, or small organic molecule libraries. Typically, a plurality of reaction mixtures are run in parallel with different agent concentrations to obtain a different response to the various concentrations. Typically, one of these concentrations serves as a negative control, i.e., at zero concentration of agent or at a concentration of agent below the limits of assay detection. <span style="display: none" class="style-scope patent-text">[0324] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0325]" class="style-scope patent-text">
    
    [0325]
  </para-num> <div id="P-0325" num="0325" class="description-line style-scope patent-text">Candidate agents encompass numerous chemical classes, although typically they are organic compounds, proteins or antibodies (and fragments thereof that bind antigen). In some preferred embodiments, the candidate agents are small organic compounds, i.e., those having a molecular weight of more than 50 yet less than about 2500, preferably less than about 1000 and, more preferably, less than about 500. Candidate agents comprise functional chemical groups necessary for structural interactions with polypeptides and/or nucleic acids, and typically include at least an amine, carbonyl, hydroxyl, or carboxyl group, preferably at least two of the functional chemical groups and more preferably at least three of the functional chemical groups. The candidate agents can comprise cyclic carbon or heterocyclic structure and/or aromatic or polyaromatic structures substituted with one or more of the above-identified functional groups. Candidate agents also can be biomolecules such as peptides, saccharides, fatty acids, sterols, isoprenoids, purines, pyrimidines, derivatives or structural analogs of the above, or combinations thereof and the like. <span style="display: none" class="style-scope patent-text">[0325] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0326]" class="style-scope patent-text">
    
    [0326]
  </para-num> <div id="P-0326" num="0326" class="description-line style-scope patent-text">Candidate agents are obtained from a wide variety of sources including libraries of synthetic or natural compounds. For example, numerous means are available for random and directed synthesis of a wide variety of organic compounds and biomolecules, including expression of randomized oligonucleotides, synthetic organic combinatorial libraries, phage display libraries of random or non-random peptides, combinatorial libraries of proteins or antibodies, and the like. Alternatively, libraries of natural compounds in the form of bacterial, fungal, plant, and animal extracts are available or readily produced. Additionally, natural and synthetically produced libraries and compounds can be readily be modified through conventional chemical, physical, and biochemical means. Further, known agents may be subjected to directed or random chemical modifications such as acylation, alkylation, esterification, amidification, etc. to produce structural analogs of the agents. <span style="display: none" class="style-scope patent-text">[0326] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0327]" class="style-scope patent-text">
    
    [0327]
  </para-num> <div id="P-0327" num="0327" class="description-line style-scope patent-text">A variety of other reagents also can be included in the mixture. These include reagents such as salts, buffers, neutral proteins (e.g., albumin), detergents, etc. which may be used to facilitate optimal protein-protein and/or protein-agent binding. Such a reagent may also reduce non-specific or background interactions of the reaction components. Other reagents that improve the efficiency of the assay such as protease inhibitors, nuclease inhibitors, antimicrobial agents, and the like may also be used. <span style="display: none" class="style-scope patent-text">[0327] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0328]" class="style-scope patent-text">
    
    [0328]
  </para-num> <div id="P-0328" num="0328" class="description-line style-scope patent-text">The mixture of the foregoing reaction materials is incubated under conditions whereby, the candidate agent interacts with the PSMA enzyme. The order of addition of components, incubation temperature, time of incubation, and other parameters of the assay may be readily determined. Such experimentation merely involves optimization of the assay parameters, not the fundamental composition of the assay. Incubation temperatures typically are between 4 C. and 40 C. Incubation times preferably are minimized to facilitate rapid, high throughput screening, and typically are between 0.1 and 10 hours. <span style="display: none" class="style-scope patent-text">[0328] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0329]" class="style-scope patent-text">
    
    [0329]
  </para-num> <div id="P-0329" num="0329" class="description-line style-scope patent-text">After incubation, the presence or absence of PSMA enzyme activity is detected by any convenient method available to the user. For example, the reaction mixture can contain a substrate for the PSMA enzyme. Preferably the substrate and/or the product formed by the action of the PSMA enzyme are detectable. The substrate usually comprises, or is coupled to, a detectable label. A wide variety of labels can be used, such as those that provide direct detection (e.g., radioactivity, luminescence, optical, or electron density, etc) or indirect detection (e.g., epitope tag such as the FLAG epitope, enzyme tag such as horseradish peroxidase, etc.). The label may be bound to the substrate, or incorporated into the structure of the substrate. <span style="display: none" class="style-scope patent-text">[0329] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0330]" class="style-scope patent-text">
    
    [0330]
  </para-num> <div id="P-0330" num="0330" class="description-line style-scope patent-text">A variety of methods may be used to detect the label, depending on the nature of the label and other assay components. For example, the label may be detected while bound to the substrate or subsequent to separation from the substrate. Labels may be directly detected through optical or electron density, radioactive emissions, nonradiative energy transfers, etc. or indirectly detected with antibody conjugates, strepavidin-biotin conjugates, etc. Methods for detecting a variety of labels are well known in the art. <span style="display: none" class="style-scope patent-text">[0330] </span> </div>
    </li> <heading class="style-scope patent-text">EXAMPLES </heading>
    <li class="style-scope patent-text"> <para-num num="[0331]" class="style-scope patent-text">
    
    [0331]
  </para-num> <div id="P-0331" num="0331" class="description-line style-scope patent-text">Materials and Methods <span style="display: none" class="style-scope patent-text">[0331] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0332]" class="style-scope patent-text">
    
    [0332]
  </para-num> <div id="P-0332" num="0332" class="description-line style-scope patent-text">DNA Constructs. All secreted PSMA constructs were derived from the original human PSMA clone p55A provided by Dr. W. D. W. Heston (Israeli et al., <span style="display: none" class="style-scope patent-text">[0332] </span> <i class="style-scope patent-text">Cancer Res. </i>53: 227-230, 1993). The constructs were subcloned into expression vector PPI4 (Trkola et al., <i class="style-scope patent-text">Nature </i>384: 184-187, 1996) for high-level expression and secretion in mammalian cells. Recombinant soluble PSMA (rsPSMA) corresponds to the entire extracellular domain of PSMA (amino acids 44-750 of SEQ ID NO:1 (GenBank Protein Accession number AAA60209)). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0333]" class="style-scope patent-text">
    
    [0333]
  </para-num> <div id="P-0333" num="0333" class="description-line style-scope patent-text">pcDNA Plasmid Constructs: Nucleic acid molecules encoding the anti-PSMA antibodies 10.3, 006, 026, 051, 069 and 077 were cloned into plasmid pcDNA. The cloning protocol is given in FIG. 13. Primers (SEQ ID NOs: 33-36, sense and anti-sense) used for the variable region amplifications are also shown. The plasmids constructed for <span style="display: none" class="style-scope patent-text">[0333] </span> <figure-callout id="006" label="anti-PSMA antibodies" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="anti-PSMA antibodies" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="051" label="anti-PSMA antibodies" filenames="US20040161776A1-20040819-D00037.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">anti-PSMA antibodies</a></figure-callout> </a></figure-callout> </a></figure-callout> 006, 026, 051, 069, 077 and 10.3 contain nucleotide sequences encoding the heavy chain of the antibodies (SEQ ID NOs: 2-7; PTA-4403, PTA-4405, PTA-4407, PTA-4409, PTA-4411, PTA-4413, respectively) or contain nucleotide sequences encoding light chain of the antibodies (SEQ ID NOs: 8-13; PTA-4404, PTA-4406, PTA-4408, PTA-4410, PTA-4412 and PTA-4414, respectively). Plasmid maps are given in FIGS. <b class="style-scope patent-text">14</b>-<b class="style-scope patent-text">25</b>. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0334]" class="style-scope patent-text">
    
    [0334]
  </para-num> <div id="P-0334" num="0334" class="description-line style-scope patent-text">Western Blots. Cells were lysed in PBS containing 1 mM EDTA, 1% NP-40, 1% Triton X-100, and 5 mg/ml aprotinin and cell debris was removed by centrifugation at 3000 g for 30 min at 4 C. Lysates were separated on a 5-20% gradient gel before transfer to nitrocellulose membranes. The resulting blots were blocked in PBS containing 5% milk, 0.02% SDS and 0.1% Triton X-100 before incubation with MAB544 primary antibody (Maine Biotechnologies) at a concentration of 2 mg/ml. After three washes, blots were incubated with a goat anti-mouse HRP-conjugated secondary antibody at a concentration of 0.2 mg/ml. Blots are visualized using the Renaissance chemiluminescence system (Perkin-Elmer Life Sciences, Boston, Mass.). <span style="display: none" class="style-scope patent-text">[0334] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0335]" class="style-scope patent-text">
    
    [0335]
  </para-num> <div id="P-0335" num="0335" class="description-line style-scope patent-text">ELISA. Cells were lysed in PBS containing 1 mM EDTA, 1% NP-40, 1% Triton X-100, and 5 mg/ml aprotinin. The resulting cell membranes were plated onto 96-well plates and dried in a sterile hood overnight. The plates were then blocked with PBS containing casein and Tween-20 before addition of mouse sera or hybridoma supernatants, using purified MAB544 (Maine Biotechnologies) or 7E11 (Cytogen) as a standard. After washing in PBS, an alkaline phosphatase conjugated secondary antibody (subclass specific) was incubated and subsequently washed in PBS. The pNPP substrate was then added for colorimetric detection at a wavelength of 405 nm. <span style="display: none" class="style-scope patent-text">[0335] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0336]" class="style-scope patent-text">
    
    [0336]
  </para-num> <div id="P-0336" num="0336" class="description-line style-scope patent-text">Flow Cytometry. Wild-type 3T3 or PSMA-expressing 3T3 cells (10<span style="display: none" class="style-scope patent-text">[0336] </span> <sup class="style-scope patent-text">6 </sup>cells per condition) were washed in PBS containing 0.1% NaN<sub class="style-scope patent-text">3</sub>. Antibodies or sera were then added (1:100 dilution in PBS) and incubated on ice for 30 minutes. After washing in PBS+0.1% NaN<sub class="style-scope patent-text">3</sub>, the cells were incubated with anti-mouse IgG+IgM (Calbiotech) for 30 minutes on ice. Cells were washed again in PB S+0.1% NaN<sub class="style-scope patent-text">3 </sub>and analyzed by flow cytometry. </div>
    </li> <heading class="style-scope patent-text">Example 1 </heading>
    <heading class="style-scope patent-text">Generation of a Panel of Monoclonal Antibodies (mAbs) to Conformational Epitopes on PSMA </heading>
    <li class="style-scope patent-text"> <para-num num="[0337]" class="style-scope patent-text">
    
    [0337]
  </para-num> <div id="P-0337" num="0337" class="description-line style-scope patent-text">A panel of anti-PSMA mAbs that represent promising candidates for therapy was created. Briefly, the mAbs were generated as follows: BALB/c mice were immunized subcutaneously with recombinant PSMA at approximately three-week intervals. After a total of 4 injections, mice were sacrificed and their splenocytes fused with a myeloma cell line using standard techniques in order to create hybridomas. Individual hybridoma supernatants were screened by ELISA for reactivity with PSMA derived from either LNCaP human prostate tumor cells or from 3T3 cells engineered to express full-length human PSMA (3T3-PSMA cells). Positive clones were secondarily screened by flow cytometry for specific reactivity with intact 3T3-PSMA and LNCaP cells so as to select antibodies that recognize native, cell-surface PSMA and thus have the greatest therapeutic potential. <span style="display: none" class="style-scope patent-text">[0337] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0338]" class="style-scope patent-text">
    
    [0338]
  </para-num> <div id="P-0338" num="0338" class="description-line style-scope patent-text">Mice having the ability to produce human antibodies (XenoMouse, Abgenix; Mendez et al., <span style="display: none" class="style-scope patent-text">[0338] </span> <i class="style-scope patent-text">Nature Genetics </i>15:146, 1997) were immunized subcutaneously once or twice weekly with 510<sup class="style-scope patent-text">6 </sup>LNCaP cells adjuvanted with alum or Titermax Gold (Sigma Chemical Co., St. Louis, Mo.). Animals were boosted twice with 10 g of recombinant PSMA protein immunoaffinity captured onto protein G magnetic microbeads (Miltenyi Biotec, Auburn, Calif.). PSMA mAb 3.11 was used for capture. Splenocytes were fused with NSO myeloma cells and the hybridomas that resulted were screened as above by flow cytometry to detect clones producing antibodies reactive with the extracellular portion of PSMA. One clone, 10.3 (PTA-3347), produced such antibodies. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0339]" class="style-scope patent-text">
    
    [0339]
  </para-num> <div id="P-0339" num="0339" class="description-line style-scope patent-text">These methods have yielded a high proportion of mAbs that react exclusively with conformation-specific epitopes on cell-surface PSMA. As shown in FIG. 1, several (mAbs 3.7, 3.9, 3.11, 5.4, and 10.3) but not all (mAb 3.12) mAbs specifically bind viable PSMA-expressing cells. Using recombinant soluble PSMA proteins expressed in Chinese hamster ovary (CHO) cell lines, it further was demonstrated that the mAbs bind epitopes in the extracellular region of PSMA. The mAbs were also tested for their ability to immunoprecipitate native PSMA from 3T3-PSMA cell lysates. The mAbs positive in flow cytometry (FIG. 1) were also effective in immunoprecipitation (FIG. 2), whereas mAb 3.12 was unreactive. FIG. 3 shows the recognition of non-denatured fill-length PSMA and recombinant soluble PSMA by several PSMA antibodies that recognize PSMA conformation. This further confirms that these methods yield a preponderance of mAbs that efficiently recognize native PSMA. <span style="display: none" class="style-scope patent-text">[0339] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0340]" class="style-scope patent-text">
    
    [0340]
  </para-num> <div id="P-0340" num="0340" class="description-line style-scope patent-text">The mAbs were tested for reactivity with denatured PSMA by Western blot analysis (FIG. 4). Lysates from the indicated cells and samples (controls: 3T3 cells, PSMA-negative human prostate cell lines PC-3 and DU145, mock supernatant; PSMA-positive samples: PSMA-expressing 3T3 cells, PSMA-positive human prostate cell line LNCaP, rsPSMA-positive supernatant) were resolved by SDS-PAGE, electroblotted, and probed with anti-PSMA mAbs 3.1 and 3.12 (ATCC Patent Deposit Designations PTA-3639 and PTA-3640, respectively). Four mAbs tested in parallel (3.7, 3.8, 3.9, 3.11) showed no reactivity to either full-length or secreted rsPSMA proteins. 7E11 mAb immunoprecipitated full-length but not secreted rsPSMA. <span style="display: none" class="style-scope patent-text">[0340] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0341]" class="style-scope patent-text">
    
    [0341]
  </para-num> <div id="P-0341" num="0341" class="description-line style-scope patent-text">The mAbs reactive in flow cytometry and immunoprecipitation (mAbs 3.7, 3.9, 3.11, 5.4, and 10.3) were all unreactive in Western blot analysis, indicating that the mAbs do not recognize linear epitopes. Taken together, the data strongly suggest that these 5 mAbs recognize conformation-specific epitopes located in the extracellular domain of PSMA. Since mAbs to conformational epitopes typically possess the greatest affinity and specificity for antigen, they represent preferred candidates for therapy. <span style="display: none" class="style-scope patent-text">[0341] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0342]" class="style-scope patent-text">
    
    [0342]
  </para-num> <div id="P-0342" num="0342" class="description-line style-scope patent-text">The reactivities of certain anti-PSMA antibodies are described in Table 2:  
<span style="display: none" class="style-scope patent-text">[0342] </span> <tables id="TABLE-US-00002" num="2" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 2</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Anti-PSMA Antibody Properties</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Reactivity</td> <td class="description-td style-scope patent-text"> </td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Flow</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">mAb</td> <td class="description-td style-scope patent-text">ELISA</td> <td class="description-td style-scope patent-text">Cytometry</td> <td class="description-td style-scope patent-text">IP</td> <td class="description-td style-scope patent-text">Western</td> <td class="description-td style-scope patent-text">Epitope</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="6" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.1</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">Linear, Extracellular,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">exposed on native PSMA</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.7</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.8</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.9</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.11</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">3.12</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">Linear, Extracellular,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">not exposed on native</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">PSMA</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">5.4</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">7.1</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">Linear, Extracellular,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">not exposed on native</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">PSMA</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">7.3</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">10.3</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Conformational,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">1.8.3</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">A3.1.3</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">A3.3.1</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">Extracellular</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="6" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="6"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0343]" class="style-scope patent-text">
    
    [0343]
  </para-num> <div id="P-0343" num="0343" class="description-line style-scope patent-text">The mAbs were determined by ELISA to be primarily of the mouse IgG2a, mouse IgG2b and human IgG1 isotypes, which mediate potent effector functions. Although a number of anti-PSMA mAbs have been described over the years and evaluated for therapeutic potential (see, e.g., Liu, H. et al. <span style="display: none" class="style-scope patent-text">[0343] </span> <i class="style-scope patent-text">Cancer Res. </i>57: 3629-3634, 1997; Chang, S. S. et al. <i class="style-scope patent-text">Cancer Res. </i>59: 3192-3198, 1999; Murphy, G. P. et al. <i class="style-scope patent-text">J Urology </i>160: 2396-2401, 1998), none inhibit the enzymatic activity of PSMA and few recognize conformational determinants on PSMA. </div>
    </li> <heading class="style-scope patent-text">Example 2 </heading>
    <heading class="style-scope patent-text">Production of Anti-PSMA mAbs </heading>
    <li class="style-scope patent-text"> <para-num num="[0344]" class="style-scope patent-text">
    
    [0344]
  </para-num> <div id="P-0344" num="0344" class="description-line style-scope patent-text">To accurately and quantitatively assess the therapeutic potential of these mAbs, the mAbs are produced in a quantity and quality suitable for extensive in vitro and in vivo characterization. Briefly, the mAb-secreting hybridomas are cultured in roller bottles in DMEM/F12 medium supplemented with 10% FBS that has been depleted of bovine IgG (Life Technologies). During the production phase of the culture, cells are maintained at 510<span style="display: none" class="style-scope patent-text">[0344] </span> <sup class="style-scope patent-text">6 </sup>cells/mL via twice-weekly exchanges of media. Collected media are clarified by filtration through a 0.22 micron filter and stored at 95 C. prior to purification. Given an average antibody expression levels of 25 mg/L, approximately 3L of roller bottle supernatants are required for each antibody to allow for losses in purification. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0345]" class="style-scope patent-text">
    
    [0345]
  </para-num> <div id="P-0345" num="0345" class="description-line style-scope patent-text">Culture supernatants from a given hybridoma are pooled and loaded onto a Protein A Sepharose affinity column. Mouse IgG2a, mouse IgG2b and human IgG1 antibodies are loaded directly, but supernatants containing mouse IgG1 antibodies are adjusted to pH 8.5 and 1M NaCl prior to loading in order to promote binding. After washing the column, the mAb is eluted with low pH buffer into fractions using 1M Tris, pH 8.0. Elution peak fractions are pooled, dialyzed against PBS buffer, concentrated to 5 mg/mL and stored in sterile aliquots at 95 C. All purification procedures are carried out using endotoxin-free buffers and sanitized chromatography columns. Purified mAbs are tested for purity by reducing and nonreducing SDS-PAGE, for PSMA binding affinity by ELISA, and for endotoxin levels by the limulus amebocyte lysate assay. These procedures routinely yield animal-grade antibody at &gt;95% purity and &lt;0.5 endotoxin units per milligram of protein. <span style="display: none" class="style-scope patent-text">[0345] </span> </div>
    </li> <heading class="style-scope patent-text">Example 3 </heading>
    <heading class="style-scope patent-text">Evaluation of the Therapeutic Potential of the Unlabeled mAbs In Vitro </heading>
    <li class="style-scope patent-text"> <para-num num="[0346]" class="style-scope patent-text">
    
    [0346]
  </para-num> <div id="P-0346" num="0346" class="description-line style-scope patent-text">Purified mAbs are tested in a battery of assays for therapeutically relevant properties, including affinity, specificity, enzyme inhibitory activity and effector functions. The ideal product candidate binds and inhibits PSMA activity at subnanomolar concentrations and mediates potent cell-killing through Fc-related effector functions. <span style="display: none" class="style-scope patent-text">[0346] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0347]" class="style-scope patent-text">
    
    [0347]
  </para-num> <div id="P-0347" num="0347" class="description-line style-scope patent-text">First, the mAbs' affinity for cell-surface and secreted forms of PSMA is measured by flow cytometry and ELISA, respectively. In the flow cytometry assay, varying amounts of mAbs are incubated with 510<span style="display: none" class="style-scope patent-text">[0347] </span> <sup class="style-scope patent-text">5 </sup>3T3-PSMA cells in FACS buffer (PBS containing 1% FBS and 0.1% NaN<sub class="style-scope patent-text">3</sub>) for 2 hr to allow for saturation binding. Cells are washed and incubated with a phycoerythrin-coupled goat antibody to mouse IgG (ICN/Cappel) for detection of bound mAb by flow cytometry. Specific binding is calculated by subtracting the fluorescence intensity observed with parental 3T3 cells. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0348]" class="style-scope patent-text">
    
    [0348]
  </para-num> <div id="P-0348" num="0348" class="description-line style-scope patent-text">For ELISA, CHO cell-derived recombinant soluble PSMA protein (rsPSMA, Progenics, Tarrytown, NY) is diluted to 1 g/ml in 50 mM carbonate buffer, pH 9.4, and coated overnight at 4 C. onto 96-well Immulon II microtiter plates at 100 l/well. The plates are then blocked for 2 hr with PBS buffer containing 5% BSA. mAbs are added in a range of concentrations in ELISA buffer (PBS buffer containing 2% BSA, 1% FBS and 0.5% Tween 20) for 2 hours at room temperature. The plates are washed, and horseradish peroxidase conjugated goat antibody to mouse IgG is added for 1 hr at room temperature. The plates are washed again and 3,3,5,5-tetramethylbenzidine dihydrochloride (TMB) substrate (Pierce, Rockford, Ill.) is added for colorimetric readout at 450 nm using an ELISA plate reader (Molecular Devices, Sunnyvale, Calif.). <span style="display: none" class="style-scope patent-text">[0348] </span> </div>
    </li> <heading class="style-scope patent-text">Example 4 </heading>
    <heading class="style-scope patent-text">mAb Cross-Competition Binding Assay </heading>
    <li class="style-scope patent-text"> <para-num num="[0349]" class="style-scope patent-text">
    
    [0349]
  </para-num> <div id="P-0349" num="0349" class="description-line style-scope patent-text">To identify whether a given group of mAbs recognize distinct or overlapping epitopes on PSMA, cross-competition binding assays are performed (Liu, H. et al. <span style="display: none" class="style-scope patent-text">[0349] </span> <i class="style-scope patent-text">Cancer Res </i>57: 3629-3634, 1997). In this flow cytometry assay, a biotinylated test mAb is incubated with 3T3-PSMA cells in the presence or absence of varying concentrations of unlabeled competitor mAbs as described above. Following washing, phycoerythrin-conjugated streptavidin is added to determine the amount of bound biotinylated mAb. The percent inhibition is defined relative to that observed in the presence of an isotype-matched mAb of irrelevant specificity (0% inhibition) and to that observed using excess unlabeled test mAb (100% inhibition). </div>
    </li> <heading class="style-scope patent-text">Example 5 </heading>
    <heading class="style-scope patent-text">Effects of mAbs on PSMA Enzymatic Activity </heading>
    <li class="style-scope patent-text"> <para-num num="[0350]" class="style-scope patent-text">
    
    [0350]
  </para-num> <div id="P-0350" num="0350" class="description-line style-scope patent-text">PSMA has been shown to possess both folate hydrolase (pteroyl-glutamyl carboxypeptidase) and N-acetylated -linked acidic dipeptidase (NAALADase) enzymatic activities, which may influence the proliferation and malignancies of the tumor cell (Heston, W. D. W. <span style="display: none" class="style-scope patent-text">[0350] </span> <i class="style-scope patent-text">Prostate: Basic and Clinical Aspects </i>(R. K. Naz, ed.). CRC Press, New York: 219-243, 1997). A first set of mAbs described above (mAb 3.9, mAb 5.4 and mAb 7.3) and mAb J591 (ATCC #HB-12126) were tested for folate hydrolase modulating activity using previously described assays for measuring PSMA enzymatic activity (Pinto, J. T. et al. <i class="style-scope patent-text">Clinical Cancer Res </i>2: 1445-1451, 1996). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0351]" class="style-scope patent-text">
    
    [0351]
  </para-num> <div id="P-0351" num="0351" class="description-line style-scope patent-text">Briefly, folate hydrolase activity was measured as follows. Fifty M methotrexate di-gamma glutamate and 10 g/ml rsPSMA (premixed with anti-PSMA or irrelevant mAb) was incubated in pH 4.5 acetate buffer in a volume of 100 l for 2 hr at 37 C. Reactions were terminated by boiling for 5 minutes prior to separation of free, mono- and di-gamma glutamate forms of methotrexate by capillary electrophoresis on a Spectra Phoresis 1000 (Thermo Separation, San Jose, Calif.). The various methotrexate derivatives were quantified based on their retention times and absorbance at 300 nm. <span style="display: none" class="style-scope patent-text">[0351] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0352]" class="style-scope patent-text">
    
    [0352]
  </para-num> <div id="P-0352" num="0352" class="description-line style-scope patent-text">The data show that mAb 5.4 potently blocks the enzymatic activity of purified rsPSMA protein and in lysates of C4-2 cells. C4-2 is an androgen independent derivative of the LNaCP cell line (human prostate cancer line) which expresses endogenous PSMA. More details regarding the C4-2 cell line maybe found in O'Keefe D. S. et al. <span style="display: none" class="style-scope patent-text">[0352] </span> <i class="style-scope patent-text">Prostate </i>45: 149-157, 2000). FIGS. 8 and 9 provide the results for two production lots of rsPSMA (<figure-callout id="7" label="rsPSMA #" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rsPSMA #</a></figure-callout>7 and rsPSMA #8). The results for the C4-2 cell lysates are shown in FIG. 10. The figures illustrate the effect of four antibodies (mAb 3.9, mAb 5.4, mAb 7.3 and mAb J591) on the enzymatic activity of folate hydrolase by way of the rate of cleavage of glutamate from methotrexate di-gamma glutamate (MTXGlu2) by folate hydrolase present in the two production lots of rsPSMA and in the C4-2 cell lysates. In addition to the inhibitory effects of mAb 5.4, mAb 3.9 was also found to inhibit folate hydrolase activity. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0353]" class="style-scope patent-text">
    
    [0353]
  </para-num> <div id="P-0353" num="0353" class="description-line style-scope patent-text">Another set of mAbs (mAb 4.40.2, <span style="display: none" class="style-scope patent-text">[0353] </span> <figure-callout id="006" label="mAb" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 006, <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 and mAb 5.4) was also tested for folate hydrolase modulating activity. The data confirm that mAb 5.4 potently blocks folate hydrolase activity of PSMA (FIG. 11). The concentration of mAb 5.4 which inhibited PSMA enzymatic activity by 50% (IC50, also referred to as EC50 or effective concentration) was determined to be 4.90210<sup class="style-scope patent-text">4 </sup>mg/mL. The data further show that <figure-callout id="006" label="mAb" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 006 and <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 also block PSMA folate hydrolase activity, while mAb 4.40.2 did not (FIG. 11). The IC50 values for <figure-callout id="006" label="mAb" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 006 and <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 were 9.33810<sup class="style-scope patent-text">3 </sup>mg/mL and 1.38510<sup class="style-scope patent-text">3 </sup>mg/mL, respectively. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0354]" class="style-scope patent-text">
    
    [0354]
  </para-num> <div id="P-0354" num="0354" class="description-line style-scope patent-text">For NAALADase activity assays, rsPSMA protein is incubated with varying amounts of anti-PSMA or control mAbs in 50 mM Tris pH 7.4, 1 mM CoCl<span style="display: none" class="style-scope patent-text">[0354] </span> <sub class="style-scope patent-text">2 </sub>for 10 minutes at 37 C. before adding 50 l of 0.6 M N-acetylaspartyl-[<sup class="style-scope patent-text">3</sup>H]glutamate. After 15 minutes, the reaction is stopped by adding 1 ml of 100 mM NaPO<sub class="style-scope patent-text">4</sub>. Cleaved glutamate is separated from the substrate by ion exchange chromatography and detected by scintillation counting. Each measurement is performed in triplicate. </div>
    </li> <heading class="style-scope patent-text">Example 6 </heading>
    <heading class="style-scope patent-text">Reactivity with Normal and Malignant Human Tissues by Immunohistochemistry </heading>
    <li class="style-scope patent-text"> <para-num num="[0355]" class="style-scope patent-text">
    
    [0355]
  </para-num> <div id="P-0355" num="0355" class="description-line style-scope patent-text">Anti-PSMA mAbs are tested by immunohistochemistry for reactivity with both normal and malignant human tissues using an avidin-biotin peroxidase method (Silver, D. A. et al. <span style="display: none" class="style-scope patent-text">[0355] </span> <i class="style-scope patent-text">Clin Cancer Res </i>3: 81-85,1997). Frozen or paraffin-embedded tissues can be used. Paraffin-embedded tissue sections are deparaffinized and endogenous peroxidase activity is blocked by incubation with 1% H<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">2 </sub>for 15 minutes. Sections are blocked in a 1:10 dilution of horse serum in 2% PBS-BSA (Sigma Chemical, St Louis, Mo.) for 30 minutes before overnight incubation with 2 g/ml anti-PSMA mAb in 2% PBS-BSA. After washing, sections are incubated with biotinylated secondary antibody, washed, and incubated with avidin:biotin peroxidase complexes (Vector Laboratories, Burlingame, Calif.) diluted 1:25 in PBS for 30 minutes. After washing, sections are visualized by immersion in PBS containing 0.05% diaminobenzidine tetrachloride, 0.01% H<sub class="style-scope patent-text">2</sub>O<sub class="style-scope patent-text">2</sub>, and 0.5% Triton X-100. Negative control sections are incubated with isotype-matched mAbs of irrelevant specificity. As a positive control, 7E11 (Cytogen, Princeton, N.J.), a well-characterized anti-PSMA mAb, is used. </div>
    </li> <heading class="style-scope patent-text">Example 7 </heading>
    <heading class="style-scope patent-text">Antibody-Dependent Cellular Cytotoxicity (ADCC) </heading>
    <li class="style-scope patent-text"> <para-num num="[0356]" class="style-scope patent-text">
    
    [0356]
  </para-num> <div id="P-0356" num="0356" class="description-line style-scope patent-text">In the ADCC assay, mAbs are serially diluted and combined with <span style="display: none" class="style-scope patent-text">[0356] </span> <sup class="style-scope patent-text">51</sup>Cr-labeled 3T3-PSMA cells or human prostate PC-3 cells that have been engineered to express human PSMA (PC-3-PSMA cells). NK effector cells are purified from lymph nodes or spleens using anti-NK microbeads (Miltenyi Biotec). Sera, NK effector cells, and <sup class="style-scope patent-text">51</sup>Cr-loaded target cells are co-incubated at effector:target cell ratios of 10:1, 20:1, and 40:1, with each condition performed in triplicate. Cells are incubated 4-5 hours at 37 C. before supernatants are collected for measurement of <sup class="style-scope patent-text">51</sup>Cr release by gamma counting. The percent specific lysis is determined relative to that observed in the presence of isotype-matched non-specific mAb (0% lysis) to that obtained using 10% sodium dodecyl sulfate (100% lysis). </div>
    </li> <heading class="style-scope patent-text">Example 8 </heading>
    <heading class="style-scope patent-text">Complement-Mediated Lysis (CML) </heading>
    <li class="style-scope patent-text"> <para-num num="[0357]" class="style-scope patent-text">
    
    [0357]
  </para-num> <div id="P-0357" num="0357" class="description-line style-scope patent-text">For CML, <span style="display: none" class="style-scope patent-text">[0357] </span> <sup class="style-scope patent-text">51</sup>Cr-loaded 3T3-PSMA or PC-3-PSMA cells serve as target cells. Serial dilutions of mAbs are co-incubated with rabbit complement and target cells for 4-5 hours at 37 C., with each condition being performed in triplicate. Supernatants are then collected and counted with a gamma counter. Specific lysis is computed as previously done with the ADCC assay data. </div>
    </li> <heading class="style-scope patent-text">Example 9 </heading>
    <heading class="style-scope patent-text">Anti-Proliferative Effects </heading>
    <li class="style-scope patent-text"> <para-num num="[0358]" class="style-scope patent-text">
    
    [0358]
  </para-num> <div id="P-0358" num="0358" class="description-line style-scope patent-text">To test anti-proliferative effects of these antibodies, anti-PSMA mAbs are serially diluted and incubated with LNCaP, PC-3-PSMA and parental PC-3 cells in log-phase growth. At 4 hr, 24 hr, and 72 hr intervals, cells are removed and analyzed for density and viability by trypan blue staining and WST-1 assay (Roche Biochemicals). <span style="display: none" class="style-scope patent-text">[0358] </span> </div>
    </li> <heading class="style-scope patent-text">Example 10 </heading>
    <heading class="style-scope patent-text">Optimization of Chelation and Radiolabeling Procedures </heading>
    <li class="style-scope patent-text"> <para-num num="[0359]" class="style-scope patent-text">
    
    [0359]
  </para-num> <div id="P-0359" num="0359" class="description-line style-scope patent-text">The most promising mAbs identified using the procedures described in the foregoing examples will be optimized for biochemical and biological stability and activity after labeling prior to evaluation in animals. Success in in vitro experiments is defined as identification of a radiolabeled mAb that specifically kills PSMA-expressing tumor cells at &gt;10-fold lower concentrations than unlabeled or similarly labeled isotype control mAb. <span style="display: none" class="style-scope patent-text">[0359] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0360]" class="style-scope patent-text">
    
    [0360]
  </para-num> <div id="P-0360" num="0360" class="description-line style-scope patent-text">Because the preferred - and -emitting isotopes are all radiometals, each of the mAbs is first conjugated with an appropriate metal chelating agent. Based on the favorable in vivo stability data and its proven use in human clinical trials, the bifunctional chelating agent C-functionalized trans cyclohexyldiethylenetriaminepentaacetic acid (p-SCN-CHX-A-DTPA) is the preferred agent for attaching either <span style="display: none" class="style-scope patent-text">[0360] </span> <sup class="style-scope patent-text">90</sup>Y or <sup class="style-scope patent-text">213</sup>Bi to the antibody (Brechbiel, M. W. et al. <i class="style-scope patent-text">J. Chem. Soc. Chem. Commun. </i>1169-1170, 1991). A form of this chelate has previously been tested in more than 70 doses in humans in ongoing trials at Memorial-Sloan Kettering Cancer Center (McDevitt, M. R. et al. <i class="style-scope patent-text">J. Nucl. Med. </i>40:1722-1727, 1999). For <sup class="style-scope patent-text">225</sup>Ac, our initial studies will examine a novel bifunctional chelating agent termed p-SCN-Bz-HEHA (1,4,7,10,13,16-hexaazacyclooctadecane-N,N,N,NN,Nhexaacetic acid) (Deal, K. A. et al. <i class="style-scope patent-text">J. Med. Chem. </i>42:2988-2992, 1999). The objective is to optimize the antibody conjugation and chelation ratios to maximize labeling yield and activity while maintaining suitable stability for in vivo utilization. Additional chelating agents also are used as they become available from the N.I.H. and other sources. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0361]" class="style-scope patent-text">
    
    [0361]
  </para-num> <div id="P-0361" num="0361" class="description-line style-scope patent-text">Initially, the antibody is rendered metal-free by incubation with a large molar excess of EDTA at pH=5. The EDTA and any metals scavenged from the antibody preparation are removed via continuous buffer exchange/dialysis so as to replace the pH=5 buffer with the conjugation buffer (Nikula, T. K. et al. <span style="display: none" class="style-scope patent-text">[0361] </span> <i class="style-scope patent-text">Nucl. Med. Biol. </i>22:387-390, 1995). Conditions that yield optimal chelator to antibody ratio but still remain immunoreactive are identified by systematically varying the chelator: antibody ratio, reaction time, temperature, and/or buffer systems about initial conditions that employ a 40-fold molar excess of chelator to antibody in HEPES buffer, pH 8.5. The number of chelates bound per antibody is determined using an established spectrophotometric method (Pippin, C. G. et al. <i class="style-scope patent-text">Bioconjugate Chemistry </i>3: 342-345, 1992). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0362]" class="style-scope patent-text">
    
    [0362]
  </para-num> <div id="P-0362" num="0362" class="description-line style-scope patent-text">For <span style="display: none" class="style-scope patent-text">[0362] </span> <sup class="style-scope patent-text">90</sup>Y and <sup class="style-scope patent-text">225</sup>Ac constructs, labeling efficiency is measured directly. For <sup class="style-scope patent-text">213</sup>Bi, initial antibody constructs are tested for chelation efficiency using <sup class="style-scope patent-text">111</sup>In, which has similar chelation chemistry as <sup class="style-scope patent-text">213</sup>Bi but possesses the advantages of a longer half life (t<sub class="style-scope patent-text">1/2</sub>=3 days), ready availability, and traceable -emission. Once optimized using <sup class="style-scope patent-text">111</sup>In, labeling efficiency is determined for <sup class="style-scope patent-text">213</sup>Bi. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0363]" class="style-scope patent-text">
    
    [0363]
  </para-num> <div id="P-0363" num="0363" class="description-line style-scope patent-text">Radiolabeled mAb is purified over a BioRad 10DG desalting column using 1% HSA as the mobile phase and evaluated by instant thin layer liquid chromatography (ITLC) and/or high performance liquid chromatography (HPLC) to determine the percent incorporation of radionuclide (Zamora, P. O. et al. <span style="display: none" class="style-scope patent-text">[0363] </span> <i class="style-scope patent-text">Biotechniques </i>16: 306-311, 1994). ITLC and HPLC provide a means of establishing purity and identifying the percent of low molecular weight radiochemical impurities (i.e., metal chelates, colloids, and free metal). Duplicate ITLC strips for each mobile phase are developed, dried, and cut at the R<sub class="style-scope patent-text">f </sub>of 0.5 mark and counted in a gamma counter. The HPLC system is equipped with both an online UV absorption detector and radioactivity detector. The HPLC elution profile directly correlates radioactivity with protein and low molecular weight species as a function of the elution time. A TSK SW3000<sub class="style-scope patent-text">XL </sub>column (TosoHaas, Montgomeryville, Pa.) is used and calibrated using a range of protein molecular weight standards. </div>
    </li> <heading class="style-scope patent-text">Example 11 </heading>
    <heading class="style-scope patent-text">Affinity and Immunoreactivity of Radiolabeled mAbs </heading>
    <li class="style-scope patent-text"> <para-num num="[0364]" class="style-scope patent-text">
    
    [0364]
  </para-num> <div id="P-0364" num="0364" class="description-line style-scope patent-text">Once radiolabeled constructs are obtained, purified, and assessed for biochemical and radiochemical purity, biological activity is determined. Binding activity of the radioconstruct is performed by Scatchard analysis of binding data obtained using whole LNCaP and 3T3-PSMA cells and/or membrane fractions as previously described (Scheinberg, D. A. et al. <span style="display: none" class="style-scope patent-text">[0364] </span> <i class="style-scope patent-text">Leukemia </i>3: 440-445 (1991). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0365]" class="style-scope patent-text">
    
    [0365]
  </para-num> <div id="P-0365" num="0365" class="description-line style-scope patent-text">The immunoreactivity of the synthetic constructs is evaluated in order to correlate the chelate:antibody molar ratio with the biological activity. Briefly, 2 ng of labeled mAb is incubated with a 25-fold excess of PSMA as expressed on 3T3-PSMA cells. After a 30 min incubation at 0 C., the cells are collected by centrifugation and the supernatant containing unbound mAb is added to fresh 3T3-PSMA cells for an additional 30 min at 0 C. Both sets of cells are centrifuged and washed twice with cold PBS. The cell pellets, supernatant and wash fractions are counted for radioactivity. Immunoreactivity is defined as the amount of radioactivity in the cell pellets divided by the total radioactivity in the cell pellets, supernatant and wash fractions. <span style="display: none" class="style-scope patent-text">[0365] </span> </div>
    </li> <heading class="style-scope patent-text">Example 12 </heading>
    <heading class="style-scope patent-text">mAb Internalization </heading>
    <li class="style-scope patent-text"> <para-num num="[0366]" class="style-scope patent-text">
    
    [0366]
  </para-num> <div id="P-0366" num="0366" class="description-line style-scope patent-text">The activity of radiolabeled mAbs can be significantly modulated by their internalization rates. Based upon previous results by other groups (Smith-Jones P. M. et al. <span style="display: none" class="style-scope patent-text">[0366] </span> <i class="style-scope patent-text">Cancer Res </i>60: 5237-5243, 2000), significant internalization of PSMA after binding with one or more of the mAb constructs was expected. Internalization of the cell surface antibody-antigen complex was measured using <sup class="style-scope patent-text">111</sup>In radiolabeled antibody (mAb 026) constructs (Caron, P. C. et al. <i class="style-scope patent-text">Cancer Res </i>52: 6761-6767, 1992). Briefly, 510<sup class="style-scope patent-text">5 </sup>C4-2 cells were incubated at 37 C. in 5% CO<sub class="style-scope patent-text">2 </sub>with <sup class="style-scope patent-text">111</sup>In radiolabeled antibody. At different times, cells were washed with PBS and cell-surface bound radiolabeled constructs were stripped with 1 ml of 50 mM glycine/150 mM NaCl, pH=2.8. Total cell-associated radioactivity and acid-resistant (internalized) radioactivity were determined by -counting. Percent internalization and total binding were calculated. <sup class="style-scope patent-text">111</sup>In labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 was found to be rapidly and efficiently internalized. FIG. 12 shows the percent internalization and total binding of <sup class="style-scope patent-text">111</sup>In labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 as a function of incubation time. Cells (such as parental 3T3 cells) that do not express PSMA can be used as a control to determine non-specific binding. </div>
    </li> <heading class="style-scope patent-text">Example 13 </heading>
    <heading class="style-scope patent-text">In Vitro Cytotoxicity Studies </heading>
    <li class="style-scope patent-text"> <para-num num="[0367]" class="style-scope patent-text">
    
    [0367]
  </para-num> <div id="P-0367" num="0367" class="description-line style-scope patent-text">Assessment of in vitro cytotoxicity of -labeled mAbs was undertaken once the immunoreactivity of the radioimmunoconjugate was established. Approximately 50,000 target cells (either LNCaP or 3T3-PSMA cells) were treated in 96 well plates and analyzed 24-96 hours later. Quantification of cell death due to <span style="display: none" class="style-scope patent-text">[0367] </span> <sup class="style-scope patent-text">225</sup>Ac-labeled constructs (or <sup class="style-scope patent-text">213</sup>Bi) was accomplished by determining the uptake of <sup class="style-scope patent-text">3</sup>H-thymidine by surviving cells (Nikula, T. K. et al. <i class="style-scope patent-text">J. Nucl. Med. </i>40: 166-176, 1999). Specificity was determined by use of control cells (PSMA-negative human prostate cell lines PC-3 and DU-145, as well as control 3T3 cells), blocking with excess unlabeled antibody, and control radioconjugates. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0368]" class="style-scope patent-text">
    
    [0368]
  </para-num> <div id="P-0368" num="0368" class="description-line style-scope patent-text">The cytotoxic effects of antibody conjugate concentration, specific activity, and time of exposure were then assessed. Cytotoxicity was expressed relative to that seen with 1M HCl (100% cell death) and media (background cell death). LD<span style="display: none" class="style-scope patent-text">[0368] </span> <sub class="style-scope patent-text">50 </sub>values were calculated by plotting cell viability as a function of the number of <sup class="style-scope patent-text">225</sup>Ac atoms bound on the cells (McDevitt, M. R. et al. (1998) <i class="style-scope patent-text">Eur. J. Nucl. Med. </i>25: 1341-1351 (1998). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0369]" class="style-scope patent-text">
    
    [0369]
  </para-num> <div id="P-0369" num="0369" class="description-line style-scope patent-text">Multicellular spheroids of LNCaP-FGC cells had been established and were used to investigate the potential of radioimmunotherapy (RIT) to eradicate minimal disease in vitro. These three-dimensional spheroids mimic tissue structures more accurately than monolayer cultures and thus provide a more relevant model of solid tumors (O'Connor, K. C. <span style="display: none" class="style-scope patent-text">[0369] </span> <i class="style-scope patent-text">Pharm. Res. </i>16: 486-493, 1999). LNCaP-FGC is a fast growing clone of the original LNCaP cell line, and the cells were grown using a liquid overlay technique to a size of 200-600 m (Ballangrud, A. M. et al. <i class="style-scope patent-text">Clin. Cancer Res. </i>5: 3171s-3176s, 1999). In larger spheroids, the inner mass of cells becomes necrotic, while the outer rim consists of proliferating tumor cells. Antibody penetration was measured by confocal microscopy, and prior results suggested that an anti-PSMA antibody should penetrate to a depth of 40-50 m (Ballangrud, A. M. et al. 7th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Princeton N.J., 1998). The in vitro cytotoxicity of <sup class="style-scope patent-text">225</sup>Ac-3.9 on LNCaP target cells is shown in FIG. 26. The percentage of viable PSMA<sup class="style-scope patent-text">+</sup> LNCaP cells was plotted as a function of activity of the radioconjugate. Addition of a 100-fold excess of unlabeled antibody was used as a control for specificity. </div>
    </li> <heading class="style-scope patent-text">Example 14 </heading>
    <heading class="style-scope patent-text">Evaluation of the In Vivo Efficacy of Unlabeled and Radiolabeled mAbs in Mouse Xenograft Models of Human Prostate Cancer </heading>
    <li class="style-scope patent-text"> <para-num num="[0370]" class="style-scope patent-text">
    
    [0370]
  </para-num> <div id="P-0370" num="0370" class="description-line style-scope patent-text">Antibodies that are successful in the foregoing assays demonstrate significant specificity and functional properties that suggest they will be useful for therapeutic use. The most promising of these radiolabeled and naked mAb constructs are evaluated in the best available mouse models of prostate cancer. The studies employ an established xenograft model in which the LNCaP human prostate tumor cell line is injected into immunocompromised nude mice and allowed to form solid tumors (Ellis, W. J. et al. <span style="display: none" class="style-scope patent-text">[0370] </span> <i class="style-scope patent-text">Clin Cancer Res </i>2: 1039-1048 (1996), which then are treated with both radiolabeled and unlabeled anti-PSMA mAb constructs. Follow-on studies also utilize a mouse xenograft model, CWR22, which reproduces many of the key biological features of human prostate cancer. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0371]" class="style-scope patent-text">
    
    [0371]
  </para-num> <div id="P-0371" num="0371" class="description-line style-scope patent-text">Lncap Tumor Cell Xenograft Model <span style="display: none" class="style-scope patent-text">[0371] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0372]" class="style-scope patent-text">
    
    [0372]
  </para-num> <div id="P-0372" num="0372" class="description-line style-scope patent-text">A construct showing high affinity and high specificity is taken into the LNCaP tumor cell xenograft in vivo model for biodistribution and pharmacokinetic analysis. <span style="display: none" class="style-scope patent-text">[0372] </span> <sup class="style-scope patent-text">111</sup>In-labeled anti-PSMA antibody is used for these studies due to its favorable chelation chemistry, radioactive half-life and traceable gamma emission. Timepoints are evaluated as appropriate for the half-lives of <sup class="style-scope patent-text">213</sup>Bi, <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">177</sup>Lu and <sup class="style-scope patent-text">90</sup>Y, which are the nuclides of therapeutic interest. Labeled radioconstructs (1-5 g) are injected i.v. into nude mice (normal and tumor bearing) and the mice are sacrificed at 5 min, 15 min, 30 min, 60 min, 2 hrs, 4 hrs, 18 hrs, and 24 hrs post-injection. Blood and major organs are taken from animals, weighed, and the percent radioactivity injected per gram of tissue is determined (Nikula, T. K. et al. <i class="style-scope patent-text">J. Nucl. Med. </i>40: 166-176, 1999). Specificity is addressed by pre-injection with excess unlabeled construct. Macroscopic tumor volume and animal survival rates is recorded throughout the experiments. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0373]" class="style-scope patent-text">
    
    [0373]
  </para-num> <div id="P-0373" num="0373" class="description-line style-scope patent-text">A dose-ranging study is also conducted to determine the toxicity of the constructs when administered via i.v. or i.p. injection to normal and tumor-bearing mice. These animals are routinely examined for toxic side effects during the course of the studies by blood chemistry and physical examination. Animals are sacrificed during and at the conclusion of the study in order to collect blood and body tissues for further evaluation. Previous data has demonstrated an approximate maximum tolerated dose of 250 Ci/mouse, so total doses are kept below that level. <span style="display: none" class="style-scope patent-text">[0373] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0374]" class="style-scope patent-text">
    
    [0374]
  </para-num> <div id="P-0374" num="0374" class="description-line style-scope patent-text">Once i.v. biodistribution and toxicity is documented, radiotherapy of tumors is assessed. Groups of five mice are injected with &lt;1 g radiolabeled anti-PSMA mAb construct both pre- and post-tumor challenge to assess anti-tumor activity. Antigen negative (RAJI or RAMOS) xenografted tumors are also used as a control. Other controls include (1) treatment with unlabeled anti-PSMA mAb only and (2) excess unlabeled anti-PSMA mAb pretreatment before <span style="display: none" class="style-scope patent-text">[0374] </span> <sup class="style-scope patent-text">213</sup>Bi, <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">177</sup>Lu and/or <sup class="style-scope patent-text">90</sup>Y-labeled anti-PSMA to block specific targeting. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0375]" class="style-scope patent-text">
    
    [0375]
  </para-num> <div id="P-0375" num="0375" class="description-line style-scope patent-text">Groups of tumor bearing mice are injected with unlabeled anti-PSMA mAbs (at equimolar concentrations) and several dose levels of radiolabeled anti-PSMA or a similarly labeled isotype control antibody. The effect on tumor growth is assessed over time. Statistical differences between therapy groups is determined using an analysis of variance (ANOVA) method and animal survival is illustrated using Kaplan-Meier plots. The efficacy of <span style="display: none" class="style-scope patent-text">[0375] </span> <sup class="style-scope patent-text">213</sup>Bi, <sup class="style-scope patent-text">225</sup>Ac, <sup class="style-scope patent-text">177</sup>Lu and/or <sup class="style-scope patent-text">90</sup>Y-labeled anti-PSMA constructs is correlated to the data obtained in vitro. Success in these experiments is defined as the ability to significantly (p&lt;0.05) increase life-span and/or decrease tumor volume as compared to a radiolabeled isotype control mAb. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0376]" class="style-scope patent-text">
    
    [0376]
  </para-num> <div id="P-0376" num="0376" class="description-line style-scope patent-text">Furthermore, the tumor models are used to test whether predosing with unlabeled antibody prior to injection of radiolabeled antibody improves delivery of the radiolabeled antibody to the tumor. The tumor-bearing mice are injected with &lt;1 g radiolabeled anti-PSMA antibody with or without a prior single injection of 5-100 g of unlabeled antibody. After several days, animals are sacrificed for evaluation of the distribution of radioactivity in the tumor, normal tissue, and blood. If predosing with unlabeled antibody improves delivery and targeting of radiolabeled antibody to the tumors, this approach is applied and optimized in toxicity and therapeutic studies. <span style="display: none" class="style-scope patent-text">[0376] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0377]" class="style-scope patent-text">
    
    [0377]
  </para-num> <div id="P-0377" num="0377" class="description-line style-scope patent-text">In addition to overall survival, the role of timing of the injection after tumor transplantation (<span style="display: none" class="style-scope patent-text">[0377] </span> <figure-callout id="1" label="Day" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Day</a></figure-callout> 1 <figure-callout id="3" label="vs" filenames="US20040161776A1-20040819-D00004.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">vs</a></figure-callout> 3 vs 7), the role of dosage (dose-response curves using 3-4 dose levels), the role of schedule (single vs multiple divided daily injections) and the specificity of the treatment (pre-treatment with unlabeled anti-PSMA to block targeting) is examined. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0378]" class="style-scope patent-text">
    
    [0378]
  </para-num> <div id="P-0378" num="0378" class="description-line style-scope patent-text">These in vivo studies are designed to address the maximum tolerated dose of radiolabeled antibody, the activity of the antibody, the optimal dosing schedule (single or multiple injections), and the effect on tumor size. Successful completion of this work enables determination of the feasibility of PSMA-targeted alpha particle radioimmunotherapy (RIT) of prostate cancer and identifies the optimal <span style="display: none" class="style-scope patent-text">[0378] </span> <sup class="style-scope patent-text">213</sup>Bi and/or <sup class="style-scope patent-text">225</sup>Ac-labeled constructs to enter into clinical development. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0379]" class="style-scope patent-text">
    
    [0379]
  </para-num> <div id="P-0379" num="0379" class="description-line style-scope patent-text">CWR22 Mouse Xenograft Model <span style="display: none" class="style-scope patent-text">[0379] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0380]" class="style-scope patent-text">
    
    [0380]
  </para-num> <div id="P-0380" num="0380" class="description-line style-scope patent-text">The most promising anti-PSMA mAbs in unlabeled, toxin-labeled and/or radiolabeled form are tested in the CWR22 human prostate cancer xenograft mouse model, (Wainstein, M. A. et al. <span style="display: none" class="style-scope patent-text">[0380] </span> <i class="style-scope patent-text">Cancer Res </i>54:6049-6052 (1994); Nagabhushan, M. et al. <i class="style-scope patent-text">Cancer Res </i>56:3042-3046 (1996); Pretlow, T. G. et al. <i class="style-scope patent-text">J Natl Cancer Inst </i>85:394-398 (1993)). This model has many features of the human condition including a dependence on androgens, a correlation between measured levels of PSA in serum and tumor size, and high-level expression of PSMA. Following androgen withdrawal, PSA levels decrease to nearly undetectable levels and tumor volume decreases. Later, the tumor regrows as an androgen-independent neoplasm, manifest initially by a rise in PSA and later, measurable tumor growth. After androgen withdrawal, tumors regrow at variable time periods. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0381]" class="style-scope patent-text">
    
    [0381]
  </para-num> <div id="P-0381" num="0381" class="description-line style-scope patent-text">Four to six week old nude athymic BALB/c male mice are obtained from the National Cancer Institute-Frederick Cancer Center and maintained in pressurized ventilated caging. While immunodeficient in many respects, these mice mediate wild-type levels of ADCC and CML. The CWR22 tumor line is propagated in the animals by the injection of minced tumor tissue from an established tumor into the subcutaneous tissue of the flanks of athymic nude mice together with reconstituted basement membrane (Matrigel, Collaborative Research, Bedford, Mass.). To maintain serum androgen levels, the mice are administered 12.5-mg sustained-release testosterone pellets (Innovative Research of America, Sarasota, FL) subcutaneously before receiving tumors. Three to four weeks after inoculation, tumors of approximately 1.51.01.0 cm are measured. Androgens are withdrawn by surgical castration under pentobarbital anesthesia and removal of the sustained-release testosterone pellets. Tumor size is determined by caliper measurements of height, width and depth. PSA values are performed on the serum of the mice after tail bleeding using a Tandem-R PSA immuno-radiometric assay (Hybritech, San Diego, Calif.). <span style="display: none" class="style-scope patent-text">[0381] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0382]" class="style-scope patent-text">
    
    [0382]
  </para-num> <div id="P-0382" num="0382" class="description-line style-scope patent-text">Groups of five mice are injected with anti-PSMA mAb or a similar isotype control mAb at dosages from 5-100 g to assess anti-tumor activity. The effect of scheduling single doses vs. multiple divided daily injections is also examined. Macroscopic tumor volume and animal survival rates are recorded throughout the experiments. Statistical differences between therapy groups are determined using an analysis of variance (ANOVA) method and animal survival are illustrated using Kaplan-Meier plots, with success defined as a difference of p&lt;0.05. Similarly, the efficacy of naked mAbs is compared to that seen with <span style="display: none" class="style-scope patent-text">[0382] </span> <sup class="style-scope patent-text">90</sup>Y, <sup class="style-scope patent-text">177</sup>Lu, <sup class="style-scope patent-text">213</sup>Bi and/or <sup class="style-scope patent-text">225</sup>Ac-labeled anti-PSMA constructs. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0383]" class="style-scope patent-text">
    
    [0383]
  </para-num> <div id="P-0383" num="0383" class="description-line style-scope patent-text">These in vivo studies are designed to address the maximum tolerated dose of mAb, the activity of the antibody, the optimal dosage and dosing schedule (single or multiple divided injections), and the effect of treatment on tumor size. Successful completion of this work will enable determination of the feasibility of PSMA-targeted immunotherapy of prostate cancer and identification of the optimal constructs to enter into clinical development. <span style="display: none" class="style-scope patent-text">[0383] </span> </div>
    </li> <heading class="style-scope patent-text">Example 15 </heading>
    <heading class="style-scope patent-text">Investigation of Native PSMA Protein Conformation </heading>
    <li class="style-scope patent-text"> <para-num num="[0384]" class="style-scope patent-text">
    
    [0384]
  </para-num> <div id="P-0384" num="0384" class="description-line style-scope patent-text">Extraction of PSMA from the Cell Surface of LNCaP and 3T3 Cells <span style="display: none" class="style-scope patent-text">[0384] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0385]" class="style-scope patent-text">
    
    [0385]
  </para-num> <div id="P-0385" num="0385" class="description-line style-scope patent-text">LNCaP or 3T3 cells were grown to confluency in a T150 cell culture flask, detached using cell dissociation solution (Mediatech, Herndon, Va.) and transferred to a 15 ml conical tube. The cells were washed twice with PBS and resuspended with 2 ml of M-Per Mammalian Protein Extraction Reagent (Pierce, Rockford, Ill.). Following incubation for 10 min at 4 C., cell debris and insoluble aggregates were removed by centrifugation at 15,000 rpm for 30 min at 4 C. The supernatant was transferred to a cryogenic vial and stored at 80 C. until further use. <span style="display: none" class="style-scope patent-text">[0385] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0386]" class="style-scope patent-text">
    
    [0386]
  </para-num> <div id="P-0386" num="0386" class="description-line style-scope patent-text">Production of Recombinant, Soluble PSMA (rsPSMA) <span style="display: none" class="style-scope patent-text">[0386] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0387]" class="style-scope patent-text">
    
    [0387]
  </para-num> <div id="P-0387" num="0387" class="description-line style-scope patent-text">The extracellular domain of PSMA (amino acids 44-750 of the full-length protein, SEQ ID NO:1) was obtained as a secreted protein from a DXB11 Chinese hamster ovary (CHO) cell line, stably transfected with an rsPSMA expression vector. The cells were grown in a Celligen Plus 2.2L Packed Bed Bioreactor (New Brunswick Scientific, Edison, NJ) in protein-free media. The Bioreactor was operated in perfusion mode, and supernatant was collected aseptically into collection bags maintained at 4 C. The protease inhibitor aprotinin was added to the harvest supernatant, which was concentrated 25-fold prior to storage at 90 C. In some instances for purification, the concentrate was thawed and purified using subsequent steps of Concanavalin A lectin affinity chromatography and Butyl-Sepharose hydrophobic interaction chromatography or according to the steps shown below. <span style="display: none" class="style-scope patent-text">[0387] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0388]" class="style-scope patent-text">
    
    [0388]
  </para-num> <div id="P-0388" num="0388" class="description-line style-scope patent-text">The purified rsPSMA protein is dimeric, and possesses folate hydrolase enzymatic activity when tested according to published procedures (Pinto et al., <span style="display: none" class="style-scope patent-text">[0388] </span> <i class="style-scope patent-text">Clinical Cancer Research </i>2:1445, 1996) and reacts with each of a panel of conformation-specific monoclonal antibodies, indicating that rsPSMA adopts a native conformation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0389]" class="style-scope patent-text">
    
    [0389]
  </para-num> <div id="P-0389" num="0389" class="description-line style-scope patent-text">Purification of Recombinant, Soluble PSMA (rsPSMA) <span style="display: none" class="style-scope patent-text">[0389] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0390]" class="style-scope patent-text">
    
    [0390]
  </para-num> <div id="P-0390" num="0390" class="description-line style-scope patent-text">Cell culture supernatants were concentrated 25-fold by tangential flow ultrafiltration and adjusted to 35% saturation with ammonium sulfate. Under these conditions, rsPSMA remains in the supernatant. Precipitated proteins were removed by centrifugation (20,000g for 30 min, SS-34, Sorvall) and the clarified supernatant was applied to a Butyl-Sepharose resin (BioRad, Hercules, Calif.) followed by a wash with 35% ammonium sulfate in neutral phosphate-buffered saline containing 1 mM Ca<span style="display: none" class="style-scope patent-text">[0390] </span> <sup class="style-scope patent-text">2+</sup> and 0.5 mM Mg<sup class="style-scope patent-text">2+</sup> (PBS+). rsPSMA eluted in the flow-through and wash fractions of the column. The fractions containing the rsPSMA protein were pooled, dialyzed into 10 mM sodium phosphate, pH 7.0, and loaded onto a Ceramic Hydroxyapatite column (BioRad, Hercules, Calif.). rsPSMA was eluted from the resin using 2M sodium chloride in 10 mM sodium phosphate, pH 7.0. The fractions containing the protein were pooled, dialyzed into 20 mM Tris, pH 7.5 containing 1 mM Ca<sup class="style-scope patent-text">2+</sup> and 0.5 mM Mg<sup class="style-scope patent-text">2+</sup>, and applied to a Q650-Sepharose column (TosoHaas, Montgomeryville, Pa.). rsPSMA was eluted from the resin with 150 mM NaCl in 20 mM Tris, pH 7.5 containing 1 mM Ca<sup class="style-scope patent-text">2+</sup> and 0.5 mM Mg<sup class="style-scope patent-text">2+</sup>. Monomeric and dimeric forms of rsPSMA present after this step were separated using preparative size exclusion chromatography on a <figure-callout id="200" label="Superdex" filenames="US20040161776A1-20040819-D00007.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Superdex</a></figure-callout> 200 resin (Amersham Biosciences, Piscataway, N.J.) and PBS+ (containing 1 mM Ca<sup class="style-scope patent-text">2+</sup> and 0.5 mM Mg<sup class="style-scope patent-text">2+</sup>) as the running buffer. Purified rsPSMA was stored at 80 C. in PBS+. Unless otherwise indicated, PSMA monomers represent spontaneously dissociated protein recovered over SEC rather than forcibly denatured material. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0391]" class="style-scope patent-text">
    
    [0391]
  </para-num> <div id="P-0391" num="0391" class="description-line style-scope patent-text">Polyacrylamide Gel Electrophoresis (PAGE) and Western Blotting of the Different PSMA Proteins <span style="display: none" class="style-scope patent-text">[0391] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0392]" class="style-scope patent-text">
    
    [0392]
  </para-num> <div id="P-0392" num="0392" class="description-line style-scope patent-text">For each individual PAGE analysis, 15 l of each cell lysate and 5 l of the purified rsPSMA were used. <span style="display: none" class="style-scope patent-text">[0392] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0393]" class="style-scope patent-text">
    
    [0393]
  </para-num> <div id="P-0393" num="0393" class="description-line style-scope patent-text">SDS-PAGE was performed using standard procedures. Samples were prepared by boiling for 5 minutes in the presence of Laemmli sample buffer (with or without the reducing agent dithiothreitol [DTT]). Samples were then applied on a 4-15% Tris-Glycine gel (BioRad, Hercules, Calif.). After electrophoresis for 1 h at 200V, the proteins were transferred onto nitrocellulose (BioRad) and analyzed by Western blotting. <span style="display: none" class="style-scope patent-text">[0393] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0394]" class="style-scope patent-text">
    
    [0394]
  </para-num> <div id="P-0394" num="0394" class="description-line style-scope patent-text">The oligomeric nature of the different PSMA proteins was analyzed using Blue Native PAGE (BN-PAGE). Each sample was diluted with an equal volume of 2BN-PAGE sample buffer (0.1M MOPS/0.1M Tris/40% glycerol/0.1% Coomassie G-250) prior to loading onto the gel. BN-PAGE was performed using 4-12% BisTris gels (Invitrogen, Carlsbad, Calif.) and 50 mM MOPS/50 mM Tris, pH 7.7 as running buffer. Coomassie Blue was omitted from the cathode buffer to avoid interference with protein binding during the transfer of the proteins onto nitrocellulose. Following electrophoresis for 2.5 hrs at 125V, the proteins were transferred onto a nitrocellulose membrane (BioRad) and analyzed by Western blotting. <span style="display: none" class="style-scope patent-text">[0394] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0395]" class="style-scope patent-text">
    
    [0395]
  </para-num> <div id="P-0395" num="0395" class="description-line style-scope patent-text">Western blotting was performed as follows: Subsequent to transfer, the nitrocellulose membrane was blocked with 5% milk in PBS/0.1% Triton X-100/0.02% SDS, which was also used for the subsequent wash and antibody incubation steps. PSMA proteins were detected using the anti-PSMA mAbs 3.1 or 3.9 (Progenics Pharmaceuticals) as primary antibody and HRP-labeled anti-mouse IgG as secondary antibody and 1 h incubation at room temperature. The membranes were colorimetrically developed using chemiluminescence (NEN Plus, Perkin Elmer Life Sciences, Boston, Mass.). <span style="display: none" class="style-scope patent-text">[0395] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0396]" class="style-scope patent-text">
    
    [0396]
  </para-num> <div id="P-0396" num="0396" class="description-line style-scope patent-text">Analytical size exclusion chromatography (SEC) was performed using a TSK G3000SW<span style="display: none" class="style-scope patent-text">[0396] </span> <sub class="style-scope patent-text">XL </sub>(TosoHaas, Montgomeryville, Pa.) column equilibrated in PBS+. The column was calibrated using bovine serum albumin (67 kDa), immunoglobulin G (150 kDa), ferritin (440 kDa) and thyroglobulin (670 kDa) as standards. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0397]" class="style-scope patent-text">
    
    [0397]
  </para-num> <div id="P-0397" num="0397" class="description-line style-scope patent-text">Results <span style="display: none" class="style-scope patent-text">[0397] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0398]" class="style-scope patent-text">
    
    [0398]
  </para-num> <div id="P-0398" num="0398" class="description-line style-scope patent-text">Both full-length PSMA and recombinant, soluble PSMA (rsPSMA) migrated on reducing and non-reducing SDS-PAGE with a molecular weight of 100 kDa (FIG. 5). Thus, like full-length PSMA, rsPSMA is a monomer in the presence of denaturing agents, and no disulfide or other covalent bonds are present to mediate oligomerization. The result for full-length PSMA is in accordance with prior observations (Israeli et al., U.S. Pat. No. 5,538,866; Murphy et al., U.S. Pat. No. 6,158,508; Israeli, et al., <span style="display: none" class="style-scope patent-text">[0398] </span> <i class="style-scope patent-text">Cancer Research </i>54:1807, 1994; Troyer et al. <i class="style-scope patent-text">Int. J. Cancer </i>62:552, 1995; Troyer et al., <i class="style-scope patent-text">The Prostate </i>30:233, 1997; Grauer et al., <i class="style-scope patent-text">Cancer Research </i>58:4787, 1998). In each of these reports, full-length PSMA migrated as a major band of 100-120 kDa, with a minor (typically &lt;5% of the total PSMA protein) 180-200 kDa band observed in a subset of reports (U.S. Pat. No. 6,158,508; Troyer et al., 1995; Troyer et al., 1997). Troyer et al. (1995) describe the 180-200 kDa species as being a noncovalently associated PSMA dimer that can be disrupted with increasing concentrations of SDS detergent. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0399]" class="style-scope patent-text">
    
    [0399]
  </para-num> <div id="P-0399" num="0399" class="description-line style-scope patent-text">rsPSMA contains 94% (707 of 750) of the amino acids present in full-length PSMA, and the two proteins were not clearly resolved in this analysis, as expected. <span style="display: none" class="style-scope patent-text">[0399] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0400]" class="style-scope patent-text">
    
    [0400]
  </para-num> <div id="P-0400" num="0400" class="description-line style-scope patent-text">SDS-PAGE allows the analysis of denatured proteins only. In order to examine native proteins in their native state, other techniques have to be employed, such as Blue Native PAGE (BN-PAGE). BN-PAGE is used to determine the native molecular weight of proteins and their noncovalent complexes (Schgger &amp; v. Jagow, <span style="display: none" class="style-scope patent-text">[0400] </span> <i class="style-scope patent-text">Anal. Biochem. </i>199:223-231, 1991; Schgger et al., <i class="style-scope patent-text">Anal. Biochem. </i>217:220-230, 1994). The dye Coomassie Blue G-250 binds to the hydrophobic domains on the surface of most proteins, enhances solubility, and introduces a charge shift on the native proteins resulting in migration towards the anode at pH 7.5 irrespective of the isoelectric point of the protein. Although the migration velocity of proteins in BN-PAGE varies somewhat, the molecular mass of proteins can be determined by their respective end points of migration due to the decreasing pore size of the acrylamide gradient present in the gels. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0401]" class="style-scope patent-text">
    
    [0401]
  </para-num> <div id="P-0401" num="0401" class="description-line style-scope patent-text">When analyzed by BN-PAGE, full-length PSMA (extracted from LNCaP or 3T3 cells with nonionic detergents) as well as purified rsPSMA migrate with a molecular weight of 190 kDa (FIG. 6A). This surprising observation for full-length PSMA indicates that the predominant form of cell-surface PSMA is a noncovalently associated dimer. This unexpected result can be contrasted with that of previous reports (U.S. Pat. No. 6,158,508; Troyer et al. 1995; Troyer et al., 1997), where the PSMA dimer represents a minor species in SDS-PAGE analyses. Presumably, the noncovalent PSMA dimer is largely dissociated by boiling in the presence of the denaturing detergent SDS. <span style="display: none" class="style-scope patent-text">[0401] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0402]" class="style-scope patent-text">
    
    [0402]
  </para-num> <div id="P-0402" num="0402" class="description-line style-scope patent-text">Moreover, the result for the purified rsPSMA protein indicates that the dimer is stabilized via interactions between extracellular amino acids in addition to or exclusive of amino acids in the transmembrane or intracellular segments, which are not present in rsPSMA. <span style="display: none" class="style-scope patent-text">[0402] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0403]" class="style-scope patent-text">
    
    [0403]
  </para-num> <div id="P-0403" num="0403" class="description-line style-scope patent-text">rsPSMA was subjected to analytical size exclusion chromatography (SEC) as a second sizing method. When analyzed in neutral PBS+buffer, purified rsPSMA eluted as a single major peak with an apparent molecular mass of 260 kDa (FIG. 6B), slightly higher than expected. However, glycoproteins (such as rsPSMA) are typically nonglobular in shape and run at higher apparent molecular mass than standard SEC calibration proteins (Schulke, N., et al. (2002) J. Virol. 76, 7760-7776). Therefore, an apparent molecular mass of 260 kDa is consistent with the proposed homodimeric structure of rsPSMA. In contrast, purified monomeric rsPSMA eluted with an apparent molecular mass of 130 kDa. The studies demonstrate that the extracellular domain of PSMA is sufficient for dimerization, and the similarities between rsPSMA (amino acids 44-750) and PSM (amino acids 58-750) suggest that the latter protein is likely to dimerize as well. <span style="display: none" class="style-scope patent-text">[0403] </span> </div>
    </li> <heading class="style-scope patent-text">Example 16 </heading>
    <heading class="style-scope patent-text">Homodimerization is Required for Enzymatic Activity </heading>
    <li class="style-scope patent-text"> <para-num num="[0404]" class="style-scope patent-text">
    
    [0404]
  </para-num> <div id="P-0404" num="0404" class="description-line style-scope patent-text">Enzyme Assays <span style="display: none" class="style-scope patent-text">[0404] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0405]" class="style-scope patent-text">
    
    [0405]
  </para-num> <div id="P-0405" num="0405" class="description-line style-scope patent-text">Pteroyl -glutamyl carboxypeptidase (folate hydrolase) activity was determined by monitoring the cleavage of poly -glutamylated methotrexate as described (Pinto, J. T., et al. (1996) Clin. Cancer Res. 2, 1445-1451) with the following exceptions. Di--glutamylated methotrexate (MTXglu2) was used as substrate and HPLC was used rather than capillary electrophoresis. At the completion of the incubation (50 M methotrexate di-gamma glutamate and 10 g/ml rsPSMA in pH 4.5 acetate buffer in a volume of 100 l for 2 hr at 37 C.), 100 l of 0.5 M Na<span style="display: none" class="style-scope patent-text">[0405] </span> <sub class="style-scope patent-text">2</sub>HPO<sub class="style-scope patent-text">4 </sub>was added to stop the reaction. Samples were loaded at a flow rate of 1.25 mmin through a 504.6 mm, 3 m PRISM reversed-phase column (Thermo Hypersil-Keystone, Bellefonte, Pa.) with a <figure-callout id="10" label="PRISM" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00006.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">PRISM</a></figure-callout> 104-mm guard column, eluted with 15% methanol in 85% 0.5M K<sub class="style-scope patent-text">2</sub>HPO<sub class="style-scope patent-text">4</sub>, pH 7.0, and quantitated based on relative peak area observed at a wavelength of 313 nm. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0406]" class="style-scope patent-text">
    
    [0406]
  </para-num> <div id="P-0406" num="0406" class="description-line style-scope patent-text">For NAALADase assays, rsPSMA was incubated with N-acetyl--L-aspartyl-L-glutamate for 22 h at 37 C. in the presence of 20 mM sodium phosphate, 50 mM NaCl, 10 mM ZnCl<span style="display: none" class="style-scope patent-text">[0406] </span> <sub class="style-scope patent-text">2</sub>, pH 7.1. Released L-glutamic acid was quantitated by using a commercial kit (R-Biopharm, Marshall, Mich.); 2-(phosphonomethyl) pentanedioic acid and Gly-Pro-7-amido-4-methylcoumarin were purchased from Sigma. Porcine kidney dipeptidyl peptidase IV (DPP IV) was used according to the manufacturer's instructions (Sigma). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0407]" class="style-scope patent-text">
    
    [0407]
  </para-num> <div id="P-0407" num="0407" class="description-line style-scope patent-text">Results <span style="display: none" class="style-scope patent-text">[0407] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0408]" class="style-scope patent-text">
    
    [0408]
  </para-num> <div id="P-0408" num="0408" class="description-line style-scope patent-text">PSMA has been reported to possess folate hydrolase, NAALADase, and DPP IV activities (Pinto, J. T., et al. (1996) Clin. Cancer Res. 2, 1445-1451; Carter, R. E., et al. (1996) Proc. Natl. <span style="display: none" class="style-scope patent-text">[0408] </span> <figure-callout id="93" label="Acad. Sci. USA" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Acad. Sci. USA</a></figure-callout> 93, 749-753; Pangalos, M. N., et al. (1999) J. Biol. Chem. 274, 8470-8483). The first two activities involve the hydrolysis of a carboxyl-terminal peptide bond to liberate a glutamic acid residue, whereas DPP IV cleaves downstream of an amino-terminal Aaa-Pro dipeptide sequence. The folate hydrolase activities of purified monomeric and dimeric forms of rsPSMA were evaluated. Whereas the dimer demonstrated high-level folate hydrolase activity, the monomer was essentially inactive (FIG. 7A). In fact, the residual activity of the monomer could be attributed to the residual amount (approximately 4%) of dimeric rsPSMA present in the preparation. High-level folate hydrolase activity was also observed for LNCaP cell lysates, consistent with prior observations (Pinto, J. T., et al. (1996) Clin. Cancer Res. 2, 1445-1451). Similarly, dimeric but not monomeric forms of rsPSMA possessed high-level NAALADase activity (FIG. 7B), which was abrogated by using 5 nM of the inhibitor 2-(phosphonomethyl)pentanedioic acid. Neither monomer nor dimer demonstrated DPP IV activity under conditions where porcine DPP IV efficiently hydrolyzed the substrate Gly-Pro-7-amido-4-methylcoumarin. This is consistent with the results reported by Barinka et al. (Barinka, C., et al. (2002) J. Neurochem. 80, 477-487), who similarly failed to confirm the DPP IV activity previously reported for PSMA (Pangalos, M. N., et al. (1999) J. Biol. Chem. 274, 8470-8483). </div>
    </li> <heading class="style-scope patent-text">Example 16 </heading>
    <heading class="style-scope patent-text">Dissociation of PSMA Multimers </heading>
    <li class="style-scope patent-text"> <para-num num="[0409]" class="style-scope patent-text">
    
    [0409]
  </para-num> <div id="P-0409" num="0409" class="description-line style-scope patent-text">PSMA is a putative zinc metalloprotease, and site-directed mutagenesis of amino acids implicated in zinc binding results in a profound loss of enzymatic activity (Speno et al., <span style="display: none" class="style-scope patent-text">[0409] </span> <i class="style-scope patent-text">Molecular Pharmacology, </i>55:179, 1999). These amino acids include His-377, Asp-387, Glu-425, Asp-453 and His-553. Ethylenediaminetetraacetic acid (EDTA) is a strong chelating agent for Zn<sup class="style-scope patent-text">2+</sup> and other divalent cations, and thus has the potential to remove Zn<sup class="style-scope patent-text">2+</sup> or other coordinate divalent cations from PSMA. We have determined that EDTA treatment causes the PSMA homodimer to dissociate into monomeric subunits. Similar results can be expected for other agents that possess similar chelating properties, such as ethyleneglycol-bis(beta-aminoethyl ether) (EGTA). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0410]" class="style-scope patent-text">
    
    [0410]
  </para-num> <div id="P-0410" num="0410" class="description-line style-scope patent-text">The purified rsPSMA protein was incubated with or without 10 mM EDTA for 16 hr at 4 C. and then analyzed by BN-PAGE. Under these conditions, the EDTA-treated protein was monomeric, whereas rsPSMA remained dimeric in the absence of EDTA. Although the dissociation of the PSMA dimer into monomer was essentially complete, any residual dimeric protein can be removed if desired by gel filtration, ultracentrifugation or other size-based separation methods that are well-known to those skilled in the art. <span style="display: none" class="style-scope patent-text">[0410] </span> </div>
    </li> <heading class="style-scope patent-text">Example 17 </heading>
    <heading class="style-scope patent-text">Methods for Identifying Promoters of PSMA Dissociation </heading>
    <li class="style-scope patent-text"> <para-num num="[0411]" class="style-scope patent-text">
    
    [0411]
  </para-num> <div id="P-0411" num="0411" class="description-line style-scope patent-text">Compounds are screened for the ability to promote dissociation of PSMA dimers using a method that includes: <span style="display: none" class="style-scope patent-text">[0411] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0412]" class="style-scope patent-text">
    
    [0412]
  </para-num> <div id="P-0412" num="0412" class="description-line style-scope patent-text">(a) contacting a PSMA dimer with a compound under conditions that do not promote dissociation of the PSMA dimer in the absence of the compound; <span style="display: none" class="style-scope patent-text">[0412] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0413]" class="style-scope patent-text">
    
    [0413]
  </para-num> <div id="P-0413" num="0413" class="description-line style-scope patent-text">(b) measuring the amount of PSMA monomer; and <span style="display: none" class="style-scope patent-text">[0413] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0414]" class="style-scope patent-text">
    
    [0414]
  </para-num> <div id="P-0414" num="0414" class="description-line style-scope patent-text">(c) comparing the amount of PSMA monomer measured in the presence of the compound with that observed in the absence of the compound. <span style="display: none" class="style-scope patent-text">[0414] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0415]" class="style-scope patent-text">
    
    [0415]
  </para-num> <div id="P-0415" num="0415" class="description-line style-scope patent-text">An increase in the amount of PSMA monomer measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. <span style="display: none" class="style-scope patent-text">[0415] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0416]" class="style-scope patent-text">
    
    [0416]
  </para-num> <div id="P-0416" num="0416" class="description-line style-scope patent-text">In a further embodiment, compounds are screened for the ability to promote dissociation of PSMA dimers using a method that includes: <span style="display: none" class="style-scope patent-text">[0416] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0417]" class="style-scope patent-text">
    
    [0417]
  </para-num> <div id="P-0417" num="0417" class="description-line style-scope patent-text">(a) contacting a PSMA dimer with a compound under conditions that do not promote dissociation of the PSMA dimer in the absence of the compound; <span style="display: none" class="style-scope patent-text">[0417] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0418]" class="style-scope patent-text">
    
    [0418]
  </para-num> <div id="P-0418" num="0418" class="description-line style-scope patent-text">(b) measuring the amount of PSMA dimer; and <span style="display: none" class="style-scope patent-text">[0418] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0419]" class="style-scope patent-text">
    
    [0419]
  </para-num> <div id="P-0419" num="0419" class="description-line style-scope patent-text">(c) comparing the amount of PSMA dimer measured in the presence of the compound with that observed in the absence of the compound. <span style="display: none" class="style-scope patent-text">[0419] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0420]" class="style-scope patent-text">
    
    [0420]
  </para-num> <div id="P-0420" num="0420" class="description-line style-scope patent-text">A decrease in the amount of PSMA dimer measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. <span style="display: none" class="style-scope patent-text">[0420] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0421]" class="style-scope patent-text">
    
    [0421]
  </para-num> <div id="P-0421" num="0421" class="description-line style-scope patent-text">In a further embodiment, compounds are screened for the ability to promote dissociation of PSMA dimers using a method that includes: <span style="display: none" class="style-scope patent-text">[0421] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0422]" class="style-scope patent-text">
    
    [0422]
  </para-num> <div id="P-0422" num="0422" class="description-line style-scope patent-text">(a) contacting a PSMA dimer with a compound under conditions that do not promote dissociation of the PSMA dimer in the absence of the compound; <span style="display: none" class="style-scope patent-text">[0422] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0423]" class="style-scope patent-text">
    
    [0423]
  </para-num> <div id="P-0423" num="0423" class="description-line style-scope patent-text">(b) measuring the amounts of PSMA monomer and PSMA dimer; <span style="display: none" class="style-scope patent-text">[0423] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0424]" class="style-scope patent-text">
    
    [0424]
  </para-num> <div id="P-0424" num="0424" class="description-line style-scope patent-text">(c) calculating a ratio of PSMA monomer to PSMA dimer; and <span style="display: none" class="style-scope patent-text">[0424] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0425]" class="style-scope patent-text">
    
    [0425]
  </para-num> <div id="P-0425" num="0425" class="description-line style-scope patent-text">(d) comparing the ratio obtained in (c) with that obtained in the absence of the compound. <span style="display: none" class="style-scope patent-text">[0425] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0426]" class="style-scope patent-text">
    
    [0426]
  </para-num> <div id="P-0426" num="0426" class="description-line style-scope patent-text">An increase in the ratio measured in the presence of the compound indicates that the compound is capable of promoting dissociation of the PSMA dimer. <span style="display: none" class="style-scope patent-text">[0426] </span> </div>
    </li> <heading class="style-scope patent-text">Example 18 </heading>
    <heading class="style-scope patent-text">Cell Surface PSMA Binding Studies </heading>
    <li class="style-scope patent-text"> <para-num num="[0427]" class="style-scope patent-text">
    
    [0427]
  </para-num> <div id="P-0427" num="0427" class="description-line style-scope patent-text">Flow Cytometry <span style="display: none" class="style-scope patent-text">[0427] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0428]" class="style-scope patent-text">
    
    [0428]
  </para-num> <div id="P-0428" num="0428" class="description-line style-scope patent-text">Parent 3T3 cells or PSMA-expressing 3T3 cells (210<span style="display: none" class="style-scope patent-text">[0428] </span> <sup class="style-scope patent-text">5 </sup>cells per condition) were washed in PBS and incubated with PBS containing goat serum (10% v/v) for 20 minutes on ice to block non-specific binding sites. Anti-PSMA monoclonal antibodies (unpurified form in supernatants or purified mAbs) were added in serial dilutions to cells in 100 l PBS and incubated on ice for 30 minutes. Control anti-human IgG (Caltag, Burlingame, Calif.) was used to establish background binding. After two washes in PBS, the cells were incubated with anti-human IgG (BD Pharmingen, San Diego, Calif.) for 30 minutes on ice. Cells were washed twice in PBS, resuspended in 250%1 PBS and analyzed by flow cytometry using a FACScan machine (Becton Dickinson, Franklin Lakes, N.J.) and CellQuest software. Viable cells were gated by forward scatter and side scatter parameters, and binding was quantified using histogram plots of mean fluorescence intensity (MFI) levels. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0429]" class="style-scope patent-text">
    
    [0429]
  </para-num> <div id="P-0429" num="0429" class="description-line style-scope patent-text">Anti-PSMA mAbs XG-006 (PTA-4403 and PTA-4404, heavy and light chain plasmids), XG-051 (PTA-4407 and PTA-4408), 4.40.1 (PTA-4360; 4.40, 4.40.1 and 4.40.2 are the same antibody that represent different stages of subcloning the hybridoma), 4.49.1, 4.292.1 (PTA-4390) and 4.304.1 were found to avidly bind to cell surface PSMA (FIG. 27). <span style="display: none" class="style-scope patent-text">[0429] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0430]" class="style-scope patent-text">
    
    [0430]
  </para-num> <div id="P-0430" num="0430" class="description-line style-scope patent-text">Maximal Binding <span style="display: none" class="style-scope patent-text">[0430] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0431]" class="style-scope patent-text">
    
    [0431]
  </para-num> <div id="P-0431" num="0431" class="description-line style-scope patent-text">Flow cytometry data (mean fluorescence intensity v. antibody concentration) were transposed and plotted using Excel software (Microsoft, Redmond, Wash.). Results from representative experiments of at least three determinations are depicted in FIGS. <span style="display: none" class="style-scope patent-text">[0431] </span> <b class="style-scope patent-text">28</b>A-<b class="style-scope patent-text">28</b>C. Binding was compared by calculation of 50% effective concentration (EC50) using the Forecast function in Excel. The EC50 value represents the concentration of antibody required for half-maximal binding. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0432]" class="style-scope patent-text">
    
    [0432]
  </para-num> <div id="P-0432" num="0432" class="description-line style-scope patent-text">Anti-PSMA mAbs 10.3 (PSMA 10.3) and XG-006 were found to bind to 3T3-PSMA cells and not 3T3 cells (FIG. 28A). Antibody (26 nM) was added to cells, which were analyzed by flow cytometry. Binding to cell-surface PSMA using serial dilutions of anti-PSMA mAb-containing culture supernatants of XG-006, 4.304.1, XG-026 (PTA-4405 and PTA-4406) and 4.49.1 also was demonstrated (FIG. 28B). Binding to cell-surface PSMA using serial dilutions of purified anti-PSMA mAbs XG-006 and 10.3 is represented by FIG. 28C. <span style="display: none" class="style-scope patent-text">[0432] </span> </div>
    </li> <heading class="style-scope patent-text">Example 19 </heading>
    <heading class="style-scope patent-text">Cytotoxicity of Toxin-Labeled Antibody </heading>
    <li class="style-scope patent-text"> <para-num num="[0433]" class="style-scope patent-text">
    
    [0433]
  </para-num> <div id="P-0433" num="0433" class="description-line style-scope patent-text">PSMA-3T3, LNCaP, and/or C4-2 cells (and control cell lines 3T3 and PC3 that do not express PSMA) were plated at 2,500 cells/100 L/well in 96-well microplates (Falcon) and were incubated overnight at 37 C. in the presence of 5% CO<span style="display: none" class="style-scope patent-text">[0433] </span> <sub class="style-scope patent-text">2</sub>. The media used for PSMA-3T3 (and 3T3) and LNCaP (and C4-2 and PC3) was DMEM or RMPI 1640, respectively, containing 2 mM L-glutamine, 10% FBS, and 1% penicillin-streptomycin. 50 ng (in 50 L) of Mab-Zap or Hum-ZAP (Advanced Targeting Systems, San Diego, Calif.) in medium was added in each well. Mab-Zap and Hum-Zap are goat anti-mouse IgG antibody or goat anti-human IgG antibody covalently linked to saporin, the most potent of the plant ribosome-inactivating proteins (RIP) from the seeds of the plant <i class="style-scope patent-text">Saponaria officinalis</i>. Saporin induces cell death by apoptosis (Bergamaschi, G., Perfetti, V., Tonon, L., Novella, A., Lucotti, C., Danova, M., Glennie, M. J., Merlini, G., Cazzola, M. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis. <i class="style-scope patent-text"> <figure-callout id="93" label="Br J Haematol" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Br J Haematol</a></figure-callout> </i>93, 789-94. (1996)). The Mab-Zap did not bind to or internalize in cells in the absence of an appropriate primary antibody. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0434]" class="style-scope patent-text">
    
    [0434]
  </para-num> <div id="P-0434" num="0434" class="description-line style-scope patent-text">Murine 3.9, 5.4, mJ591 (ATCC# HB-12126) and human 006, 4.40, 4.304 anti-PSMA antibodies (and control IgG antibodies) were added into plates at different concentrations to bring the total volume to 200 L in triplicate. The plates were kept cold on ice for at least 30 min to maximize Map-Zap or Hum-Zap binding to PSMA antibodies before internalization. The plates were incubated for 2 days and then the medium was changed and incubated for another 2 days. After 4 days incubation, the medium was withdrawn and fresh medium containing 10% Alamar Blue (20 L, Bioscience, Camarillo, Calif.) was added into each well and incubated for 2 hrs. A CytoFlour plate reader was used to measure fluorescence in 96-well plates at wavelengths of 530 nm excitation and 590 nm emission. Internalization of toxin was mediated by anti-PSMA antibodies. The cell kill is illustrated in FIG. 29 on C4-2 cells and in FIG. 30 on PSMA-3T3 cells. <span style="display: none" class="style-scope patent-text">[0434] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0435]" class="style-scope patent-text">
    
    [0435]
  </para-num> <div id="P-0435" num="0435" class="description-line style-scope patent-text">Human 4.304 anti-PSMA antibody was directly conjugated with saporin (Wrenn et al., <span style="display: none" class="style-scope patent-text">[0435] </span> <i class="style-scope patent-text">Brain Res. </i>740:175-184, 1996), and its cytotoxicity was demonstrated using a similar protocol as described above (see FIG. 31). </div>
    </li> <heading class="style-scope patent-text">Example 20 </heading>
    <heading class="style-scope patent-text">Immunoreactivity </heading>
    <li class="style-scope patent-text"> <para-num num="[0436]" class="style-scope patent-text">
    
    [0436]
  </para-num> <div id="P-0436" num="0436" class="description-line style-scope patent-text">PSMA-3T3, LNCaP and C4-2 were used as PSMA expressing cell lines and 3T3 was used as a control cell line not expressing PSMA. The cells were blocked with 10% goat serum on ice to reduce non-specific binding in this assay. <span style="display: none" class="style-scope patent-text">[0436] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0437]" class="style-scope patent-text">
    
    [0437]
  </para-num> <div id="P-0437" num="0437" class="description-line style-scope patent-text">A small amount (1-5 ng) of labeled mAb was added into a cell pellet of 10 million cells and incubated at 0 C. (on ice) with gentle mixing. After a 1 hour incubation, the cells were collected by centrifugation and the supernatant containing unbound mAb was transferred to a fresh cell pellet for an additional 1 hour incubation at 0 C. Both sets of cells were centrifuged and washed twice with cold PBS. The cell pellets, supernatant and wash fractions were counted for radioactivity. Immunoreactivity is defined as the amount of radioactivity in the cell pellets divided by the total radioactivity in the cell pellets, supernatant and wash fractions. These data are shown below in Table 3.  
<span style="display: none" class="style-scope patent-text">[0437] </span> <tables id="TABLE-US-00003" num="3" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 3</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Immunoreactivity of <sup class="style-scope patent-text">111</sup>In Radiolabeled</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Antibody on PSMA Expressing Cells</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Radiolabeled mAb</td> <td class="description-td style-scope patent-text">Immunoreactivity (%)</td> <td class="description-td style-scope patent-text">Cell line</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <sup class="style-scope patent-text">111</sup>In 4.304</td> <td class="description-td style-scope patent-text">92.6 (1.4)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">92.6</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">91.4 (1.7)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">89.1</td> <td class="description-td style-scope patent-text">LNCaP</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">92.4</td> <td class="description-td style-scope patent-text">C4-2</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Average =</td> <td class="description-td style-scope patent-text">91.6  1.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <sup class="style-scope patent-text">111</sup>In 4.40</td> <td class="description-td style-scope patent-text">87.7 (0.5)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">86.8</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">89.4 (1.5)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Average =</td> <td class="description-td style-scope patent-text">88.0  1.3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <sup class="style-scope patent-text">111</sup>In mJ591</td> <td class="description-td style-scope patent-text">58.5</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">54.9 (1.1)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Average =</td> <td class="description-td style-scope patent-text">56.7  2.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <sup class="style-scope patent-text">111</sup>In 3.9</td> <td class="description-td style-scope patent-text">88</td> <td class="description-td style-scope patent-text">LNCaP</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">87</td> <td class="description-td style-scope patent-text">C4-2</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">89 (2)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">95.3 (0.5)</td> <td class="description-td style-scope patent-text">PSMA-3T3 (3T3)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">88.6</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">84.8</td> <td class="description-td style-scope patent-text">C4-2</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">89.3</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Average =</td> <td class="description-td style-scope patent-text">88.6  3.2</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0438]" class="style-scope patent-text">
    
    [0438]
  </para-num> <div id="P-0438" num="0438" class="description-line style-scope patent-text">Antibodies 4.40, 4.304 and mJ591 were conjugated to the bifunctional chelate CHX-A-DTPA and antibody 3.9 was conjugated to C-DOTA. <span style="display: none" class="style-scope patent-text">[0438] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0439]" class="style-scope patent-text">
    
    [0439]
  </para-num> <div id="P-0439" num="0439" class="description-line style-scope patent-text">Immunoreactivity of <span style="display: none" class="style-scope patent-text">[0439] </span> <sup class="style-scope patent-text">225</sup>Ac radiolabeled antibody (026 and 4.40) was also assessed with a methodology similar to that described above for the <sup class="style-scope patent-text">111</sup>In labeled antibodies. <sup class="style-scope patent-text">225</sup>Ac was chelated with the bifunctional DOTA at 50 C. for 30 minutes. The chelated <sup class="style-scope patent-text">225</sup>Ac was then conjugated to <figure-callout id="026" label="antibodies" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">antibodies</a></figure-callout> 026 and 4.40 at 35 C. for 30 minutes. Unconjugated <sup class="style-scope patent-text">225</sup>Ac was removed by a PD10 column (Amersham Biosciences, Picataway, N.J.). The immunoreactivity of the radiolabeled antibodies was then determined. The data are presented below in Table 4. In addition to the assessment of the immunoreactivity of these antibodies, the yield of the labeling procedure was also assessed, and these data are also provided below in Table 4.  
<tables id="TABLE-US-00004" num="4" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 4</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Yield and Immunoreactivity of <sup class="style-scope patent-text">225</sup>Ac Radiolabeled Antibody</td> </tr>  </tbody></table> <figure-callout id="026" label="Antibody Yield Immunoreactivity" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <figure-callout id="026" label="Antibody Yield Immunoreactivity" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Antibody</a></figure-callout> </td> <td class="description-td style-scope patent-text">Yield</td> <td class="description-td style-scope patent-text">Immunoreactivity</td>  <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="3" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">026</td> <td class="description-td style-scope patent-text">9.3 +/ 0.8 (n = 2)</td> <td class="description-td style-scope patent-text">61.3 +/ 1.1 (n = 2)</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.40</td> <td class="description-td style-scope patent-text">14.3 +/ 0.6 (n = 2)</td> <td class="description-td style-scope patent-text">78.1 +/ 0.1 (n = 2)</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="3" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="3"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <heading class="style-scope patent-text">Example 21 </heading>
    <heading class="style-scope patent-text">Competitive Binding Assay to Identify Binding Epitopes </heading>
    <li class="style-scope patent-text"> <para-num num="[0440]" class="style-scope patent-text">
    
    [0440]
  </para-num> <div id="P-0440" num="0440" class="description-line style-scope patent-text">To identify whether a given group of mAbs recognize distinct or overlapping epitopes on PSMA, competition binding assays were performed with <span style="display: none" class="style-scope patent-text">[0440] </span> <sup class="style-scope patent-text">111</sup>In radiolabeled antibodies. 210<sup class="style-scope patent-text">5 </sup>cells (100 L) of PSMA-3T3 were plated into 96-well microplates, and antibodies 4.40, 4.304 and mJ591 (100 L) at different concentrations (series dilution) were added. The cells were incubated at 0 C. for 30 min. 20 L of In-111 radiolabeled CHX-A-DTPA antibody constructs were added into each well. After a 2 hour incubation on ice for competition binding, the cells were washed 5 times using cold PBS. The cells containing bound <sup class="style-scope patent-text">111</sup>In antibodies were recovered from microplates into test tubes and counted in a gamma counter. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0441]" class="style-scope patent-text">
    
    [0441]
  </para-num> <div id="P-0441" num="0441" class="description-line style-scope patent-text">Results detailed in FIG. 32 show that mJ591 blocked <span style="display: none" class="style-scope patent-text">[0441] </span> <sup class="style-scope patent-text">111</sup>In 4.40 binding to PSMA-3T3 cells and did not block <sup class="style-scope patent-text">111</sup>In 4.304. In addition, 4.40 and 4.304 did not block each other. Unmodified antibodies 4.304 and mJ591 were also used to compete with <sup class="style-scope patent-text">111</sup>In radiolabeled mJ591. Human 4.304 did not compete with <sup class="style-scope patent-text">111</sup>In mJ591 for binding to PSMA-3T3 (FIG. 33). </div>
    </li> <heading class="style-scope patent-text">Example 22 </heading>
    <heading class="style-scope patent-text">Binding <figure-callout id="3000" label="Affinity Using Biacore" filenames="US20040161776A1-20040819-D00034.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Affinity Using Biacore</a></figure-callout> 3000 </heading>
    <li class="style-scope patent-text"> <para-num num="[0442]" class="style-scope patent-text">
    
    [0442]
  </para-num> <div id="P-0442" num="0442" class="description-line style-scope patent-text">To determine the kinetics and affinity of the antibodies, the antibodies in crude supernatants, in purified form and in bifunctional chelate modified forms were analyzed using a <span style="display: none" class="style-scope patent-text">[0442] </span> <figure-callout id="3000" label="Biacore" filenames="US20040161776A1-20040819-D00034.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Biacore</a></figure-callout> 3000 instrument (Biacore Inc., Piscataway, N.J.). <figure-callout id="3000" label="Biacore" filenames="US20040161776A1-20040819-D00034.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Biacore</a></figure-callout> 3000 is a fully automated surface plasmon resonance (SPR)-based biosensor system that is designed to provide real-time kinetic data from assay formats that require no tags or labeling of compounds for biomolecular interactions. It is ideal for screening crude supernatants. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0443]" class="style-scope patent-text">
    
    [0443]
  </para-num> <div id="P-0443" num="0443" class="description-line style-scope patent-text">The streptavidin-coated sensor chips (SA chips, Biacore) were used to capture biotinylated anti-human IgG antibody (Sigma, St. Louis, Mo.). The entire sensor chip surface was conditioned with five injections of conditioning solution (1 M NaCl, 50 mM NaOH) and equilibrated with PBS buffer containing 0.005<span style="display: none" class="style-scope patent-text">[0443] </span> <figure-callout id="20" label="% polysorbate" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% polysorbate</a></figure-callout> 20. Two to three thousand resonance units (RU) of biotinylated anti-human IgG antibody (Sigma) were immobilized onto the SA chip followed by an injection of regeneration buffer (glycine-HCl, pH 2.2). Antibodies in supernatants were diluted to 2 g/mL in PBS buffer and captured onto one anti-human IgG flow cell, while isotype-matched control human antibody (Sigma) was similarly captured on a second flow cell. rsPSMA at different concentrations in PBS buffer was flowed over the cells at 30 L/min for 3 min in an association phase followed by a dissociation phase for 10 min. SPR was monitored and displayed as a function of time. For each antibody at one concentration, the chip was regenerated and equilibrated. Examples of the analysis of antibody PRGX1-XG-006 in association phase and dissociation phase at different concentrations of rsPSMA from 100 nM to 6.25 nM are shown in FIG. 34. Thermodynamic and kinetic rate constants of binding were calculated using the Biacore Evaluation software. For example, the affinity of XG-006 antibodies in a supernatant to rsPSMA was determined to be 4.9210<sup class="style-scope patent-text">10 </sup>M with a K<sub class="style-scope patent-text">a </sub>of 1.310<sup class="style-scope patent-text">5 </sup>M<sup class="style-scope patent-text">1</sup>s<sup class="style-scope patent-text">1 </sup>and a K<sub class="style-scope patent-text">d </sub>of 6.410<sup class="style-scope patent-text">5 </sup>s<sup class="style-scope patent-text">1</sup>. Selective data for several human PSMA antibodies in crude supernatant, purified form, and modified with bifunctional chelate is listed in Table 5 for comparison. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0444]" class="style-scope patent-text">
    
    [0444]
  </para-num> <div id="P-0444" num="0444" class="description-line style-scope patent-text">Binding activity of <span style="display: none" class="style-scope patent-text">[0444] </span> <sup class="style-scope patent-text">111</sup>In radiolabeled antibodies was determined by Scatchard analysis of binding data obtained using PSMA-expressing cells (LNCaP, C4-2, PSMA-3T3 and parental 3T3 as a control). The experimental procedures and methods of data analysis have been described previously (Scheinberg, D. A. et al. <i class="style-scope patent-text">Leukemia </i>3: 440-445 (1991).  
<tables id="TABLE-US-00005" num="5" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 5</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Kinetic Rate Constants of Antibodies in Crude Supernatant,</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified, Bifunctional Chelate Modified Forms along with KD</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Determined Using<sup class="style-scope patent-text">111</sup>In Radiolabeled Scatchard Analysis</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Ka</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(M<sup class="style-scope patent-text">1</sup>,</td> <td class="description-td style-scope patent-text">Kd</td> <td class="description-td style-scope patent-text">KD</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Antibodies</td> <td class="description-td style-scope patent-text">s<sup class="style-scope patent-text">1</sup>)</td> <td class="description-td style-scope patent-text">(s<sup class="style-scope patent-text">1</sup>)</td> <td class="description-td style-scope patent-text">(M<sup class="style-scope patent-text">1</sup>)</td> <td class="description-td style-scope patent-text">Avg KD</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">006 Supernatant</td> <td class="description-td style-scope patent-text">1.30E+05</td> <td class="description-td style-scope patent-text">6.40E05</td> <td class="description-td style-scope patent-text">4.92E10</td> <td class="description-td style-scope patent-text">4.92E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 006-1</td> <td class="description-td style-scope patent-text">2.94E+05</td> <td class="description-td style-scope patent-text">1.37E04</td> <td class="description-td style-scope patent-text">4.66E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 006-2</td> <td class="description-td style-scope patent-text">2.26E+05</td> <td class="description-td style-scope patent-text">1.27E04</td> <td class="description-td style-scope patent-text">5.62E10</td> <td class="description-td style-scope patent-text">5.14E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.40 Supernatant</td> <td class="description-td style-scope patent-text">2.10E+05</td> <td class="description-td style-scope patent-text">1.25E04</td> <td class="description-td style-scope patent-text">5.95E10</td> <td class="description-td style-scope patent-text">5.95E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 4.40-1</td> <td class="description-td style-scope patent-text">2.54E+05</td> <td class="description-td style-scope patent-text">1.52E04</td> <td class="description-td style-scope patent-text">5.98E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 4.40-2</td> <td class="description-td style-scope patent-text">2.43E+05</td> <td class="description-td style-scope patent-text">2.37E04</td> <td class="description-td style-scope patent-text">9.75E10</td> <td class="description-td style-scope patent-text">7.87E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">CHX-4.40-1</td> <td class="description-td style-scope patent-text">2.57E+05</td> <td class="description-td style-scope patent-text">1.60E04</td> <td class="description-td style-scope patent-text">6.23E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">CHX-4.40-2</td> <td class="description-td style-scope patent-text">2.47E+05</td> <td class="description-td style-scope patent-text">1.55E04</td> <td class="description-td style-scope patent-text">6.28E10</td> <td class="description-td style-scope patent-text">6.25E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">IN-111CHX-4.40-1</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">4.44E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">IN-111CHX-4.40-2</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">4.95E09</td> <td class="description-td style-scope patent-text">4.70E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.304 Supernatant</td> <td class="description-td style-scope patent-text">1.40E+05</td> <td class="description-td style-scope patent-text">1.25E04</td> <td class="description-td style-scope patent-text">8.93E10</td> <td class="description-td style-scope patent-text">8.93E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 4.304-1</td> <td class="description-td style-scope patent-text">8.31E+04</td> <td class="description-td style-scope patent-text">1.20E04</td> <td class="description-td style-scope patent-text">1.44E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 4.304-2</td> <td class="description-td style-scope patent-text">1.06E+05</td> <td class="description-td style-scope patent-text">6.33E05</td> <td class="description-td style-scope patent-text">5.97E10</td> <td class="description-td style-scope patent-text">1.02E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">CHX-4.304-1</td> <td class="description-td style-scope patent-text">6.19E+04</td> <td class="description-td style-scope patent-text">1.21E04</td> <td class="description-td style-scope patent-text">1.95E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">CHX-4.304-2</td> <td class="description-td style-scope patent-text">6.79E+04</td> <td class="description-td style-scope patent-text">1.49E04</td> <td class="description-td style-scope patent-text">2.19E09</td> <td class="description-td style-scope patent-text">2.07E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">IN-111CHX-4.304-1</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">9.63E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">IN-111CHX-4.304-2</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">5.97E09</td> <td class="description-td style-scope patent-text">7.80E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">10.3 Supernatant</td> <td class="description-td style-scope patent-text">1.90E+05</td> <td class="description-td style-scope patent-text">3.63E04</td> <td class="description-td style-scope patent-text">1.91E09</td> <td class="description-td style-scope patent-text">1.91E09</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 10.3-1</td> <td class="description-td style-scope patent-text">3.28E+05</td> <td class="description-td style-scope patent-text">6.32E05</td> <td class="description-td style-scope patent-text">1.93E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Purified 10.3-2</td> <td class="description-td style-scope patent-text">2.96E+05</td> <td class="description-td style-scope patent-text">6.43E05</td> <td class="description-td style-scope patent-text">2.17E10</td> <td class="description-td style-scope patent-text">2.05E10</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0445]" class="style-scope patent-text">
    
    [0445]
  </para-num> <div id="P-0445" num="0445" class="description-line style-scope patent-text">A comparison of the fully human antibodies 4.40.1, 4.49.1, 051 and 006 and the murine antibody 3.9 was performed by Biacore. For each antibody for comparison, response was normalized to 100 RU. The graph of time vs. response difference for these antibodies is given in FIG. 35. The binding affinities for these antibodies were determined to be 6.1, 6.7, 5.8, 4.8 and 13.710<span style="display: none" class="style-scope patent-text">[0445] </span> <sup class="style-scope patent-text">10</sup>M, respectively. </div>
    </li> <heading class="style-scope patent-text">Example 23 </heading>
    <heading class="style-scope patent-text">Characterization of Cell Lines for In Vitro and In Vivo Studies </heading>
    <li class="style-scope patent-text"> <para-num num="[0446]" class="style-scope patent-text">
    
    [0446]
  </para-num> <div id="P-0446" num="0446" class="description-line style-scope patent-text">Results from a Scatchard analysis using <span style="display: none" class="style-scope patent-text">[0446] </span> <sup class="style-scope patent-text">111</sup>In labeled anti-PSMA antibody 3.9 are represented in FIG. 36. Transfected murine 3T3 cells express &gt;1 million copies of PSMA per cell, LNCAP cells (androgen dependent human prostate cancer cell line) express 0.64 million copies, while C4-2 cells (androgen independent) express 0.25 million copies per cell. The affinity of 3.9 for cell surface PSMA is 6.4 M for PSMA-3T3, 4.0 nM for LNCAP and 3.3 nM for C4-2 (4.6 nM is the average of these data). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0447]" class="style-scope patent-text">
    
    [0447]
  </para-num> <div id="P-0447" num="0447" class="description-line style-scope patent-text">A summary of the analyses of crude supernatants for the human anti-PSMA antibodies is given in Table 6 below.  
<span style="display: none" class="style-scope patent-text">[0447] </span> <tables id="TABLE-US-00006" num="6" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" pgwide="1" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 6</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Characterization of Anti-PSMA Monoclonal Antibodies</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Binding to 3T3-</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Ab Conc</td> <td class="description-td style-scope patent-text">PSMA (FACS)</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Biacore studies</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="9" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">(g/mL)</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">AVG</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Anti-</td> <td class="description-td style-scope patent-text">KD,</td> <td class="description-td style-scope patent-text">Ka,</td> <td class="description-td style-scope patent-text">Kd,</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="11" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Lysate</td> <td class="description-td style-scope patent-text">PGNX</td> <td class="description-td style-scope patent-text">Max</td> <td class="description-td style-scope patent-text">AVG</td> <td class="description-td style-scope patent-text">C4.2</td> <td class="description-td style-scope patent-text">PSMA</td> <td class="description-td style-scope patent-text">M-1</td> <td class="description-td style-scope patent-text">M-1s-1</td> <td class="description-td style-scope patent-text">s-1</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Supernatant</td> <td class="description-td style-scope patent-text">PGNX</td> <td class="description-td style-scope patent-text">EIA</td> <td class="description-td style-scope patent-text">FACS</td> <td class="description-td style-scope patent-text">binding</td> <td class="description-td style-scope patent-text">EC50</td> <td class="description-td style-scope patent-text">FACS</td> <td class="description-td style-scope patent-text">Western</td> <td class="description-td style-scope patent-text">(10<sup class="style-scope patent-text">10</sup>)</td> <td class="description-td style-scope patent-text">(10<sup class="style-scope patent-text">5</sup>)</td> <td class="description-td style-scope patent-text">( 10  5)</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="11" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="11"> </td> </tr>  </tbody></table> <figure-callout id="19" label="ND ND ND" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table align="left" colsep="0" rowsep="0" cols="11" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PRGX1-XG1-</td> <td class="description-td style-scope patent-text">4.7</td> <td class="description-td style-scope patent-text">ND<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">148</td> <td class="description-td style-scope patent-text">2.4</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">Conf.<sup class="style-scope patent-text">2</sup> </td> <td class="description-td style-scope patent-text">2.0</td> <td class="description-td style-scope patent-text">1.5</td> <td class="description-td style-scope patent-text">2.9</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">026</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.4.1</td> <td class="description-td style-scope patent-text">4.7</td> <td class="description-td style-scope patent-text">0.08</td> <td class="description-td style-scope patent-text">7</td> <td class="description-td style-scope patent-text">8</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">5.2</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">4.2</td> <td class="description-td style-scope patent-text">2.3</td> <td class="description-td style-scope patent-text">9.7</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PRGX1-XG1-</td> <td class="description-td style-scope patent-text">1.8</td> <td class="description-td style-scope patent-text">0.39</td> <td class="description-td style-scope patent-text">114</td> <td class="description-td style-scope patent-text">183</td> <td class="description-td style-scope patent-text">3.4</td> <td class="description-td style-scope patent-text">9.5</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">4.8</td> <td class="description-td style-scope patent-text">1.3</td> <td class="description-td style-scope patent-text">6.4</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">006</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PRGX1-XG1-</td> <td class="description-td style-scope patent-text">3.5</td> <td class="description-td style-scope patent-text">0.48</td> <td class="description-td style-scope patent-text">83</td> <td class="description-td style-scope patent-text">202</td> <td class="description-td style-scope patent-text">2.0</td> <td class="description-td style-scope patent-text">9.9</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">5.8</td> <td class="description-td style-scope patent-text">1.4</td> <td class="description-td style-scope patent-text">8.2</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">051</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.40.1</td> <td class="description-td style-scope patent-text">4.3</td> <td class="description-td style-scope patent-text">0.33</td> <td class="description-td style-scope patent-text">53</td> <td class="description-td style-scope patent-text">163</td> <td class="description-td style-scope patent-text">2.3</td> <td class="description-td style-scope patent-text">10.8</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">6.1</td> <td class="description-td style-scope patent-text">2.1</td> <td class="description-td style-scope patent-text">12.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.49.1</td> <td class="description-td style-scope patent-text">2.6</td> <td class="description-td style-scope patent-text">0.36</td> <td class="description-td style-scope patent-text">362</td> <td class="description-td style-scope patent-text">162</td> <td class="description-td style-scope patent-text">0.9</td> <td class="description-td style-scope patent-text">16.2</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">6.7</td> <td class="description-td style-scope patent-text">3.1</td> <td class="description-td style-scope patent-text">20.7</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.292.1</td> <td class="description-td style-scope patent-text">2.7</td> <td class="description-td style-scope patent-text">0.18</td> <td class="description-td style-scope patent-text">75</td> <td class="description-td style-scope patent-text">195</td> <td class="description-td style-scope patent-text">6.0</td> <td class="description-td style-scope patent-text">9.2</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">6.8</td> <td class="description-td style-scope patent-text">1.2</td> <td class="description-td style-scope patent-text">8.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.304.1</td> <td class="description-td style-scope patent-text">4.1</td> <td class="description-td style-scope patent-text">0.39</td> <td class="description-td style-scope patent-text">92</td> <td class="description-td style-scope patent-text">184</td> <td class="description-td style-scope patent-text">9.1</td> <td class="description-td style-scope patent-text">8.4</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">8.7</td> <td class="description-td style-scope patent-text">1.4</td> <td class="description-td style-scope patent-text">12.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.232.1</td> <td class="description-td style-scope patent-text">2.4</td> <td class="description-td style-scope patent-text">0.49</td> <td class="description-td style-scope patent-text">97</td> <td class="description-td style-scope patent-text">138</td> <td class="description-td style-scope patent-text">2.7</td> <td class="description-td style-scope patent-text">6.0</td> <td class="description-td style-scope patent-text">Linear<sup class="style-scope patent-text">3</sup> </td> <td class="description-td style-scope patent-text">9.4</td> <td class="description-td style-scope patent-text">1.5</td> <td class="description-td style-scope patent-text">13.8</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.153.1</td> <td class="description-td style-scope patent-text">5.9</td> <td class="description-td style-scope patent-text">0.29</td> <td class="description-td style-scope patent-text">279</td> <td class="description-td style-scope patent-text">182</td> <td class="description-td style-scope patent-text">5.3</td> <td class="description-td style-scope patent-text">14.8</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">9.5</td> <td class="description-td style-scope patent-text">1.2</td> <td class="description-td style-scope patent-text">11.8</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.333.1</td> <td class="description-td style-scope patent-text">2.9</td> <td class="description-td style-scope patent-text">0.18</td> <td class="description-td style-scope patent-text">82</td> <td class="description-td style-scope patent-text">168</td> <td class="description-td style-scope patent-text">3.1</td> <td class="description-td style-scope patent-text">6.6</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">11</td> <td class="description-td style-scope patent-text">0.7</td> <td class="description-td style-scope patent-text">8.5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PRGX1-XG1-</td> <td class="description-td style-scope patent-text">3.9</td> <td class="description-td style-scope patent-text">0.45</td> <td class="description-td style-scope patent-text">392</td> <td class="description-td style-scope patent-text">227</td> <td class="description-td style-scope patent-text">6.0</td> <td class="description-td style-scope patent-text">12.4</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">16</td> <td class="description-td style-scope patent-text">0.6</td> <td class="description-td style-scope patent-text">10.4</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">077</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">10.3</td> <td class="description-td style-scope patent-text">8.5</td> <td class="description-td style-scope patent-text">1.06</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text"> <figure-callout id="19" label="ND ND ND" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ND</a></figure-callout> </td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td>  <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">19</td> <td class="description-td style-scope patent-text">1.9</td> <td class="description-td style-scope patent-text">36.4</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">pure 10.3</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">0.44</td> <td class="description-td style-scope patent-text">130</td> <td class="description-td style-scope patent-text">181</td> <td class="description-td style-scope patent-text">7.5</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">ND</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">4.7</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.22.1</td> <td class="description-td style-scope patent-text">2.8</td> <td class="description-td style-scope patent-text">0.08</td> <td class="description-td style-scope patent-text">7</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">4.7</td> <td class="description-td style-scope patent-text"> <figure-callout id="20" label="ND" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ND</a></figure-callout> </td> <td class="description-td style-scope patent-text">20</td> <td class="description-td style-scope patent-text">1.7</td> <td class="description-td style-scope patent-text">33</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.248.1</td> <td class="description-td style-scope patent-text">3.5</td> <td class="description-td style-scope patent-text">0.37</td> <td class="description-td style-scope patent-text">7</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">4.1</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">27</td> <td class="description-td style-scope patent-text">1.0</td> <td class="description-td style-scope patent-text">28</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.54.1</td> <td class="description-td style-scope patent-text">10</td> <td class="description-td style-scope patent-text">0.14</td> <td class="description-td style-scope patent-text">267</td> <td class="description-td style-scope patent-text">162</td> <td class="description-td style-scope patent-text">3.9</td> <td class="description-td style-scope patent-text">13.6</td> <td class="description-td style-scope patent-text"> <figure-callout id="30" label="ND" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ND</a></figure-callout> </td> <td class="description-td style-scope patent-text">30</td> <td class="description-td style-scope patent-text">1.9</td> <td class="description-td style-scope patent-text">56</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.7.1</td> <td class="description-td style-scope patent-text">5</td> <td class="description-td style-scope patent-text">0.23</td> <td class="description-td style-scope patent-text">156</td> <td class="description-td style-scope patent-text">141</td> <td class="description-td style-scope patent-text">1.6</td> <td class="description-td style-scope patent-text">10.2</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">32</td> <td class="description-td style-scope patent-text">1.7</td> <td class="description-td style-scope patent-text">56</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.78.1</td> <td class="description-td style-scope patent-text">5.3</td> <td class="description-td style-scope patent-text">0.00</td> <td class="description-td style-scope patent-text">205</td> <td class="description-td style-scope patent-text">118</td> <td class="description-td style-scope patent-text">1.0</td> <td class="description-td style-scope patent-text">7.9</td> <td class="description-td style-scope patent-text">Conf.</td> <td class="description-td style-scope patent-text">53</td> <td class="description-td style-scope patent-text">2.4</td> <td class="description-td style-scope patent-text">125</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.48.1</td> <td class="description-td style-scope patent-text">4.9</td> <td class="description-td style-scope patent-text">0.06</td> <td class="description-td style-scope patent-text">14</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">7.7</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">62</td> <td class="description-td style-scope patent-text">0.9</td> <td class="description-td style-scope patent-text">59</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.209.1</td> <td class="description-td style-scope patent-text">3.5</td> <td class="description-td style-scope patent-text">0.22</td> <td class="description-td style-scope patent-text">60</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">6.7</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">142</td> <td class="description-td style-scope patent-text">0.9</td> <td class="description-td style-scope patent-text">125</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.177.1</td> <td class="description-td style-scope patent-text">1.1</td> <td class="description-td style-scope patent-text">0.15</td> <td class="description-td style-scope patent-text">236</td> <td class="description-td style-scope patent-text">174</td> <td class="description-td style-scope patent-text">2.4</td> <td class="description-td style-scope patent-text">10.6</td> <td class="description-td style-scope patent-text"> <figure-callout id="155" label="ND" filenames="US20040161776A1-20040819-D00053.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ND</a></figure-callout> </td> <td class="description-td style-scope patent-text">155</td> <td class="description-td style-scope patent-text">0.6</td> <td class="description-td style-scope patent-text">93</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.152.1</td> <td class="description-td style-scope patent-text">3.4</td> <td class="description-td style-scope patent-text">0.38</td> <td class="description-td style-scope patent-text">81</td> <td class="description-td style-scope patent-text">85</td> <td class="description-td style-scope patent-text">4.0</td> <td class="description-td style-scope patent-text">7.5</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">163</td> <td class="description-td style-scope patent-text">0.8</td> <td class="description-td style-scope patent-text">126</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.28.1</td> <td class="description-td style-scope patent-text">4.2</td> <td class="description-td style-scope patent-text">0.04</td> <td class="description-td style-scope patent-text">112</td> <td class="description-td style-scope patent-text">155</td> <td class="description-td style-scope patent-text">4.2</td> <td class="description-td style-scope patent-text">11.3</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">167</td> <td class="description-td style-scope patent-text">1.2</td> <td class="description-td style-scope patent-text">192</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.16.1</td> <td class="description-td style-scope patent-text">5.3</td> <td class="description-td style-scope patent-text">0.00</td> <td class="description-td style-scope patent-text">8</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">7.8</td> <td class="description-td style-scope patent-text"> <figure-callout id="177" label="ND" filenames="US20040161776A1-20040819-D00043.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ND</a></figure-callout> </td> <td class="description-td style-scope patent-text">177</td> <td class="description-td style-scope patent-text">1.8</td> <td class="description-td style-scope patent-text">313</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.360.1</td> <td class="description-td style-scope patent-text">1.5</td> <td class="description-td style-scope patent-text">0.02</td> <td class="description-td style-scope patent-text">112</td> <td class="description-td style-scope patent-text">130</td> <td class="description-td style-scope patent-text">2.2</td> <td class="description-td style-scope patent-text">7.9</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">197</td> <td class="description-td style-scope patent-text">1.0</td> <td class="description-td style-scope patent-text">201</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.288.1</td> <td class="description-td style-scope patent-text">15.4</td> <td class="description-td style-scope patent-text">0.02</td> <td class="description-td style-scope patent-text">67</td> <td class="description-td style-scope patent-text">141</td> <td class="description-td style-scope patent-text">4.1</td> <td class="description-td style-scope patent-text">6.5</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">198</td> <td class="description-td style-scope patent-text">1.3</td> <td class="description-td style-scope patent-text">257</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.219.2</td> <td class="description-td style-scope patent-text">0.5</td> <td class="description-td style-scope patent-text">0.34</td> <td class="description-td style-scope patent-text">69</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">5.9</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="10" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PRGX1-XG1-</td> <td class="description-td style-scope patent-text">6.5</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">71</td> <td class="description-td style-scope patent-text">7.9</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">ND</td> <td class="description-td style-scope patent-text">No Binding</td> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">069</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="11" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Murine 3.9</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">13.7</td> <td class="description-td style-scope patent-text">0.7</td> <td class="description-td style-scope patent-text">9.7</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Control</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">6.34</td> <td class="description-td style-scope patent-text">2.24</td> <td class="description-td style-scope patent-text">14.2</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="11" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="11"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="11" align="left" class="description-td style-scope patent-text" colspan="11"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="11" align="left" class="description-td style-scope patent-text" colspan="11"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="11" align="left" class="description-td style-scope patent-text" colspan="11"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <heading class="style-scope patent-text">Example 24 </heading>
    <heading class="style-scope patent-text">Cytotoxicity of Radiolabeled Antibody </heading>
    <li class="style-scope patent-text"> <para-num num="[0448]" class="style-scope patent-text">
    
    [0448]
  </para-num> <div id="P-0448" num="0448" class="description-line style-scope patent-text">The in vitro cytotoxicity of <span style="display: none" class="style-scope patent-text">[0448] </span> <sup class="style-scope patent-text">225</sup>Ac labeled anti-PSMA antibody (4.40 and 026) was determined using methodology similar to that used in Example 19. Prostate cancer cells (100 L of C4-2, LNCaP, and PC3 cells at a concentration of 210<sup class="style-scope patent-text">4 </sup>cells/mL) were placed into separate wells of a 96 well microplate. For tests with the 026 antibody, C4-2 and PC3 cells were placed into separate wells of a 96 well microplate. After overnight incubation, the cells were treated with <sup class="style-scope patent-text">225</sup>Ac labeled human anti-PSMA antibody at different concentrations for over 4 days. Cell cytotoxicity was quantified using Alamar Blue (Biosource International, Camarillo, Calif.). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0449]" class="style-scope patent-text">
    
    [0449]
  </para-num> <div id="P-0449" num="0449" class="description-line style-scope patent-text">FIG. 37 shows a plot of cell survival vs. <span style="display: none" class="style-scope patent-text">[0449]</span> <sup class="style-scope patent-text">225</sup>Ac activity concentration using <sup class="style-scope patent-text">225</sup>Ac labeled 4.40 antibody. The EC50 for PSMA expressing cells (C4-2 and LNCaP) was &lt;2 nCi/mL. However, the EC50 was 420 nCi/mL for PC3 cells, which do not express PSMA on the cell surface. Therefore, the <sup class="style-scope patent-text">225</sup>Ac labeled human anti-PSMA 4.40 antibody shows &gt;200-fold selectivity in killing PSMA expressing prostate cancer cells (C4-2 and LNCaP) vs. control cells (PC3). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0450]" class="style-scope patent-text">
    
    [0450]
  </para-num> <div id="P-0450" num="0450" class="description-line style-scope patent-text">FIG. 38 shows a plot of cell survival vs. <span style="display: none" class="style-scope patent-text">[0450]</span> <sup class="style-scope patent-text">225</sup>Ac activity concentration using <sup class="style-scope patent-text">225</sup>Ac labeled 026 antibody. The <sup class="style-scope patent-text">225</sup>Ac labeled human anti-PSMA 026 antibody shows &gt;50-fold selectivity in killing PSMA expressing prostate cancer cells (C4-2) vs. control cells (PC3). </div>
    </li> <heading class="style-scope patent-text">Example 25 </heading>
    <heading class="style-scope patent-text">Cytotoxicity of <sup class="style-scope patent-text">225</sup>Ac Labeled Antibody vs. Control Antibody </heading>
    <li class="style-scope patent-text"> <para-num num="[0451]" class="style-scope patent-text">
    
    [0451]
  </para-num> <div id="P-0451" num="0451" class="description-line style-scope patent-text">The in vitro cytotoxicity of <span style="display: none" class="style-scope patent-text">[0451] </span> <sup class="style-scope patent-text">225</sup>Ac labeled anti-PSMA antibody was determined using methodology similar to that used in Example 19 and Example 24 above. Human prostate cancer cells (100 L of C4-2 and LNCaP cells at a concentration of 210<sup class="style-scope patent-text">4 </sup>cells/mL) were placed into separate wells of a 96 well microplate. After overnight incubation, the cells were treated with <sup class="style-scope patent-text">225</sup>Ac labeled human anti-PSMA 026 antibody at different concentrations for 4 days. Cell cytotoxicity was quantified using Alamar Blue (Biosource International, Camarillo, Calif.). Human IgG (HuIgG) was used as a control. The cytotoxicity of an <figure-callout id="026" label="anti-PSMA mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">anti-PSMA mAb</a></figure-callout> 026 2 hour wash was also determined. A 2 hour wash means that the cells were incubated with <sup class="style-scope patent-text">225</sup>Ac labeled antibody for 2 hours. After 2 hours, the media was removed and fresh media was added for the 4 day incubation. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0452]" class="style-scope patent-text">
    
    [0452]
  </para-num> <div id="P-0452" num="0452" class="description-line style-scope patent-text">FIG. 39 shows a plot of cell survival vs. the <span style="display: none" class="style-scope patent-text">[0452]</span> <sup class="style-scope patent-text">225</sup>Ac activity concentration for both C4-2 and LNCaP cells using <figure-callout id="026" label="radiolabeled mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">radiolabeled mAb</a></figure-callout> 026, <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 2 hour wash and HuIgG. <sup class="style-scope patent-text">225</sup>Ac labeled <figure-callout id="026" label="mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAb</a></figure-callout> 026 showed an IC50 of &lt;1 nCi/mL. Therefore, the <sup class="style-scope patent-text">225</sup>Ac labeled human anti-PSMA 026 antibody showed &gt;50-fold selectivity in killing the prostate cancer cells vs. the control antibody. </div>
    </li> <heading class="style-scope patent-text">Example 26 </heading>
    <heading class="style-scope patent-text">Cytotoxicity of <sup class="style-scope patent-text">225</sup>Ac Labeled Antibody vs. Control Antibody Evaluated by <sup class="style-scope patent-text">3</sup>H Thymidine Incorporation </heading>
    <li class="style-scope patent-text"> <para-num num="[0453]" class="style-scope patent-text">
    
    [0453]
  </para-num> <div id="P-0453" num="0453" class="description-line style-scope patent-text">Human prostate cancer cells (C4-2) in a 96 microplate were treated with <span style="display: none" class="style-scope patent-text">[0453] </span> <sup class="style-scope patent-text">225</sup>Ac labeled mAbs at different concentrations for 4 days. Cell survival was assessed using <sup class="style-scope patent-text">3</sup>H thymidine incorporation (Nikula, T.K, et al. <i class="style-scope patent-text">J. Nucl. Med. </i>40: 166-176, 1999). </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0454]" class="style-scope patent-text">
    
    [0454]
  </para-num> <div id="P-0454" num="0454" class="description-line style-scope patent-text">FIG. 40 shows a plot of cell survival vs. the <span style="display: none" class="style-scope patent-text">[0454]</span> <sup class="style-scope patent-text">225</sup>Ac activity concentration for C4-2 cells using <figure-callout id="026" label="radiolabeled mAb" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">radiolabeled mAb</a></figure-callout> 026 and control mAb (HuM195). The IC50 was 0.12 nCi/mL using <sup class="style-scope patent-text">225</sup>Ac labeled 026 vs. 13 nCi/ml with the control mAb (HuM195). The radiolabeled 026 antibody, therefore, showed &gt;100-fold selectivity in killing the PSMA expressing C4-2 cells vs. the control antibody. </div>
    </li> <heading class="style-scope patent-text">Example 27 </heading>
    <heading class="style-scope patent-text">In Vivo Radioimmunotherapy with <sup class="style-scope patent-text">177</sup>Lu Labeled Antibodies </heading>
    <li class="style-scope patent-text"> <para-num num="[0455]" class="style-scope patent-text">
    
    [0455]
  </para-num> <div id="P-0455" num="0455" class="description-line style-scope patent-text">Athymic nude mice from the National Cancer Institute were implanted subcutaneously with 210<span style="display: none" class="style-scope patent-text">[0455] </span> <sup class="style-scope patent-text">6 </sup>PSMA-3T3 cells. After measurable tumors appeared at <figure-callout id="7" label="day" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">day</a></figure-callout> 7 post implantation, the mice were treated by injection with either a single 250 Ci dose human anti-PSMA antibody 4.40 or 4.304 labeled with <sup class="style-scope patent-text">177</sup>Lu (University of Missouri Research Reactor), or were injected with buffer only as control. The tumor size of individual animals was measured using an electronic caliper. FIG. 41 shows a plot of the median tumor size in each group over time. Tumor growths were substantially reduced in <sup class="style-scope patent-text">177</sup>Lu antibody treated groups compared to the control group. </div>
    </li> <heading class="style-scope patent-text">Example 28 </heading>
    <heading class="style-scope patent-text">In Vivo Biodistribution Study with <sup class="style-scope patent-text">177</sup>Lu Labeled Antibodies </heading>
    <li class="style-scope patent-text"> <para-num num="[0456]" class="style-scope patent-text">
    
    [0456]
  </para-num> <div id="P-0456" num="0456" class="description-line style-scope patent-text">Athymic nude mice from the National Cancer Institute (male, approximately 6 weeks old) were injected subcutaneously with 410<span style="display: none" class="style-scope patent-text">[0456] </span> <sup class="style-scope patent-text">6 </sup>PSMA-3T3 cells and 2.810<sup class="style-scope patent-text">6 </sup>3T3 cells in 0.2 mL in the right and left flank of each animal, respectively. <figure-callout id="006" label="Anti-PSMA antibodies" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="Anti-PSMA antibodies" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Anti-PSMA antibodies</a></figure-callout> </a></figure-callout> 006, 026, mJ591 and HuIgG (control) modified with CHX-A-DTPA were labeled with <sup class="style-scope patent-text">177</sup>Lu. FIG. 42 shows the radio-HPLC profile of the radiolabeled antibodies as well as the cell-based immunoreactivity performed as quality control. On <figure-callout id="6" label="day" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">day</a></figure-callout> 6 after tumor implantation, <sup class="style-scope patent-text">177</sup>Lu labeled antibodies (10 Ci and 1 g in 0.15 mL) were injected retro-orbitally. The animals were randomized before antibody injection. Mice (30 per antibody, 5 per time point) were sacrificed at different times (days 0.17, 1, 2, 4, 7 and 12). Tumors and individual organs (PSMA+ tumor, PSMA tumor, blood, liver, kidneys, spleen, lungs, heart, bone, muscle, carcass) were taken and weighed. Activity in each organ along with standards prepared from injection solutions were counted using a multi-channel gamma counter. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0457]" class="style-scope patent-text">
    
    [0457]
  </para-num> <div id="P-0457" num="0457" class="description-line style-scope patent-text">Results of this study show that <span style="display: none" class="style-scope patent-text">[0457] </span> <sup class="style-scope patent-text">177</sup>Lu labeled antibodies specifically bound to tumors expressing PSMA in vivo in the animal model. The percent injected dose per gram of tissue (% ID/g) was calculated and plotted over time for the different antibodies in the PSMA+ and PSMA tumors (FIG. 43A). PSMA specific tumor targeting (ratio of PSMA+/PSMA tumor uptake) is provided in FIG. 43B. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0458]" class="style-scope patent-text">
    
    [0458]
  </para-num> <div id="P-0458" num="0458" class="description-line style-scope patent-text">FIG. 44 shows the percent activity in the tumors with the various radiolabeled antibodies (006, 026, mJ591 and HuIgG) over time (% tumor retention vs. total body retention). The data again illustrate the specificity by which the radiolabeled antibodies target the PSMA expressing tumors. FIG. 44A shows the activity over time in the PSMA+ tumors while FIG. 44B shows the percent activity over time in the PSMA tumors for the different antibodies. FIG. 45 shows the data for normal organ (blood, liver, kidneys, spleen, lungs, bone, heart and muscle) uptake (% ID/g) plotted over time. <span style="display: none" class="style-scope patent-text">[0458]</span> </div>
    </li> <heading class="style-scope patent-text">Example 29 </heading>
    <heading class="style-scope patent-text">In Vivo Therapeutic Efficacy of <sup class="style-scope patent-text">177</sup>Lu Radiolabeled Antibodies </heading>
    <li class="style-scope patent-text"> <para-num num="[0459]" class="style-scope patent-text">
    
    [0459]
  </para-num> <div id="P-0459" num="0459" class="description-line style-scope patent-text">Athymic nude mice from the National Cancer Institute (male, approximately 6 weeks old) were injected subcutaneously with 410<span style="display: none" class="style-scope patent-text">[0459] </span> <sup class="style-scope patent-text">6 </sup>PSMA-3T3 cells and 2.810<sup class="style-scope patent-text">6 </sup>3T3 cells in 0.2 mL in the right and left flank of each animal, respectively. <sup class="style-scope patent-text">177</sup>Lu labeled mAb 026 (0 Ci, n=5; 300 Ci and 10 g, n=9; and 400 Ci and 13.5 g, n=5) were injected into the mice on <figure-callout id="6" label="day" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">day</a></figure-callout> 6 after tumor implantation. Animals were weighed and tumors were measured over time. Tumor size (mm<sup class="style-scope patent-text">3</sup>) was calculated using the formula: length(width)<sup class="style-scope patent-text">2</sup>/2. Mice were sacrificed if tumor size reached 1000 mm<sup class="style-scope patent-text">3</sup>. Animal survival was also assessed, and the Kaplan-Meier plot was created. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0460]" class="style-scope patent-text">
    
    [0460]
  </para-num> <div id="P-0460" num="0460" class="description-line style-scope patent-text">The results of the study show that treatment decreased tumor size and increased survival in the mice. FIG. 46A shows the tumor size in the mice treated with the radiolabeled antibodies (<span style="display: none" class="style-scope patent-text">[0460] </span> <sup class="style-scope patent-text">177</sup>Lu labeled mAb 026) at all three dose levels. The mice treated with 300 Ci and 400 Ci had consistently smaller tumors than the mice in the control group (0 Ci). FIG. 46B shows that the mice treated with 300 Ci and 400 Ci had increased survival relative to the control mice. Median survival was increased by 2.4-fold in mice treated with 300 Ci and 3.5-fold in mice treated with 400 Ci using time after treatment. Treatment with 400 Ci was found to be non-toxic. Additionally, at the end of the experiment (48 days after tumor implantation), one animal from each treated group remained PSMA-3T3 tumor free but had large 3T3 tumors. </div>
    </li> <heading class="style-scope patent-text">Example 30 </heading>
    <heading class="style-scope patent-text">Binding of Antibodies to rsPSMA Dimer and Monomer </heading>
    <li class="style-scope patent-text"> <para-num num="[0461]" class="style-scope patent-text">
    
    [0461]
  </para-num> <div id="P-0461" num="0461" class="description-line style-scope patent-text">A <span style="display: none" class="style-scope patent-text">[0461] </span> <figure-callout id="3000" label="Biacore" filenames="US20040161776A1-20040819-D00034.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Biacore</a></figure-callout> 3000 instrument was used to monitor, in real time, binding of rsPSMA dimer and monomer to anti-PSMA mAbs. Antibodies were immobilized at approximately 10,000 resonance units to CM5 sensor chips according to the manufacturer's instructions for amine coupling (Biacore, Inc., Piscataway, N.J.). A reference surface of isotype-matched antibody of irrelevant specificity was used as a background control. Binding experiments were performed at 25 C. in PBS buffer with 0.005% [vol/vol] Surfactant P20. Purified rsPSMA dimer (50 nM) or monomer (100 nM) was passed over control and test flow cells at a flow rate of 5 L/min. The sensor surface was regenerated with two pulses of 20 nM HCl. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0462]" class="style-scope patent-text">
    
    [0462]
  </para-num> <div id="P-0462" num="0462" class="description-line style-scope patent-text">FIGS. 47 and 48, respectively, show that <span style="display: none" class="style-scope patent-text">[0462]</span> <figure-callout id="006" label="anti-PSMA mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="anti-PSMA mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">anti-PSMA mAbs</a></figure-callout> </a></figure-callout> 006 and 026 bind preferentially to the rsPSMA dimer rather than the rsPSMA monomer. Anti-PSMA antibodies 4.40 and mJ591, however, were shown to bind both the rsPSMA dimer and monomer at significant levels (FIGS. 49 and 50, respectively). This study illustrates that <figure-callout id="006" label="anti-PSMA mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="anti-PSMA mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">anti-PSMA mAbs</a></figure-callout> </a></figure-callout> 006 and 026 are PSMA dimer-specific antibodies and bind dimer-specific epitopes on PSMA. The results also indicate that the native conformation of PSMA is a homodimer, and that the monomer possesses a partially denatured conformation or exposes epitopes located at the dimer surface and/or dimer interface that are not accessible in the dimer. </div>
    </li> <heading class="style-scope patent-text">Example 31 </heading>
    <heading class="style-scope patent-text">Immunization with rsPSMA Dimer Preparations </heading>
    <li class="style-scope patent-text"> <para-num num="[0463]" class="style-scope patent-text">
    
    [0463]
  </para-num> <div id="P-0463" num="0463" class="description-line style-scope patent-text">Immunization <span style="display: none" class="style-scope patent-text">[0463] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0464]" class="style-scope patent-text">
    
    [0464]
  </para-num> <div id="P-0464" num="0464" class="description-line style-scope patent-text">BALB/c mice were immunized by subcutaneous injection at <span style="display: none" class="style-scope patent-text">[0464] </span> <figure-callout id="0" label="days" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="7" label="days" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00009.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="14" label="days" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="42" label="days" filenames="US20040161776A1-20040819-D00044.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">days</a></figure-callout> </a></figure-callout> </a></figure-callout> </a></figure-callout> 0, 7, 14, and 42 with either 5 g clinical rsPSMA lot # 4019-C001 (75% dimer/25% monomer) or 5 g rsPSMA batch # TD045-003 <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/peak 2 (100% monomer) on alum (250 g per dose, Sigma) or adjuvanted with 50 g alhydrogel per dose. Serum was drawn 10 days after the fourth immunization and analyzed by enzyme-linked immunoassay (EFIA) and flow cytometry. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0465]" class="style-scope patent-text">
    
    [0465]
  </para-num> <div id="P-0465" num="0465" class="description-line style-scope patent-text">EIA <span style="display: none" class="style-scope patent-text">[0465] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0466]" class="style-scope patent-text">
    
    [0466]
  </para-num> <div id="P-0466" num="0466" class="description-line style-scope patent-text">rsPSMA lot # 4019-C001 or rsPSMA batch # TD045-003 <span style="display: none" class="style-scope patent-text">[0466] </span> <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/<figure-callout id="2" label="peak" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">peak</a></figure-callout> 2 was passively adsorbed to 96-well microtiter plates. Remaining binding sites on the plate were blocked with a PBS/Casein/<figure-callout id="20" label="Tween" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Tween</a></figure-callout> 20 buffer. Serially diluted mouse serum or controls were added and bound antibody was detected using a goat anti-mouse IgG antibody conjugated to alkaline phosphatase. The EIA was developed with the substrate pNPP which produces a color change that is directly proportional to the amount of anti-PSMA antibody bound. Absorbance was read at 405 nm with a correction of 620 nm. Antibody titer was defined as the highest dilution of mouse serum yielding a blank corrected absorbance of 0.1. Immune mouse serum with a known anti-PSMA titer or normal mouse serum with no anti-PSMA reactivity was used as controls. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0467]" class="style-scope patent-text">
    
    [0467]
  </para-num> <div id="P-0467" num="0467" class="description-line style-scope patent-text">Flow Cytometry Analysis <span style="display: none" class="style-scope patent-text">[0467] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0468]" class="style-scope patent-text">
    
    [0468]
  </para-num> <div id="P-0468" num="0468" class="description-line style-scope patent-text">PSMA-3T3 cells were incubated with 200 L of immune serum at a dilution of 1/50 in PBS with 0.1% sodium azide on ice for 30 minutes. Immune mouse serum with known anti-PSMA titer or normal mouse serum with no anti-PSMA reactivity was used as controls. The cells were washed twice with PBS with 0.1% sodium azide and incubated for 30 minutes on ice with FITC-conjugated goat anti-mouse IgG. Cells were washed once, resuspended in PBS with 0.1% sodium azide and subjected to flow cytometric analysis on FACScaliber (Becton Dickinson). <span style="display: none" class="style-scope patent-text">[0468] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0469]" class="style-scope patent-text">
    
    [0469]
  </para-num> <div id="P-0469" num="0469" class="description-line style-scope patent-text">Results <span style="display: none" class="style-scope patent-text">[0469] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0470]" class="style-scope patent-text">
    
    [0470]
  </para-num> <div id="P-0470" num="0470" class="description-line style-scope patent-text">5/5 mice immunized with rsPSMA lot # 4019-C001 showed an anti-PSMA antibody response by EIA. Antibody titer was similar for assay plates coated with rsPSMA lot # 4019-C001 (75% dimer/25% monomer) and assay plates coated with rsPSMA batch # TD045-003 <span style="display: none" class="style-scope patent-text">[0470] </span> <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/peak 2 (100% monomer). Median response for the group was 1/6400. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0471]" class="style-scope patent-text">
    
    [0471]
  </para-num> <div id="P-0471" num="0471" class="description-line style-scope patent-text">4/5 mice immunized with rsPSMA batch # TD045-003 <span style="display: none" class="style-scope patent-text">[0471] </span> <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/<figure-callout id="2" label="peak" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">peak</a></figure-callout> 2 showed an anti-PSMA antibody response by EIA. One mouse was negative. Antibody titer was similar for assay plates coated with rsPSMA lot # 4019-C001 (75% dimer/25% monomer) and assay plates coated with rsPSMA batch # TD045-003 <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/peak 2 (100% monomer). Median response for the group was 1/6400. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0472]" class="style-scope patent-text">
    
    [0472]
  </para-num> <div id="P-0472" num="0472" class="description-line style-scope patent-text">The results of the EIA analysis are provided in Table 7. <span style="display: none" class="style-scope patent-text">[0472] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0473]" class="style-scope patent-text">
    
    [0473]
  </para-num> <div id="P-0473" num="0473" class="description-line style-scope patent-text">The results of the flow cytometry analysis are provided in FIG. 51.  
<span style="display: none" class="style-scope patent-text">[0473] </span> <tables id="TABLE-US-00007" num="7" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 7</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Specificity of the Anti-PSMA Antibody Response in Mice Vaccinated</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4 Times with <figure-callout id="5" label="rsPSMA" filenames="US20040161776A1-20040819-D00007.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rsPSMA</a></figure-callout> 5 g/dose and 50 g/dose Alhydrogel</td> </tr>  </tbody></table> <figure-callout id="1" label="C001 run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">EIA Titer</td> <td class="description-td style-scope patent-text">Median</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">EIA Titer</td> <td class="description-td style-scope patent-text">vs. Batch</td> <td class="description-td style-scope patent-text">RFI vs.</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Mouse</td> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">vs. Lot</td> <td class="description-td style-scope patent-text">TD045-003</td> <td class="description-td style-scope patent-text">PSMA-3T3</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ID #</td> <td class="description-td style-scope patent-text">Immunogen</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001 run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">run</td>  <td class="description-td style-scope patent-text"> 1/<figure-callout id="2" label="peak" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">peak</a></figure-callout> 2</td> <td class="description-td style-scope patent-text">cells</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> <figure-callout id="1" label="Dimer ABIM156 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="Dimer ABIM156 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="ABIM157 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="0" label="ABIM158 Monomer" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="ABIM159 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><figure-callout id="1" label="ABIM160 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> </a></figure-callout><table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM151</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">1/3200</td> <td class="description-td style-scope patent-text">1/3200</td> <td class="description-td style-scope patent-text">84</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM152</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">1/3200</td> <td class="description-td style-scope patent-text">1/3200</td> <td class="description-td style-scope patent-text">41</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM153</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">1/25600</td> <td class="description-td style-scope patent-text">1/25600</td> <td class="description-td style-scope patent-text">76</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM154</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">1/12800</td> <td class="description-td style-scope patent-text">1/12800</td> <td class="description-td style-scope patent-text">63</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM155</td> <td class="description-td style-scope patent-text">4019-<figure-callout id="1" label="C001" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">C001</a></figure-callout> </td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">74</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text"> <figure-callout id="1" label="Dimer ABIM156 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Dimer</a></figure-callout> </td>  </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">ABIM156</td> <td class="description-td style-scope patent-text">Monomer</td> </tr>  <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">1/1600</td> <td class="description-td style-scope patent-text">1/1600</td> <td class="description-td style-scope patent-text">5</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <figure-callout id="1" label="ABIM157 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ABIM157</a></figure-callout> </td> <td class="description-td style-scope patent-text">Monomer</td>  <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">1/12800</td> <td class="description-td style-scope patent-text">8</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <figure-callout id="0" label="ABIM158 Monomer" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ABIM158</a></figure-callout> </td> <td class="description-td style-scope patent-text">Monomer</td>  <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">0</td> <td class="description-td style-scope patent-text">0</td> <td class="description-td style-scope patent-text">6</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <figure-callout id="1" label="ABIM159 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ABIM159</a></figure-callout> </td> <td class="description-td style-scope patent-text">Monomer</td>  <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">6</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> <figure-callout id="1" label="ABIM160 Monomer" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ABIM160</a></figure-callout> </td> <td class="description-td style-scope patent-text">Monomer</td>  <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">1/6400</td> <td class="description-td style-scope patent-text">12</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0474]" class="style-scope patent-text">
    
    [0474]
  </para-num> <div id="P-0474" num="0474" class="description-line style-scope patent-text">When tested by ELISA, sera from both monomer and dimer immunized animals showed similar levels of anti-PSMA antibodies, indicating that each protein was immunogenic when formulated on alum. For dimer immunized animals, the median endpoint titers were 1/6,400 (<span style="display: none" class="style-scope patent-text">[0474] </span> <figure-callout id="1" label="range" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">range</a></figure-callout> 1/3,200 to 1/12,800) regardless of whether rsPSMA monomer or dimer was used as the coating antigen. Similarly, monomer-immunized animals had median endpoint titers of 1/6,400 in both assay formats, although the range varied depending on whether the monomer (range &lt;1/400 to 1/12,800) or dimer (range &lt;1/400 to 1/6,400) was used for coating. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0475]" class="style-scope patent-text">
    
    [0475]
  </para-num> <div id="P-0475" num="0475" class="description-line style-scope patent-text">However, a difference between sera was observed with cell-based flow cytometry (FIG. 51). Anti-PSMA antibody in the serum of mice immunized with a dimer preparation of rsPSMA (lot # 4019-C001) showed strong binding to PSMA-3T3 cells. Anti-PSMA antibody in the serum of mice immunized with a 100% monomer preparation of rsPSMA (batch # TD045-003 <span style="display: none" class="style-scope patent-text">[0475] </span> <figure-callout id="1" label="run" filenames="US20040161776A1-20040819-D00008.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">run</a></figure-callout> 1/peak 2) showed no binding to PSMA-3T3 cells. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0476]" class="style-scope patent-text">
    
    [0476]
  </para-num> <div id="P-0476" num="0476" class="description-line style-scope patent-text">Each dimer immunized animal elicited high-titered antibodies to PSMA-3T3 cells (median mean fluorescence intensity (MFI)=74, range 41-84), but such antibodies were very weak to absent in monomer-immunized animals (median MFI=6, range 5-12). The level of binding observed for monomer immunized animals was comparable to that for nave animals. Similar background levels of binding to parental 3T3 cells were observed for all sera (median MFI=6 in all cases). <span style="display: none" class="style-scope patent-text">[0476] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0477]" class="style-scope patent-text">
    
    [0477]
  </para-num> <div id="P-0477" num="0477" class="description-line style-scope patent-text">An identical pattern of reactivity was observed with human prostate cancer cell lines. Consistent, high-level reactivity with PSMA-expressing C4-2 cells was observed for sera from dimer immunized animals (median MFI=28.0, range 23.1-28.8) but not monomer immunized (median MFI=12.8, range 11.2-14.5) or control animals (median MFI=12.3, range 8.6-16.0). Background levels of binding to PSMA-negative PC-3 cells were observed for all sera (median MFI=7 in all cases). <span style="display: none" class="style-scope patent-text">[0477] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0478]" class="style-scope patent-text">
    
    [0478]
  </para-num> <div id="P-0478" num="0478" class="description-line style-scope patent-text">Thus, while it is possible to elicit the production of antibodies that recognize native PSMA using monomeric forms of the PSMA protein or fragments thereof, these results speak to the relative efficiency of eliciting an immune response to native PSMA using dimeric forms of PSMA protein. Additionally, flow cytometry but not ELISA was able to reveal the differences in the humoral immune responses elicited by monomeric and dimeric forms of PSMA. The inability of the ELISA to uncover such differences suggests that rsPSMA adopts a partially denatured conformation upon adsorption to plastic. <span style="display: none" class="style-scope patent-text">[0478] </span> </div>
    </li> <heading class="style-scope patent-text">Example 32 </heading>
    <heading class="style-scope patent-text"> <figure-callout id="006" label="mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAbs</a></figure-callout> </a></figure-callout> 006 and 026 Mediate Efficient ADCC of Human Prostate Cancer Cells </heading>
    <li class="style-scope patent-text"> <para-num num="[0479]" class="style-scope patent-text">
    
    [0479]
  </para-num> <div id="P-0479" num="0479" class="description-line style-scope patent-text"> <span style="display: none" class="style-scope patent-text">[0479]</span> <sup class="style-scope patent-text">51</sup>Cr labeled C4-2 cells (110<sup class="style-scope patent-text">4</sup>/well, target cells) were incubated in triplicates with 10 g/mL mAb at 4 C. for 1 hour. Fresh human PBMCs (effector cells) were added to washed target cells at effector to target (E/T) ratios of 40:1, 20:1, and 10:1 and incubated at 37 C. overnight. <sup class="style-scope patent-text">51</sup>Cr in harvested supernatants was measured using a -scintillation counter and % cell lysis was calculated. <figure-callout id="006" label="mAbs" filenames="US20040161776A1-20040819-D00020.png,US20040161776A1-20040819-D00028.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout"> <figure-callout id="026" label="mAbs" filenames="US20040161776A1-20040819-D00029.png,US20040161776A1-20040819-D00041.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAbs</a></figure-callout> </a></figure-callout> 006 and 026 demonstrated statistically significant antibody dependent cell-mediated cytotoxicity (ADCC) of C4-2 cells compared to isotype matched human IgG1 mAb control (FIG. 52). No effect was observed when PSMA-negative human prostate tumor cells (PC-3) were used. </div>
    </li> <heading class="style-scope patent-text">Example 33 </heading>
    <heading class="style-scope patent-text">Monomer-Dimer Equilibrium </heading>
    <li class="style-scope patent-text"> <para-num num="[0480]" class="style-scope patent-text">
    
    [0480]
  </para-num> <div id="P-0480" num="0480" class="description-line style-scope patent-text">Purified dimeric and monomeric forms of rsPSMA were resolved by preparative size exclusion chromatography (SEC) in PBS+ buffer and collected in separate fractions. To assess whether dimer and monomer exist in a reversible equilibrium, the buffer conditions were perturbed, and the monomer-dimer ratio was analyzed by SEC. As indicated in FIG. 53A, a dimer preparation that contained approximately 5% monomer initially was converted to 100% dimer upon incubation for 72 h at ambient temperature in PBS+ supplemented with 2M sodium chloride (FIG. 53A). Conversely, the addition of 2 mM of the metal-chelating agent EDTA converted the dimer into monomer with a half-life of approximately 2 days (FIG. 53A), indicating that dimer stability is dependent upon the presence of metal ions, such as Zn<span style="display: none" class="style-scope patent-text">[0480] </span> <sup class="style-scope patent-text">2+</sup> in the active site of PSMA. </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0481]" class="style-scope patent-text">
    
    [0481]
  </para-num> <div id="P-0481" num="0481" class="description-line style-scope patent-text">For a preparation that initially comprised &gt;95% monomer, high salt similarly drove the equilibrium to mostly (81%) dimer within 72 h (FIG. 53B). EDTA had little influence on the oligomeric state of the monomer. Thus, regardless of the initial oligomeric state of the protein, high salt concentrations promoted dimerization, whereas metal-chelating agents dissociated dimers into monomers. <span style="display: none" class="style-scope patent-text">[0481] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0482]" class="style-scope patent-text">
    
    [0482]
  </para-num> <div id="P-0482" num="0482" class="description-line style-scope patent-text">PSMA shares modest sequence and structural homology with human transferrin receptor (TfR), which contains a vestigial catalytic domain but lacks enzymatic activity. TfR is expressed as a type II membrane protein that forms a disulfide-linked homodimer, but the intermolecular disulfides are not required for dimerization (Alvarez, E., et al. (1989) EMBO J. 8, 2231-2240.0). The high-resolution crystal structure of the TfR ectodomain reveals that the protein is organized into three distinct domains known as the protease-like, apical, and helical domains, with the last domain being principally responsible for dimerization (Lawrence, C. M., et al. (1999) Science 286, 779-782). PSMA and TfR share 30%, 30%, and 24% sequence identity within these domains, respectively. The helical dimerization domain of PSMA are amino acids 601-750 of SEQ ID NO: 1. <span style="display: none" class="style-scope patent-text">[0482] </span> </div>
    </li> <heading class="style-scope patent-text">Example 34 </heading>
    <heading class="style-scope patent-text">rsPSMA Formulation Studies </heading>
    <li class="style-scope patent-text"> <para-num num="[0483]" class="style-scope patent-text">
    
    [0483]
  </para-num> <div id="P-0483" num="0483" class="description-line style-scope patent-text">pH Stability of rsPSMA <span style="display: none" class="style-scope patent-text">[0483] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0484]" class="style-scope patent-text">
    
    [0484]
  </para-num> <div id="P-0484" num="0484" class="description-line style-scope patent-text">Dimeric rsPSMA (2 mg/ml in PBS+) was diluted 10-fold into a broad-range base buffer solution (2 mM glycine, 2 mM citric acid, 2 mM Hepes, 2 mM MES, 2 mM Tris Base) that was adjusted to cover <span style="display: none" class="style-scope patent-text">[0484] </span> <figure-callout id="4" label="pH" filenames="US20040161776A1-20040819-D00006.png,US20040161776A1-20040819-D00008.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pH</a></figure-callout> 4 to pH 8.5 in steps of 0.5 pH units. Following incubation for 4 days at 45 C., the individual samples were subjected to analytical TSK gel filtration chromatography (run at pH 7.5) and analyzed for protein recovery and the preservation of the dimeric structure of rsPSMA. The findings are summarized in Table 8.  
<tables id="TABLE-US-00008" num="8" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 8</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Recovery and Structure of rsPSMA at Various pHs</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery from</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">pH</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.0</td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">4.5</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">5.0</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">5.5</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">6.0</td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">6.5</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">7.0</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">7.5</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">8.0</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">8.5</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0485]" class="style-scope patent-text">
    
    [0485]
  </para-num> <div id="P-0485" num="0485" class="description-line style-scope patent-text">Base Buffer Evaluation <span style="display: none" class="style-scope patent-text">[0485] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0486]" class="style-scope patent-text">
    
    [0486]
  </para-num> <div id="P-0486" num="0486" class="description-line style-scope patent-text">Dimeric rsPSMA (2 mg/ml in PBS+) was diluted 10-fold into the following buffer solutions: <span style="display: none" class="style-scope patent-text">[0486] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0487]" class="style-scope patent-text">
    
    [0487]
  </para-num> <div id="P-0487" num="0487" class="description-line style-scope patent-text">PBS+<span style="display: none" class="style-scope patent-text">[0487] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0488]" class="style-scope patent-text">
    
    [0488]
  </para-num> <div id="P-0488" num="0488" class="description-line style-scope patent-text">20 mM Hepes, pH 7.0 <span style="display: none" class="style-scope patent-text">[0488] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0489]" class="style-scope patent-text">
    
    [0489]
  </para-num> <div id="P-0489" num="0489" class="description-line style-scope patent-text">20 mM sodium phosphate+150 mM NaCl, pH 6.5 <span style="display: none" class="style-scope patent-text">[0489] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0490]" class="style-scope patent-text">
    
    [0490]
  </para-num> <div id="P-0490" num="0490" class="description-line style-scope patent-text">20 mM histidine+150 mM NaCl, pH 6.0 <span style="display: none" class="style-scope patent-text">[0490] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0491]" class="style-scope patent-text">
    
    [0491]
  </para-num> <div id="P-0491" num="0491" class="description-line style-scope patent-text">20 mM sodium phosphate+150 mM NaCl, pH 6.0 <span style="display: none" class="style-scope patent-text">[0491] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0492]" class="style-scope patent-text">
    
    [0492]
  </para-num> <div id="P-0492" num="0492" class="description-line style-scope patent-text">20 mM sodium acetate+150 mM NaCl, pH 6.0 <span style="display: none" class="style-scope patent-text">[0492] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0493]" class="style-scope patent-text">
    
    [0493]
  </para-num> <div id="P-0493" num="0493" class="description-line style-scope patent-text">20 mM sodium citrate+150 mM NaCl, pH 6.0 <span style="display: none" class="style-scope patent-text">[0493] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0494]" class="style-scope patent-text">
    
    [0494]
  </para-num> <div id="P-0494" num="0494" class="description-line style-scope patent-text">Each sample was incubated for 3 or 4 days at 45 C. and subsequently analyzed by analytical TSK gel filtration chromatography for protein recovery and the preservation of the dimeric structure of rsPSMA. The findings are summarized in Table 9.  
<span style="display: none" class="style-scope patent-text">[0494] </span> <tables id="TABLE-US-00009" num="9" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 9</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Recovery and Structure of rsPSMA with Various Buffers</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Base</td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery from</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Buffer</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">PBS+</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Phosphate</td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Acetate</td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Citrate</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text"></td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Histidine</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text">+</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0495]" class="style-scope patent-text">
    
    [0495]
  </para-num> <div id="P-0495" num="0495" class="description-line style-scope patent-text">Excipients <span style="display: none" class="style-scope patent-text">[0495] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0496]" class="style-scope patent-text">
    
    [0496]
  </para-num> <div id="P-0496" num="0496" class="description-line style-scope patent-text">Dimeric rsPSMA (2 mg/ml in PBS+) was dialyzed over night into 20 mM sodium acetate, pH 6.0 and 150 mM NaCl. To evaluate the effect of the individual amino acids, the protein was diluted 8-fold into 20 mM sodium acetate, pH 6.0 and 150 mM NaCl containing 50 mM of either glycine, histidine, proline, isoleucine, leucine, alanine, lysine, arginine, threonine, glutamic acid, or aspartic acid as excipients. Following incubation for 5 days at 45 C., each sample was analyzed by analytical TSK gel filtration chromatography for protein recovery and the preservation of the dimeric structure of the protein. The findings are summarized in Table 10.  
<span style="display: none" class="style-scope patent-text">[0496] </span> <tables id="TABLE-US-00010" num="10" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 10</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Recovery and Structure of rsPSMA with Various Amino Acids</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery from</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Amino Acid</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Glycine</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Histidine</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">+</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Proline</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Isoleucine</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Leucine</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Alanine</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Arginine</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Threonine</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text">N/A</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Glutamic Acid</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Aspartic Acid</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text">+++</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0497]" class="style-scope patent-text">
    
    [0497]
  </para-num> <div id="P-0497" num="0497" class="description-line style-scope patent-text">Surfactants <span style="display: none" class="style-scope patent-text">[0497] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0498]" class="style-scope patent-text">
    
    [0498]
  </para-num> <div id="P-0498" num="0498" class="description-line style-scope patent-text">Dimeric rsPSMA (2 mg/ml in PBS+) was diluted 10-fold into PBS+ containing 0.5% (w/v) of either Triton X-100, dodecylmaltoside, cholic acid, or CHAPS and incubated for 4 days at 4 C. Each sample was subsequently analyzed by analytical TSK gel filtration chromatography for protein recovery and the preservation of the dimeric structure of the protein. The findings are summarized in Table 11.  
<span style="display: none" class="style-scope patent-text">[0498] </span> <tables id="TABLE-US-00011" num="11" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 11</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Recovery and Structure of rsPSMA with Various Surfactants</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery from</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Surfactant</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Triton X-100</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Dodecylmaltoside</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Cholic Acid</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">CHAPS</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0499]" class="style-scope patent-text">
    
    [0499]
  </para-num> <div id="P-0499" num="0499" class="description-line style-scope patent-text">Other Excipients <span style="display: none" class="style-scope patent-text">[0499] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0500]" class="style-scope patent-text">
    
    [0500]
  </para-num> <div id="P-0500" num="0500" class="description-line style-scope patent-text">Dimeric rsPSMA (2 mg/ml in PBS+) was diluted 10-fold into PBS+ containing either 1.4 M (35% saturation) ammonium sulfate, 5 mM EDTA, 1 mM DTT, or 10% glycerol and incubated for 4 days at 4 C. Each sample was subsequently analyzed by analytical TSK gel filtration chromatography for protein recovery and the preservation of the dimeric structure of the protein. The findings are summarized in Table 12.  
<span style="display: none" class="style-scope patent-text">[0500] </span> <tables id="TABLE-US-00012" num="12" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 12</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Recovery and Structure of rsPSMA with Various Excipients</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Excipient</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">from column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Ammonium Sulfate</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">EDTA</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">DTT</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Glycerol</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0501]" class="style-scope patent-text">
    
    [0501]
  </para-num> <div id="P-0501" num="0501" class="description-line style-scope patent-text">Conversion of Monomers into Dimers <span style="display: none" class="style-scope patent-text">[0501] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0502]" class="style-scope patent-text">
    
    [0502]
  </para-num> <div id="P-0502" num="0502" class="description-line style-scope patent-text">To evaluate the potential of reversing monomeric rsPSMA into dimers, monomeric rsPSMA (2 mg/ml in PBS+) was diluted 10-fold into PBS+ containing either 1.4 M (35% saturation) ammonium sulfate, 2 M NaCl, 1 mM DTT, 5 mM EDTA, or 10% glycerol and incubated for up to 4 days at 4 C. Each sample was subsequently analyzed by analytical TSK gel filtration chromatography for protein recovery and the formation of the dimeric structure of the protein. The findings are summarized in Table 13.  
<span style="display: none" class="style-scope patent-text">[0502] </span> <tables id="TABLE-US-00013" num="13" class="style-scope patent-text"> <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text"> <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%"> <thead class="style-scope patent-text"> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" class="description-td style-scope patent-text" colspan="1">TABLE 13</td> </tr> </thead>  <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="1"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Conversion of rsPSMA Monomers</td> </tr>  </tbody></table> <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%"> <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text"> </td> <td class="description-td style-scope patent-text">Dimer</td> <td class="description-td style-scope patent-text">Monomer</td> <td class="description-td style-scope patent-text">Aggregate</td> <td class="description-td style-scope patent-text">Recovery from</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Excipient</td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">Content<sup class="style-scope patent-text">1</sup> </td> <td class="description-td style-scope patent-text">column<sup class="style-scope patent-text">2</sup> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Ammonium Sulfate</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">NaCl</td> <td class="description-td style-scope patent-text">+++</td> <td class="description-td style-scope patent-text">++</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">DTT</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">EDTA</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td class="description-td style-scope patent-text">Glycerol</td> <td class="description-td style-scope patent-text">+</td> <td class="description-td style-scope patent-text">++++</td> <td class="description-td style-scope patent-text"></td> <td class="description-td style-scope patent-text">+++++</td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr> <tr class="description-tr style-scope patent-text"> <td namest="1" nameend="5" align="left" class="description-td style-scope patent-text" colspan="5"> </td> </tr>  </tbody></table> </patent-tables> </tables>
</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0503]" class="style-scope patent-text">
    
    [0503]
  </para-num> <div id="P-0503" num="0503" class="description-line style-scope patent-text">Although the invention has been described in detail for the purpose of illustration, it is understood that such detail is solely for that purpose and variations can be made by those skilled in the art without departing from the spirit and scope of the invention which is defined by the following claims. <span style="display: none" class="style-scope patent-text">[0503] </span> </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0504]" class="style-scope patent-text">
    
    [0504]
  </para-num> <div id="P-0504" num="0504" class="description-line style-scope patent-text">The contents of all references, patents and published patent applications cited throughout this application are incorporated herein by reference. <span style="display: none" class="style-scope patent-text">[0504] </span> </div>
    
    </li> <li class="style-scope patent-text"> <div class="description-line style-scope patent-text">
      <sequence-cwu id="SEQLST-1" class="style-scope patent-text">
        <number class="style-scope patent-text">1</number>
        <sequence-list-new-rules class="style-scope patent-text">
          <s100 class="style-scope patent-text">
            <s160 class="style-scope patent-text">33 </s160>
          </s100>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">1 </s210>
            <s211 class="style-scope patent-text">750 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 1 

Met Trp Asn Leu Leu His Glu Thr Asp Ser Ala Val Ala Thr Ala Arg 
1               5                   10                  15 

Arg Pro Arg Trp Leu Cys Ala Gly Ala Leu Val Leu Ala Gly Gly Phe 
            20                  25                  30 

Phe Leu Leu Gly Phe Leu Phe Gly Trp Phe Ile Lys Ser Ser Asn Glu 
        35                  40                  45 

Ala Thr Asn Ile Thr Pro Lys His Asn Met Lys Ala Phe Leu Asp Glu 
    50                  55                  60 

Leu Lys Ala Glu Asn Ile Lys Lys Phe Leu Tyr Asn Phe Thr Gln Ile 
65                  70                  75                  80 

Pro His Leu Ala Gly Thr Glu Gln Asn Phe Gln Leu Ala Lys Gln Ile 
                85                  90                  95 

Gln Ser Gln Trp Lys Glu Phe Gly Leu Asp Ser Val Glu Leu Ala His 
            100                 105                 110 

Tyr Asp Val Leu Leu Ser Tyr Pro Asn Lys Thr His Pro Asn Tyr Ile 
        115                 120                 125 

Ser Ile Ile Asn Glu Asp Gly Asn Glu Ile Phe Asn Thr Ser Leu Phe 
    130                 135                 140 

Glu Pro Pro Pro Pro Gly Tyr Glu Asn Val Ser Asp Ile Val Pro Pro 
145                 150                 155                 160 

Phe Ser Ala Phe Ser Pro Gln Gly Met Pro Glu Gly Asp Leu Val Tyr 
                165                 170                 175 

Val Asn Tyr Ala Arg Thr Glu Asp Phe Phe Lys Leu Glu Arg Asp Met 
            180                 185                 190 

Lys Ile Asn Cys Ser Gly Lys Ile Val Ile Ala Arg Tyr Gly Lys Val 
        195                 200                 205 

Phe Arg Gly Asn Lys Val Lys Asn Ala Gln Leu Ala Gly Ala Lys Gly 
    210                 215                 220 

Val Ile Leu Tyr Ser Asp Pro Ala Asp Tyr Phe Ala Pro Gly Val Lys 
225                 230                 235                 240 

Ser Tyr Pro Asp Gly Trp Asn Leu Pro Gly Gly Gly Val Gln Arg Gly 
                245                 250                 255 

Asn Ile Leu Asn Leu Asn Gly Ala Gly Asp Pro Leu Thr Pro Gly Tyr 
            260                 265                 270 

Pro Ala Asn Glu Tyr Ala Tyr Arg Arg Gly Ile Ala Glu Ala Val Gly 
        275                 280                 285 

Leu Pro Ser Ile Pro Val His Pro Ile Gly Tyr Tyr Asp Ala Gln Lys 
    290                 295                 300 

Leu Leu Glu Lys Met Gly Gly Ser Ala Pro Pro Asp Ser Ser Trp Arg 
305                 310                 315                 320 

Gly Ser Leu Lys Val Pro Tyr Asn Val Gly Pro Gly Phe Thr Gly Asn 
                325                 330                 335 

Phe Ser Thr Gln Lys Val Lys Met His Ile His Ser Thr Asn Glu Val 
            340                 345                 350 

Thr Arg Ile Tyr Asn Val Ile Gly Thr Leu Arg Gly Ala Val Glu Pro 
        355                 360                 365 

Asp Arg Tyr Val Ile Leu Gly Gly His Arg Asp Ser Trp Val Phe Gly 
    370                 375                 380 

Gly Ile Asp Pro Gln Ser Gly Ala Ala Val Val His Glu Ile Val Arg 
385                 390                 395                 400 

Ser Phe Gly Thr Leu Lys Lys Glu Gly Trp Arg Pro Arg Arg Thr Ile 
                405                 410                 415 

Leu Phe Ala Ser Trp Asp Ala Glu Glu Phe Gly Leu Leu Gly Ser Thr 
            420                 425                 430 

Glu Trp Ala Glu Glu Asn Ser Arg Leu Leu Gln Glu Arg Gly Val Ala 
        435                 440                 445 

Tyr Ile Asn Ala Asp Ser Ser Ile Glu Gly Asn Tyr Thr Leu Arg Val 
    450                 455                 460 

Asp Cys Thr Pro Leu Met Tyr Ser Leu Val His Asn Leu Thr Lys Glu 
465                 470                 475                 480 

Leu Lys Ser Pro Asp Glu Gly Phe Glu Gly Lys Ser Leu Tyr Glu Ser 
                485                 490                 495 

Trp Thr Lys Lys Ser Pro Ser Pro Glu Phe Ser Gly Met Pro Arg Ile 
            500                 505                 510 

Ser Lys Leu Gly Ser Gly Asn Asp Phe Glu Val Phe Phe Gln Arg Leu 
        515                 520                 525 

Gly Ile Ala Ser Gly Arg Ala Arg Tyr Thr Lys Asn Trp Glu Thr Asn 
    530                 535                 540 

Lys Phe Ser Gly Tyr Pro Leu Tyr His Ser Val Tyr Glu Thr Tyr Glu 
545                 550                 555                 560 

Leu Val Glu Lys Phe Tyr Asp Pro Met Phe Lys Tyr His Leu Thr Val 
                565                 570                 575 

Ala Gln Val Arg Gly Gly Met Val Phe Glu Leu Ala Asn Ser Ile Val 
            580                 585                 590 

Leu Pro Phe Asp Cys Arg Asp Tyr Ala Val Val Leu Arg Lys Tyr Ala 
        595                 600                 605 

Asp Lys Ile Tyr Ser Ile Ser Met Lys His Pro Gln Glu Met Lys Thr 
    610                 615                 620 

Tyr Ser Val Ser Phe Asp Ser Leu Phe Ser Ala Val Lys Asn Phe Thr 
625                 630                 635                 640 

Glu Ile Ala Ser Lys Phe Ser Glu Arg Leu Gln Asp Phe Asp Lys Ser 
                645                 650                 655 

Asn Pro Ile Val Leu Arg Met Met Asn Asp Gln Leu Met Phe Leu Glu 
            660                 665                 670 

Arg Ala Phe Ile Asp Pro Leu Gly Leu Pro Asp Arg Pro Phe Tyr Arg 
        675                 680                 685 

His Val Ile Tyr Ala Pro Ser Ser His Asn Lys Tyr Ala Gly Glu Ser 
    690                 695                 700 

Phe Pro Gly Ile Tyr Asp Ala Leu Phe Asp Ile Glu Ser Lys Val Asp 
705                 710                 715                 720 

Pro Ser Lys Ala Trp Gly Glu Val Lys Arg Gln Ile Tyr Val Ala Ala 
                725                 730                 735 

Phe Thr Val Gln Ala Ala Ala Glu Thr Leu Ser Glu Val Ala 
            740                 745                 750 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">2 </s210>
            <s211 class="style-scope patent-text">7570 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 2 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccaagc ttggatctca ccatggagtt gggactgcgc tggggcttcc tcgttgctct    960 

tttaagaggt gtccagtgtc aggtgcaatt ggtggagtct gggggaggcg tggtccagcc   1020 

tgggaggtcc ctgagactct cctgtgcagc gtctggattc gccttcagta gatatggcat   1080 

gcactgggtc cgccaggctc caggcaaggg gctggagtgg gtggcagtta tatggtatga   1140 

tggaagtaat aaatactatg cagactccgt gaagggccga ttcaccatct ccagagacaa   1200 

ttccaagaac acgcagtatc tgcaaatgaa cagcctgaga gccgaggaca cggctgtgta   1260 

ttactgtgcg agaggcggtg acttcctcta ctactactat tacggtatgg acgtctgggg   1320 

ccaagggacc acggtcaccg tctcctcagc ctccaccaag ggcccatcgg tcttccccct   1380 

ggcaccctct agcaagagca cctctggggg cacagcggcc ctgggctgcc tggtcaagga   1440 

ctacttcccc gaaccggtga cggtgtcgtg gaactcaggc gccctgacca gcggcgtgca   1500 

caccttcccg gctgtcctac agtcctcagg actctactcc ctcagcagcg tggtgaccgt   1560 

gccctccagc agcttgggca cccagaccta catctgcaac gtgaatcaca agcccagcaa   1620 

caccaaggtg gacaagagag ttggtgagag gccagcacag ggagggaggg tgtctgctgg   1680 

aagccaggct cagcgctcct gcctggacgc atcccggcta tgcagtccca gtccagggca   1740 

gcaaggcagg ccccgtctgc ctcttcaccc ggaggcctct gcccgcccca ctcatgctca   1800 

gggagagggt cttctggctt tttccccagg ctctgggcag gcacaggcta ggtgccccta   1860 

acccaggccc tgcacacaaa ggggcaggtg ctgggctcag acctgccaag agccatatcc   1920 

gggaggaccc tgcccctgac ctaagcccac cccaaaggcc aaactctcca ctccctcagc   1980 

tcggacacct tctctcctcc cagattccag taactcccaa tcttctctct gcagagccca   2040 

aatcttgtga caaaactcac acatgcccac cgtgcccagg taagccagcc caggcctcgc   2100 

cctccagctc aaggcgggac aggtgcccta gagtagcctg catccaggga caggccccag   2160 

ccgggtgctg acacgtccac ctccatctct tcctcagcac ctgaactcct ggggggaccg   2220 

tcagtcttcc tcttcccccc aaaacccaag gacaccctca tgatctcccg gacccctgag   2280 

gtcacatgcg tggtggtgga cgtgagccac gaagaccctg aggtcaagtt caactggtac   2340 

gtggacggcg tggaggtgca taatgccaag acaaagccgc gggaggagca gtacaacagc   2400 

acgtaccgtg tggtcagcgt cctcaccgtc ctgcaccagg actggctgaa tggcaaggag   2460 

tacaagtgca aggtctccaa caaagccctc ccagccccca tcgagaaaac catctccaaa   2520 

gccaaaggtg ggacccgtgg ggtgcgaggg ccacatggac agaggccggc tcggcccacc   2580 

ctctgccctg agagtgaccg ctgtaccaac ctctgtccct acagggcagc cccgagaacc   2640 

acaggtgtac accctgcccc catcccggga ggagatgacc aagaaccagg tcagcctgac   2700 

ctgcctggtc aaaggcttct atcccagcga catcgccgtg gagtgggaga gcaatgggca   2760 

gccggagaac aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct   2820 

ctatagcaag ctcaccgtgg acaagagcag gtggcagcag gggaacgtct tctcatgctc   2880 

cgtgatgcat gaggctctgc acaaccacta cacgcagaag agcctctccc tgtctccggg   2940 

taaatgagaa ttcctcgagt ctagagggcc cgtttaaacc cgctgatcag cctcgactgt   3000 

gccttctagt tgccagccat ctgttgtttg cccctccccc gtgccttcct tgaccctgga   3060 

aggtgccact cccactgtcc tttcctaata aaatgaggaa attgcatcgc attgtctgag   3120 

taggtgtcat tctattctgg ggggtggggt ggggcaggac agcaaggggg aggattggga   3180 

agacaatagc aggcatgctg gggatgcggt gggctctatg gcttctgagg cggaaagaac   3240 

cagctggggc tctagggggt atccccacgc gccctgtagc ggcgcattaa gcgcggcggg   3300 

tgtggtggtt acgcgcagcg tgaccgctac acttgccagc gccctagcgc ccgctccttt   3360 

cgctttcttc ccttcctttc tcgccacgtt cgccggcttt ccccgtcaag ctctaaatcg   3420 

gggcatccct ttagggttcc gatttagtgc tttacggcac ctcgacccca aaaaacttga   3480 

ttagggtgat ggttcacgta gtgggccatc gccctgatag acggtttttc gccctttgac   3540 

gttggagtcc acgttcttta atagtggact cttgttccaa actggaacaa cactcaaccc   3600 

tatctcggtc tattcttttg atttataagg gattttgggg atttcggcct attggttaaa   3660 

aaatgagctg atttaacaaa aatttaacgc gaattaattc tgtggaatgt gtgtcagtta   3720 

gggtgtggaa agtccccagg ctccccaggc aggcagaagt atgcaaagca tgcatctcaa   3780 

ttagtcagca accaggtgtg gaaagtcccc aggctcccca gcaggcagaa gtatgcaaag   3840 

catgcatctc aattagtcag caaccatagt cccgccccta actccgccca tcccgcccct   3900 

aactccgccc agttccgccc attctccgcc ccatggctga ctaatttttt ttatttatgc   3960 

agaggccgag gccgcctctg cctctgagct attccagaag tagtgaggag gcttttttgg   4020 

aggcctaggc ttttgcaaaa agctcccggg agcttgtata tccattttcg gatctgatca   4080 

gcacgtgatg aaaaagcctg aactcaccgc gacgtctgtc gagaagtttc tgatcgaaaa   4140 

gttcgacagc gtctccgacc tgatgcagct ctcggagggc gaagaatctc gtgctttcag   4200 

cttcgatgta ggagggcgtg gatatgtcct gcgggtaaat agctgcgccg atggtttcta   4260 

caaagatcgt tatgtttatc ggcactttgc atcggccgcg ctcccgattc cggaagtgct   4320 

tgacattggg gaattcagcg agagcctgac ctattgcatc tcccgccgtg cacagggtgt   4380 

cacgttgcaa gacctgcctg aaaccgaact gcccgctgtt ctgcagccgg tcgcggaggc   4440 

catggatgcg atcgctgcgg ccgatcttag ccagacgagc gggttcggcc cattcggacc   4500 

gcaaggaatc ggtcaataca ctacatggcg tgatttcata tgcgcgattg ctgatcccca   4560 

tgtgtatcac tggcaaactg tgatggacga caccgtcagt gcgtccgtcg cgcaggctct   4620 

cgatgagctg atgctttggg ccgaggactg ccccgaagtc cggcacctcg tgcacgcgga   4680 

tttcggctcc aacaatgtcc tgacggacaa tggccgcata acagcggtca ttgactggag   4740 

cgaggcgatg ttcggggatt cccaatacga ggtcgccaac atcttcttct ggaggccgtg   4800 

gttggcttgt atggagcagc agacgcgcta cttcgagcgg aggcatccgg agcttgcagg   4860 

atcgccgcgg ctccgggcgt atatgctccg cattggtctt gaccaactct atcagagctt   4920 

ggttgacggc aatttcgatg atgcagcttg ggcgcagggt cgatgcgacg caatcgtccg   4980 

atccggagcc gggactgtcg ggcgtacaca aatcgcccgc agaagcgcgg ccgtctggac   5040 

cgatggctgt gtagaagtac tcgccgatag tggaaaccga cgccccagca ctcgtccgag   5100 

ggcaaaggaa tagcacgtgc tacgagattt cgattccacc gccgccttct atgaaaggtt   5160 

gggcttcgga atcgttttcc gggacgccgg ctggatgatc ctccagcgcg gggatctcat   5220 

gctggagttc ttcgcccacc ccaacttgtt tattgcagct tataatggtt acaaataaag   5280 

caatagcatc acaaatttca caaataaagc atttttttca ctgcattcta gttgtggttt   5340 

gtccaaactc atcaatgtat cttatcatgt ctgtataccg tcgacctcta gctagagctt   5400 

ggcgtaatca tggtcatagc tgtttcctgt gtgaaattgt tatccgctca caattccaca   5460 

caacatacga gccggaagca taaagtgtaa agcctggggt gcctaatgag tgagctaact   5520 

cacattaatt gcgttgcgct cactgcccgc tttccagtcg ggaaacctgt cgtgccagct   5580 

gcattaatga atcggccaac gcgcggggag aggcggtttg cgtattgggc gctcttccgc   5640 

ttcctcgctc actgactcgc tgcgctcggt cgttcggctg cggcgagcgg tatcagctca   5700 

ctcaaaggcg gtaatacggt tatccacaga atcaggggat aacgcaggaa agaacatgtg   5760 

agcaaaaggc cagcaaaagg ccaggaaccg taaaaaggcc gcgttgctgg cgtttttcca   5820 

taggctccgc ccccctgacg agcatcacaa aaatcgacgc tcaagtcaga ggtggcgaaa   5880 

cccgacagga ctataaagat accaggcgtt tccccctgga agctccctcg tgcgctctcc   5940 

tgttccgacc ctgccgctta ccggatacct gtccgccttt ctcccttcgg gaagcgtggc   6000 

gctttctcaa tgctcacgct gtaggtatct cagttcggtg taggtcgttc gctccaagct   6060 

gggctgtgtg cacgaacccc ccgttcagcc cgaccgctgc gccttatccg gtaactatcg   6120 

tcttgagtcc aacccggtaa gacacgactt atcgccactg gcagcagcca ctggtaacag   6180 

gattagcaga gcgaggtatg taggcggtgc tacagagttc ttgaagtggt ggcctaacta   6240 

cggctacact agaaggacag tatttggtat ctgcgctctg ctgaagccag ttaccttcgg   6300 

aaaaagagtt ggtagctctt gatccggcaa acaaaccacc gctggtagcg gtggtttttt   6360 

tgtttgcaag cagcagatta cgcgcagaaa aaaaggatct caagaagatc ctttgatctt   6420 

ttctacgggg tctgacgctc agtggaacga aaactcacgt taagggattt tggtcatgag   6480 

attatcaaaa aggatcttca cctagatcct tttaaattaa aaatgaagtt ttaaatcaat   6540 

ctaaagtata tatgagtaaa cttggtctga cagttaccaa tgcttaatca gtgaggcacc   6600 

tatctcagcg atctgtctat ttcgttcatc catagttgcc tgactccccg tcgtgtagat   6660 

aactacgata cgggagggct taccatctgg ccccagtgct gcaatgatac cgcgagaccc   6720 

acgctcaccg gctccagatt tatcagcaat aaaccagcca gccggaaggg ccgagcgcag   6780 

aagtggtcct gcaactttat ccgcctccat ccagtctatt aattgttgcc gggaagctag   6840 

agtaagtagt tcgccagtta atagtttgcg caacgttgtt gccattgcta caggcatcgt   6900 

ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc ggttcccaac gatcaaggcg   6960 

agttacatga tcccccatgt tgtgcaaaaa agcggttagc tccttcggtc ctccgatcgt   7020 

tgtcagaagt aagttggccg cagtgttatc actcatggtt atggcagcac tgcataattc   7080 

tcttactgtc atgccatccg taagatgctt ttctgtgact ggtgagtact caaccaagtc   7140 

attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc ccggcgtcaa tacgggataa   7200 

taccgcgcca catagcagaa ctttaaaagt gctcatcatt ggaaaacgtt cttcggggcg   7260 

aaaactctca aggatcttac cgctgttgag atccagttcg atgtaaccca ctcgtgcacc   7320 

caactgatct tcagcatctt ttactttcac cagcgtttct gggtgagcaa aaacaggaag   7380 

gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa tgttgaatac tcatactctt   7440 

cctttttcaa tattattgaa gcatttatca gggttattgt ctcatgagcg gatacatatt   7500 

tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc acatttcccc gaaaagtgcc   7560 

acctgacgtc                                                          7570 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">3 </s210>
            <s211 class="style-scope patent-text">7597 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 3 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccaagc ttggatctca ccatggggtc aaccgccatc ctcaccatgg agttggggct    960 

gcgctgggtt ctcctcgttg ctcttttaag aggtgtccag tgtcaggtgc agctggtgga   1020 

gtctggggga ggcgtggtcc agcctgggag gtccctgaga ctctcctgtg cagcgtctgg   1080 

attcaccttc agtaactatg tcatgcactg ggtccgccag gctccaggca aggggctgga   1140 

gtgggtggca attatatggt atgatggaag taataaatac tatgcagact ccgtgaaggg   1200 

ccgattcacc atctccagag acaattccaa gaacacgctg tatctgcaaa tgaacagcct   1260 

gagagccgag gacacggctg tgtattactg tgcgggtgga tataactgga actacgagta   1320 

ccactactac ggtatggacg tctggggcca agggaccacg gtcaccgtct cctcagcctc   1380 

caccaagggc ccatcggtct tccccctggc accctctagc aagagcacct ctgggggcac   1440 

agcggccctg ggctgcctgg tcaaggacta cttccccgaa ccggtgacgg tgtcgtggaa   1500 

ctcaggcgcc ctgaccagcg gcgtgcacac cttcccggct gtcctacagt cctcaggact   1560 

ctactccctc agcagcgtgg tgaccgtgcc ctccagcagc ttgggcaccc agacctacat   1620 

ctgcaacgtg aatcacaagc ccagcaacac caaggtggac aagagagttg gtgagaggcc   1680 

agcacaggga gggagggtgt ctgctggaag ccaggctcag cgctcctgcc tggacgcatc   1740 

ccggctatgc agtcccagtc cagggcagca aggcaggccc cgtctgcctc ttcacccgga   1800 

ggcctctgcc cgccccactc atgctcaggg agagggtctt ctggcttttt ccccaggctc   1860 

tgggcaggca caggctaggt gcccctaacc caggccctgc acacaaaggg gcaggtgctg   1920 

ggctcagacc tgccaagagc catatccggg aggaccctgc ccctgaccta agcccacccc   1980 

aaaggccaaa ctctccactc cctcagctcg gacaccttct ctcctcccag attccagtaa   2040 

ctcccaatct tctctctgca gagcccaaat cttgtgacaa aactcacaca tgcccaccgt   2100 

gcccaggtaa gccagcccag gcctcgccct ccagctcaag gcgggacagg tgccctagag   2160 

tagcctgcat ccagggacag gccccagccg ggtgctgaca cgtccacctc catctcttcc   2220 

tcagcacctg aactcctggg gggaccgtca gtcttcctct tccccccaaa acccaaggac   2280 

accctcatga tctcccggac ccctgaggtc acatgcgtgg tggtggacgt gagccacgaa   2340 

gaccctgagg tcaagttcaa ctggtacgtg gacggcgtgg aggtgcataa tgccaagaca   2400 

aagccgcggg aggagcagta caacagcacg taccgtgtgg tcagcgtcct caccgtcctg   2460 

caccaggact ggctgaatgg caaggagtac aagtgcaagg tctccaacaa agccctccca   2520 

gcccccatcg agaaaaccat ctccaaagcc aaaggtggga cccgtggggt gcgagggcca   2580 

catggacaga ggccggctcg gcccaccctc tgccctgaga gtgaccgctg taccaacctc   2640 

tgtccctaca gggcagcccc gagaaccaca ggtgtacacc ctgcccccat cccgggagga   2700 

gatgaccaag aaccaggtca gcctgacctg cctggtcaaa ggcttctatc ccagcgacat   2760 

cgccgtggag tgggagagca atgggcagcc ggagaacaac tacaagacca cgcctcccgt   2820 

gctggactcc gacggctcct tcttcctcta tagcaagctc accgtggaca agagcaggtg   2880 

gcagcagggg aacgtcttct catgctccgt gatgcatgag gctctgcaca accactacac   2940 

gcagaagagc ctctccctgt ctccgggtaa atgagaattc ctcgagtcta gagggcccgt   3000 

ttaaacccgc tgatcagcct cgactgtgcc ttctagttgc cagccatctg ttgtttgccc   3060 

ctcccccgtg ccttccttga ccctggaagg tgccactccc actgtccttt cctaataaaa   3120 

tgaggaaatt gcatcgcatt gtctgagtag gtgtcattct attctggggg gtggggtggg   3180 

gcaggacagc aagggggagg attgggaaga caatagcagg catgctgggg atgcggtggg   3240 

ctctatggct tctgaggcgg aaagaaccag ctggggctct agggggtatc cccacgcgcc   3300 

ctgtagcggc gcattaagcg cggcgggtgt ggtggttacg cgcagcgtga ccgctacact   3360 

tgccagcgcc ctagcgcccg ctcctttcgc tttcttccct tcctttctcg ccacgttcgc   3420 

cggctttccc cgtcaagctc taaatcgggg catcccttta gggttccgat ttagtgcttt   3480 

acggcacctc gaccccaaaa aacttgatta gggtgatggt tcacgtagtg ggccatcgcc   3540 

ctgatagacg gtttttcgcc ctttgacgtt ggagtccacg ttctttaata gtggactctt   3600 

gttccaaact ggaacaacac tcaaccctat ctcggtctat tcttttgatt tataagggat   3660 

tttggggatt tcggcctatt ggttaaaaaa tgagctgatt taacaaaaat ttaacgcgaa   3720 

ttaattctgt ggaatgtgtg tcagttaggg tgtggaaagt ccccaggctc cccaggcagg   3780 

cagaagtatg caaagcatgc atctcaatta gtcagcaacc aggtgtggaa agtccccagg   3840 

ctccccagca ggcagaagta tgcaaagcat gcatctcaat tagtcagcaa ccatagtccc   3900 

gcccctaact ccgcccatcc cgcccctaac tccgcccagt tccgcccatt ctccgcccca   3960 

tggctgacta atttttttta tttatgcaga ggccgaggcc gcctctgcct ctgagctatt   4020 

ccagaagtag tgaggaggct tttttggagg cctaggcttt tgcaaaaagc tcccgggagc   4080 

ttgtatatcc attttcggat ctgatcagca cgtgatgaaa aagcctgaac tcaccgcgac   4140 

gtctgtcgag aagtttctga tcgaaaagtt cgacagcgtc tccgacctga tgcagctctc   4200 

ggagggcgaa gaatctcgtg ctttcagctt cgatgtagga gggcgtggat atgtcctgcg   4260 

ggtaaatagc tgcgccgatg gtttctacaa agatcgttat gtttatcggc actttgcatc   4320 

ggccgcgctc ccgattccgg aagtgcttga cattggggaa ttcagcgaga gcctgaccta   4380 

ttgcatctcc cgccgtgcac agggtgtcac gttgcaagac ctgcctgaaa ccgaactgcc   4440 

cgctgttctg cagccggtcg cggaggccat ggatgcgatc gctgcggccg atcttagcca   4500 

gacgagcggg ttcggcccat tcggaccgca aggaatcggt caatacacta catggcgtga   4560 

tttcatatgc gcgattgctg atccccatgt gtatcactgg caaactgtga tggacgacac   4620 

cgtcagtgcg tccgtcgcgc aggctctcga tgagctgatg ctttgggccg aggactgccc   4680 

cgaagtccgg cacctcgtgc acgcggattt cggctccaac aatgtcctga cggacaatgg   4740 

ccgcataaca gcggtcattg actggagcga ggcgatgttc ggggattccc aatacgaggt   4800 

cgccaacatc ttcttctgga ggccgtggtt ggcttgtatg gagcagcaga cgcgctactt   4860 

cgagcggagg catccggagc ttgcaggatc gccgcggctc cgggcgtata tgctccgcat   4920 

tggtcttgac caactctatc agagcttggt tgacggcaat ttcgatgatg cagcttgggc   4980 

gcagggtcga tgcgacgcaa tcgtccgatc cggagccggg actgtcgggc gtacacaaat   5040 

cgcccgcaga agcgcggccg tctggaccga tggctgtgta gaagtactcg ccgatagtgg   5100 

aaaccgacgc cccagcactc gtccgagggc aaaggaatag cacgtgctac gagatttcga   5160 

ttccaccgcc gccttctatg aaaggttggg cttcggaatc gttttccggg acgccggctg   5220 

gatgatcctc cagcgcgggg atctcatgct ggagttcttc gcccacccca acttgtttat   5280 

tgcagcttat aatggttaca aataaagcaa tagcatcaca aatttcacaa ataaagcatt   5340 

tttttcactg cattctagtt gtggtttgtc caaactcatc aatgtatctt atcatgtctg   5400 

tataccgtcg acctctagct agagcttggc gtaatcatgg tcatagctgt ttcctgtgtg   5460 

aaattgttat ccgctcacaa ttccacacaa catacgagcc ggaagcataa agtgtaaagc   5520 

ctggggtgcc taatgagtga gctaactcac attaattgcg ttgcgctcac tgcccgcttt   5580 

ccagtcggga aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg cggggagagg   5640 

cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt   5700 

tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc   5760 

aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa   5820 

aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa   5880 

tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc   5940 

ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc   6000 

cgcctttctc ccttcgggaa gcgtggcgct ttctcaatgc tcacgctgta ggtatctcag   6060 

ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga   6120 

ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc   6180 

gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac   6240 

agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg   6300 

cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca   6360 

aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa   6420 

aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa   6480 

ctcacgttaa gggattttgg tcatgagatt atcaaaaagg atcttcacct agatcctttt   6540 

aaattaaaaa tgaagtttta aatcaatcta aagtatatat gagtaaactt ggtctgacag   6600 

ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc tgtctatttc gttcatccat   6660 

agttgcctga ctccccgtcg tgtagataac tacgatacgg gagggcttac catctggccc   6720 

cagtgctgca atgataccgc gagacccacg ctcaccggct ccagatttat cagcaataaa   6780 

ccagccagcc ggaagggccg agcgcagaag tggtcctgca actttatccg cctccatcca   6840 

gtctattaat tgttgccggg aagctagagt aagtagttcg ccagttaata gtttgcgcaa   6900 

cgttgttgcc attgctacag gcatcgtggt gtcacgctcg tcgtttggta tggcttcatt   6960 

cagctccggt tcccaacgat caaggcgagt tacatgatcc cccatgttgt gcaaaaaagc   7020 

ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag ttggccgcag tgttatcact   7080 

catggttatg gcagcactgc ataattctct tactgtcatg ccatccgtaa gatgcttttc   7140 

tgtgactggt gagtactcaa ccaagtcatt ctgagaatag tgtatgcggc gaccgagttg   7200 

ctcttgcccg gcgtcaatac gggataatac cgcgccacat agcagaactt taaaagtgct   7260 

catcattgga aaacgttctt cggggcgaaa actctcaagg atcttaccgc tgttgagatc   7320 

cagttcgatg taacccactc gtgcacccaa ctgatcttca gcatctttta ctttcaccag   7380 

cgtttctggg tgagcaaaaa caggaaggca aaatgccgca aaaaagggaa taagggcgac   7440 

acggaaatgt tgaatactca tactcttcct ttttcaatat tattgaagca tttatcaggg   7500 

ttattgtctc atgagcggat acatatttga atgtatttag aaaaataaac aaataggggt   7560 

tccgcgcaca tttccccgaa aagtgccacc tgacgtc                            7597 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">4 </s210>
            <s211 class="style-scope patent-text">7579 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 4 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccaagc ttggatctca ccatggagtt gggacttagc tgggttttcc tcgttgctct    960 

tttaagaggt gtccagtgtc aggtccagct ggtggagtct gggggaggcg tggtccagcc   1020 

tgggaggtcc ctgagactct cctgtgcagc gtctggattc accttcagta gctatggcat   1080 

gcactgggtc cgccaggctc caggcaaggg gctggactgg gtggcaatta tttggcatga   1140 

tggaagtaat aaatactatg cagactccgt gaagggccga ttcaccatct ccagagacaa   1200 

ttccaagaag acgctgtacc tgcaaatgaa cagtttgaga gccgaggaca cggctgtgta   1260 

ttactgtgcg agagcttggg cctatgacta cggtgactat gaatactact tcggtatgga   1320 

cgtctggggc caagggacca cggtcaccgt ctcctcagcc tccaccaagg gcccatcggt   1380 

cttccccctg gcaccctcta gcaagagcac ctctgggggc acagcggccc tgggctgcct   1440 

ggtcaaggac tacttccccg aaccggtgac ggtgtcgtgg aactcaggcg ccctgaccag   1500 

cggcgtgcac accttcccgg ctgtcctaca gtcctcagga ctctactccc tcagcagcgt   1560 

ggtgaccgtg ccctccagca gcttgggcac ccagacctac atctgcaacg tgaatcacaa   1620 

gcccagcaac accaaggtgg acaagagagt tggtgagagg ccagcacagg gagggagggt   1680 

gtctgctgga agccaggctc agcgctcctg cctggacgca tcccggctat gcagtcccag   1740 

tccagggcag caaggcaggc cccgtctgcc tcttcacccg gaggcctctg cccgccccac   1800 

tcatgctcag ggagagggtc ttctggcttt ttccccaggc tctgggcagg cacaggctag   1860 

gtgcccctaa cccaggccct gcacacaaag gggcaggtgc tgggctcaga cctgccaaga   1920 

gccatatccg ggaggaccct gcccctgacc taagcccacc ccaaaggcca aactctccac   1980 

tccctcagct cggacacctt ctctcctccc agattccagt aactcccaat cttctctctg   2040 

cagagcccaa atcttgtgac aaaactcaca catgcccacc gtgcccaggt aagccagccc   2100 

aggcctcgcc ctccagctca aggcgggaca ggtgccctag agtagcctgc atccagggac   2160 

aggccccagc cgggtgctga cacgtccacc tccatctctt cctcagcacc tgaactcctg   2220 

gggggaccgt cagtcttcct cttcccccca aaacccaagg acaccctcat gatctcccgg   2280 

acccctgagg tcacatgcgt ggtggtggac gtgagccacg aagaccctga ggtcaagttc   2340 

aactggtacg tggacggcgt ggaggtgcat aatgccaaga caaagccgcg ggaggagcag   2400 

tacaacagca cgtaccgtgt ggtcagcgtc ctcaccgtcc tgcaccagga ctggctgaat   2460 

ggcaaggagt acaagtgcaa ggtctccaac aaagccctcc cagcccccat cgagaaaacc   2520 

atctccaaag ccaaaggtgg gacccgtggg gtgcgagggc cacatggaca gaggccggct   2580 

cggcccaccc tctgccctga gagtgaccgc tgtaccaacc tctgtcccta cagggcagcc   2640 

ccgagaacca caggtgtaca ccctgccccc atcccgggag gagatgacca agaaccaggt   2700 

cagcctgacc tgcctggtca aaggcttcta tcccagcgac atcgccgtgg agtgggagag   2760 

caatgggcag ccggagaaca actacaagac cacgcctccc gtgctggact ccgacggctc   2820 

cttcttcctc tatagcaagc tcaccgtgga caagagcagg tggcagcagg ggaacgtctt   2880 

ctcatgctcc gtgatgcatg aggctctgca caaccactac acgcagaaga gcctctccct   2940 

gtctccgggt aaatgagaat tcctcgagtc tagagggccc gtttaaaccc gctgatcagc   3000 

ctcgactgtg ccttctagtt gccagccatc tgttgtttgc ccctcccccg tgccttcctt   3060 

gaccctggaa ggtgccactc ccactgtcct ttcctaataa aatgaggaaa ttgcatcgca   3120 

ttgtctgagt aggtgtcatt ctattctggg gggtggggtg gggcaggaca gcaaggggga   3180 

ggattgggaa gacaatagca ggcatgctgg ggatgcggtg ggctctatgg cttctgaggc   3240 

ggaaagaacc agctggggct ctagggggta tccccacgcg ccctgtagcg gcgcattaag   3300 

cgcggcgggt gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg ccctagcgcc   3360 

cgctcctttc gctttcttcc cttcctttct cgccacgttc gccggctttc cccgtcaagc   3420 

tctaaatcgg ggcatccctt tagggttccg atttagtgct ttacggcacc tcgaccccaa   3480 

aaaacttgat tagggtgatg gttcacgtag tgggccatcg ccctgataga cggtttttcg   3540 

ccctttgacg ttggagtcca cgttctttaa tagtggactc ttgttccaaa ctggaacaac   3600 

actcaaccct atctcggtct attcttttga tttataaggg attttgggga tttcggccta   3660 

ttggttaaaa aatgagctga tttaacaaaa atttaacgcg aattaattct gtggaatgtg   3720 

tgtcagttag ggtgtggaaa gtccccaggc tccccaggca ggcagaagta tgcaaagcat   3780 

gcatctcaat tagtcagcaa ccaggtgtgg aaagtcccca ggctccccag caggcagaag   3840 

tatgcaaagc atgcatctca attagtcagc aaccatagtc ccgcccctaa ctccgcccat   3900 

cccgccccta actccgccca gttccgccca ttctccgccc catggctgac taattttttt   3960 

tatttatgca gaggccgagg ccgcctctgc ctctgagcta ttccagaagt agtgaggagg   4020 

cttttttgga ggcctaggct tttgcaaaaa gctcccggga gcttgtatat ccattttcgg   4080 

atctgatcag cacgtgatga aaaagcctga actcaccgcg acgtctgtcg agaagtttct   4140 

gatcgaaaag ttcgacagcg tctccgacct gatgcagctc tcggagggcg aagaatctcg   4200 

tgctttcagc ttcgatgtag gagggcgtgg atatgtcctg cgggtaaata gctgcgccga   4260 

tggtttctac aaagatcgtt atgtttatcg gcactttgca tcggccgcgc tcccgattcc   4320 

ggaagtgctt gacattgggg aattcagcga gagcctgacc tattgcatct cccgccgtgc   4380 

acagggtgtc acgttgcaag acctgcctga aaccgaactg cccgctgttc tgcagccggt   4440 

cgcggaggcc atggatgcga tcgctgcggc cgatcttagc cagacgagcg ggttcggccc   4500 

attcggaccg caaggaatcg gtcaatacac tacatggcgt gatttcatat gcgcgattgc   4560 

tgatccccat gtgtatcact ggcaaactgt gatggacgac accgtcagtg cgtccgtcgc   4620 

gcaggctctc gatgagctga tgctttgggc cgaggactgc cccgaagtcc ggcacctcgt   4680 

gcacgcggat ttcggctcca acaatgtcct gacggacaat ggccgcataa cagcggtcat   4740 

tgactggagc gaggcgatgt tcggggattc ccaatacgag gtcgccaaca tcttcttctg   4800 

gaggccgtgg ttggcttgta tggagcagca gacgcgctac ttcgagcgga ggcatccgga   4860 

gcttgcagga tcgccgcggc tccgggcgta tatgctccgc attggtcttg accaactcta   4920 

tcagagcttg gttgacggca atttcgatga tgcagcttgg gcgcagggtc gatgcgacgc   4980 

aatcgtccga tccggagccg ggactgtcgg gcgtacacaa atcgcccgca gaagcgcggc   5040 

cgtctggacc gatggctgtg tagaagtact cgccgatagt ggaaaccgac gccccagcac   5100 

tcgtccgagg gcaaaggaat agcacgtgct acgagatttc gattccaccg ccgccttcta   5160 

tgaaaggttg ggcttcggaa tcgttttccg ggacgccggc tggatgatcc tccagcgcgg   5220 

ggatctcatg ctggagttct tcgcccaccc caacttgttt attgcagctt ataatggtta   5280 

caaataaagc aatagcatca caaatttcac aaataaagca tttttttcac tgcattctag   5340 

ttgtggtttg tccaaactca tcaatgtatc ttatcatgtc tgtataccgt cgacctctag   5400 

ctagagcttg gcgtaatcat ggtcatagct gtttcctgtg tgaaattgtt atccgctcac   5460 

aattccacac aacatacgag ccggaagcat aaagtgtaaa gcctggggtg cctaatgagt   5520 

gagctaactc acattaattg cgttgcgctc actgcccgct ttccagtcgg gaaacctgtc   5580 

gtgccagctg cattaatgaa tcggccaacg cgcggggaga ggcggtttgc gtattgggcg   5640 

ctcttccgct tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt   5700 

atcagctcac tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa   5760 

gaacatgtga gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc   5820 

gtttttccat aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag   5880 

gtggcgaaac ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt   5940 

gcgctctcct gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg   6000 

aagcgtggcg ctttctcaat gctcacgctg taggtatctc agttcggtgt aggtcgttcg   6060 

ctccaagctg ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg   6120 

taactatcgt cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac   6180 

tggtaacagg attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg   6240 

gcctaactac ggctacacta gaaggacagt atttggtatc tgcgctctgc tgaagccagt   6300 

taccttcgga aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg   6360 

tggttttttt gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc   6420 

tttgatcttt tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt   6480 

ggtcatgaga ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt   6540 

taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag   6600 

tgaggcacct atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt   6660 

cgtgtagata actacgatac gggagggctt accatctggc cccagtgctg caatgatacc   6720 

gcgagaccca cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc   6780 

cgagcgcaga agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg   6840 

ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctac   6900 

aggcatcgtg gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg   6960 

atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc   7020 

tccgatcgtt gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact   7080 

gcataattct cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc   7140 

aaccaagtca ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaat   7200 

acgggataat accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc   7260 

ttcggggcga aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac   7320 

tcgtgcaccc aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa   7380 

aacaggaagg caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact   7440 

catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg   7500 

atacatattt gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg   7560 

aaaagtgcca cctgacgtc                                                7579 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">5 </s210>
            <s211 class="style-scope patent-text">7558 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 5 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccaagc ttggatccca ccatggggtc aaccgtcatc ctcgccctcc tcctggctgt    960 

tctccaagga gtctgtgccg aggtgcagct ggtgcagtct ggagcagagg tgaaaaagcc   1020 

cggggagtct ctgaagatct cctgtaaggg ttctggatac agctttacca gttactggat   1080 

cggctgggtg cgccagatgc ccgggaaagg cctggagtgg atggggatca tctatcctgg   1140 

tgactctgat accagataca gcccgtcctt ccaaggccag gtcaccatct cagccgacaa   1200 

gtccatcagc accgcctacc tgcagtggag cagcctgaag gcctcggaca ccgccatgta   1260 

ttactgtgcg agacggatgg cagcagctgg cccctttgac tactggggcc agggaaccct   1320 

ggtcaccgtc tcctcagcct ccaccaaggg cccatcggtc ttccccctgg caccctctag   1380 

caagagcacc tctgggggca cagcggccct gggctgcctg gtcaaggact acttccccga   1440 

accggtgacg gtgtcgtgga actcaggcgc cctgaccagc ggcgtgcaca ccttcccggc   1500 

tgtcctacag tcctcaggac tctactccct cagcagcgtg gtgaccgtgc cctccagcag   1560 

cttgggcacc cagacctaca tctgcaacgt gaatcacaag cccagcaaca ccaaggtgga   1620 

caagagagtt ggtgagaggc cagcacaggg agggagggtg tctgctggaa gccaggctca   1680 

gcgctcctgc ctggacgcat cccggctatg cagtcccagt ccagggcagc aaggcaggcc   1740 

ccgtctgcct cttcacccgg aggcctctgc ccgccccact catgctcagg gagagggtct   1800 

tctggctttt tccccaggct ctgggcaggc acaggctagg tgcccctaac ccaggccctg   1860 

cacacaaagg ggcaggtgct gggctcagac ctgccaagag ccatatccgg gaggaccctg   1920 

cccctgacct aagcccaccc caaaggccaa actctccact ccctcagctc ggacaccttc   1980 

tctcctccca gattccagta actcccaatc ttctctctgc agagcccaaa tcttgtgaca   2040 

aaactcacac atgcccaccg tgcccaggta agccagccca ggcctcgccc tccagctcaa   2100 

ggcgggacag gtgccctaga gtagcctgca tccagggaca ggccccagcc gggtgctgac   2160 

acgtccacct ccatctcttc ctcagcacct gaactcctgg ggggaccgtc agtcttcctc   2220 

ttccccccaa aacccaagga caccctcatg atctcccgga cccctgaggt cacatgcgtg   2280 

gtggtggacg tgagccacga agaccctgag gtcaagttca actggtacgt ggacggcgtg   2340 

gaggtgcata atgccaagac aaagccgcgg gaggagcagt acaacagcac gtaccgtgtg   2400 

gtcagcgtcc tcaccgtcct gcaccaggac tggctgaatg gcaaggagta caagtgcaag   2460 

gtctccaaca aagccctccc agcccccatc gagaaaacca tctccaaagc caaaggtggg   2520 

acccgtgggg tgcgagggcc acatggacag aggccggctc ggcccaccct ctgccctgag   2580 

agtgaccgct gtaccaacct ctgtccctac agggcagccc cgagaaccac aggtgtacac   2640 

cctgccccca tcccgggagg agatgaccaa gaaccaggtc agcctgacct gcctggtcaa   2700 

aggcttctat cccagcgaca tcgccgtgga gtgggagagc aatgggcagc cggagaacaa   2760 

ctacaagacc acgcctcccg tgctggactc cgacggctcc ttcttcctct atagcaagct   2820 

caccgtggac aagagcaggt ggcagcaggg gaacgtcttc tcatgctccg tgatgcatga   2880 

ggctctgcac aaccactaca cgcagaagag cctctccctg tctccgggta aatgagaatt   2940 

cctcgagtct agagggcccg tttaaacccg ctgatcagcc tcgactgtgc cttctagttg   3000 

ccagccatct gttgtttgcc cctcccccgt gccttccttg accctggaag gtgccactcc   3060 

cactgtcctt tcctaataaa atgaggaaat tgcatcgcat tgtctgagta ggtgtcattc   3120 

tattctgggg ggtggggtgg ggcaggacag caagggggag gattgggaag acaatagcag   3180 

gcatgctggg gatgcggtgg gctctatggc ttctgaggcg gaaagaacca gctggggctc   3240 

tagggggtat ccccacgcgc cctgtagcgg cgcattaagc gcggcgggtg tggtggttac   3300 

gcgcagcgtg accgctacac ttgccagcgc cctagcgccc gctcctttcg ctttcttccc   3360 

ttcctttctc gccacgttcg ccggctttcc ccgtcaagct ctaaatcggg gcatcccttt   3420 

agggttccga tttagtgctt tacggcacct cgaccccaaa aaacttgatt agggtgatgg   3480 

ttcacgtagt gggccatcgc cctgatagac ggtttttcgc cctttgacgt tggagtccac   3540 

gttctttaat agtggactct tgttccaaac tggaacaaca ctcaacccta tctcggtcta   3600 

ttcttttgat ttataaggga ttttggggat ttcggcctat tggttaaaaa atgagctgat   3660 

ttaacaaaaa tttaacgcga attaattctg tggaatgtgt gtcagttagg gtgtggaaag   3720 

tccccaggct ccccaggcag gcagaagtat gcaaagcatg catctcaatt agtcagcaac   3780 

caggtgtgga aagtccccag gctccccagc aggcagaagt atgcaaagca tgcatctcaa   3840 

ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa ctccgcccag   3900 

ttccgcccat tctccgcccc atggctgact aatttttttt atttatgcag aggccgaggc   3960 

cgcctctgcc tctgagctat tccagaagta gtgaggaggc ttttttggag gcctaggctt   4020 

ttgcaaaaag ctcccgggag cttgtatatc cattttcgga tctgatcagc acgtgatgaa   4080 

aaagcctgaa ctcaccgcga cgtctgtcga gaagtttctg atcgaaaagt tcgacagcgt   4140 

ctccgacctg atgcagctct cggagggcga agaatctcgt gctttcagct tcgatgtagg   4200 

agggcgtgga tatgtcctgc gggtaaatag ctgcgccgat ggtttctaca aagatcgtta   4260 

tgtttatcgg cactttgcat cggccgcgct cccgattccg gaagtgcttg acattgggga   4320 

attcagcgag agcctgacct attgcatctc ccgccgtgca cagggtgtca cgttgcaaga   4380 

cctgcctgaa accgaactgc ccgctgttct gcagccggtc gcggaggcca tggatgcgat   4440 

cgctgcggcc gatcttagcc agacgagcgg gttcggccca ttcggaccgc aaggaatcgg   4500 

tcaatacact acatggcgtg atttcatatg cgcgattgct gatccccatg tgtatcactg   4560 

gcaaactgtg atggacgaca ccgtcagtgc gtccgtcgcg caggctctcg atgagctgat   4620 

gctttgggcc gaggactgcc ccgaagtccg gcacctcgtg cacgcggatt tcggctccaa   4680 

caatgtcctg acggacaatg gccgcataac agcggtcatt gactggagcg aggcgatgtt   4740 

cggggattcc caatacgagg tcgccaacat cttcttctgg aggccgtggt tggcttgtat   4800 

ggagcagcag acgcgctact tcgagcggag gcatccggag cttgcaggat cgccgcggct   4860 

ccgggcgtat atgctccgca ttggtcttga ccaactctat cagagcttgg ttgacggcaa   4920 

tttcgatgat gcagcttggg cgcagggtcg atgcgacgca atcgtccgat ccggagccgg   4980 

gactgtcggg cgtacacaaa tcgcccgcag aagcgcggcc gtctggaccg atggctgtgt   5040 

agaagtactc gccgatagtg gaaaccgacg ccccagcact cgtccgaggg caaaggaata   5100 

gcacgtgcta cgagatttcg attccaccgc cgccttctat gaaaggttgg gcttcggaat   5160 

cgttttccgg gacgccggct ggatgatcct ccagcgcggg gatctcatgc tggagttctt   5220 

cgcccacccc aacttgttta ttgcagctta taatggttac aaataaagca atagcatcac   5280 

aaatttcaca aataaagcat ttttttcact gcattctagt tgtggtttgt ccaaactcat   5340 

caatgtatct tatcatgtct gtataccgtc gacctctagc tagagcttgg cgtaatcatg   5400 

gtcatagctg tttcctgtgt gaaattgtta tccgctcaca attccacaca acatacgagc   5460 

cggaagcata aagtgtaaag cctggggtgc ctaatgagtg agctaactca cattaattgc   5520 

gttgcgctca ctgcccgctt tccagtcggg aaacctgtcg tgccagctgc attaatgaat   5580 

cggccaacgc gcggggagag gcggtttgcg tattgggcgc tcttccgctt cctcgctcac   5640 

tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta tcagctcact caaaggcggt   5700 

aatacggtta tccacagaat caggggataa cgcaggaaag aacatgtgag caaaaggcca   5760 

gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccata ggctccgccc   5820 

ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact   5880 

ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct   5940 

gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcaatg   6000 

ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca   6060 

cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa   6120 

cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc   6180 

gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg gctacactag   6240 

aaggacagta tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg   6300 

tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca   6360 

gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc   6420 

tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag   6480 

gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata   6540 

tgagtaaact tggtctgaca gttaccaatg cttaatcagt gaggcaccta tctcagcgat   6600 

ctgtctattt cgttcatcca tagttgcctg actccccgtc gtgtagataa ctacgatacg   6660 

ggagggctta ccatctggcc ccagtgctgc aatgataccg cgagacccac gctcaccggc   6720 

tccagattta tcagcaataa accagccagc cggaagggcc gagcgcagaa gtggtcctgc   6780 

aactttatcc gcctccatcc agtctattaa ttgttgccgg gaagctagag taagtagttc   6840 

gccagttaat agtttgcgca acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc   6900 

gtcgtttggt atggcttcat tcagctccgg ttcccaacga tcaaggcgag ttacatgatc   6960 

ccccatgttg tgcaaaaaag cggttagctc cttcggtcct ccgatcgttg tcagaagtaa   7020 

gttggccgca gtgttatcac tcatggttat ggcagcactg cataattctc ttactgtcat   7080 

gccatccgta agatgctttt ctgtgactgg tgagtactca accaagtcat tctgagaata   7140 

gtgtatgcgg cgaccgagtt gctcttgccc ggcgtcaata cgggataata ccgcgccaca   7200 

tagcagaact ttaaaagtgc tcatcattgg aaaacgttct tcggggcgaa aactctcaag   7260 

gatcttaccg ctgttgagat ccagttcgat gtaacccact cgtgcaccca actgatcttc   7320 

agcatctttt actttcacca gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc   7380 

aaaaaaggga ataagggcga cacggaaatg ttgaatactc atactcttcc tttttcaata   7440 

ttattgaagc atttatcagg gttattgtct catgagcgga tacatatttg aatgtattta   7500 

gaaaaataaa caaatagggg ttccgcgcac atttccccga aaagtgccac ctgacgtc     7558 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">6 </s210>
            <s211 class="style-scope patent-text">7576 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 6 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccaagc ttggatctca ccatggagtt tgggctgtgc tggattttcc tcgttgctct    960 

tttaagaggt gtccagtgtc aggtgcagct ggtggagtct gggggaggcg tggtccagcc   1020 

tgggaggtcc ctgagactct cctgtgcagc ctctggattc accttcatta gctatggcat   1080 

gcactgggtc cgccaggctc caggcaaggg gctggagtgg gtggcagtta tatcatatga   1140 

tggaagtaat aaatactatg cagactccgt gaagggccga ttcaccatct ccagagacaa   1200 

ttccaagaac acgctgtatc tgcaaatgaa cagcctgaga gctgaggaca cggctgtgta   1260 

ttactgtgcg agagtattag tgggagcttt atattattat aactactacg ggatggacgt   1320 

ctggggccaa gggaccacgg tcaccgtctc ctcagcctcc accaagggcc catcggtctt   1380 

ccccctggca ccctctagca agagcacctc tgggggcaca gcggccctgg gctgcctggt   1440 

caaggactac ttccccgaac cggtgacggt gtcgtggaac tcaggcgccc tgaccagcgg   1500 

cgtgcacacc ttcccggctg tcctacagtc ctcaggactc tactccctca gcagcgtggt   1560 

gaccgtgccc tccagcagct tgggcaccca gacctacatc tgcaacgtga atcacaagcc   1620 

cagcaacacc aaggtggaca agagagttgg tgagaggcca gcacagggag ggagggtgtc   1680 

tgctggaagc caggctcagc gctcctgcct ggacgcatcc cggctatgca gtcccagtcc   1740 

agggcagcaa ggcaggcccc gtctgcctct tcacccggag gcctctgccc gccccactca   1800 

tgctcaggga gagggtcttc tggctttttc cccaggctct gggcaggcac aggctaggtg   1860 

cccctaaccc aggccctgca cacaaagggg caggtgctgg gctcagacct gccaagagcc   1920 

atatccggga ggaccctgcc cctgacctaa gcccacccca aaggccaaac tctccactcc   1980 

ctcagctcgg acaccttctc tcctcccaga ttccagtaac tcccaatctt ctctctgcag   2040 

agcccaaatc ttgtgacaaa actcacacat gcccaccgtg cccaggtaag ccagcccagg   2100 

cctcgccctc cagctcaagg cgggacaggt gccctagagt agcctgcatc cagggacagg   2160 

ccccagccgg gtgctgacac gtccacctcc atctcttcct cagcacctga actcctgggg   2220 

ggaccgtcag tcttcctctt ccccccaaaa cccaaggaca ccctcatgat ctcccggacc   2280 

cctgaggtca catgcgtggt ggtggacgtg agccacgaag accctgaggt caagttcaac   2340 

tggtacgtgg acggcgtgga ggtgcataat gccaagacaa agccgcggga ggagcagtac   2400 

aacagcacgt accgtgtggt cagcgtcctc accgtcctgc accaggactg gctgaatggc   2460 

aaggagtaca agtgcaaggt ctccaacaaa gccctcccag cccccatcga gaaaaccatc   2520 

tccaaagcca aaggtgggac ccgtggggtg cgagggccac atggacagag gccggctcgg   2580 

cccaccctct gccctgagag tgaccgctgt accaacctct gtccctacag ggcagccccg   2640 

agaaccacag gtgtacaccc tgcccccatc ccgggaggag atgaccaaga accaggtcag   2700 

cctgacctgc ctggtcaaag gcttctatcc cagcgacatc gccgtggagt gggagagcaa   2760 

tgggcagccg gagaacaact acaagaccac gcctcccgtg ctggactccg acggctcctt   2820 

cttcctctat agcaagctca ccgtggacaa gagcaggtgg cagcagggga acgtcttctc   2880 

atgctccgtg atgcatgagg ctctgcacaa ccactacacg cagaagagcc tctccctgtc   2940 

tccgggtaaa tgagaattcc tcgagtctag agggcccgtt taaacccgct gatcagcctc   3000 

gactgtgcct tctagttgcc agccatctgt tgtttgcccc tcccccgtgc cttccttgac   3060 

cctggaaggt gccactccca ctgtcctttc ctaataaaat gaggaaattg catcgcattg   3120 

tctgagtagg tgtcattcta ttctgggggg tggggtgggg caggacagca agggggagga   3180 

ttgggaagac aatagcaggc atgctgggga tgcggtgggc tctatggctt ctgaggcgga   3240 

aagaaccagc tggggctcta gggggtatcc ccacgcgccc tgtagcggcg cattaagcgc   3300 

ggcgggtgtg gtggttacgc gcagcgtgac cgctacactt gccagcgccc tagcgcccgc   3360 

tcctttcgct ttcttccctt cctttctcgc cacgttcgcc ggctttcccc gtcaagctct   3420 

aaatcggggc atccctttag ggttccgatt tagtgcttta cggcacctcg accccaaaaa   3480 

acttgattag ggtgatggtt cacgtagtgg gccatcgccc tgatagacgg tttttcgccc   3540 

tttgacgttg gagtccacgt tctttaatag tggactcttg ttccaaactg gaacaacact   3600 

caaccctatc tcggtctatt cttttgattt ataagggatt ttggggattt cggcctattg   3660 

gttaaaaaat gagctgattt aacaaaaatt taacgcgaat taattctgtg gaatgtgtgt   3720 

cagttagggt gtggaaagtc cccaggctcc ccaggcaggc agaagtatgc aaagcatgca   3780 

tctcaattag tcagcaacca ggtgtggaaa gtccccaggc tccccagcag gcagaagtat   3840 

gcaaagcatg catctcaatt agtcagcaac catagtcccg cccctaactc cgcccatccc   3900 

gcccctaact ccgcccagtt ccgcccattc tccgccccat ggctgactaa ttttttttat   3960 

ttatgcagag gccgaggccg cctctgcctc tgagctattc cagaagtagt gaggaggctt   4020 

ttttggaggc ctaggctttt gcaaaaagct cccgggagct tgtatatcca ttttcggatc   4080 

tgatcagcac gtgatgaaaa agcctgaact caccgcgacg tctgtcgaga agtttctgat   4140 

cgaaaagttc gacagcgtct ccgacctgat gcagctctcg gagggcgaag aatctcgtgc   4200 

tttcagcttc gatgtaggag ggcgtggata tgtcctgcgg gtaaatagct gcgccgatgg   4260 

tttctacaaa gatcgttatg tttatcggca ctttgcatcg gccgcgctcc cgattccgga   4320 

agtgcttgac attggggaat tcagcgagag cctgacctat tgcatctccc gccgtgcaca   4380 

gggtgtcacg ttgcaagacc tgcctgaaac cgaactgccc gctgttctgc agccggtcgc   4440 

ggaggccatg gatgcgatcg ctgcggccga tcttagccag acgagcgggt tcggcccatt   4500 

cggaccgcaa ggaatcggtc aatacactac atggcgtgat ttcatatgcg cgattgctga   4560 

tccccatgtg tatcactggc aaactgtgat ggacgacacc gtcagtgcgt ccgtcgcgca   4620 

ggctctcgat gagctgatgc tttgggccga ggactgcccc gaagtccggc acctcgtgca   4680 

cgcggatttc ggctccaaca atgtcctgac ggacaatggc cgcataacag cggtcattga   4740 

ctggagcgag gcgatgttcg gggattccca atacgaggtc gccaacatct tcttctggag   4800 

gccgtggttg gcttgtatgg agcagcagac gcgctacttc gagcggaggc atccggagct   4860 

tgcaggatcg ccgcggctcc gggcgtatat gctccgcatt ggtcttgacc aactctatca   4920 

gagcttggtt gacggcaatt tcgatgatgc agcttgggcg cagggtcgat gcgacgcaat   4980 

cgtccgatcc ggagccggga ctgtcgggcg tacacaaatc gcccgcagaa gcgcggccgt   5040 

ctggaccgat ggctgtgtag aagtactcgc cgatagtgga aaccgacgcc ccagcactcg   5100 

tccgagggca aaggaatagc acgtgctacg agatttcgat tccaccgccg ccttctatga   5160 

aaggttgggc ttcggaatcg ttttccggga cgccggctgg atgatcctcc agcgcgggga   5220 

tctcatgctg gagttcttcg cccaccccaa cttgtttatt gcagcttata atggttacaa   5280 

ataaagcaat agcatcacaa atttcacaaa taaagcattt ttttcactgc attctagttg   5340 

tggtttgtcc aaactcatca atgtatctta tcatgtctgt ataccgtcga cctctagcta   5400 

gagcttggcg taatcatggt catagctgtt tcctgtgtga aattgttatc cgctcacaat   5460 

tccacacaac atacgagccg gaagcataaa gtgtaaagcc tggggtgcct aatgagtgag   5520 

ctaactcaca ttaattgcgt tgcgctcact gcccgctttc cagtcgggaa acctgtcgtg   5580 

ccagctgcat taatgaatcg gccaacgcgc ggggagaggc ggtttgcgta ttgggcgctc   5640 

ttccgcttcc tcgctcactg actcgctgcg ctcggtcgtt cggctgcggc gagcggtatc   5700 

agctcactca aaggcggtaa tacggttatc cacagaatca ggggataacg caggaaagaa   5760 

catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt tgctggcgtt   5820 

tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa gtcagaggtg   5880 

gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct ccctcgtgcg   5940 

ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc cttcgggaag   6000 

cgtggcgctt tctcaatgct cacgctgtag gtatctcagt tcggtgtagg tcgttcgctc   6060 

caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct tatccggtaa   6120 

ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag cagccactgg   6180 

taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga agtggtggcc   6240 

taactacggc tacactagaa ggacagtatt tggtatctgc gctctgctga agccagttac   6300 

cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg gtagcggtgg   6360 

tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag aagatccttt   6420 

gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag ggattttggt   6480 

catgagatta tcaaaaagga tcttcaccta gatcctttta aattaaaaat gaagttttaa   6540 

atcaatctaa agtatatatg agtaaacttg gtctgacagt taccaatgct taatcagtga   6600 

ggcacctatc tcagcgatct gtctatttcg ttcatccata gttgcctgac tccccgtcgt   6660 

gtagataact acgatacggg agggcttacc atctggcccc agtgctgcaa tgataccgcg   6720 

agacccacgc tcaccggctc cagatttatc agcaataaac cagccagccg gaagggccga   6780 

gcgcagaagt ggtcctgcaa ctttatccgc ctccatccag tctattaatt gttgccggga   6840 

agctagagta agtagttcgc cagttaatag tttgcgcaac gttgttgcca ttgctacagg   6900 

catcgtggtg tcacgctcgt cgtttggtat ggcttcattc agctccggtt cccaacgatc   6960 

aaggcgagtt acatgatccc ccatgttgtg caaaaaagcg gttagctcct tcggtcctcc   7020 

gatcgttgtc agaagtaagt tggccgcagt gttatcactc atggttatgg cagcactgca   7080 

taattctctt actgtcatgc catccgtaag atgcttttct gtgactggtg agtactcaac   7140 

caagtcattc tgagaatagt gtatgcggcg accgagttgc tcttgcccgg cgtcaatacg   7200 

ggataatacc gcgccacata gcagaacttt aaaagtgctc atcattggaa aacgttcttc   7260 

ggggcgaaaa ctctcaagga tcttaccgct gttgagatcc agttcgatgt aacccactcg   7320 

tgcacccaac tgatcttcag catcttttac tttcaccagc gtttctgggt gagcaaaaac   7380 

aggaaggcaa aatgccgcaa aaaagggaat aagggcgaca cggaaatgtt gaatactcat   7440 

actcttcctt tttcaatatt attgaagcat ttatcagggt tattgtctca tgagcggata   7500 

catatttgaa tgtatttaga aaaataaaca aataggggtt ccgcgcacat ttccccgaaa   7560 

agtgccacct gacgtc                                                   7576 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">7 </s210>
            <s211 class="style-scope patent-text">7561 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 7 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

ggtaccggat ctcaccatgg agttggggct gagctgggtt ttcctcgttg ctcttttaag    960 

aggtgtccag tgtcaggagc agctggtgga gtctggggga ggcgtggtcc agcctgggag   1020 

gtccctgaga ctctcctgtg cagcgtctgg attcaccttc agtacctatg gcatgcactg   1080 

ggtccgccag gctccaggca aggggctgga gtgggtggca gttacatggc atgatggaag   1140 

taataaatac tatgcagact ccgtgaaggg ccgattcacc atctccagag acaactccaa   1200 

gaacacgctg tatctgcaaa tgaacagcct gagagccgag gacacggctg tgtattactg   1260 

tgcgagagga ggagtgggag caacttacta ctactactac ggtatggacg tctggggcca   1320 

agggaccacg gtcaccgtct cctcagcctc caccaagggc ccatcggtct tccccctggc   1380 

accctctagc aagagcacct ctgggggcac agcggccctg ggctgcctgg tcaaggacta   1440 

cttccccgaa ccggtgacgg tgtcgtggaa ctcaggcgcc ctgaccagcg gcgtgcacac   1500 

cttcccggct gtcctacagt cctcaggact ctactccctc agcagcgtgg tgaccgtgcc   1560 

ctccagcagc ttgggcaccc agacctacat ctgcaacgtg aatcacaagc ccagcaacac   1620 

caaggtggac aagagagttg gtgagaggcc agcacaggga gggagggtgt ctgctggaag   1680 

ccaggctcag cgctcctgcc tggacgcatc ccggctatgc agtcccagtc cagggcagca   1740 

aggcaggccc cgtctgcctc ttcacccgga ggcctctgcc cgccccactc atgctcaggg   1800 

agagggtctt ctggcttttt ccccaggctc tgggcaggca caggctaggt gcccctaacc   1860 

caggccctgc acacaaaggg gcaggtgctg ggctcagacc tgccaagagc catatccggg   1920 

aggaccctgc ccctgaccta agcccacccc aaaggccaaa ctctccactc cctcagctcg   1980 

gacaccttct ctcctcccag attccagtaa ctcccaatct tctctctgca gagcccaaat   2040 

cttgtgacaa aactcacaca tgcccaccgt gcccaggtaa gccagcccag gcctcgccct   2100 

ccagctcaag gcgggacagg tgccctagag tagcctgcat ccagggacag gccccagccg   2160 

ggtgctgaca cgtccacctc catctcttcc tcagcacctg aactcctggg gggaccgtca   2220 

gtcttcctct tccccccaaa acccaaggac accctcatga tctcccggac ccctgaggtc   2280 

acatgcgtgg tggtggacgt gagccacgaa gaccctgagg tcaagttcaa ctggtacgtg   2340 

gacggcgtgg aggtgcataa tgccaagaca aagccgcggg aggagcagta caacagcacg   2400 

taccgtgtgg tcagcgtcct caccgtcctg caccaggact ggctgaatgg caaggagtac   2460 

aagtgcaagg tctccaacaa agccctccca gcccccatcg agaaaaccat ctccaaagcc   2520 

aaaggtggga cccgtggggt gcgagggcca catggacaga ggccggctcg gcccaccctc   2580 

tgccctgaga gtgaccgctg taccaacctc tgtccctaca gggcagcccc gagaaccaca   2640 

ggtgtacacc ctgcccccat cccgggagga gatgaccaag aaccaggtca gcctgacctg   2700 

cctggtcaaa ggcttctatc ccagcgacat cgccgtggag tgggagagca atgggcagcc   2760 

ggagaacaac tacaagacca cgcctcccgt gctggactcc gacggctcct tcttcctcta   2820 

tagcaagctc accgtggaca agagcaggtg gcagcagggg aacgtcttct catgctccgt   2880 

gatgcatgag gctctgcaca accactacac gcagaagagc ctctccctgt ctccgggtaa   2940 

atgactcgag tctagagggc ccgtttaaac ccgctgatca gcctcgactg tgccttctag   3000 

ttgccagcca tctgttgttt gcccctcccc cgtgccttcc ttgaccctgg aaggtgccac   3060 

tcccactgtc ctttcctaat aaaatgagga aattgcatcg cattgtctga gtaggtgtca   3120 

ttctattctg gggggtgggg tggggcagga cagcaagggg gaggattggg aagacaatag   3180 

caggcatgct ggggatgcgg tgggctctat ggcttctgag gcggaaagaa ccagctgggg   3240 

ctctaggggg tatccccacg cgccctgtag cggcgcatta agcgcggcgg gtgtggtggt   3300 

tacgcgcagc gtgaccgcta cacttgccag cgccctagcg cccgctcctt tcgctttctt   3360 

cccttccttt ctcgccacgt tcgccggctt tccccgtcaa gctctaaatc ggggcatccc   3420 

tttagggttc cgatttagtg ctttacggca cctcgacccc aaaaaacttg attagggtga   3480 

tggttcacgt agtgggccat cgccctgata gacggttttt cgccctttga cgttggagtc   3540 

cacgttcttt aatagtggac tcttgttcca aactggaaca acactcaacc ctatctcggt   3600 

ctattctttt gatttataag ggattttggg gatttcggcc tattggttaa aaaatgagct   3660 

gatttaacaa aaatttaacg cgaattaatt ctgtggaatg tgtgtcagtt agggtgtgga   3720 

aagtccccag gctccccagg caggcagaag tatgcaaagc atgcatctca attagtcagc   3780 

aaccaggtgt ggaaagtccc caggctcccc agcaggcaga agtatgcaaa gcatgcatct   3840 

caattagtca gcaaccatag tcccgcccct aactccgccc atcccgcccc taactccgcc   3900 

cagttccgcc cattctccgc cccatggctg actaattttt tttatttatg cagaggccga   3960 

ggccgcctct gcctctgagc tattccagaa gtagtgagga ggcttttttg gaggcctagg   4020 

cttttgcaaa aagctcccgg gagcttgtat atccattttc ggatctgatc agcacgtgat   4080 

gaaaaagcct gaactcaccg cgacgtctgt cgagaagttt ctgatcgaaa agttcgacag   4140 

cgtctccgac ctgatgcagc tctcggaggg cgaagaatct cgtgctttca gcttcgatgt   4200 

aggagggcgt ggatatgtcc tgcgggtaaa tagctgcgcc gatggtttct acaaagatcg   4260 

ttatgtttat cggcactttg catcggccgc gctcccgatt ccggaagtgc ttgacattgg   4320 

ggaattcagc gagagcctga cctattgcat ctcccgccgt gcacagggtg tcacgttgca   4380 

agacctgcct gaaaccgaac tgcccgctgt tctgcagccg gtcgcggagg ccatggatgc   4440 

gatcgctgcg gccgatctta gccagacgag cgggttcggc ccattcggac cgcaaggaat   4500 

cggtcaatac actacatggc gtgatttcat atgcgcgatt gctgatcccc atgtgtatca   4560 

ctggcaaact gtgatggacg acaccgtcag tgcgtccgtc gcgcaggctc tcgatgagct   4620 

gatgctttgg gccgaggact gccccgaagt ccggcacctc gtgcacgcgg atttcggctc   4680 

caacaatgtc ctgacggaca atggccgcat aacagcggtc attgactgga gcgaggcgat   4740 

gttcggggat tcccaatacg aggtcgccaa catcttcttc tggaggccgt ggttggcttg   4800 

tatggagcag cagacgcgct acttcgagcg gaggcatccg gagcttgcag gatcgccgcg   4860 

gctccgggcg tatatgctcc gcattggtct tgaccaactc tatcagagct tggttgacgg   4920 

caatttcgat gatgcagctt gggcgcaggg tcgatgcgac gcaatcgtcc gatccggagc   4980 

cgggactgtc gggcgtacac aaatcgcccg cagaagcgcg gccgtctgga ccgatggctg   5040 

tgtagaagta ctcgccgata gtggaaaccg acgccccagc actcgtccga gggcaaagga   5100 

atagcacgtg ctacgagatt tcgattccac cgccgccttc tatgaaaggt tgggcttcgg   5160 

aatcgttttc cgggacgccg gctggatgat cctccagcgc ggggatctca tgctggagtt   5220 

cttcgcccac cccaacttgt ttattgcagc ttataatggt tacaaataaa gcaatagcat   5280 

cacaaatttc acaaataaag catttttttc actgcattct agttgtggtt tgtccaaact   5340 

catcaatgta tcttatcatg tctgtatacc gtcgacctct agctagagct tggcgtaatc   5400 

atggtcatag ctgtttcctg tgtgaaattg ttatccgctc acaattccac acaacatacg   5460 

agccggaagc ataaagtgta aagcctgggg tgcctaatga gtgagctaac tcacattaat   5520 

tgcgttgcgc tcactgcccg ctttccagtc gggaaacctg tcgtgccagc tgcattaatg   5580 

aatcggccaa cgcgcgggga gaggcggttt gcgtattggg cgctcttccg cttcctcgct   5640 

cactgactcg ctgcgctcgg tcgttcggct gcggcgagcg gtatcagctc actcaaaggc   5700 

ggtaatacgg ttatccacag aatcagggga taacgcagga aagaacatgt gagcaaaagg   5760 

ccagcaaaag gccaggaacc gtaaaaaggc cgcgttgctg gcgtttttcc ataggctccg   5820 

cccccctgac gagcatcaca aaaatcgacg ctcaagtcag aggtggcgaa acccgacagg   5880 

actataaaga taccaggcgt ttccccctgg aagctccctc gtgcgctctc ctgttccgac   5940 

cctgccgctt accggatacc tgtccgcctt tctcccttcg ggaagcgtgg cgctttctca   6000 

atgctcacgc tgtaggtatc tcagttcggt gtaggtcgtt cgctccaagc tgggctgtgt   6060 

gcacgaaccc cccgttcagc ccgaccgctg cgccttatcc ggtaactatc gtcttgagtc   6120 

caacccggta agacacgact tatcgccact ggcagcagcc actggtaaca ggattagcag   6180 

agcgaggtat gtaggcggtg ctacagagtt cttgaagtgg tggcctaact acggctacac   6240 

tagaaggaca gtatttggta tctgcgctct gctgaagcca gttaccttcg gaaaaagagt   6300 

tggtagctct tgatccggca aacaaaccac cgctggtagc ggtggttttt ttgtttgcaa   6360 

gcagcagatt acgcgcagaa aaaaaggatc tcaagaagat cctttgatct tttctacggg   6420 

gtctgacgct cagtggaacg aaaactcacg ttaagggatt ttggtcatga gattatcaaa   6480 

aaggatcttc acctagatcc ttttaaatta aaaatgaagt tttaaatcaa tctaaagtat   6540 

atatgagtaa acttggtctg acagttacca atgcttaatc agtgaggcac ctatctcagc   6600 

gatctgtcta tttcgttcat ccatagttgc ctgactcccc gtcgtgtaga taactacgat   6660 

acgggagggc ttaccatctg gccccagtgc tgcaatgata ccgcgagacc cacgctcacc   6720 

ggctccagat ttatcagcaa taaaccagcc agccggaagg gccgagcgca gaagtggtcc   6780 

tgcaacttta tccgcctcca tccagtctat taattgttgc cgggaagcta gagtaagtag   6840 

ttcgccagtt aatagtttgc gcaacgttgt tgccattgct acaggcatcg tggtgtcacg   6900 

ctcgtcgttt ggtatggctt cattcagctc cggttcccaa cgatcaaggc gagttacatg   6960 

atcccccatg ttgtgcaaaa aagcggttag ctccttcggt cctccgatcg ttgtcagaag   7020 

taagttggcc gcagtgttat cactcatggt tatggcagca ctgcataatt ctcttactgt   7080 

catgccatcc gtaagatgct tttctgtgac tggtgagtac tcaaccaagt cattctgaga   7140 

atagtgtatg cggcgaccga gttgctcttg cccggcgtca atacgggata ataccgcgcc   7200 

acatagcaga actttaaaag tgctcatcat tggaaaacgt tcttcggggc gaaaactctc   7260 

aaggatctta ccgctgttga gatccagttc gatgtaaccc actcgtgcac ccaactgatc   7320 

ttcagcatct tttactttca ccagcgtttc tgggtgagca aaaacaggaa ggcaaaatgc   7380 

cgcaaaaaag ggaataaggg cgacacggaa atgttgaata ctcatactct tcctttttca   7440 

atattattga agcatttatc agggttattg tctcatgagc ggatacatat ttgaatgtat   7500 

ttagaaaaat aaacaaatag gggttccgcg cacatttccc cgaaaagtgc cacctgacgt   7560 

c                                                                   7561 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">8 </s210>
            <s211 class="style-scope patent-text">6082 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 8 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatga gggtccctgc tcagctcctg ggactcctgc tgctctggct    960 

cccagatacc agatgtgaca tccagatgac ccagtctcca tcctccctgt ctgcatctgt   1020 

aggagacaga gtcaccatca cttgccgggc gagtcagggc attagcaatt atttagcctg   1080 

gtatcagcag aaaacaggga aagttcctaa gttcctgatc tatgaagcat ccactttgca   1140 

atcaggggtc ccatctcggt tcagtggcgg tggatctggg acagatttca ctctcaccat   1200 

cagcagcctg cagcctgaag atgttgcaac ttattactgt caaaattata acagtgcccc   1260 

attcactttc ggccctggga ccaaagtgga tatcaaacga actgtggctg caccctctgt   1320 

cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgctagcg ttgtgtgcct   1380 

gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca   1440 

atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct   1500 

cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga   1560 

agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta   1620 

ggaattcgcg gccgctcgag tctagagggc ccgtttaaac ccgctgatca gcctcgactg   1680 

tgccttctag ttgccagcca tctgttgttt gcccctcccc cgtgccttcc ttgaccctgg   1740 

aaggtgccac tcccactgtc ctttcctaat aaaatgagga aattgcatcg cattgtctga   1800 

gtaggtgtca ttctattctg gggggtgggg tggggcagga cagcaagggg gaggattggg   1860 

aagacaatag caggcatgct ggggatgcgg tgggctctat ggcttctgag gcggaaagaa   1920 

ccagctgggg ctctaggggg tatccccacg cgccctgtag cggcgcatta agcgcggcgg   1980 

gtgtggtggt tacgcgcagc gtgaccgcta cacttgccag cgccctagcg cccgctcctt   2040 

tcgctttctt cccttccttt ctcgccacgt tcgccggctt tccccgtcaa gctctaaatc   2100 

ggggcatccc tttagggttc cgatttagtg ctttacggca cctcgacccc aaaaaacttg   2160 

attagggtga tggttcacgt agtgggccat cgccctgata gacggttttt cgccctttga   2220 

cgttggagtc cacgttcttt aatagtggac tcttgttcca aactggaaca acactcaacc   2280 

ctatctcggt ctattctttt gatttataag ggattttggg gatttcggcc tattggttaa   2340 

aaaatgagct gatttaacaa aaatttaacg cgaattaatt ctgtggaatg tgtgtcagtt   2400 

agggtgtgga aagtccccag gctccccagg caggcagaag tatgcaaagc atgcatctca   2460 

attagtcagc aaccaggtgt ggaaagtccc caggctcccc agcaggcaga agtatgcaaa   2520 

gcatgcatct caattagtca gcaaccatag tcccgcccct aactccgccc atcccgcccc   2580 

taactccgcc cagttccgcc cattctccgc cccatggctg actaattttt tttatttatg   2640 

cagaggccga ggccgcctct gcctctgagc tattccagaa gtagtgagga ggcttttttg   2700 

gaggcctagg cttttgcaaa aagctcccgg gagcttgtat atccattttc ggatctgatc   2760 

aagagacagg atgaggatcg tttcgcatga ttgaacaaga tggattgcac gcaggttctc   2820 

cggccgcttg ggtggagagg ctattcggct atgactgggc acaacagaca atcggctgct   2880 

ctgatgccgc cgtgttccgg ctgtcagcgc aggggcgccc ggttcttttt gtcaagaccg   2940 

acctgtccgg tgccctgaat gaactgcagg acgaggcagc gcggctatcg tggctggcca   3000 

cgacgggcgt tccttgcgca gctgtgctcg acgttgtcac tgaagcggga agggactggc   3060 

tgctattggg cgaagtgccg gggcaggatc tcctgtcatc tcaccttgct cctgccgaga   3120 

aagtatccat catggctgat gcaatgcggc ggctgcatac gcttgatccg gctacctgcc   3180 

cattcgacca ccaagcgaaa catcgcatcg agcgagcacg tactcggatg gaagccggtc   3240 

ttgtcgatca ggatgatctg gacgaagagc atcaggggct cgcgccagcc gaactgttcg   3300 

ccaggctcaa ggcgcgcatg cccgacggcg aggatctcgt cgtgacccat ggcgatgcct   3360 

gcttgccgaa tatcatggtg gaaaatggcc gcttttctgg attcatcgac tgtggccggc   3420 

tgggtgtggc ggaccgctat caggacatag cgttggctac ccgtgatatt gctgaagagc   3480 

ttggcggcga atgggctgac cgcttcctcg tgctttacgg tatcgccgct cccgattcgc   3540 

agcgcatcgc cttctatcgc cttcttgacg agttcttctg agcgggactc tggggttcga   3600 

aatgaccgac caagcgacgc ccaacctgcc atcacgagat ttcgattcca ccgccgcctt   3660 

ctatgaaagg ttgggcttcg gaatcgtttt ccgggacgcc ggctggatga tcctccagcg   3720 

cggggatctc atgctggagt tcttcgccca ccccaacttg tttattgcag cttataatgg   3780 

ttacaaataa agcaatagca tcacaaattt cacaaataaa gcattttttt cactgcattc   3840 

tagttgtggt ttgtccaaac tcatcaatgt atcttatcat gtctgtatac cgtcgacctc   3900 

tagctagagc ttggcgtaat catggtcata gctgtttcct gtgtgaaatt gttatccgct   3960 

cacaattcca cacaacatac gagccggaag cataaagtgt aaagcctggg gtgcctaatg   4020 

agtgagctaa ctcacattaa ttgcgttgcg ctcactgccc gctttccagt cgggaaacct   4080 

gtcgtgccag ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg   4140 

gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc   4200 

ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg   4260 

aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct   4320 

ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca   4380 

gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct   4440 

cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc   4500 

gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt   4560 

tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc   4620 

cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc   4680 

cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg   4740 

gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc   4800 

agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag   4860 

cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga   4920 

tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat   4980 

tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt aaaaatgaag   5040 

ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc aatgcttaat   5100 

cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg cctgactccc   5160 

cgtcgtgtag ataactacga tacgggaggg cttaccatct ggccccagtg ctgcaatgat   5220 

accgcgagac ccacgctcac cggctccaga tttatcagca ataaaccagc cagccggaag   5280 

ggccgagcgc agaagtggtc ctgcaacttt atccgcctcc atccagtcta ttaattgttg   5340 

ccgggaagct agagtaagta gttcgccagt taatagtttg cgcaacgttg ttgccattgc   5400 

tacaggcatc gtggtgtcac gctcgtcgtt tggtatggct tcattcagct ccggttccca   5460 

acgatcaagg cgagttacat gatcccccat gttgtgcaaa aaagcggtta gctccttcgg   5520 

tcctccgatc gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg ttatggcagc   5580 

actgcataat tctcttactg tcatgccatc cgtaagatgc ttttctgtga ctggtgagta   5640 

ctcaaccaag tcattctgag aatagtgtat gcggcgaccg agttgctctt gcccggcgtc   5700 

aatacgggat aataccgcgc cacatagcag aactttaaaa gtgctcatca ttggaaaacg   5760 

ttcttcgggg cgaaaactct caaggatctt accgctgttg agatccagtt cgatgtaacc   5820 

cactcgtgca cccaactgat cttcagcatc ttttactttc accagcgttt ctgggtgagc   5880 

aaaaacagga aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga aatgttgaat   5940 

actcatactc ttcctttttc aatattattg aagcatttat cagggttatt gtctcatgag   6000 

cggatacata tttgaatgta tttagaaaaa taaacaaata ggggttccgc gcacatttcc   6060 

ccgaaaagtg ccacctgacg tc                                            6082 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">9 </s210>
            <s211 class="style-scope patent-text">6082 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 9 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatga gggtccccgc tcagctcctg gggctcctgc tgctctgttt    960 

cccaggtgcc agatgtgaca tccagatgac ccagtctcca tcctcactgt ctgcatctgt   1020 

aggagacaga gtcaccatca cttgtcgggc gagtcagggc attaccaatt atttagcctg   1080 

gtttcagcag aaaccaggga aagcccctaa gtcccttatc tatgctgcat ccagtttgca   1140 

aagtggggtc ccatcaaagt tcagcggcag tggatctggg acagatttca gtctcaccat   1200 

cagcagcctg cagcctgaag attttgcaac ttattactgc caacagtata atagttaccc   1260 

gatcaccttc ggccaaggga cacgactgga gattaaacga actgtggctg caccatctgt   1320 

cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgctagcg ttgtgtgcct   1380 

gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca   1440 

atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct   1500 

cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga   1560 

agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta   1620 

ggaattcgcg gccgctcgag tctagagggc ccgtttaaac ccgctgatca gcctcgactg   1680 

tgccttctag ttgccagcca tctgttgttt gcccctcccc cgtgccttcc ttgaccctgg   1740 

aaggtgccac tcccactgtc ctttcctaat aaaatgagga aattgcatcg cattgtctga   1800 

gtaggtgtca ttctattctg gggggtgggg tggggcagga cagcaagggg gaggattggg   1860 

aagacaatag caggcatgct ggggatgcgg tgggctctat ggcttctgag gcggaaagaa   1920 

ccagctgggg ctctaggggg tatccccacg cgccctgtag cggcgcatta agcgcggcgg   1980 

gtgtggtggt tacgcgcagc gtgaccgcta cacttgccag cgccctagcg cccgctcctt   2040 

tcgctttctt cccttccttt ctcgccacgt tcgccggctt tccccgtcaa gctctaaatc   2100 

ggggcatccc tttagggttc cgatttagtg ctttacggca cctcgacccc aaaaaacttg   2160 

attagggtga tggttcacgt agtgggccat cgccctgata gacggttttt cgccctttga   2220 

cgttggagtc cacgttcttt aatagtggac tcttgttcca aactggaaca acactcaacc   2280 

ctatctcggt ctattctttt gatttataag ggattttggg gatttcggcc tattggttaa   2340 

aaaatgagct gatttaacaa aaatttaacg cgaattaatt ctgtggaatg tgtgtcagtt   2400 

agggtgtgga aagtccccag gctccccagg caggcagaag tatgcaaagc atgcatctca   2460 

attagtcagc aaccaggtgt ggaaagtccc caggctcccc agcaggcaga agtatgcaaa   2520 

gcatgcatct caattagtca gcaaccatag tcccgcccct aactccgccc atcccgcccc   2580 

taactccgcc cagttccgcc cattctccgc cccatggctg actaattttt tttatttatg   2640 

cagaggccga ggccgcctct gcctctgagc tattccagaa gtagtgagga ggcttttttg   2700 

gaggcctagg cttttgcaaa aagctcccgg gagcttgtat atccattttc ggatctgatc   2760 

aagagacagg atgaggatcg tttcgcatga ttgaacaaga tggattgcac gcaggttctc   2820 

cggccgcttg ggtggagagg ctattcggct atgactgggc acaacagaca atcggctgct   2880 

ctgatgccgc cgtgttccgg ctgtcagcgc aggggcgccc ggttcttttt gtcaagaccg   2940 

acctgtccgg tgccctgaat gaactgcagg acgaggcagc gcggctatcg tggctggcca   3000 

cgacgggcgt tccttgcgca gctgtgctcg acgttgtcac tgaagcggga agggactggc   3060 

tgctattggg cgaagtgccg gggcaggatc tcctgtcatc tcaccttgct cctgccgaga   3120 

aagtatccat catggctgat gcaatgcggc ggctgcatac gcttgatccg gctacctgcc   3180 

cattcgacca ccaagcgaaa catcgcatcg agcgagcacg tactcggatg gaagccggtc   3240 

ttgtcgatca ggatgatctg gacgaagagc atcaggggct cgcgccagcc gaactgttcg   3300 

ccaggctcaa ggcgcgcatg cccgacggcg aggatctcgt cgtgacccat ggcgatgcct   3360 

gcttgccgaa tatcatggtg gaaaatggcc gcttttctgg attcatcgac tgtggccggc   3420 

tgggtgtggc ggaccgctat caggacatag cgttggctac ccgtgatatt gctgaagagc   3480 

ttggcggcga atgggctgac cgcttcctcg tgctttacgg tatcgccgct cccgattcgc   3540 

agcgcatcgc cttctatcgc cttcttgacg agttcttctg agcgggactc tggggttcga   3600 

aatgaccgac caagcgacgc ccaacctgcc atcacgagat ttcgattcca ccgccgcctt   3660 

ctatgaaagg ttgggcttcg gaatcgtttt ccgggacgcc ggctggatga tcctccagcg   3720 

cggggatctc atgctggagt tcttcgccca ccccaacttg tttattgcag cttataatgg   3780 

ttacaaataa agcaatagca tcacaaattt cacaaataaa gcattttttt cactgcattc   3840 

tagttgtggt ttgtccaaac tcatcaatgt atcttatcat gtctgtatac cgtcgacctc   3900 

tagctagagc ttggcgtaat catggtcata gctgtttcct gtgtgaaatt gttatccgct   3960 

cacaattcca cacaacatac gagccggaag cataaagtgt aaagcctggg gtgcctaatg   4020 

agtgagctaa ctcacattaa ttgcgttgcg ctcactgccc gctttccagt cgggaaacct   4080 

gtcgtgccag ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg   4140 

gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc   4200 

ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg   4260 

aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct   4320 

ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca   4380 

gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct   4440 

cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc   4500 

gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt   4560 

tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc   4620 

cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc   4680 

cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg   4740 

gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc   4800 

agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag   4860 

cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga   4920 

tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat   4980 

tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt aaaaatgaag   5040 

ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc aatgcttaat   5100 

cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg cctgactccc   5160 

cgtcgtgtag ataactacga tacgggaggg cttaccatct ggccccagtg ctgcaatgat   5220 

accgcgagac ccacgctcac cggctccaga tttatcagca ataaaccagc cagccggaag   5280 

ggccgagcgc agaagtggtc ctgcaacttt atccgcctcc atccagtcta ttaattgttg   5340 

ccgggaagct agagtaagta gttcgccagt taatagtttg cgcaacgttg ttgccattgc   5400 

tacaggcatc gtggtgtcac gctcgtcgtt tggtatggct tcattcagct ccggttccca   5460 

acgatcaagg cgagttacat gatcccccat gttgtgcaaa aaagcggtta gctccttcgg   5520 

tcctccgatc gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg ttatggcagc   5580 

actgcataat tctcttactg tcatgccatc cgtaagatgc ttttctgtga ctggtgagta   5640 

ctcaaccaag tcattctgag aatagtgtat gcggcgaccg agttgctctt gcccggcgtc   5700 

aatacgggat aataccgcgc cacatagcag aactttaaaa gtgctcatca ttggaaaacg   5760 

ttcttcgggg cgaaaactct caaggatctt accgctgttg agatccagtt cgatgtaacc   5820 

cactcgtgca cccaactgat cttcagcatc ttttactttc accagcgttt ctgggtgagc   5880 

aaaaacagga aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga aatgttgaat   5940 

actcatactc ttcctttttc aatattattg aagcatttat cagggttatt gtctcatgag   6000 

cggatacata tttgaatgta tttagaaaaa taaacaaata ggggttccgc gcacatttcc   6060 

ccgaaaagtg ccacctgacg tc                                            6082 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">10 </s210>
            <s211 class="style-scope patent-text">6082 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 10 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatga gggtccctgc tcagctcctg gggctcctgc tgctctgttt    960 

cccaggtgcc agatgtgaca tccagatgac ccagtctcca tcctcactgt ctgcatctgt   1020 

aggagacaga gtcaccatca cttgtcgggc gagtcagggc attagccatt atttagcctg   1080 

gtttcagcag aaaccaggga aagcccctaa gtccctgatc tatgctgcat ccagtttgca   1140 

aagtggggtc ccatcaaagt tcagcggcag tggatctggg acagatttca ctctcaccat   1200 

cagcagccta cagcctgaag attttgcaac ttattactgc caacagtata atagtttccc   1260 

gctcactttc ggcggaggga ccaaggtgga gatcaaacga actgtggctg caccatctgt   1320 

cttcatcttc ccgccatctg atgagcagtt gaaatctgga actgctagcg ttgtgtgcct   1380 

gctgaataac ttctatccca gagaggccaa agtacagtgg aaggtggata acgccctcca   1440 

atcgggtaac tcccaggaga gtgtcacaga gcaggacagc aaggacagca cctacagcct   1500 

cagcagcacc ctgacgctga gcaaagcaga ctacgagaaa cacaaagtct acgcctgcga   1560 

agtcacccat cagggcctga gctcgcccgt cacaaagagc ttcaacaggg gagagtgtta   1620 

ggaattcgcg gccgctcgag tctagagggc ccgtttaaac ccgctgatca gcctcgactg   1680 

tgccttctag ttgccagcca tctgttgttt gcccctcccc cgtgccttcc ttgaccctgg   1740 

aaggtgccac tcccactgtc ctttcctaat aaaatgagga aattgcatcg cattgtctga   1800 

gtaggtgtca ttctattctg gggggtgggg tggggcagga cagcaagggg gaggattggg   1860 

aagacaatag caggcatgct ggggatgcgg tgggctctat ggcttctgag gcggaaagaa   1920 

ccagctgggg ctctaggggg tatccccacg cgccctgtag cggcgcatta agcgcggcgg   1980 

gtgtggtggt tacgcgcagc gtgaccgcta cacttgccag cgccctagcg cccgctcctt   2040 

tcgctttctt cccttccttt ctcgccacgt tcgccggctt tccccgtcaa gctctaaatc   2100 

ggggcatccc tttagggttc cgatttagtg ctttacggca cctcgacccc aaaaaacttg   2160 

attagggtga tggttcacgt agtgggccat cgccctgata gacggttttt cgccctttga   2220 

cgttggagtc cacgttcttt aatagtggac tcttgttcca aactggaaca acactcaacc   2280 

ctatctcggt ctattctttt gatttataag ggattttggg gatttcggcc tattggttaa   2340 

aaaatgagct gatttaacaa aaatttaacg cgaattaatt ctgtggaatg tgtgtcagtt   2400 

agggtgtgga aagtccccag gctccccagg caggcagaag tatgcaaagc atgcatctca   2460 

attagtcagc aaccaggtgt ggaaagtccc caggctcccc agcaggcaga agtatgcaaa   2520 

gcatgcatct caattagtca gcaaccatag tcccgcccct aactccgccc atcccgcccc   2580 

taactccgcc cagttccgcc cattctccgc cccatggctg actaattttt tttatttatg   2640 

cagaggccga ggccgcctct gcctctgagc tattccagaa gtagtgagga ggcttttttg   2700 

gaggcctagg cttttgcaaa aagctcccgg gagcttgtat atccattttc ggatctgatc   2760 

aagagacagg atgaggatcg tttcgcatga ttgaacaaga tggattgcac gcaggttctc   2820 

cggccgcttg ggtggagagg ctattcggct atgactgggc acaacagaca atcggctgct   2880 

ctgatgccgc cgtgttccgg ctgtcagcgc aggggcgccc ggttcttttt gtcaagaccg   2940 

acctgtccgg tgccctgaat gaactgcagg acgaggcagc gcggctatcg tggctggcca   3000 

cgacgggcgt tccttgcgca gctgtgctcg acgttgtcac tgaagcggga agggactggc   3060 

tgctattggg cgaagtgccg gggcaggatc tcctgtcatc tcaccttgct cctgccgaga   3120 

aagtatccat catggctgat gcaatgcggc ggctgcatac gcttgatccg gctacctgcc   3180 

cattcgacca ccaagcgaaa catcgcatcg agcgagcacg tactcggatg gaagccggtc   3240 

ttgtcgatca ggatgatctg gacgaagagc atcaggggct cgcgccagcc gaactgttcg   3300 

ccaggctcaa ggcgcgcatg cccgacggcg aggatctcgt cgtgacccat ggcgatgcct   3360 

gcttgccgaa tatcatggtg gaaaatggcc gcttttctgg attcatcgac tgtggccggc   3420 

tgggtgtggc ggaccgctat caggacatag cgttggctac ccgtgatatt gctgaagagc   3480 

ttggcggcga atgggctgac cgcttcctcg tgctttacgg tatcgccgct cccgattcgc   3540 

agcgcatcgc cttctatcgc cttcttgacg agttcttctg agcgggactc tggggttcga   3600 

aatgaccgac caagcgacgc ccaacctgcc atcacgagat ttcgattcca ccgccgcctt   3660 

ctatgaaagg ttgggcttcg gaatcgtttt ccgggacgcc ggctggatga tcctccagcg   3720 

cggggatctc atgctggagt tcttcgccca ccccaacttg tttattgcag cttataatgg   3780 

ttacaaataa agcaatagca tcacaaattt cacaaataaa gcattttttt cactgcattc   3840 

tagttgtggt ttgtccaaac tcatcaatgt atcttatcat gtctgtatac cgtcgacctc   3900 

tagctagagc ttggcgtaat catggtcata gctgtttcct gtgtgaaatt gttatccgct   3960 

cacaattcca cacaacatac gagccggaag cataaagtgt aaagcctggg gtgcctaatg   4020 

agtgagctaa ctcacattaa ttgcgttgcg ctcactgccc gctttccagt cgggaaacct   4080 

gtcgtgccag ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg   4140 

gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc   4200 

ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg   4260 

aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct   4320 

ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca   4380 

gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct   4440 

cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc   4500 

gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt   4560 

tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc   4620 

cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc   4680 

cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg   4740 

gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc   4800 

agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag   4860 

cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga   4920 

tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat   4980 

tttggtcatg agattatcaa aaaggatctt cacctagatc cttttaaatt aaaaatgaag   5040 

ttttaaatca atctaaagta tatatgagta aacttggtct gacagttacc aatgcttaat   5100 

cagtgaggca cctatctcag cgatctgtct atttcgttca tccatagttg cctgactccc   5160 

cgtcgtgtag ataactacga tacgggaggg cttaccatct ggccccagtg ctgcaatgat   5220 

accgcgagac ccacgctcac cggctccaga tttatcagca ataaaccagc cagccggaag   5280 

ggccgagcgc agaagtggtc ctgcaacttt atccgcctcc atccagtcta ttaattgttg   5340 

ccgggaagct agagtaagta gttcgccagt taatagtttg cgcaacgttg ttgccattgc   5400 

tacaggcatc gtggtgtcac gctcgtcgtt tggtatggct tcattcagct ccggttccca   5460 

acgatcaagg cgagttacat gatcccccat gttgtgcaaa aaagcggtta gctccttcgg   5520 

tcctccgatc gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg ttatggcagc   5580 

actgcataat tctcttactg tcatgccatc cgtaagatgc ttttctgtga ctggtgagta   5640 

ctcaaccaag tcattctgag aatagtgtat gcggcgaccg agttgctctt gcccggcgtc   5700 

aatacgggat aataccgcgc cacatagcag aactttaaaa gtgctcatca ttggaaaacg   5760 

ttcttcgggg cgaaaactct caaggatctt accgctgttg agatccagtt cgatgtaacc   5820 

cactcgtgca cccaactgat cttcagcatc ttttactttc accagcgttt ctgggtgagc   5880 

aaaaacagga aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga aatgttgaat   5940 

actcatactc ttcctttttc aatattattg aagcatttat cagggttatt gtctcatgag   6000 

cggatacata tttgaatgta tttagaaaaa taaacaaata ggggttccgc gcacatttcc   6060 

ccgaaaagtg ccacctgacg tc                                            6082 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">11 </s210>
            <s211 class="style-scope patent-text">6085 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 11 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatga gggtccccgc tcagcttctc ttccttctgc tactctggct    960 

cccagatacc actggaggaa tagtgatgac gcagtctcca gccaccctgt ctgtgtctcc   1020 

aggggaaaga gccaccctct cctgcaggac cagtcagagt attggctgga acttagcctg   1080 

gtaccaacag aaacctggcc aggctcccag gctcctcatc tatggtgcat cttccaggac   1140 

cactggtatc ccagccaggt tcagtggcag tgggtctggg acagagttca ctctcaccat   1200 

cagcagcctg cagtctgaag attctgcagt ttattactgt cagcattatg ataactggcc   1260 

catgtgcagt tttggccagg ggaccgagct ggagatcaaa cgaactgtgg ctgcaccatc   1320 

tgtcttcatc ttcccgccat ctgatgagca gttgaaatct ggaactgcta gcgttgtgtg   1380 

cctgctgaat aacttctatc ccagagaggc caaagtacag tggaaggtgg ataacgccct   1440 

ccaatcgggt aactcccagg agagtgtcac agagcaggac agcaaggaca gcacctacag   1500 

cctcagcagc accctgacgc tgagcaaagc agactacgag aaacacaaag tctacgcctg   1560 

cgaagtcacc catcagggcc tgagctcgcc cgtcacaaag agcttcaaca ggggagagtg   1620 

ttaggaattc gcggccgctc gagtctagag ggcccgttta aacccgctga tcagcctcga   1680 

ctgtgccttc tagttgccag ccatctgttg tttgcccctc ccccgtgcct tccttgaccc   1740 

tggaaggtgc cactcccact gtcctttcct aataaaatga ggaaattgca tcgcattgtc   1800 

tgagtaggtg tcattctatt ctggggggtg gggtggggca ggacagcaag ggggaggatt   1860 

gggaagacaa tagcaggcat gctggggatg cggtgggctc tatggcttct gaggcggaaa   1920 

gaaccagctg gggctctagg gggtatcccc acgcgccctg tagcggcgca ttaagcgcgg   1980 

cgggtgtggt ggttacgcgc agcgtgaccg ctacacttgc cagcgcccta gcgcccgctc   2040 

ctttcgcttt cttcccttcc tttctcgcca cgttcgccgg ctttccccgt caagctctaa   2100 

atcggggcat ccctttaggg ttccgattta gtgctttacg gcacctcgac cccaaaaaac   2160 

ttgattaggg tgatggttca cgtagtgggc catcgccctg atagacggtt tttcgccctt   2220 

tgacgttgga gtccacgttc tttaatagtg gactcttgtt ccaaactgga acaacactca   2280 

accctatctc ggtctattct tttgatttat aagggatttt ggggatttcg gcctattggt   2340 

taaaaaatga gctgatttaa caaaaattta acgcgaatta attctgtgga atgtgtgtca   2400 

gttagggtgt ggaaagtccc caggctcccc aggcaggcag aagtatgcaa agcatgcatc   2460 

tcaattagtc agcaaccagg tgtggaaagt ccccaggctc cccagcaggc agaagtatgc   2520 

aaagcatgca tctcaattag tcagcaacca tagtcccgcc cctaactccg cccatcccgc   2580 

ccctaactcc gcccagttcc gcccattctc cgccccatgg ctgactaatt ttttttattt   2640 

atgcagaggc cgaggccgcc tctgcctctg agctattcca gaagtagtga ggaggctttt   2700 

ttggaggcct aggcttttgc aaaaagctcc cgggagcttg tatatccatt ttcggatctg   2760 

atcaagagac aggatgagga tcgtttcgca tgattgaaca agatggattg cacgcaggtt   2820 

ctccggccgc ttgggtggag aggctattcg gctatgactg ggcacaacag acaatcggct   2880 

gctctgatgc cgccgtgttc cggctgtcag cgcaggggcg cccggttctt tttgtcaaga   2940 

ccgacctgtc cggtgccctg aatgaactgc aggacgaggc agcgcggcta tcgtggctgg   3000 

ccacgacggg cgttccttgc gcagctgtgc tcgacgttgt cactgaagcg ggaagggact   3060 

ggctgctatt gggcgaagtg ccggggcagg atctcctgtc atctcacctt gctcctgccg   3120 

agaaagtatc catcatggct gatgcaatgc ggcggctgca tacgcttgat ccggctacct   3180 

gcccattcga ccaccaagcg aaacatcgca tcgagcgagc acgtactcgg atggaagccg   3240 

gtcttgtcga tcaggatgat ctggacgaag agcatcaggg gctcgcgcca gccgaactgt   3300 

tcgccaggct caaggcgcgc atgcccgacg gcgaggatct cgtcgtgacc catggcgatg   3360 

cctgcttgcc gaatatcatg gtggaaaatg gccgcttttc tggattcatc gactgtggcc   3420 

ggctgggtgt ggcggaccgc tatcaggaca tagcgttggc tacccgtgat attgctgaag   3480 

agcttggcgg cgaatgggct gaccgcttcc tcgtgcttta cggtatcgcc gctcccgatt   3540 

cgcagcgcat cgccttctat cgccttcttg acgagttctt ctgagcggga ctctggggtt   3600 

cgaaatgacc gaccaagcga cgcccaacct gccatcacga gatttcgatt ccaccgccgc   3660 

cttctatgaa aggttgggct tcggaatcgt tttccgggac gccggctgga tgatcctcca   3720 

gcgcggggat ctcatgctgg agttcttcgc ccaccccaac ttgtttattg cagcttataa   3780 

tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca   3840 

ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtctgta taccgtcgac   3900 

ctctagctag agcttggcgt aatcatggtc atagctgttt cctgtgtgaa attgttatcc   3960 

gctcacaatt ccacacaaca tacgagccgg aagcataaag tgtaaagcct ggggtgccta   4020 

atgagtgagc taactcacat taattgcgtt gcgctcactg cccgctttcc agtcgggaaa   4080 

cctgtcgtgc cagctgcatt aatgaatcgg ccaacgcgcg gggagaggcg gtttgcgtat   4140 

tgggcgctct tccgcttcct cgctcactga ctcgctgcgc tcggtcgttc ggctgcggcg   4200 

agcggtatca gctcactcaa aggcggtaat acggttatcc acagaatcag gggataacgc   4260 

aggaaagaac atgtgagcaa aaggccagca aaaggccagg aaccgtaaaa aggccgcgtt   4320 

gctggcgttt ttccataggc tccgcccccc tgacgagcat cacaaaaatc gacgctcaag   4380 

tcagaggtgg cgaaacccga caggactata aagataccag gcgtttcccc ctggaagctc   4440 

cctcgtgcgc tctcctgttc cgaccctgcc gcttaccgga tacctgtccg cctttctccc   4500 

ttcgggaagc gtggcgcttt ctcaatgctc acgctgtagg tatctcagtt cggtgtaggt   4560 

cgttcgctcc aagctgggct gtgtgcacga accccccgtt cagcccgacc gctgcgcctt   4620 

atccggtaac tatcgtcttg agtccaaccc ggtaagacac gacttatcgc cactggcagc   4680 

agccactggt aacaggatta gcagagcgag gtatgtaggc ggtgctacag agttcttgaa   4740 

gtggtggcct aactacggct acactagaag gacagtattt ggtatctgcg ctctgctgaa   4800 

gccagttacc ttcggaaaaa gagttggtag ctcttgatcc ggcaaacaaa ccaccgctgg   4860 

tagcggtggt ttttttgttt gcaagcagca gattacgcgc agaaaaaaag gatctcaaga   4920 

agatcctttg atcttttcta cggggtctga cgctcagtgg aacgaaaact cacgttaagg   4980 

gattttggtc atgagattat caaaaaggat cttcacctag atccttttaa attaaaaatg   5040 

aagttttaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt accaatgctt   5100 

aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag ttgcctgact   5160 

ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca gtgctgcaat   5220 

gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc agccagccgg   5280 

aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt ctattaattg   5340 

ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg ttgttgccat   5400 

tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca gctccggttc   5460 

ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg ttagctcctt   5520 

cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca tggttatggc   5580 

agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg tgactggtga   5640 

gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct cttgcccggc   5700 

gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca tcattggaaa   5760 

acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca gttcgatgta   5820 

acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg tttctgggtg   5880 

agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac ggaaatgttg   5940 

aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt attgtctcat   6000 

gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggttc cgcgcacatt   6060 

tccccgaaaa gtgccacctg acgtc                                         6085 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">12 </s210>
            <s211 class="style-scope patent-text">6097 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 12 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatga gggtccctgc tcagctcctg gggctgctaa tgctctggat    960 

acctggatcc agtgcagata ttgtgatgac ccagactcca ctctctctgt ccgtcacccc   1020 

tggacagccg gcctccatct cctgcaagtc tagtcagagc ctcctgcata gtgatggaaa   1080 

gacctttttg tattggtatc tgcagaagcc aggccagcct ccacagctcc tgatctatga   1140 

ggtttccaac cggttctctg gagtgccaga taggttcagt ggcagcgggt cagggacaga   1200 

tttcacactg aaaatcagcc gggtggaggc tgaggatgtt gggctttatt actgcatgca   1260 

aagtatacag cttccgctca ctttcggcgg agggaccaag gtggagatca aacgaactgt   1320 

ggctgcacca tctgtcttca tcttcccgcc atctgatgag cagttgaaat ctggaactgc   1380 

tagcgttgtg tgcctgctga ataacttcta tcccagagag gccaaagtac agtggaaggt   1440 

ggataacgcc ctccaatcgg gtaactccca ggagagtgtc acagagcagg acagcaagga   1500 

cagcacctac agcctcagca gcaccctgac gctgagcaaa gcagactacg agaaacacaa   1560 

agtctacgcc tgcgaagtca cccatcaggg cctgagctcg cccgtcacaa agagcttcaa   1620 

caggggagag tgttaggaat tcgcggccgc tcgagtctag agggcccgtt taaacccgct   1680 

gatcagcctc gactgtgcct tctagttgcc agccatctgt tgtttgcccc tcccccgtgc   1740 

cttccttgac cctggaaggt gccactccca ctgtcctttc ctaataaaat gaggaaattg   1800 

catcgcattg tctgagtagg tgtcattcta ttctgggggg tggggtgggg caggacagca   1860 

agggggagga ttgggaagac aatagcaggc atgctgggga tgcggtgggc tctatggctt   1920 

ctgaggcgga aagaaccagc tggggctcta gggggtatcc ccacgcgccc tgtagcggcg   1980 

cattaagcgc ggcgggtgtg gtggttacgc gcagcgtgac cgctacactt gccagcgccc   2040 

tagcgcccgc tcctttcgct ttcttccctt cctttctcgc cacgttcgcc ggctttcccc   2100 

gtcaagctct aaatcggggc atccctttag ggttccgatt tagtgcttta cggcacctcg   2160 

accccaaaaa acttgattag ggtgatggtt cacgtagtgg gccatcgccc tgatagacgg   2220 

tttttcgccc tttgacgttg gagtccacgt tctttaatag tggactcttg ttccaaactg   2280 

gaacaacact caaccctatc tcggtctatt cttttgattt ataagggatt ttggggattt   2340 

cggcctattg gttaaaaaat gagctgattt aacaaaaatt taacgcgaat taattctgtg   2400 

gaatgtgtgt cagttagggt gtggaaagtc cccaggctcc ccaggcaggc agaagtatgc   2460 

aaagcatgca tctcaattag tcagcaacca ggtgtggaaa gtccccaggc tccccagcag   2520 

gcagaagtat gcaaagcatg catctcaatt agtcagcaac catagtcccg cccctaactc   2580 

cgcccatccc gcccctaact ccgcccagtt ccgcccattc tccgccccat ggctgactaa   2640 

ttttttttat ttatgcagag gccgaggccg cctctgcctc tgagctattc cagaagtagt   2700 

gaggaggctt ttttggaggc ctaggctttt gcaaaaagct cccgggagct tgtatatcca   2760 

ttttcggatc tgatcaagag acaggatgag gatcgtttcg catgattgaa caagatggat   2820 

tgcacgcagg ttctccggcc gcttgggtgg agaggctatt cggctatgac tgggcacaac   2880 

agacaatcgg ctgctctgat gccgccgtgt tccggctgtc agcgcagggg cgcccggttc   2940 

tttttgtcaa gaccgacctg tccggtgccc tgaatgaact gcaggacgag gcagcgcggc   3000 

tatcgtggct ggccacgacg ggcgttcctt gcgcagctgt gctcgacgtt gtcactgaag   3060 

cgggaaggga ctggctgcta ttgggcgaag tgccggggca ggatctcctg tcatctcacc   3120 

ttgctcctgc cgagaaagta tccatcatgg ctgatgcaat gcggcggctg catacgcttg   3180 

atccggctac ctgcccattc gaccaccaag cgaaacatcg catcgagcga gcacgtactc   3240 

ggatggaagc cggtcttgtc gatcaggatg atctggacga agagcatcag gggctcgcgc   3300 

cagccgaact gttcgccagg ctcaaggcgc gcatgcccga cggcgaggat ctcgtcgtga   3360 

cccatggcga tgcctgcttg ccgaatatca tggtggaaaa tggccgcttt tctggattca   3420 

tcgactgtgg ccggctgggt gtggcggacc gctatcagga catagcgttg gctacccgtg   3480 

atattgctga agagcttggc ggcgaatggg ctgaccgctt cctcgtgctt tacggtatcg   3540 

ccgctcccga ttcgcagcgc atcgccttct atcgccttct tgacgagttc ttctgagcgg   3600 

gactctgggg ttcgaaatga ccgaccaagc gacgcccaac ctgccatcac gagatttcga   3660 

ttccaccgcc gccttctatg aaaggttggg cttcggaatc gttttccggg acgccggctg   3720 

gatgatcctc cagcgcgggg atctcatgct ggagttcttc gcccacccca acttgtttat   3780 

tgcagcttat aatggttaca aataaagcaa tagcatcaca aatttcacaa ataaagcatt   3840 

tttttcactg cattctagtt gtggtttgtc caaactcatc aatgtatctt atcatgtctg   3900 

tataccgtcg acctctagct agagcttggc gtaatcatgg tcatagctgt ttcctgtgtg   3960 

aaattgttat ccgctcacaa ttccacacaa catacgagcc ggaagcataa agtgtaaagc   4020 

ctggggtgcc taatgagtga gctaactcac attaattgcg ttgcgctcac tgcccgcttt   4080 

ccagtcggga aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg cggggagagg   4140 

cggtttgcgt attgggcgct cttccgcttc ctcgctcact gactcgctgc gctcggtcgt   4200 

tcggctgcgg cgagcggtat cagctcactc aaaggcggta atacggttat ccacagaatc   4260 

aggggataac gcaggaaaga acatgtgagc aaaaggccag caaaaggcca ggaaccgtaa   4320 

aaaggccgcg ttgctggcgt ttttccatag gctccgcccc cctgacgagc atcacaaaaa   4380 

tcgacgctca agtcagaggt ggcgaaaccc gacaggacta taaagatacc aggcgtttcc   4440 

ccctggaagc tccctcgtgc gctctcctgt tccgaccctg ccgcttaccg gatacctgtc   4500 

cgcctttctc ccttcgggaa gcgtggcgct ttctcaatgc tcacgctgta ggtatctcag   4560 

ttcggtgtag gtcgttcgct ccaagctggg ctgtgtgcac gaaccccccg ttcagcccga   4620 

ccgctgcgcc ttatccggta actatcgtct tgagtccaac ccggtaagac acgacttatc   4680 

gccactggca gcagccactg gtaacaggat tagcagagcg aggtatgtag gcggtgctac   4740 

agagttcttg aagtggtggc ctaactacgg ctacactaga aggacagtat ttggtatctg   4800 

cgctctgctg aagccagtta ccttcggaaa aagagttggt agctcttgat ccggcaaaca   4860 

aaccaccgct ggtagcggtg gtttttttgt ttgcaagcag cagattacgc gcagaaaaaa   4920 

aggatctcaa gaagatcctt tgatcttttc tacggggtct gacgctcagt ggaacgaaaa   4980 

ctcacgttaa gggattttgg tcatgagatt atcaaaaagg atcttcacct agatcctttt   5040 

aaattaaaaa tgaagtttta aatcaatcta aagtatatat gagtaaactt ggtctgacag   5100 

ttaccaatgc ttaatcagtg aggcacctat ctcagcgatc tgtctatttc gttcatccat   5160 

agttgcctga ctccccgtcg tgtagataac tacgatacgg gagggcttac catctggccc   5220 

cagtgctgca atgataccgc gagacccacg ctcaccggct ccagatttat cagcaataaa   5280 

ccagccagcc ggaagggccg agcgcagaag tggtcctgca actttatccg cctccatcca   5340 

gtctattaat tgttgccggg aagctagagt aagtagttcg ccagttaata gtttgcgcaa   5400 

cgttgttgcc attgctacag gcatcgtggt gtcacgctcg tcgtttggta tggcttcatt   5460 

cagctccggt tcccaacgat caaggcgagt tacatgatcc cccatgttgt gcaaaaaagc   5520 

ggttagctcc ttcggtcctc cgatcgttgt cagaagtaag ttggccgcag tgttatcact   5580 

catggttatg gcagcactgc ataattctct tactgtcatg ccatccgtaa gatgcttttc   5640 

tgtgactggt gagtactcaa ccaagtcatt ctgagaatag tgtatgcggc gaccgagttg   5700 

ctcttgcccg gcgtcaatac gggataatac cgcgccacat agcagaactt taaaagtgct   5760 

catcattgga aaacgttctt cggggcgaaa actctcaagg atcttaccgc tgttgagatc   5820 

cagttcgatg taacccactc gtgcacccaa ctgatcttca gcatctttta ctttcaccag   5880 

cgtttctggg tgagcaaaaa caggaaggca aaatgccgca aaaaagggaa taagggcgac   5940 

acggaaatgt tgaatactca tactcttcct ttttcaatat tattgaagca tttatcaggg   6000 

ttattgtctc atgagcggat acatatttga atgtatttag aaaaataaac aaataggggt   6060 

tccgcgcaca tttccccgaa aagtgccacc tgacgtc                            6097 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">13 </s210>
            <s211 class="style-scope patent-text">6094 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Plasmid </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 13 

gacggatcgg gagatctccc gatcccctat ggtcgactct cagtacaatc tgctctgatg     60 

ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg    120 

cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc    180 

ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt    240 

gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata    300 

tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc    360 

cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc    420 

attgacgtca atgggtggac tatttacggt aaactgccca cttggcagta catcaagtgt    480 

atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt    540 

atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca    600 

tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg    660 

actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc    720 

aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg    780 

gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca    840 

ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctaga    900 

aagcttggat ctcaccatgg tgttgcagac ccaggtcttc atttctctgt tactctggat    960 

ctctggtgcc tacggggaca tcgtgatgac ccagtctcca gactccctgg ctgtgtctct   1020 

gggcgagagg gccaccatca actgcaagtc caaccagagt gtcttacaca gctccaacaa   1080 

taagaactat ttagcttggt accagcagaa accaggacag cctcctaaat tgctcattta   1140 

ttgggcattc ctccgggaat ccggggtccc tgaccgcttc agtggcagcg ggtctgggac   1200 

agatttcact ctcaccatca gcagcctgca ggctgaagat gtggcagttt attactgtca   1260 

ccaatattat tctactttat atactttcgg cggagggacc aaggtagaga tcaaacgaac   1320 

ygtggctgca ccatctgtct tcatcttccc gccatctgat gagcagttga aatctggaac   1380 

tgctagcgtt gtgtgcctgc tgaataactt ctatcccaga gaggccaaag tacagtggaa   1440 

ggtggataac gccctccaat cgggtaactc ccaggagagt gtcacagagc aggacagcaa   1500 

ggacagcacc tacagcctca gcagcaccct gacgctgagc aaagcagact acgagaaaca   1560 

caaagtctac gcctgcgaag tcacccatca gggcctgagc tcgcccgtca caaagagctt   1620 

caacagggga gagtgttagg cggccgctcg agtctagagg gcccgtttaa acccgctgat   1680 

cagcctcgac tgtgccttct agttgccagc catctgttgt ttgcccctcc cccgtgcctt   1740 

ccttgaccct ggaaggtgcc actcccactg tcctttccta ataaaatgag gaaattgcat   1800 

cgcattgtct gagtaggtgt cattctattc tggggggtgg ggtggggcag gacagcaagg   1860 

gggaggattg ggaagacaat agcaggcatg ctggggatgc ggtgggctct atggcttctg   1920 

aggcggaaag aaccagctgg ggctctaggg ggtatcccca cgcgccctgt agcggcgcat   1980 

taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc agcgccctag   2040 

cgcccgctcc tttcgctttc ttcccttcct ttctcgccac gttcgccggc tttccccgtc   2100 

aagctctaaa tcggggcatc cctttagggt tccgatttag tgctttacgg cacctcgacc   2160 

ccaaaaaact tgattagggt gatggttcac gtagtgggcc atcgccctga tagacggttt   2220 

ttcgcccttt gacgttggag tccacgttct ttaatagtgg actcttgttc caaactggaa   2280 

caacactcaa ccctatctcg gtctattctt ttgatttata agggattttg gggatttcgg   2340 

cctattggtt aaaaaatgag ctgatttaac aaaaatttaa cgcgaattaa ttctgtggaa   2400 

tgtgtgtcag ttagggtgtg gaaagtcccc aggctcccca ggcaggcaga agtatgcaaa   2460 

gcatgcatct caattagtca gcaaccaggt gtggaaagtc cccaggctcc ccagcaggca   2520 

gaagtatgca aagcatgcat ctcaattagt cagcaaccat agtcccgccc ctaactccgc   2580 

ccatcccgcc cctaactccg cccagttccg cccattctcc gccccatggc tgactaattt   2640 

tttttattta tgcagaggcc gaggccgcct ctgcctctga gctattccag aagtagtgag   2700 

gaggcttttt tggaggccta ggcttttgca aaaagctccc gggagcttgt atatccattt   2760 

tcggatctga tcaagagaca ggatgaggat cgtttcgcat gattgaacaa gatggattgc   2820 

acgcaggttc tccggccgct tgggtggaga ggctattcgg ctatgactgg gcacaacaga   2880 

caatcggctg ctctgatgcc gccgtgttcc ggctgtcagc gcaggggcgc ccggttcttt   2940 

ttgtcaagac cgacctgtcc ggtgccctga atgaactgca ggacgaggca gcgcggctat   3000 

cgtggctggc cacgacgggc gttccttgcg cagctgtgct cgacgttgtc actgaagcgg   3060 

gaagggactg gctgctattg ggcgaagtgc cggggcagga tctcctgtca tctcaccttg   3120 

ctcctgccga gaaagtatcc atcatggctg atgcaatgcg gcggctgcat acgcttgatc   3180 

cggctacctg cccattcgac caccaagcga aacatcgcat cgagcgagca cgtactcgga   3240 

tggaagccgg tcttgtcgat caggatgatc tggacgaaga gcatcagggg ctcgcgccag   3300 

ccgaactgtt cgccaggctc aaggcgcgca tgcccgacgg cgaggatctc gtcgtgaccc   3360 

atggcgatgc ctgcttgccg aatatcatgg tggaaaatgg ccgcttttct ggattcatcg   3420 

actgtggccg gctgggtgtg gcggaccgct atcaggacat agcgttggct acccgtgata   3480 

ttgctgaaga gcttggcggc gaatgggctg accgcttcct cgtgctttac ggtatcgccg   3540 

ctcccgattc gcagcgcatc gccttctatc gccttcttga cgagttcttc tgagcgggac   3600 

tctggggttc gaaatgaccg accaagcgac gcccaacctg ccatcacgag atttcgattc   3660 

caccgccgcc ttctatgaaa ggttgggctt cggaatcgtt ttccgggacg ccggctggat   3720 

gatcctccag cgcggggatc tcatgctgga gttcttcgcc caccccaact tgtttattgc   3780 

agcttataat ggttacaaat aaagcaatag catcacaaat ttcacaaata aagcattttt   3840 

ttcactgcat tctagttgtg gtttgtccaa actcatcaat gtatcttatc atgtctgtat   3900 

accgtcgacc tctagctaga gcttggcgta atcatggtca tagctgtttc ctgtgtgaaa   3960 

ttgttatccg ctcacaattc cacacaacat acgagccgga agcataaagt gtaaagcctg   4020 

gggtgcctaa tgagtgagct aactcacatt aattgcgttg cgctcactgc ccgctttcca   4080 

gtcgggaaac ctgtcgtgcc agctgcatta atgaatcggc caacgcgcgg ggagaggcgg   4140 

tttgcgtatt gggcgctctt ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg   4200 

gctgcggcga gcggtatcag ctcactcaaa ggcggtaata cggttatcca cagaatcagg   4260 

ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa   4320 

ggccgcgttg ctggcgtttt tccataggct ccgcccccct gacgagcatc acaaaaatcg   4380 

acgctcaagt cagaggtggc gaaacccgac aggactataa agataccagg cgtttccccc   4440 

tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat acctgtccgc   4500 

ctttctccct tcgggaagcg tggcgctttc tcaatgctca cgctgtaggt atctcagttc   4560 

ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa ccccccgttc agcccgaccg   4620 

ctgcgcctta tccggtaact atcgtcttga gtccaacccg gtaagacacg acttatcgcc   4680 

actggcagca gccactggta acaggattag cagagcgagg tatgtaggcg gtgctacaga   4740 

gttcttgaag tggtggccta actacggcta cactagaagg acagtatttg gtatctgcgc   4800 

tctgctgaag ccagttacct tcggaaaaag agttggtagc tcttgatccg gcaaacaaac   4860 

caccgctggt agcggtggtt tttttgtttg caagcagcag attacgcgca gaaaaaaagg   4920 

atctcaagaa gatcctttga tcttttctac ggggtctgac gctcagtgga acgaaaactc   4980 

acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga tccttttaaa   5040 

ttaaaaatga agttttaaat caatctaaag tatatatgag taaacttggt ctgacagtta   5100 

ccaatgctta atcagtgagg cacctatctc agcgatctgt ctatttcgtt catccatagt   5160 

tgcctgactc cccgtcgtgt agataactac gatacgggag ggcttaccat ctggccccag   5220 

tgctgcaatg ataccgcgag acccacgctc accggctcca gatttatcag caataaacca   5280 

gccagccgga agggccgagc gcagaagtgg tcctgcaact ttatccgcct ccatccagtc   5340 

tattaattgt tgccgggaag ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt   5400 

tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag   5460 

ctccggttcc caacgatcaa ggcgagttac atgatccccc atgttgtgca aaaaagcggt   5520 

tagctccttc ggtcctccga tcgttgtcag aagtaagttg gccgcagtgt tatcactcat   5580 

ggttatggca gcactgcata attctcttac tgtcatgcca tccgtaagat gcttttctgt   5640 

gactggtgag tactcaacca agtcattctg agaatagtgt atgcggcgac cgagttgctc   5700 

ttgcccggcg tcaatacggg ataataccgc gccacatagc agaactttaa aagtgctcat   5760 

cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag   5820 

ttcgatgtaa cccactcgtg cacccaactg atcttcagca tcttttactt tcaccagcgt   5880 

ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg   5940 

gaaatgttga atactcatac tcttcctttt tcaatattat tgaagcattt atcagggtta   6000 

ttgtctcatg agcggataca tatttgaatg tatttagaaa aataaacaaa taggggttcc   6060 

gcgcacattt ccccgaaaag tgccacctga cgtc                               6094 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">14 </s210>
            <s211 class="style-scope patent-text">481 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 14 

ggatctcacc atggagttgg gactgcgctg gggcttcctc gttgctcttt taagaggtgt     60 

ccagtgtcag gtgcaattgg tggagtctgg gggaggcgtg gtccagcctg ggaggtccct    120 

gagactctcc tgtgcagcgt ctggattcgc cttcagtaga tatggcatgc actgggtccg    180 

ccaggctcca ggcaaggggc tggagtgggt ggcagttata tggtatgatg gaagtaataa    240 

atactatgca gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac    300 

gcagtatctg caaatgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag    360 

aggcggtgac ttcctctact actactatta cggtatggac gtctggggcc aagggaccac    420 

ggtcaccgtc tcctcagcct ccaccaaggg cccatcggtc ttccccctgg caccctctag    480 

c                                                                    481 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">15 </s210>
            <s211 class="style-scope patent-text">142 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 15 

Met Glu Leu Gly Leu Arg Trp Gly Phe Leu Val Ala Leu Leu Arg Gly 
1               5                   10                  15 

Val Gln Cys Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln 
            20                  25                  30 

Pro Gly Arg Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ala Phe 
        35                  40                  45 

Ser Arg Tyr Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60 

Glu Trp Val Ala Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala 
65                  70                  75                  80 

Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn 
                85                  90                  95 

Thr Gln Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val 
            100                 105                 110 

Tyr Tyr Cys Ala Arg Gly Gly Asp Phe Leu Tyr Tyr Tyr Tyr Tyr Gly 
        115                 120                 125 

Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
    130                 135                 140 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">16 </s210>
            <s211 class="style-scope patent-text">463 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 16 

ggatctcacc atgagggtcc ctgctcagct cctgggactc ctgctgctct ggctcccaga     60 

taccagatgt gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga    120 

cagagtcacc atcacttgcc gggcgagtca gggcattagc aattatttag cctggtatca    180 

gcagaaaaca gggaaagttc ctaagttcct gatctatgaa gcatccactt tgcaatcagg    240 

ggtcccatct cggttcagtg gcggtggatc tgggacagat ttcactctca ccatcagcag    300 

cctgcagcct gaagatgttg caacttatta ctgtcaaaat tataacagtg ccccattcac    360 

tttcggccct gggaccaaag tggatatcaa acgaactgtg gctgcaccct ctgtcttcat    420 

cttcccgcca tctgatgagc agttgaaatc tggaactgct agc                      463 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">17 </s210>
            <s211 class="style-scope patent-text">127 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 17 

Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Leu Leu Trp Leu Pro 
1               5                   10                  15 

Asp Thr Arg Cys Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser 
            20                  25                  30 

Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly 
        35                  40                  45 

Ile Ser Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Thr Gly Lys Val Pro 
    50                  55                  60 

Lys Phe Leu Ile Tyr Glu Ala Ser Thr Leu Gln Ser Gly Val Pro Ser 
65                  70                  75                  80 

Arg Phe Ser Gly Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
                85                  90                  95 

Ser Leu Gln Pro Glu Asp Val Ala Thr Tyr Tyr Cys Gln Asn Tyr Asn 
            100                 105                 110 

Ser Ala Pro Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
        115                 120                 125 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">18 </s210>
            <s211 class="style-scope patent-text">508 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 18 

ggatctcacc atggggtcaa ccgccatcct caccatggag ttggggctgc gctgggttct     60 

cctcgttgct cttttaagag gtgtccagtg tcaggtgcag ctggtggagt ctgggggagg    120 

cgtggtccag cctgggaggt ccctgagact ctcctgtgca gcgtctggat tcaccttcag    180 

taactatgtc atgcactggg tccgccaggc tccaggcaag gggctggagt gggtggcaat    240 

tatatggtat gatggaagta ataaatacta tgcagactcc gtgaagggcc gattcaccat    300 

ctccagagac aattccaaga acacgctgta tctgcaaatg aacagcctga gagccgagga    360 

cacggctgtg tattactgtg cgggtggata taactggaac tacgagtacc actactacgg    420 

tatggacgtc tggggccaag ggaccacggt caccgtctcc tcagcctcca ccaagggccc    480 

atcggtcttc cccctggcac cctctagc                                       508 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">19 </s210>
            <s211 class="style-scope patent-text">143 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sap<figure-callout id="19" label="iens" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">iens</a></figure-callout> </s213>
          </s200>
          <s400 class="style-scope patent-text"> 19 

Met Glu Leu Gly Leu Arg Trp Val Leu Leu Val Ala Leu Leu Arg Gly 
1               5                   10                  15 

Val Gln Cys Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln 
            20                  25                  30 

Pro Gly Arg Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
        35                  40                  45 

Ser Asn Tyr Val Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60 

Glu Trp Val Ala Ile Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala 
65                  70                  75                  80 

Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn 
                85                  90                  95 

Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val 
            100                 105                 110 

Tyr Tyr Cys Ala Gly Gly Tyr Asn Trp Asn Tyr Glu Tyr His Tyr Tyr 
        115                 120                 125 

Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
    130                 135                 140 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">20 </s210>
            <s211 class="style-scope patent-text">463 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) <figure-callout id="20" label="cloning junction" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00007.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cloning junction</a></figure-callout> </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 20 

ggatctcacc atgagggtcc ccgctcagct cctggggctc ctgctgctct gtttcccagg     60 

tgccagatgt gacatccaga tgacccagtc tccatcctca ctgtctgcat <figure-callout id="120" label="ctgtaggaga" filenames="US20040161776A1-20040819-D00010.png,US20040161776A1-20040819-D00031.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ctgtaggaga</a></figure-callout>    120 

cagagtcacc atcacttgtc gggcgagtca gggcattacc aattatttag cctggtttca    180 

gcagaaacca gggaaagccc ctaagtccct tatctatgct gcatccagtt tgcaaagtgg    240 

ggtcccatca aagttcagcg gcagtggatc tgggacagat ttcagtctca ccatcagcag    300 

cctgcagcct gaagattttg caacttatta ctgccaacag tataatagtt acccgatcac    360 

cttcggccaa gggacacgac tggagattaa acgaactgtg gctgcaccat ctgtcttcat    420 

cttcccgcca tctgatgagc agttgaaatc tggaactgct agc                      463 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">21 </s210>
            <s211 class="style-scope patent-text">127 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 21 

Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Leu Leu Cys Phe Pro 
1               5                   10                  15 

Gly Ala Arg Cys Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser 
            20                  25                  30 

Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly 
        35                  40                  45 

Ile Thr Asn Tyr Leu Ala Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro 
    50                  55                  60 

Lys Ser Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser 
65                  70                  75                  80 

Lys Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser 
                85                  90                  95 

Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn 
            100                 105                 110 

Ser Tyr Pro Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
        115                 120                 125 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">22 </s210>
            <s211 class="style-scope patent-text">490 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 22 

ggatctcacc atggagttgg gacttagctg ggttttcctc gttgctcttt taagaggtgt     60 

ccagtgtcag gtccagctgg tggagtctgg gggaggcgtg gtccagcctg ggaggtccct    120 

gagactctcc tgtgcagcgt ctggattcac cttcagtagc tatggcatgc actgggtccg    180 

ccaggctcca ggcaaggggc tggactgggt ggcaattatt tggcatgatg gaagtaataa    240 

atactatgca gactccgtga agggccgatt caccatctcc agagacaatt <figure-callout id="300" label="ccaagaagac" filenames="US20040161776A1-20040819-D00036.png,US20040161776A1-20040819-D00043.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ccaagaagac</a></figure-callout>    300 

gctgtacctg caaatgaaca gtttgagagc cgaggacacg gctgtgtatt actgtgcgag    360 

agcttgggcc tatgactacg gtgactatga atactacttc ggtatggacg tctggggcca    420 

agggaccacg gtcaccgtct cctcagcctc caccaagggc ccatcggtct tccccctggc    480 

accctctagc                                                           490 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">23 </s210>
            <s211 class="style-scope patent-text">145 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 23 

Met Glu Leu Gly Leu Ser Trp Val Phe Leu Val Ala Leu Leu Arg Gly 
1               5                   10                  15 

Val Gln Cys Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln 
            20                  25                  30 

Pro Gly Arg Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr <figure-callout id="35" label="Phe" filenames="US20040161776A1-20040819-D00047.png,US20040161776A1-20040819-D00054.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Phe</a></figure-callout> 
        35                  40                  45 

Ser Ser Tyr Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60 

Asp Trp Val Ala Ile Ile Trp His Asp Gly Ser Asn Lys Tyr Tyr Ala 
65                  70                  75                  80 

Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys 
                85                  90                  95 

Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val 
            100                 105                 110 

Tyr Tyr Cys Ala Arg Ala Trp Ala Tyr Asp Tyr Gly Asp Tyr Glu Tyr 
        115                 120                 125 

Tyr Phe Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
    130                 135                 140 

<figure-callout id="145" label="Ser" filenames="US20040161776A1-20040819-D00004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Ser</a></figure-callout> 
145 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">24 </s210>
            <s211 class="style-scope patent-text">463 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) <figure-callout id="24" label="cloning junction" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cloning junction</a></figure-callout> </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 24 

ggatctcacc atgagggtcc ctgctcagct cctggggctc ctgctgctct gtttcccagg     60 

tgccagatgt gacatccaga tgacccagtc tccatcctca <figure-callout id="120" label="ctgtctgcat ctgtaggaga" filenames="US20040161776A1-20040819-D00010.png,US20040161776A1-20040819-D00031.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">ctgtctgcat ctgtaggaga</a></figure-callout>    120 

cagagtcacc atcacttgtc gggcgagtca gggcattagc cattatttag cctggtttca    180 

gcagaaacca gggaaagccc ctaagtccct gatctatgct gcatccagtt tgcaaagtgg    240 

ggtcccatca aagttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag    300 

cctacagcct gaagattttg caacttatta ctgccaacag tataatagtt tcccgctcac    360 

tttcggcgga gggaccaagg tggagatcaa acgaactgtg gctgcaccat ctgtcttcat    420 

cttcccgcca tctgatgagc agttgaaatc tggaactgct agc                      463 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">25 </s210>
            <s211 class="style-scope patent-text">127 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 25 

Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Leu Leu Cys Phe Pro 
1               5                   10                  15 

Gly Ala Arg Cys Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser 
            20                  25                  30 

Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly 
        35                  40                  45 

Ile Ser His Tyr Leu Ala Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro 
    50                  55                  60 

Lys Ser Leu Ile Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser 
65                  70                  75                  80 

Lys Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser 
                85                  90                  95 

Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn 
            100                 105                 110 

Ser Phe Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
        115                 120                 125 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">26 </s210>
            <s211 class="style-scope patent-text">469 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 26 

ggatcccacc atggggtcaa ccgtcatcct cgccctcctc ctggctgttc tccaaggagt     60 

ctgtgccgag gtgcagctgg tgcagtctgg agcagaggtg aaaaagcccg <figure-callout id="120" label="gggagtctct" filenames="US20040161776A1-20040819-D00010.png,US20040161776A1-20040819-D00031.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">gggagtctct</a></figure-callout>    120 

gaagatctcc tgtaagggtt ctggatacag ctttaccagt tactggatcg gctgggtgcg    180 

ccagatgccc gggaaaggcc tggagtggat ggggatcatc tatcctggtg actctgatac    240 

cagatacagc ccgtccttcc aaggccaggt caccatctca gccgacaagt ccatcagcac    300 

cgcctacctg cagtggagca gcctgaaggc ctcggacacc gccatgtatt actgtgcgag    360 

acggatggca gcagctggcc cctttgacta ctggggccag ggaaccctgg tcaccgtctc    420 

ctcagcctcc accaagggcc catcggtctt ccccctggca ccctctagc                469 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">27 </s210>
            <s211 class="style-scope patent-text">138 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 27 

Met Gly Ser Thr Val Ile Leu Ala Leu Leu Leu Ala Val Leu Gln Gly 
1               5                   10                  15 

Val Cys Ala Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys 
            20                  25                  30 

Pro Gly Glu Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe 
        35                  40                  45 

Thr Ser Tyr Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu 
    50                  55                  60 

Glu Trp Met Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser 
65                  70                  75                  80 

Pro Ser Phe Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser 
                85                  90                  95 

Thr Ala Tyr Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met 
            100                 105                 110 

Tyr Tyr Cys Ala Arg Arg Met Ala Ala Ala Gly Pro Phe Asp Tyr Trp 
        115                 120                 125 

Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
    130                 135 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">28 </s210>
            <s211 class="style-scope patent-text">466 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) <figure-callout id="28" label="cloning junction" filenames="US20040161776A1-20040819-D00055.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cloning junction</a></figure-callout> </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 28 

ggatctcacc atgagggtcc ccgctcagct tctcttcctt ctgctactct ggctcccaga     60 

taccactgga ggaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga    120 

aagagccacc ctctcctgca ggaccagtca gagtattggc tggaacttag cctggtacca    180 

acagaaacct ggccaggctc ccaggctcct catctatggt gcatcttcca ggaccactgg    240 

tatcccagcc aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag    300 

cctgcagtct gaagattctg cagtttatta ctgtcagcat tatgataact ggcccatgtg    360 

cagttttggc caggggaccg agctggagat caaacgaact gtggctgcac catctgtctt    420 

catcttcccg ccatctgatg agcagttgaa atctggaact gctagc                   466 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">29 </s210>
            <s211 class="style-scope patent-text">128 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 29 

Met Arg Val Pro Ala Gln Leu Leu Phe Leu Leu Leu Leu Trp Leu Pro 
1               5                   10                  15 

Asp Thr Thr Gly Gly Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser 
            20                  25                  30 

Val Ser Pro Gly Glu Arg Ala Thr Leu Ser Cys Arg Thr Ser Gln Ser 
        35                  40                  45 

Ile Gly Trp Asn Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro 
    50                  55                  60 

Arg Leu Leu Ile Tyr Gly Ala Ser Ser Arg Thr Thr Gly Ile Pro Ala 
65                  70                  75                  80 

Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser 
                85                  90                  95 

Ser Leu Gln Ser Glu Asp Ser Ala Val Tyr Tyr Cys Gln His Tyr <figure-callout id="100" label="Asp" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00004.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Asp</a></figure-callout> 
            100                 105                 110 

Asn Trp Pro Met Cys Ser Phe Gly Gln Gly Thr Glu Leu Glu Ile Lys 
        115                 120                 125 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">30 </s210>
            <s211 class="style-scope patent-text">487 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) <figure-callout id="30" label="cloning junction" filenames="US20040161776A1-20040819-D00001.png,US20040161776A1-20040819-D00011.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cloning junction</a></figure-callout> </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 30 

ggatctcacc atggagtttg ggctgtgctg gattttcctc gttgctcttt taagaggtgt     60 

ccagtgtcag gtgcagctgg tggagtctgg gggaggcgtg gtccagcctg ggaggtccct    120 

gagactctcc tgtgcagcct ctggattcac cttcattagc tatggcatgc actgggtccg    180 

ccaggctcca ggcaaggggc tggagtgggt ggcagttata tcatatgatg gaagtaataa    240 

atactatgca gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac    300 

gctgtatctg caaatgaaca gcctgagagc tgaggacacg gctgtgtatt actgtgcgag    360 

agtattagtg ggagctttat attattataa ctactacggg atggacgtct ggggccaagg    420 

gaccacggtc accgtctcct cagcctccac caagggccca tcggtcttcc ccctggcacc    480 

ctctagc                                                              487 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">31 </s210>
            <s211 class="style-scope patent-text">144 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 31 

Met Glu Phe Gly Leu Cys Trp Ile Phe Leu Val Ala Leu Leu Arg Gly 
1               5                   10                  15 

Val Gln Cys Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln 
            20                  25                  30 

Pro Gly Arg Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe 
        35                  40                  45 

Ile Ser Tyr Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu 
    50                  55                  60 

Glu Trp Val Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala 
65                  70                  75                  80 

Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn 
                85                  90                  95 

Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val 
            100                 105                 110 

Tyr Tyr Cys Ala Arg Val Leu Val Gly Ala Leu Tyr Tyr Tyr Asn Tyr 
        115                 120                 125 

Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
    130                 135                 140 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">32 </s210>
            <s211 class="style-scope patent-text">478 </s211>
            <s212 class="style-scope patent-text">DNA </s212>
            <s213 class="style-scope patent-text">Artificial Sequence </s213>
            <s220 class="style-scope patent-text">
              <s223 class="style-scope patent-text">Includes BamHI/Bg1II cloning junction, signal 
      peptide, V region, portion of C region and 3XbaI/NheI (heavy) or 
      NheI (light) cloning junction </s223>
            </s220>
          </s200>
          <s400 class="style-scope patent-text"> 32 

ggatctcacc atgagggtcc ctgctcagct cctggggctg ctaatgctct ggatacctgg     60 

atccagtgca gatattgtga tgacccagac tccactctct ctgtccgtca cccctggaca    120 

gccggcctcc atctcctgca agtctagtca gagcctcctg catagtgatg gaaagacctt    180 

tttgtattgg tatctgcaga agccaggcca gcctccacag ctcctgatct atgaggtttc    240 

caaccggttc tctggagtgc cagataggtt cagtggcagc gggtcaggga <figure-callout id="300" label="cagatttcac" filenames="US20040161776A1-20040819-D00036.png,US20040161776A1-20040819-D00043.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">cagatttcac</a></figure-callout>    300 

actgaaaatc agccgggtgg aggctgagga tgttgggctt tattactgca tgcaaagtat    360 

acagcttccg ctcactttcg gcggagggac caaggtggag atcaaacgaa ctgtggctgc    420 

accatctgtc ttcatcttcc cgccatctga tgagcagttg aaatctggaa ctgctagc      478 

</s400>
          <s200 class="style-scope patent-text">
            <s210 class="style-scope patent-text">33 </s210>
            <s211 class="style-scope patent-text">132 </s211>
            <s212 class="style-scope patent-text">PRT </s212>
            <s213 class="style-scope patent-text">Homo sapiens </s213>
          </s200>
          <s400 class="style-scope patent-text"> 33 

Met Arg Val Pro Ala Gln Leu Leu Gly Leu Leu Met Leu Trp Ile Pro 
1               5                   10                  15 

Gly Ser Ser Ala Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser 
            20                  25                  30 

Val Thr Pro Gly Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser 
        35                  40                  45 

Leu Leu His Ser Asp Gly Lys Thr Phe Leu Tyr Trp Tyr Leu Gln Lys 
    50                  55                  60 

Pro Gly Gln Pro Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe 
65                  70                  75                  80 

Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
                85                  90                  95 

Thr Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Leu Tyr Tyr 
            100                 105                 110 

Cys Met Gln Ser Ile Gln Leu Pro Leu Thr Phe Gly Gly Gly Thr Lys 
        115                 120                 125 

Val Glu Ile Lys 
    130
</s400>
        </sequence-list-new-rules>
      </sequence-cwu>
    </div>
  </li> </ul>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(193)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM60518231" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <div class="claim style-scope patent-text"> <div num="1" id="US-20040161776-A1-CLM-00001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">1</b>. A composition comprising isolated PSMA protein, wherein at least 5% of the isolated PSMA protein is an isolated PSMA protein multimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="2" id="US-20040161776-A1-CLM-00002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">2</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein the isolated PSMA protein multimer is an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="3" id="US-20040161776-A1-CLM-00003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">3</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein the isolated PSMA protein dimer comprises a fragment of full-length PSMA (SEQ ID NO: 1). </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="4" id="US-20040161776-A1-CLM-00004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">4</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein the isolated PSMA protein dimer comprises a fragment of the extracellular portion of PSMA (amino acids 44-750 of SEQ ID NO: 1). </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="5" id="US-20040161776-A1-CLM-00005" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">5</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00003" class="style-scope patent-text">claim 3</claim-ref>, wherein the fragment comprises amino acids 58-750 of SEQ ID NO: 1. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="6" id="US-20040161776-A1-CLM-00006" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">6</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00003" class="style-scope patent-text">claim 3</claim-ref>, wherein the fragment comprises amino acids 44-750 of SEQ ID NO: 1. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="7" id="US-20040161776-A1-CLM-00007" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">7</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00003" class="style-scope patent-text">claim 3</claim-ref>, wherein the fragment comprises amino acids 601-750 of SEQ ID NO: 1. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="8" id="US-20040161776-A1-CLM-00008" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">8</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein at least 25% of the isolated PSMA protein is in the form of an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="9" id="US-20040161776-A1-CLM-00009" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">9</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein at least 50% of the isolated PSMA protein is in the form of an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="10" id="US-20040161776-A1-CLM-00010" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">10</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein at least 75% of the isolated PSMA protein is in the form of an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="11" id="US-20040161776-A1-CLM-00011" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">11</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein at least 90% of the isolated PSMA protein is in the form of an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="12" id="US-20040161776-A1-CLM-00012" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">12</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein at least 95% of the isolated PSMA protein is in the form of an isolated PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="13" id="US-20040161776-A1-CLM-00013" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">13</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">12</b>, wherein the composition further comprises at least 0.25 molar equivalents of metal ion to PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="14" id="US-20040161776-A1-CLM-00014" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">14</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00013" class="style-scope patent-text">claim 13</claim-ref>, wherein the composition comprises at least 0.5 molar equivalents of metal ion to PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="15" id="US-20040161776-A1-CLM-00015" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">15</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00013" class="style-scope patent-text">claim 13</claim-ref>, wherein the composition comprises at least 1 molar equivalent of metal ion to PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="16" id="US-20040161776-A1-CLM-00016" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">16</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00013" class="style-scope patent-text">claim 13</claim-ref>, wherein the composition comprises a molar excess of metal ion to PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="17" id="US-20040161776-A1-CLM-00017" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">17</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">16</b>, wherein the composition is in a liquid or lyophilized form. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="18" id="US-20040161776-A1-CLM-00018" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">18</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">17</b>, wherein the composition further comprises an adjuvant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="19" id="US-20040161776-A1-CLM-00019" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">19</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00018" class="style-scope patent-text">claim 18</claim-ref>, wherein the adjuvant is alum, monophosphoryl lipid A, a saponin, an immunostimulatory oligonucleotide, incomplete Freund's adjuvant, complete Freund's adjuvant, montanide, vitamin E, a water-in-oil emulsions prepared from a biodegradable oil, Quil A, a MPL and mycobacterial cell wall skeleton combination, ENHANZYN, CRL-1005, L-121, alpha-galactosylceramide or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="20" id="US-20040161776-A1-CLM-00020" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">20</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00019" class="style-scope patent-text">claim 19</claim-ref>, wherein the adjuvant is alum. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="21" id="US-20040161776-A1-CLM-00021" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">21</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b>, wherein the composition further comprises a cytokine. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="22" id="US-20040161776-A1-CLM-00022" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">22</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition is sterile. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="23" id="US-20040161776-A1-CLM-00023" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">23</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition is free of chelating agents. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="24" id="US-20040161776-A1-CLM-00024" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">24</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition further comprises at least one buffer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="25" id="US-20040161776-A1-CLM-00025" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">25</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00024" class="style-scope patent-text">claim 24</claim-ref>, wherein the at least one buffer is PBS (phosphate buffered saline), citric acid, sodium citrate, sodium acetate, acetic acid, sodium phosphate, phosphoric acid, sodium ascorbate, tartartic acid, maleic acid, glycine, sodium lactate, lactic acid, ascorbic acid, imidazole, sodium bicarbonate, carbonic acid, sodium succinate, succinic acid, histidine, sodium benzoate, benzoic acid or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="26" id="US-20040161776-A1-CLM-00026" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">26</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition further comprises a free amino acid, wherein the free amino acid is naturally occurring or non-naturally occurring. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="27" id="US-20040161776-A1-CLM-00027" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">27</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00026" class="style-scope patent-text">claim 26</claim-ref>, wherein the naturally occurring or non-naturally occurring free amino acid is a non-acidic free amino acid. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="28" id="US-20040161776-A1-CLM-00028" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">28</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00027" class="style-scope patent-text">claim 27</claim-ref>, wherein the non-acidic free amino acid is glycine, proline, isoleucine, leucine, alanine, arginine or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="29" id="US-20040161776-A1-CLM-00029" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">29</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition further comprises a surfactant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="30" id="US-20040161776-A1-CLM-00030" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">30</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00029" class="style-scope patent-text">claim 29</claim-ref>, wherein the surfactant is Tween20, Tween80, Triton X-100, dodecylmaltoside, cholic acid, CHAPS or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="31" id="US-20040161776-A1-CLM-00031" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">31</b>. The composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">18</b> and <b class="style-scope patent-text">21</b>, wherein the composition further comprises a cryoprotectant, an antioxidant, a preservative or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="32" id="US-20040161776-A1-CLM-00032" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">32</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00031" class="style-scope patent-text">claim 31</claim-ref>, wherein the cryoprotectant is a sugar, a polyol, an amino acid, a polymer, an inorganic salt, an organic salt, trimethylamine N-oxide, sarcosine, betaine, gamma-aminobutyric acid, octapine, alanopine, strombine, dimethylsulfoxide or ethanol. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="33" id="US-20040161776-A1-CLM-00033" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">33</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the sugar is sucrose, lactose, glucose, trehalose or maltose. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="34" id="US-20040161776-A1-CLM-00034" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">34</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the polyol is inositol, ethylene glycol, glycerol, sorbitol, xylitol, mannitol or 2-methyl-2,4-pentane-diol. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="35" id="US-20040161776-A1-CLM-00035" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">35</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the amino acid is Na glutamate, proline, alpha-alanine, beta-alanine, glycine, lysine-HCl or 4-hydroxyproline. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="36" id="US-20040161776-A1-CLM-00036" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">36</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the polymer is polyethylene glycol, dextran or polyvinylpyrrolidone. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="37" id="US-20040161776-A1-CLM-00037" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">37</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the inorganic salt is sodium sulfate, ammonium sulfate, potassium phosphate, magnesium sulfate or sodium fluoride. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="38" id="US-20040161776-A1-CLM-00038" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">38</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00032" class="style-scope patent-text">claim 32</claim-ref>, wherein the organic salt is sodium acetate, sodium polyethylene, sodium caprylate, proprionate, lactate or succinate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="39" id="US-20040161776-A1-CLM-00039" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">39</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00031" class="style-scope patent-text">claim 31</claim-ref>, where the antioxidant is ascorbic acid, an ascorbic acid derivative, butylated hydroxy anisole, butylated hydroxy toluene, alkylgallate, dithiothreitol (DTT), sodium meta-bisulfite, sodium bisulfite, sodium dithionite, sodium thioglycollic acid, sodium formaldehyde sulfoxylate, tocopherol, a tocopherol derivative, monothioglycerol or sodium sulfite. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="40" id="US-20040161776-A1-CLM-00040" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">40</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00039" class="style-scope patent-text">claim 39</claim-ref>, wherein the ascorbic acid derivative is ascorbylpalmitate, ascorbylstearate, sodium ascorbate or calcium ascorbate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="41" id="US-20040161776-A1-CLM-00041" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">41</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00039" class="style-scope patent-text">claim 39</claim-ref>, wherein the tocopherol derivative is d-alpha tocopherol, d-alpha tocopherol acetate, dl-alpha tocopherol acetate, d-alpha tocopherol succinate, beta tocopherol, delta tocopherol, gamma tocopherol or d-alpha tocopherol polyoxyethylene glycol 1000 succinate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="42" id="US-20040161776-A1-CLM-00042" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">42</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00031" class="style-scope patent-text">claim 31</claim-ref>, wherein the preservative is benzalkonium chloride, chlorobutanol, parabens, thimerosal, benzyl alcohol or phenol. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="43" id="US-20040161776-A1-CLM-00043" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">43</b>. A composition comprising isolated multimeric PSMA protein, wherein the composition comprises less than 35% of a monomeric PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="44" id="US-20040161776-A1-CLM-00044" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">44</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00043" class="style-scope patent-text">claim 43</claim-ref>, wherein the isolated multimeric PSMA protein is an isolated dimeric PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="45" id="US-20040161776-A1-CLM-00045" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">45</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00043" class="style-scope patent-text">claim 43</claim-ref> or <b class="style-scope patent-text">44</b>, wherein the composition comprises less than 20% of the monomeric PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="46" id="US-20040161776-A1-CLM-00046" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">46</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00045" class="style-scope patent-text">claim 45</claim-ref>, wherein the composition comprises less than 15% of the monomeric PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="47" id="US-20040161776-A1-CLM-00047" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">47</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00046" class="style-scope patent-text">claim 46</claim-ref>, wherein the composition comprises less than 5% of the monomeric PSMA protein. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="48" id="US-20040161776-A1-CLM-00048" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">48</b>. A composition comprising PSMA protein in a solution that promotes or preserves multimeric association of PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="49" id="US-20040161776-A1-CLM-00049" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">49</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00048" class="style-scope patent-text">claim 48</claim-ref>, wherein the solution that promotes or preserves multimeric association of PSMA protein is a solution that promotes or preserves dimeric association of PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="50" id="US-20040161776-A1-CLM-00050" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">50</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00048" class="style-scope patent-text">claim 48</claim-ref> or <b class="style-scope patent-text">49</b>, wherein the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 4 to 8. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="51" id="US-20040161776-A1-CLM-00051" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">51</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00050" class="style-scope patent-text">claim 50</claim-ref>, wherein the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="52" id="US-20040161776-A1-CLM-00052" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">52</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00051" class="style-scope patent-text">claim 51</claim-ref>, wherein the solution that promotes or preserves dimeric association of PSMA protein has a pH that ranges from 5.5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="53" id="US-20040161776-A1-CLM-00053" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">53</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00051" class="style-scope patent-text">claim 51</claim-ref>, wherein the solution that promotes or preserves dimeric association of PSMA protein has a pH of 6. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="54" id="US-20040161776-A1-CLM-00054" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">54</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">53</b>, wherein the solution that promotes or preserves dimeric association of PSMA protein comprises a salt. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="55" id="US-20040161776-A1-CLM-00055" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">55</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00054" class="style-scope patent-text">claim 54</claim-ref>, wherein the cationic component of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and wherein the anionic component of the salt is chloride, sulfate, acetate or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="56" id="US-20040161776-A1-CLM-00056" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">56</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00055" class="style-scope patent-text">claim 55</claim-ref>, wherein the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="57" id="US-20040161776-A1-CLM-00057" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">57</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00056" class="style-scope patent-text">claim 56</claim-ref>, wherein the salt is present at a concentration in the range of 50 mM to 2M. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="58" id="US-20040161776-A1-CLM-00058" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">58</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00057" class="style-scope patent-text">claim 57</claim-ref>, wherein the salt is present at a concentration in the range of 100 mM to 300 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="59" id="US-20040161776-A1-CLM-00059" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">59</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00058" class="style-scope patent-text">claim 58</claim-ref>, wherein the salt is present at a concentration of 150 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="60" id="US-20040161776-A1-CLM-00060" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">60</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00057" class="style-scope patent-text">claim 57</claim-ref>, wherein the composition further comprises an adjuvant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="61" id="US-20040161776-A1-CLM-00061" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">61</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00057" class="style-scope patent-text">claim 57</claim-ref>, wherein the composition is physiologically acceptable. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="62" id="US-20040161776-A1-CLM-00062" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">62</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">61</b>, wherein the solution that promotes or preserves dimeric association of PSMA protein comprises metal ions. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="63" id="US-20040161776-A1-CLM-00063" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">63</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00062" class="style-scope patent-text">claim 62</claim-ref>, wherein the metal ions are zinc ions, calcium ions, magnesium ions, cobalt ions, manganese ions or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="64" id="US-20040161776-A1-CLM-00064" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">64</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00063" class="style-scope patent-text">claim 63</claim-ref>, wherein the metal ions are zinc ions and calcium ions. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="65" id="US-20040161776-A1-CLM-00065" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">65</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00064" class="style-scope patent-text">claim 64</claim-ref>, wherein the zinc ions and calcium ions are present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="66" id="US-20040161776-A1-CLM-00066" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">66</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00064" class="style-scope patent-text">claim 64</claim-ref>, wherein the zinc ions are present at a concentration that is lower than the concentration of the calcium ions. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="67" id="US-20040161776-A1-CLM-00067" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">67</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00066" class="style-scope patent-text">claim 66</claim-ref>, wherein the zinc ions are present at a concentration of 0.1 mM and the calcium ions are present at a concentration of 1 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="68" id="US-20040161776-A1-CLM-00068" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">68</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00063" class="style-scope patent-text">claim 63</claim-ref>, wherein the metal ions are magnesium ions. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="69" id="US-20040161776-A1-CLM-00069" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">69</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00068" class="style-scope patent-text">claim 68</claim-ref>, wherein the magnesium ions are present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="70" id="US-20040161776-A1-CLM-00070" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">70</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00069" class="style-scope patent-text">claim 69</claim-ref>, wherein the magnesium ions are present at a concentration of 0.5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="71" id="US-20040161776-A1-CLM-00071" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">71</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the solution that promotes or preserves dimeric association of PSMA protein is free of chelating agents. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="72" id="US-20040161776-A1-CLM-00072" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">72</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition further comprises at least one buffer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="73" id="US-20040161776-A1-CLM-00073" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">73</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00072" class="style-scope patent-text">claim 72</claim-ref>, wherein the at least one buffer is PBS (phosphate buffered saline), citric acid, sodium citrate, sodium acetate, acetic acid, sodium phosphate, phosphoric acid, sodium ascorbate, tartartic acid, maleic acid, glycine, sodium lactate, lactic acid, ascorbic acid, imidazole, sodium bicarbonate, carbonic acid, sodium succinate, succinic acid, histidine, sodium benzoate, benzoic acid or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="74" id="US-20040161776-A1-CLM-00074" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">74</b>. The composition of claim <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition further comprises a free amino acid, wherein the free amino acid is naturally occurring or non-naturally occurring. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="75" id="US-20040161776-A1-CLM-00075" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">75</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00074" class="style-scope patent-text">claim 74</claim-ref>, wherein the naturally occurring or non-naturally occurring free amino acid is a non-acidic free amino acid. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="76" id="US-20040161776-A1-CLM-00076" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">76</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00075" class="style-scope patent-text">claim 75</claim-ref>, wherein the non-acidic free amino acid is glycine, proline, isoleucine, leucine, alanine, arginine or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="77" id="US-20040161776-A1-CLM-00077" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">77</b>. The composition of claim <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition further comprises a surfactant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="78" id="US-20040161776-A1-CLM-00078" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">78</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00077" class="style-scope patent-text">claim 77</claim-ref>, wherein the surfactant is Tween20, Tween80, Triton X-100, dodecylmaltoside, cholic acid, CHAPS or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="79" id="US-20040161776-A1-CLM-00079" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">79</b>. The composition of claim <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition further comprises a cryoprotectant, an antioxidant, a preservative or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="80" id="US-20040161776-A1-CLM-00080" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">80</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00079" class="style-scope patent-text">claim 79</claim-ref>, wherein the cryoprotectant is a sugar, a polyol, an amino acid, a polymer, an inorganic salt, an organic salt, trimethylamine N-oxide, sarcosine, betaine, gamma-aminobutyric acid, octapine, alanopine, strombine, dimethylsulfoxide or ethanol. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="81" id="US-20040161776-A1-CLM-00081" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">81</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the sugar is sucrose, lactose, glucose, trehalose or maltose. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="82" id="US-20040161776-A1-CLM-00082" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">82</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the polyol is inositol, ethylene glycol, glycerol, sorbitol, xylitol, mannitol or 2-methyl-2,4-pentane-diol. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="83" id="US-20040161776-A1-CLM-00083" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">83</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the amino acid is Na glutamate, proline, alpha-alanine, beta-alanine, glycine, lysine-HCl or 4-hydroxyproline. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="84" id="US-20040161776-A1-CLM-00084" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">84</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the polymer is polyethylene glycol, dextran or polyvinylpyrrolidone. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="85" id="US-20040161776-A1-CLM-00085" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">85</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the inorganic salt is sodium sulfate, ammonium sulfate, potassium phosphate, magnesium sulfate or sodium fluoride. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="86" id="US-20040161776-A1-CLM-00086" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">86</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00080" class="style-scope patent-text">claim 80</claim-ref>, wherein the organic salt is sodium acetate, sodium polyethylene, sodium caprylate, proprionate, lactate or succinate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="87" id="US-20040161776-A1-CLM-00087" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">87</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00079" class="style-scope patent-text">claim 79</claim-ref>, where the antioxidant is ascorbic acid, an ascorbic acid derivative, butylated hydroxy anisole, butylated hydroxy toluene, alkylgallate, dithiothreitol (DTT), sodium meta-bisulfite, sodium bisulfite, sodium dithionite, sodium thioglycollic acid, sodium formaldehyde sulfoxylate, tocopherol, a tocopherol derivative, monothioglycerol or sodium sulfite. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="88" id="US-20040161776-A1-CLM-00088" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">88</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00087" class="style-scope patent-text">claim 87</claim-ref>, wherein the ascorbic acid derivative is ascorbylpalmitate, ascorbylstearate, sodium ascorbate or calcium ascorbate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="89" id="US-20040161776-A1-CLM-00089" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">89</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00087" class="style-scope patent-text">claim 87</claim-ref>, wherein the tocopherol derivative is d-alpha tocopherol, d-alpha tocopherol acetate, dl-alpha tocopherol acetate, d-alpha tocopherol succinate, beta tocopherol, delta tocopherol, gamma tocopherol or d-alpha tocopherol polyoxyethylene glycol 1000 succinate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="90" id="US-20040161776-A1-CLM-00090" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">90</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00079" class="style-scope patent-text">claim 79</claim-ref>, wherein the preservative is benzalkonium chloride, chlorobutanol, parabens, thimerosal, benzyl alcohol or phenol. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="91" id="US-20040161776-A1-CLM-00091" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">91</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition is stable when stored at 80 C. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="92" id="US-20040161776-A1-CLM-00092" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">92</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition is stable when stored at 20 C. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="93" id="US-20040161776-A1-CLM-00093" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">93</b>. The composition of any one of claims <b class="style-scope patent-text">48</b>-<b class="style-scope patent-text">70</b>, wherein the composition is stable when stored at 4 C. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="94" id="US-20040161776-A1-CLM-00094" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">94</b>. The composition of any one of claims <b class="style-scope patent-text">39</b>-<b class="style-scope patent-text">58</b>, wherein the composition is stable when stored at room temperature. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="95" id="US-20040161776-A1-CLM-00095" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">95</b>. A composition comprising isolated PSMA protein in a solution that promotes or preserves dimeric association of PSMA protein wherein the solution comprises: 
<div class="claim-text style-scope patent-text">(a) 5 to 20 mM of sodium phosphate, sodium acetate or a combination thereof, </div> <div class="claim-text style-scope patent-text">(b) 100 to 300 mM sodium chloride or sodium sulfate, and </div> <div class="claim-text style-scope patent-text">(c) 0.1 to 2 mM of at least one metal ion. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="96" id="US-20040161776-A1-CLM-00096" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">96</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00095" class="style-scope patent-text">claim 95</claim-ref>, wherein the solution has a pH in the range of 4 to 8. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="97" id="US-20040161776-A1-CLM-00097" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">97</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00096" class="style-scope patent-text">claim 96</claim-ref>, wherein the solution has a pH in a range of 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="98" id="US-20040161776-A1-CLM-00098" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">98</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00097" class="style-scope patent-text">claim 97</claim-ref>, wherein the solution has a pH in a range of 6 to 6.5. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="99" id="US-20040161776-A1-CLM-00099" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">99</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00096" class="style-scope patent-text">claim 96</claim-ref>, wherein the composition further comprises an adjuvant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="100" id="US-20040161776-A1-CLM-00100" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">100</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00099" class="style-scope patent-text">claim 99</claim-ref>, wherein the adjuvant is alum. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="101" id="US-20040161776-A1-CLM-00101" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">101</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00095" class="style-scope patent-text">claim 95</claim-ref>, wherein the metal ion is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="102" id="US-20040161776-A1-CLM-00102" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">102</b>. A method of promoting or preserving dimeric association of PSMA protein in a solution comprising: 
<div class="claim-text style-scope patent-text">obtaining a solution of PSMA protein, and </div> <div class="claim-text style-scope patent-text">adjusting the pH to be in the range of 4 to 8. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="103" id="US-20040161776-A1-CLM-00103" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">103</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00102" class="style-scope patent-text">claim 102</claim-ref>, wherein the pH is adjusted to be in the range of 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="104" id="US-20040161776-A1-CLM-00104" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">104</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00103" class="style-scope patent-text">claim 103</claim-ref>, wherein the pH is adjusted to be in the range of 5.5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="105" id="US-20040161776-A1-CLM-00105" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">105</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00104" class="style-scope patent-text">claim 104</claim-ref>, wherein the pH is adjusted to be 6. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="106" id="US-20040161776-A1-CLM-00106" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">106</b>. A method of processing a PSMA protein comprising: 
<div class="claim-text style-scope patent-text">contacting the PSMA protein in a solution with a first agent that promotes or preserves dimeric association of PSMA protein in an amount effective to promote or preserve PSMA protein dimer formation. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="107" id="US-20040161776-A1-CLM-00107" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">107</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00106" class="style-scope patent-text">claim 106</claim-ref>, wherein the amount effective to promote or preserve PSMA protein dimer formation is enough to promote or maintain at least 5%, 25%, 50%, 75% or 95% of the PSMA protein in PSMA dimer form. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="108" id="US-20040161776-A1-CLM-00108" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">108</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00106" class="style-scope patent-text">claim 106</claim-ref>, wherein the first agent that promotes or preserves dimeric association of PSMA protein is a salt, metal ion or a pH adjusting agent. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="109" id="US-20040161776-A1-CLM-00109" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">109</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00108" class="style-scope patent-text">claim 108</claim-ref>, wherein the cationic components of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and wherein the anionic component of the salt is chloride, sulfate, acetate or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="110" id="US-20040161776-A1-CLM-00110" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">110</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00109" class="style-scope patent-text">claim 109</claim-ref>, wherein the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="111" id="US-20040161776-A1-CLM-00111" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">111</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00109" class="style-scope patent-text">claim 109</claim-ref>, wherein the salt is present at a concentration in the range of 50 mM to 2M. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="112" id="US-20040161776-A1-CLM-00112" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">112</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00111" class="style-scope patent-text">claim 111</claim-ref>, wherein the salt is present at a concentration in the range of 100 mM to 300 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="113" id="US-20040161776-A1-CLM-00113" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">113</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00111" class="style-scope patent-text">claim 111</claim-ref>, further comprising combining the PSMA protein solution with an adjuvant or diluent. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="114" id="US-20040161776-A1-CLM-00114" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">114</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00113" class="style-scope patent-text">claim 113</claim-ref>, wherein the adjuvant or diluent is combined with the PSMA protein in an amount to dilute the salt concentration to 100 mM to 300 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="115" id="US-20040161776-A1-CLM-00115" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">115</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00114" class="style-scope patent-text">claim 114</claim-ref>, wherein the salt concentration is diluted to 150 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="116" id="US-20040161776-A1-CLM-00116" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">116</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00108" class="style-scope patent-text">claim 108</claim-ref>, wherein the metal ion is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="117" id="US-20040161776-A1-CLM-00117" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">117</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00116" class="style-scope patent-text">claim 116</claim-ref>, wherein the metal ion is a combination of zinc ion and calcium ion. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="118" id="US-20040161776-A1-CLM-00118" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">118</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00117" class="style-scope patent-text">claim 117</claim-ref>, wherein the zinc ion and calcium ion are present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="119" id="US-20040161776-A1-CLM-00119" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">119</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00117" class="style-scope patent-text">claim 117</claim-ref>, wherein the zinc ion is present at a concentration that is lower than the concentration of the calcium ion. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="120" id="US-20040161776-A1-CLM-00120" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">120</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00119" class="style-scope patent-text">claim 119</claim-ref>, wherein the zinc ion is present at a concentration of 0.1 mM and the calcium ion is present at a concentration of 1 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="121" id="US-20040161776-A1-CLM-00121" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">121</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00116" class="style-scope patent-text">claim 116</claim-ref>, wherein the metal ion is a magnesium ion. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="122" id="US-20040161776-A1-CLM-00122" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">122</b>. The method of claims <b class="style-scope patent-text">121</b>, wherein the magnesium ion is present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="123" id="US-20040161776-A1-CLM-00123" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">123</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00122" class="style-scope patent-text">claim 122</claim-ref>, wherein the magnesium ion is present at a concentration of 0.5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="124" id="US-20040161776-A1-CLM-00124" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">124</b>. The method of any one of claims <b class="style-scope patent-text">108</b>-<b class="style-scope patent-text">123</b>, wherein the pH of the solution is adjusted to be in the range of 4 to 8. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="125" id="US-20040161776-A1-CLM-00125" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">125</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00124" class="style-scope patent-text">claim 124</claim-ref>, wherein the pH of the solution is adjusted to be in the range of 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="126" id="US-20040161776-A1-CLM-00126" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">126</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00125" class="style-scope patent-text">claim 125</claim-ref>, wherein the pH of the solution is adjusted to be in the range of 5.5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="127" id="US-20040161776-A1-CLM-00127" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">127</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00126" class="style-scope patent-text">claim 126</claim-ref>, wherein the pH of the solution is adjusted to be 6. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="128" id="US-20040161776-A1-CLM-00128" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">128</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00108" class="style-scope patent-text">claim 108</claim-ref>, wherein the method further comprises contacting the PSMA protein with a second agent that promotes or preserves dimeric association of PSMA protein, and wherein the second agent is different than the first agent. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="129" id="US-20040161776-A1-CLM-00129" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">129</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00128" class="style-scope patent-text">claim 128</claim-ref>, wherein the second agent that promotes or preserves dimeric association of PSMA protein is a metal ion, salt or pH adjusting agent. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="130" id="US-20040161776-A1-CLM-00130" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">130</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00129" class="style-scope patent-text">claim 129</claim-ref>, wherein the metal ion is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="131" id="US-20040161776-A1-CLM-00131" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">131</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00129" class="style-scope patent-text">claim 129</claim-ref>, wherein the cationic components of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and wherein the anionic component of the salt is chloride, sulfate, acetate or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="132" id="US-20040161776-A1-CLM-00132" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">132</b>. The composition of <claim-ref idref="US-20040161776-A1-CLM-00131" class="style-scope patent-text">claim 131</claim-ref>, wherein the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="133" id="US-20040161776-A1-CLM-00133" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">133</b>. The method of any one of claims <b class="style-scope patent-text">128</b>-<b class="style-scope patent-text">132</b>, wherein the pH of the solution is adjusted to be in the range of 4 to 8. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="134" id="US-20040161776-A1-CLM-00134" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">134</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00133" class="style-scope patent-text">claim 133</claim-ref>, wherein the pH of the solution is adjusted to be in the range of 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="135" id="US-20040161776-A1-CLM-00135" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">135</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00134" class="style-scope patent-text">claim 134</claim-ref>, wherein the pH of the solution is adjusted to be in the range of 5.5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="136" id="US-20040161776-A1-CLM-00136" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">136</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00135" class="style-scope patent-text">claim 135</claim-ref>, wherein the pH of the solution is adjusted to be 6. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="137" id="US-20040161776-A1-CLM-00137" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">137</b>. A method of purifying a sample containing PSMA protein comprising: 
<div class="claim-text style-scope patent-text">subjecting the sample containing PSMA to chromatography in the presence of an agent that preserves or promotes the dimeric association of PSMA. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="138" id="US-20040161776-A1-CLM-00138" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">138</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00137" class="style-scope patent-text">claim 137</claim-ref>, wherein the agent that promotes or preserves the dimeric association of PSMA is a metal ion, a salt or a solution with a pH in the range of 4 to 8 or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="139" id="US-20040161776-A1-CLM-00139" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">139</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00138" class="style-scope patent-text">claim 138</claim-ref>, wherein the metal ion is a zinc ion, calcium ion, magnesium ion, cobalt ion, manganese ion or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="140" id="US-20040161776-A1-CLM-00140" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">140</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00139" class="style-scope patent-text">claim 139</claim-ref>, wherein the metal ion is a combination of calcium ion and magnesium ion. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="141" id="US-20040161776-A1-CLM-00141" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">141</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00140" class="style-scope patent-text">claim 140</claim-ref>, wherein the calcium ion and magnesium ion are each present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="142" id="US-20040161776-A1-CLM-00142" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">142</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00141" class="style-scope patent-text">claim 141</claim-ref>, wherein the calcium ion and magnesium ion are present at a concentration of 1 mM and 0.5 mM, respectively. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="143" id="US-20040161776-A1-CLM-00143" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">143</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00138" class="style-scope patent-text">claim 138</claim-ref>, wherein the cationic component of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and wherein the anionic component of the salt is chloride, sulfate, acetate or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="144" id="US-20040161776-A1-CLM-00144" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">144</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00143" class="style-scope patent-text">claim 143</claim-ref>, wherein the salt is sodium chloride, sodium sulfate, sodium acetate or ammonium sulfate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="145" id="US-20040161776-A1-CLM-00145" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">145</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00143" class="style-scope patent-text">claim 143</claim-ref>, wherein the salt is present at a concentration in the range of 50 mM to 2M. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="146" id="US-20040161776-A1-CLM-00146" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">146</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00145" class="style-scope patent-text">claim 145</claim-ref>, wherein the salt is present at a concentration of 2M. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="147" id="US-20040161776-A1-CLM-00147" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">147</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00138" class="style-scope patent-text">claim 138</claim-ref>, wherein the pH of the solution is in the range of 5 to 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="148" id="US-20040161776-A1-CLM-00148" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">148</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00147" class="style-scope patent-text">claim 147</claim-ref>, wherein the pH of the solution is maintained in the range of 6 to 7.5. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="149" id="US-20040161776-A1-CLM-00149" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">149</b>. A method of purifying a sample containing PSMA protein comprising: 
<div class="claim-text style-scope patent-text">applying the sample to a first column, </div> <div class="claim-text style-scope patent-text">washing the first column with a first wash solution containing salt and metal ions, and collecting the PSMA protein that elutes from the first column. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="150" id="US-20040161776-A1-CLM-00150" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">150</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00149" class="style-scope patent-text">claim 149</claim-ref>, wherein the metal ions are zinc ions, calcium ions, magnesium ions, cobalt ions, manganese ions or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="151" id="US-20040161776-A1-CLM-00151" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">151</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00150" class="style-scope patent-text">claim 150</claim-ref>, wherein the metal ions are calcium and magnesium ions. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="152" id="US-20040161776-A1-CLM-00152" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">152</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00151" class="style-scope patent-text">claim 151</claim-ref>, wherein the calcium ions and magnesium ions are present at a concentration in the range of 0.1 mM to 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="153" id="US-20040161776-A1-CLM-00153" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">153</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00152" class="style-scope patent-text">claim 152</claim-ref>, wherein the calcium ions and magnesium ions are present at a concentration of 1 mM and 0.5 mM, respectively. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="154" id="US-20040161776-A1-CLM-00154" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">154</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00152" class="style-scope patent-text">claim 152</claim-ref>, wherein the cationic component of the salt is sodium, potassium, ammonium, magnesium, calcium, zinc or a combination thereof, and wherein the anionic component of the salt is chloride, sulfate acetate or a combination thereof. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="155" id="US-20040161776-A1-CLM-00155" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">155</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00154" class="style-scope patent-text">claim 154</claim-ref>, wherein the salt is ammonium sulfate at a saturation of no more than 35% in the wash solution. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="156" id="US-20040161776-A1-CLM-00156" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">156</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00149" class="style-scope patent-text">claim 149</claim-ref>, further comprising dialyzing or diafiltering the eluted PSMA protein with a first salt solution at a pH in the range of 6 to 7.5 to yield a dialyzed or diafiltrated solution containing PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="157" id="US-20040161776-A1-CLM-00157" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">157</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00156" class="style-scope patent-text">claim 156</claim-ref>, wherein the first salt solution has a salt concentration of at least 5 mM. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="158" id="US-20040161776-A1-CLM-00158" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">158</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00157" class="style-scope patent-text">claim 157</claim-ref>, wherein the first salt solution is a 10M sodium phosphate solution with a pH of 7. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="159" id="US-20040161776-A1-CLM-00159" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">159</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00149" class="style-scope patent-text">claim 149</claim-ref> or <b class="style-scope patent-text">156</b>, further comprising: 
<div class="claim-text style-scope patent-text">loading the eluted PSMA protein, dialyzed or diafiltrated solution containing PSMA protein onto a second column, </div>
<div class="claim-text style-scope patent-text">washing the second column with a second salt solution, </div>
<div class="claim-text style-scope patent-text">and collecting the PSMA eluted by the second salt solution. </div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="160" id="US-20040161776-A1-CLM-00160" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">160</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00159" class="style-scope patent-text">claim 159</claim-ref>, wherein the second salt solution has a salt concentration of 100 mM to 2M. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="161" id="US-20040161776-A1-CLM-00161" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">161</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00160" class="style-scope patent-text">claim 160</claim-ref>, wherein the second salt solution is 2M sodium chloride in 10 mM sodium phosphate. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="162" id="US-20040161776-A1-CLM-00162" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">162</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00159" class="style-scope patent-text">claim 159</claim-ref> or <b class="style-scope patent-text">160</b>, wherein the second salt solution has a pH in the range of 6 to 7.5. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="163" id="US-20040161776-A1-CLM-00163" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">163</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00159" class="style-scope patent-text">claim 159</claim-ref>, further comprising 
<div class="claim-text style-scope patent-text">dialyzing or diafiltrating the PSMA eluted by the second salt solution with a metal ion solution, </div> <div class="claim-text style-scope patent-text">applying the dialyzed or diafiltrated PSMA eluted by the second salt solution onto a third column, </div> <div class="claim-text style-scope patent-text">washing the third column with a second wash solution containing salt and metal ions and collecting the PSMA eluted. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="164" id="US-20040161776-A1-CLM-00164" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">164</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00163" class="style-scope patent-text">claim 163</claim-ref>, wherein the pH is maintained in the range of 6 to 7.5 through all of the purification steps. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="165" id="US-20040161776-A1-CLM-00165" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">165</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00163" class="style-scope patent-text">claim 163</claim-ref>, further comprising separating the different forms of PSMA protein, wherein the different forms of PSMA protein are monomeric, dimeric or other multimeric forms of PSMA. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="166" id="US-20040161776-A1-CLM-00166" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">166</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00165" class="style-scope patent-text">claim 165</claim-ref>, wherein the different forms of PSMA protein are separated by size exclusion chromatography. </div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div num="167" id="US-20040161776-A1-CLM-00167" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">167</b>. A method of identifying an agent which promotes or preserves dimeric association of PSMA protein comprising: 
<div class="claim-text style-scope patent-text">determining the amount of a form of PSMA protein in a sample prior to exposure to a candidate agent, </div> <div class="claim-text style-scope patent-text">exposing the sample to the candidate agent, </div> <div class="claim-text style-scope patent-text">determining the amount of the form of PSMA protein in the sample after the exposure, and </div> <div class="claim-text style-scope patent-text">comparing the amount of the form of PSMA protein in the sample prior to and after the exposure. </div> </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="168" id="US-20040161776-A1-CLM-00168" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">168</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00167" class="style-scope patent-text">claim 167</claim-ref>, wherein the form of PSMA protein is monomer or dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="169" id="US-20040161776-A1-CLM-00169" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">169</b>. A method of treating a subject to elicit or enhance an immune response to cells in the subject expressing PSMA, comprising administering to the subject an effective amount of the composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="170" id="US-20040161776-A1-CLM-00170" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">170</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00171" class="style-scope patent-text">claim 171</claim-ref>, wherein the expressed PSMA is expressed on the cell surface. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="171" id="US-20040161776-A1-CLM-00171" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">171</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00169" class="style-scope patent-text">claim 169</claim-ref>, wherein the method further comprises administering one or more booster doses of a composition comprising PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="172" id="US-20040161776-A1-CLM-00172" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">172</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00171" class="style-scope patent-text">claim 171</claim-ref>, wherein the composition comprising PSMA protein is a composition of PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="173" id="US-20040161776-A1-CLM-00173" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">173</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00171" class="style-scope patent-text">claim 171</claim-ref>, wherein the booster dose composition further comprises an adjuvant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="174" id="US-20040161776-A1-CLM-00174" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">174</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00171" class="style-scope patent-text">claim 171</claim-ref>, wherein the booster dose composition is the composition of any one of claim <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="175" id="US-20040161776-A1-CLM-00175" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">175</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00169" class="style-scope patent-text">claim 169</claim-ref>, wherein the composition is administered by intravenous, intramuscular, subcutaneous, parenteral, spinal, intradermal or epidermal administration. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="176" id="US-20040161776-A1-CLM-00176" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">176</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00175" class="style-scope patent-text">claim 175</claim-ref>, wherein the composition is administered by subcutaneous administration. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="177" id="US-20040161776-A1-CLM-00177" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">177</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00169" class="style-scope patent-text">claim 169</claim-ref>, wherein the subject has cancer or has been treated for cancer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="178" id="US-20040161776-A1-CLM-00178" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">178</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00177" class="style-scope patent-text">claim 177</claim-ref>, wherein the cancer is a primary tumor or is metastatic cancer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="179" id="US-20040161776-A1-CLM-00179" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">179</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00177" class="style-scope patent-text">claim 177</claim-ref>, wherein the subject has prostate cancer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="180" id="US-20040161776-A1-CLM-00180" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">180</b>. A method of eliciting an immune response, comprising administering to a subject an effective amount of the composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="181" id="US-20040161776-A1-CLM-00181" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">181</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00180" class="style-scope patent-text">claim 180</claim-ref>, wherein the method further comprises administering one or more booster doses of a composition comprising PSMA protein. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="182" id="US-20040161776-A1-CLM-00182" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">182</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00181" class="style-scope patent-text">claim 181</claim-ref>, wherein the composition comprising PSMA protein is a composition PSMA protein dimer. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="183" id="US-20040161776-A1-CLM-00183" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">183</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00181" class="style-scope patent-text">claim 181</claim-ref>, wherein the booster dose composition further comprises an adjuvant. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="184" id="US-20040161776-A1-CLM-00184" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">184</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00181" class="style-scope patent-text">claim 181</claim-ref>, wherein the booster dose composition is the composition of any one of claim <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="185" id="US-20040161776-A1-CLM-00185" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">185</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00180" class="style-scope patent-text">claim 180</claim-ref>, wherein the composition is administered by intravenous, intramuscular, subcutaneous, parenteral, spinal, intradermal or epidermal administration. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="186" id="US-20040161776-A1-CLM-00186" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">186</b>. The method of <claim-ref idref="US-20040161776-A1-CLM-00185" class="style-scope patent-text">claim 185</claim-ref>, wherein the composition is administered by subcutaneous administration. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="187" id="US-20040161776-A1-CLM-00187" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">187</b>. A kit which comprises the composition of any one of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b> and instructions for use. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="188" id="US-20040161776-A1-CLM-00188" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">188</b>. A kit which comprises the composition of any one of <claim-ref idref="US-20040161776-A1-CLM-00022" class="style-scope patent-text">claim 22</claim-ref>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">58</b>, <b class="style-scope patent-text">39</b>-<b class="style-scope patent-text">49</b>, <b class="style-scope patent-text">62</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>, an adjuvant and instructions for mixing. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="189" id="US-20040161776-A1-CLM-00189" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">189</b>. The kit of <claim-ref idref="US-20040161776-A1-CLM-00188" class="style-scope patent-text">claim 188</claim-ref>, wherein the adjuvant is alum. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="190" id="US-20040161776-A1-CLM-00190" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">190</b>. A kit which comprises the composition of any one of claims <b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">58</b>, <b class="style-scope patent-text">39</b>-<b class="style-scope patent-text">49</b>, <b class="style-scope patent-text">62</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>, a diluent and instructions for mixing. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="191" id="US-20040161776-A1-CLM-00191" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">191</b>. The kit of any one of claims <b class="style-scope patent-text">187</b>, <b class="style-scope patent-text">188</b>, and <b class="style-scope patent-text">189</b>, wherein the composition is provided in a vial or ampoule with a septum or a syringe. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="192" id="US-20040161776-A1-CLM-00192" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">192</b>. The kit of any one of claims <b class="style-scope patent-text">187</b>, <b class="style-scope patent-text">188</b>, and <b class="style-scope patent-text">189</b>, wherein the composition is in lyophilized form. </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div num="193" id="US-20040161776-A1-CLM-00193" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">193</b>. A pharmaceutical composition comprising the composition of any one of the compositions of claims <b class="style-scope patent-text">1</b>-<b class="style-scope patent-text">22</b>, <b class="style-scope patent-text">43</b>-<b class="style-scope patent-text">71</b> and <b class="style-scope patent-text">95</b>, and a pharmaceutically acceptable carrier.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (15)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US215472A/en"><a id="link" href="#" class="style-scope state-modifier">US215472A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">1879-05-20</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Improvement in stove-legs </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5804602A/en"><a id="link" href="#" class="style-scope state-modifier">US5804602A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-06-17</span>
                    <span class="td style-scope patent-result">1998-09-08</span>
                    <span class="td style-scope patent-result">Guilford Pharmaceuticals Inc.</span>
                    <span class="td style-scope patent-result">Methods of cancer treatment using naaladase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6107090A/en"><a id="link" href="#" class="style-scope state-modifier">US6107090A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-06</span>
                    <span class="td style-scope patent-result">2000-08-22</span>
                    <span class="td style-scope patent-result">Cornell Research Foundation, Inc.</span>
                    <span class="td style-scope patent-result">Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040033229A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040033229A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-23</span>
                    <span class="td style-scope patent-result">2004-02-19</span>
                    <span class="td style-scope patent-result">Maddon Paul J.</span>
                    <span class="td style-scope patent-result">PSMA antibodies and protein multimers 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB8823869D0/en"><a id="link" href="#" class="style-scope state-modifier">GB8823869D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-10-12</span>
                    <span class="td style-scope patent-result">1988-11-16</span>
                    <span class="td style-scope patent-result">Medical Res Council</span>
                    <span class="td style-scope patent-result">Production of antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5175384A/en"><a id="link" href="#" class="style-scope state-modifier">US5175384A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-12-05</span>
                    <span class="td style-scope patent-result">1992-12-29</span>
                    <span class="td style-scope patent-result">Genpharm International</span>
                    <span class="td style-scope patent-result">Transgenic mice depleted in mature t-cells and methods for making transgenic mice 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6150584A/en"><a id="link" href="#" class="style-scope state-modifier">US6150584A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-01-12</span>
                    <span class="td style-scope patent-result">2000-11-21</span>
                    <span class="td style-scope patent-result">Abgenix, Inc.</span>
                    <span class="td style-scope patent-result">Human antibodies derived from immunized xenomice 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5124471A/en"><a id="link" href="#" class="style-scope state-modifier">US5124471A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-03-26</span>
                    <span class="td style-scope patent-result">1992-06-23</span>
                    <span class="td style-scope patent-result">The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Bifunctional dtpa-type ligand 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5545806A/en"><a id="link" href="#" class="style-scope state-modifier">US5545806A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-08-29</span>
                    <span class="td style-scope patent-result">1996-08-13</span>
                    <span class="td style-scope patent-result">Genpharm International, Inc.</span>
                    <span class="td style-scope patent-result">Ransgenic non-human animals for producing heterologous antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5756825A/en"><a id="link" href="#" class="style-scope state-modifier">US5756825A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-09-08</span>
                    <span class="td style-scope patent-result">1998-05-26</span>
                    <span class="td style-scope patent-result">Safavy; Ahmad</span>
                    <span class="td style-scope patent-result">Hydroxamic acid-based bifunctional chelating compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6034065A/en"><a id="link" href="#" class="style-scope state-modifier">US6034065A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-12-03</span>
                    <span class="td style-scope patent-result">2000-03-07</span>
                    <span class="td style-scope patent-result">Arizona Board Of Regents</span>
                    <span class="td style-scope patent-result">Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0690452A3/en"><a id="link" href="#" class="style-scope state-modifier">EP0690452A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-06-28</span>
                    <span class="td style-scope patent-result">1999-01-07</span>
                    <span class="td style-scope patent-result">Advanced Micro Devices, Inc.</span>
                    <span class="td style-scope patent-result">Electrically erasable memory and method of erasure 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5994292A/en"><a id="link" href="#" class="style-scope state-modifier">US5994292A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-05-31</span>
                    <span class="td style-scope patent-result">1999-11-30</span>
                    <span class="td style-scope patent-result">The United States Of America As Represented By The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Interferon-inducible protein 10 is a potent inhibitor of angiogenesis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2260788T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2260788T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-25</span>
                    <span class="td style-scope patent-result">2006-11-01</span>
                    <span class="td style-scope patent-result">Medarex, Inc.</span>
                    <span class="td style-scope patent-result">
  SPECIFIC MONOCLONAL ANTIBODIES FOR THE SPECIFIC MEMBRANE ANTIGEN ESTRACELLULAR DOMAIN OF THE PROSTATE.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0973540B1/en"><a id="link" href="#" class="style-scope state-modifier">EP0973540B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2005-11-02</span>
                    <span class="td style-scope patent-result">Arizona Board Of Regents</span>
                    <span class="td style-scope patent-result">Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (45)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20070160617A1/en"><a id="link" href="#" class="style-scope state-modifier">US20070160617A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-06-20</span>
                    <span class="td style-scope patent-result">2007-07-12</span>
                    <span class="td style-scope patent-result">Psma Development Company, Llc</span>
                    <span class="td style-scope patent-result">PSMA antibody-drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080064861A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080064861A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-08</span>
                    <span class="td style-scope patent-result">2008-03-13</span>
                    <span class="td style-scope patent-result">Wyeth</span>
                    <span class="td style-scope patent-result">Arginine wash in protein purification using affinity chromotography 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20080286284A1/en"><a id="link" href="#" class="style-scope state-modifier">US20080286284A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-23</span>
                    <span class="td style-scope patent-result">2008-11-20</span>
                    <span class="td style-scope patent-result">Psma Development Company, Llc</span>
                    <span class="td style-scope patent-result">Compositions of PSMA antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110165081A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110165081A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-23</span>
                    <span class="td style-scope patent-result">2011-07-07</span>
                    <span class="td style-scope patent-result">Psma Development Company, Llc</span>
                    <span class="td style-scope patent-result">Psma antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20110189093A1/en"><a id="link" href="#" class="style-scope state-modifier">US20110189093A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-04-14</span>
                    <span class="td style-scope patent-result">2011-08-04</span>
                    <span class="td style-scope patent-result">Proscan Rx Pharma</span>
                    <span class="td style-scope patent-result">Prostate specific membrane antigen antibodies and antigen binding fragments 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20120141619A1/en"><a id="link" href="#" class="style-scope state-modifier">US20120141619A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-06</span>
                    <span class="td style-scope patent-result">2012-06-07</span>
                    <span class="td style-scope patent-result">Allergan, Inc.</span>
                    <span class="td style-scope patent-result">Non-protein stabilized clostridial toxin pharmaceutical compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8273361B2/en"><a id="link" href="#" class="style-scope state-modifier">US8273361B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-26</span>
                    <span class="td style-scope patent-result">2012-09-25</span>
                    <span class="td style-scope patent-result">Infectious Disease Research Institute</span>
                    <span class="td style-scope patent-result">Vaccine composition containing synthetic adjuvant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8343512B2/en"><a id="link" href="#" class="style-scope state-modifier">US8343512B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-09-26</span>
                    <span class="td style-scope patent-result">2013-01-01</span>
                    <span class="td style-scope patent-result">Infectious Disease Research Institute</span>
                    <span class="td style-scope patent-result">Treatment of allergic conditions using a composition containing synthetic adjuvant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8722064B2/en"><a id="link" href="#" class="style-scope state-modifier">US8722064B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-06-05</span>
                    <span class="td style-scope patent-result">2014-05-13</span>
                    <span class="td style-scope patent-result">Infectious Disease Research Institute</span>
                    <span class="td style-scope patent-result">Synthetic glucopyranosyl lipid adjuvants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8957047B2/en"><a id="link" href="#" class="style-scope state-modifier">US8957047B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">2015-02-17</span>
                    <span class="td style-scope patent-result">Immune Design Corp.</span>
                    <span class="td style-scope patent-result">GLA monotherapy for use in cancer treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9044420B2/en"><a id="link" href="#" class="style-scope state-modifier">US9044420B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-04-08</span>
                    <span class="td style-scope patent-result">2015-06-02</span>
                    <span class="td style-scope patent-result">Immune Design Corp.</span>
                    <span class="td style-scope patent-result">Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9242012B2/en"><a id="link" href="#" class="style-scope state-modifier">US9242012B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-09-08</span>
                    <span class="td style-scope patent-result">2016-01-26</span>
                    <span class="td style-scope patent-result">Psma Development Company, Llc</span>
                    <span class="td style-scope patent-result">Methods for killing PSMA-expressing, taxane-resistant cancer cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9463198B2/en"><a id="link" href="#" class="style-scope state-modifier">US9463198B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-06-04</span>
                    <span class="td style-scope patent-result">2016-10-11</span>
                    <span class="td style-scope patent-result">Infectious Disease Research Institute</span>
                    <span class="td style-scope patent-result">Compositions and methods for reducing or preventing metastasis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9895435B2/en"><a id="link" href="#" class="style-scope state-modifier">US9895435B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-16</span>
                    <span class="td style-scope patent-result">2018-02-20</span>
                    <span class="td style-scope patent-result">Immune Design Corp.</span>
                    <span class="td style-scope patent-result">Vaccines for HSV-2 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10973890B2/en"><a id="link" href="#" class="style-scope state-modifier">US10973890B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-09-13</span>
                    <span class="td style-scope patent-result">2021-04-13</span>
                    <span class="td style-scope patent-result">Allergan, Inc.</span>
                    <span class="td style-scope patent-result">Non-protein clostridial toxin compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11033625B2/en"><a id="link" href="#" class="style-scope state-modifier">US11033625B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-06</span>
                    <span class="td style-scope patent-result">2021-06-15</span>
                    <span class="td style-scope patent-result">Allergan, Inc.</span>
                    <span class="td style-scope patent-result">Method for stabilizing a toxin 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN114594257A/en"><a id="link" href="#" class="style-scope state-modifier">CN114594257A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-05-09</span>
                    <span class="td style-scope patent-result">2022-06-07</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Desorption composition of CpG ODN-containing adsorption type vaccine and application thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN115876993A/en"><a id="link" href="#" class="style-scope state-modifier">CN115876993A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-11-17</span>
                    <span class="td style-scope patent-result">2023-03-31</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Establishment of method for detecting affinity of pathogenic biological agglutinin and sialyllactose based on biomembrane interference technology 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN116643056A/en"><a id="link" href="#" class="style-scope state-modifier">CN116643056A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-02-15</span>
                    <span class="td style-scope patent-result">2023-08-25</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Thyroid stimulating hormone receptor complex, kit, preparation method and application 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4903036B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4903036B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-06</span>
                    <span class="td style-scope patent-result">2012-03-21</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Aprotinin and analogs as carriers that cross the blood brain barrier
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1907009A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1907009A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-07-15</span>
                    <span class="td style-scope patent-result">2009-09-02</span>
                    <span class="td style-scope patent-result">Angiochem Inc</span>
                    <span class="td style-scope patent-result">Use of aprotinin polypeptides as carriers in pharmaceutical conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8367054B2/en"><a id="link" href="#" class="style-scope state-modifier">US8367054B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-11-24</span>
                    <span class="td style-scope patent-result">2013-02-05</span>
                    <span class="td style-scope patent-result">Cadila Healthcare Limited</span>
                    <span class="td style-scope patent-result">Formulations of PEG-interferon alpha conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9365634B2/en"><a id="link" href="#" class="style-scope state-modifier">US9365634B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-29</span>
                    <span class="td style-scope patent-result">2016-06-14</span>
                    <span class="td style-scope patent-result">Angiochem Inc.</span>
                    <span class="td style-scope patent-result">Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2279008T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2279008T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-04-18</span>
                    <span class="td style-scope patent-result">2019-04-29</span>
                    <span class="td style-scope patent-result">Angiochem Inc</span>
                    <span class="td style-scope patent-result">
  PHARMACEUTICAL COMPOSITIONS OF PACLITAXEL, PACLITAXEL ANALOGS OR PACLITAXEL CONJUGATES AND RELATED PROCEDURES FOR PREPARATION AND USE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5770629B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5770629B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-08-15</span>
                    <span class="td style-scope patent-result">2015-08-26</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">
  Stable solid formulation of GC-C receptor agonist polypeptide suitable for oral administration
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102245642A/en"><a id="link" href="#" class="style-scope state-modifier">CN102245642A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-15</span>
                    <span class="td style-scope patent-result">2011-11-16</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Conjugates of GLP-1 agonists and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2531591C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2531591C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-15</span>
                    <span class="td style-scope patent-result">2014-10-20</span>
                    <span class="td style-scope patent-result"> .</span>
                    <span class="td style-scope patent-result">Etoposide and doxorubicin conjugates for drug delivery 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2009322043A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2009322043A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-05</span>
                    <span class="td style-scope patent-result">2011-07-07</span>
                    <span class="td style-scope patent-result">Angiochem Inc.</span>
                    <span class="td style-scope patent-result">Conjugates of neurotensin or neurotensin analogs and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0922611A2/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0922611A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-12-17</span>
                    <span class="td style-scope patent-result">2018-11-06</span>
                    <span class="td style-scope patent-result">Angiochem Inc</span>
                    <span class="td style-scope patent-result">
  type 1 membrane matrix metalloprotein inhibitors and uses thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2759129C/en"><a id="link" href="#" class="style-scope state-modifier">CA2759129C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-04-20</span>
                    <span class="td style-scope patent-result">2018-12-11</span>
                    <span class="td style-scope patent-result">Angiochem Inc.</span>
                    <span class="td style-scope patent-result">Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9161988B2/en"><a id="link" href="#" class="style-scope state-modifier">US9161988B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-07-02</span>
                    <span class="td style-scope patent-result">2015-10-20</span>
                    <span class="td style-scope patent-result">Angiochem Inc.</span>
                    <span class="td style-scope patent-result">Multimeric peptide conjugates and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2770077A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2770077A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-06</span>
                    <span class="td style-scope patent-result">2011-02-10</span>
                    <span class="td style-scope patent-result">Ironwood Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Formulations comprising linaclotide 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN102869677B/en"><a id="link" href="#" class="style-scope state-modifier">CN102869677B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-17</span>
                    <span class="td style-scope patent-result">2015-07-08</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Treatments for gastrointestinal disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112012025047A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112012025047A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">2016-06-21</span>
                    <span class="td style-scope patent-result">Stabilitech Ltd</span>
                    <span class="td style-scope patent-result">
  stabilized liquid formulations
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2543795T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2543795T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">2015-08-21</span>
                    <span class="td style-scope patent-result">Stabilitech Ltd.</span>
                    <span class="td style-scope patent-result">
  Stabilization of viral particles
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2552410T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2552410T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-03-31</span>
                    <span class="td style-scope patent-result">2019-02-18</span>
                    <span class="td style-scope patent-result">Stabilitech Biopharma Ltd</span>
                    <span class="td style-scope patent-result">
  PROCEDURE FOR THE CONSERVATION OF ALUNADUVANCES AND VACCINES WITH ALUNADUVANCES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/SI2603232T1/en"><a id="link" href="#" class="style-scope state-modifier">SI2603232T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-08-11</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Ironwood Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Stable formulations of linaclotide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX347354B/en"><a id="link" href="#" class="style-scope state-modifier">MX347354B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-08-17</span>
                    <span class="td style-scope patent-result">2017-04-24</span>
                    <span class="td style-scope patent-result">Ironwood Pharmaceuticals Inc</span>
                    <span class="td style-scope patent-result">Treatments for gastrointestinal disorders. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201117233D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201117233D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-05</span>
                    <span class="td style-scope patent-result">2011-11-16</span>
                    <span class="td style-scope patent-result">Stabilitech Ltd</span>
                    <span class="td style-scope patent-result">Stabilisation of polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2855356A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2855356A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-11</span>
                    <span class="td style-scope patent-result">2013-05-16</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Biomarkers of response to proteasome inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201406569D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201406569D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-11</span>
                    <span class="td style-scope patent-result">2014-05-28</span>
                    <span class="td style-scope patent-result">Stabilitech Ltd</span>
                    <span class="td style-scope patent-result">Vaccine compositions 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK3307326T3/en"><a id="link" href="#" class="style-scope state-modifier">DK3307326T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-15</span>
                    <span class="td style-scope patent-result">2020-10-19</span>
                    <span class="td style-scope patent-result">Angiochem Inc</span>
                    <span class="td style-scope patent-result">
  METHODS FOR THE TREATMENT OF LEPTOMENINGAL CARCINOMATOSIS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20170189548A1/en"><a id="link" href="#" class="style-scope state-modifier">US20170189548A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-11-25</span>
                    <span class="td style-scope patent-result">2017-07-06</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Pharmaceutical formulations and methods of use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3050085A1/en"><a id="link" href="#" class="style-scope state-modifier">CA3050085A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-01-20</span>
                    <span class="td style-scope patent-result">2018-07-26</span>
                    <span class="td style-scope patent-result">Juno Therapeutics Gmbh</span>
                    <span class="td style-scope patent-result">Cell surface conjugates and related cell compositions and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB2562241B/en"><a id="link" href="#" class="style-scope state-modifier">GB2562241B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-05-08</span>
                    <span class="td style-scope patent-result">2022-04-06</span>
                    <span class="td style-scope patent-result">Stabilitech Biopharma Ltd</span>
                    <span class="td style-scope patent-result">Vaccine compositions 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2464239C/en"><a id="link" href="#" class="style-scope state-modifier">CA2464239C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-07-12</span>
                    <span class="td style-scope patent-result">Psma antibodies and protein multimers 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040161776A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-08-19</span>
                    <span class="td style-scope patent-result">PSMA formulations and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2612762C/en"><a id="link" href="#" class="style-scope state-modifier">CA2612762C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-12-10</span>
                    <span class="td style-scope patent-result">Psma antibody-drug conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101553506B/en"><a id="link" href="#" class="style-scope state-modifier">CN101553506B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-08-07</span>
                    <span class="td style-scope patent-result">Lingo binding molecules and pharmaceutical use thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2692865T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2692865T3</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-16</span>
                    <span class="td style-scope patent-result">Transponeringsmedieret identification of specific binding proteins, or functional 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101605899B/en"><a id="link" href="#" class="style-scope state-modifier">CN101605899B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-07-31</span>
                    <span class="td style-scope patent-result">A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109260478A/en"><a id="link" href="#" class="style-scope state-modifier">CN109260478A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-25</span>
                    <span class="td style-scope patent-result">Immunogenic ligand/effector molecule conjugate method is prepared by sequence-specific transpeptidase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20080031024A/en"><a id="link" href="#" class="style-scope state-modifier">KR20080031024A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-04-07</span>
                    <span class="td style-scope patent-result">Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL149142A/en"><a id="link" href="#" class="style-scope state-modifier">IL149142A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-05-31</span>
                    <span class="td style-scope patent-result">Ligand activated transcriptional regulator fusion protein, nucleic acid molecule encoding the same and use thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110023500A/en"><a id="link" href="#" class="style-scope state-modifier">CN110023500A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-07-16</span>
                    <span class="td style-scope patent-result">The attenuation glutamine synthelase alternatively marked 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20210108423A/en"><a id="link" href="#" class="style-scope state-modifier">KR20210108423A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-09-02</span>
                    <span class="td style-scope patent-result">
  Adeno-associated virus (AAV) producer cell lines and related methods
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102584628B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102584628B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-10-04</span>
                    <span class="td style-scope patent-result">
  An engineered multicomponent system for the identification and characterization of T-cell receptors, T-cell antigens, and their functional interactions.
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20240037185A/en"><a id="link" href="#" class="style-scope state-modifier">KR20240037185A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-03-21</span>
                    <span class="td style-scope patent-result">
  Chimeric costimulatory receptors, chemokine receptors, and their uses in cellular immunotherapy
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20190076991A/en"><a id="link" href="#" class="style-scope state-modifier">KR20190076991A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-07-02</span>
                    <span class="td style-scope patent-result">
  A manipulated multicomponent system for identification and characterization of T-cell receptors and T-cell antigens
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20230117327A/en"><a id="link" href="#" class="style-scope state-modifier">KR20230117327A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-08-08</span>
                    <span class="td style-scope patent-result">
  An expression vector comprising a soluble alkaline phosphatase construct and a polynucleotide encoding the soluble alkaline phosphatase construct.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102393402B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102393402B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-05-04</span>
                    <span class="td style-scope patent-result">Composition for the preventing or treating cancer comprising an expression vector for dual genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20240022571A/en"><a id="link" href="#" class="style-scope state-modifier">KR20240022571A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2024-02-20</span>
                    <span class="td style-scope patent-result">
  Systems, methods and components for RNA-guided effector recruitment
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU775429B2/en"><a id="link" href="#" class="style-scope state-modifier">AU775429B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-07-29</span>
                    <span class="td style-scope patent-result">A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            
            <h3 id="parentApplications" class="scroll-target style-scope patent-result">
              Parent Applications (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003034903A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/US2002/033944</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2002-10-23</span>
                    <span class="td nowrap style-scope patent-result">
                        Continuation-In-Part<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">Psma antibodies and protein multimers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7850971B2/en"><a id="link" href="#" class="style-scope state-modifier">US10/395,894</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2003-03-21</span>
                    <span class="td nowrap style-scope patent-result">
                        Continuation-In-Part<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">PSMA antibodies and protein multimers 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationChildApps" class="scroll-target style-scope patent-result">
              Child Applications (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Relation</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050215472A1/en"><a id="link" href="#" class="style-scope state-modifier">US10/976,352</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td nowrap style-scope patent-result">
                        Continuation-In-Part<template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">PSMA formulations and uses thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="applicationPriorityApps" class="scroll-target style-scope patent-result">
              Priority Applications (9)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier">US10/695,667</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        PSMA formulations and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007509977A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006538350A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
  PSMA formulations and uses thereof
 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1691840A2/en"><a id="link" href="#" class="style-scope state-modifier">EP04810137A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Psma formulations and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005042029A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/US2004/036120</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Psma formulations and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050215472A1/en"><a id="link" href="#" class="style-scope state-modifier">US10/976,352</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        PSMA formulations and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2543703A1/en"><a id="link" href="#" class="style-scope state-modifier">CA002543703A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        Psma formulations and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2004285543A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2004285543A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td nowrap style-scope patent-result">2004-10-27</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        PSMA formulations and uses thereof 
     <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8470330B2/en"><a id="link" href="#" class="style-scope state-modifier">US12/845,686</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2010-07-28</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        PSMA antibodies and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9695248B2/en"><a id="link" href="#" class="style-scope state-modifier">US13/608,337</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td nowrap style-scope patent-result">2012-09-10</span>
                    <span class="td style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        PSMA antibodies and uses thereof 
       <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (6)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US33521501P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-10-23</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US36274702P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2002-03-07</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US41261802P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2002-09-20</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003034903A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/US2002/033944</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2002-10-23</span>
                    <span class="td style-scope patent-result">Psma antibodies and protein multimers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7850971B2/en"><a id="link" href="#" class="style-scope state-modifier">US10/395,894</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-03-21</span>
                    <span class="td style-scope patent-result">PSMA antibodies and protein multimers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040161776A1/en"><a id="link" href="#" class="style-scope state-modifier">US10/695,667</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2003-10-27</span>
                    <span class="td style-scope patent-result">PSMA formulations and uses thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2004-04-28</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: PSMA DEVELOPMENT COMPANY, LLC, NEW YORK</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MADDON, PAUL J.;DONOVAN, GERALD P.;OLSON, WILLIAM C.;AND OTHERS;REEL/FRAME:014575/0705;SIGNING DATES FROM 20031231 TO 20040106</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2010-07-30</span>
                    <span class="td nowrap style-scope patent-result">STCB</span>
                    <span class="td nowrap style-scope patent-result">Information on status: application discontinuation</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: EXPRESSLY ABANDONED  --  DURING EXAMINATION</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu"></span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Anatomy</div>
          
            <div class="item style-scope dropdown-menu">Chemical class</div>
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          
            <div class="item style-scope dropdown-menu">Chemical group</div>
          
            <div class="item style-scope dropdown-menu">Diseases</div>
          
            <div class="item style-scope dropdown-menu">Drugs</div>
          
            <div class="item style-scope dropdown-menu">Effects</div>
          
            <div class="item style-scope dropdown-menu">Human genes</div>
          
            <div class="item style-scope dropdown-menu">Inorganic materials</div>
          
            <div class="item style-scope dropdown-menu">Methods</div>
          
            <div class="item style-scope dropdown-menu">Natural products</div>
          
            <div class="item style-scope dropdown-menu">Nutrition</div>
          
            <div class="item style-scope dropdown-menu">Polymers</div>
          
            <div class="item style-scope dropdown-menu">Proteins</div>
          
            <div class="item style-scope dropdown-menu">Species</div>
          
            <div class="item style-scope dropdown-menu">Substances</div>
          
            <div class="item style-scope dropdown-menu">Toxicity</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Homo sapiens Glutamate carboxypeptidase 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">769</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glutamate carboxypeptidase 2</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">760</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mixture</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">295</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">poly(stearyl methacrylate)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">82</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">formulation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">title,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">218</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">53</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Prostate cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">40</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Prostatic Neoplasms</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">39</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,abstract,description</span>
                        <span class="td nowrap style-scope patent-result">29</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">148</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">fragment</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">136</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium chloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">129</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">salts</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">109</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">solution</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">106</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chemical substances by application</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">105</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dimer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">79</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">metal ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">69</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">61</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">60</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">amino acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">59</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">41</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sodium chloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">40</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">adjuvant</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">40</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Calcium cation</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">39</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Magnesium ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">36</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">36</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Zinc dication</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">29</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">monomer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">29</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">montanide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">28</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glycine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">26</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">()--Tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">23</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">protein dimer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">22</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">buffer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">21</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ethylene glycol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">salt solution</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium chloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">20</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sodium acetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium acetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium acetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">19</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glycerine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">citric acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cryoprotective agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">18</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ilexoside XXIX</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">17</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ascorbic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chelating agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phosphate buffered saline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">16</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acetic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">15</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ethanol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sodium Sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ammonium sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ammonium sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ammonium sulphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">immunostimulating effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium sulphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">14</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Alpha-Lactose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glycine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Lactose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pH adjusting agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">13</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Benzyl alcohol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">beta-alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">biosynthetic process</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cobalt(2+)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">imidazole</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sarcosine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">surface-active agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Calcium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-glutamic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antioxidant agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antioxidants</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cobalt ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diluting agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">drug carrier</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gamma-aminobutyric acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">manganese ion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">trisodium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">11</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Phosphoric acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glutamate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glutamate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">immune response</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">preservative agent</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">10</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Magnesium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Potassium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">potassium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">potassium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">potassium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sugar</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">washing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">9</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">2-methylpentane-2,4-diol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ammonium</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Human genes style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cytokines</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cytokines</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-alpha-tocopherylacetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Dimethylsulphoxide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-Proline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Magnesium sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Phenol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Proline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Zinc</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acidificating effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">anionic group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ascorbic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ascorbic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ascorbic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cationic group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chlorobutanol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dithiothreitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">pharmaceutical composition</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polymer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyols</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">processing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">proline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">promoting effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium fluoride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium sulfite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium-L-ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">succinate(2-)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocofersolan</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol acetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tripotassium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">zinc</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">zinc</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">8</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Acetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-Glucitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-glucitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-ascorbic acids</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Manganese(2+)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alum</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">antioxidant effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gamma-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">oil</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyethylene glycol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sorbitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sorbitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">subcutaneous administration</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">7</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-Mannitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Glucose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Mannitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Oligonucleotide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sarcosine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">beta-D-glucose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chlorine compounds</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dl-hydroxyproline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycerol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glycine betaine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inorganic salt</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mannitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mannitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyvinylpyrrolidone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyvinylpyrrolidone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">preservative effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol derivatives</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">6</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(+/-)-DABA</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">100676-05-9</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hydroxyproline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-histidine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Maltose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Polyethylene glycol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sucrose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">aluminium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">beta-alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">beta-maltose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ethanol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gamma aminobutyric acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">histidine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">histidine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hydroxyproline</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">intramuscular administration</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">intravenous administration</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">mixing</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyvinylpyrrolidone</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sarcosine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">size-exclusion chromatography</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium citrate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium citrate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sucrose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">5</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">&amp;alpha;-D-glucopyranosyl-&amp;alpha;-D-glucopyranoside</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">(3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">2,2'-iminodipropanoic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">4-(4-fluorophenyl)oxane-4-carboxylic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Arginine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ascorbyl stearate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Ascorbyl stearate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Benzoic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Benzoic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Butylated hydroxyanisole</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Butylated hydroxytoluene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Butylhydroxytoluene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cholic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-alpha-Tocopheryl Acid Succinate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">D-delta tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">DL-alpha-tocopherylacetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">DL-alpha-tocopherylacetate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Dextran</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Hexa-Ac-myo-Inositol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-argininium(2+)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-ascorbyl-6-palmitate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-ascorbyl-6-palmitate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-isoleucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-leucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Lactate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Leucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">N-(carboxymethyl)-D-alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Poly (ethylene oxide)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Polyethylene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Polysorbate 20</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Propanedioic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sodium bisulfite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Succinic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Trehalose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Triton X-100</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Triton X-100</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Xylitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alanine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">alpha,alpha-trehalose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">arginine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">arginine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ascorbyl palmitate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ascorbyl stearate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzalkonium chloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzoic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzoic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzyl alcohol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzyl alcohol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">benzyl(dimethyl)azanium;chloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">beta tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">betaine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butanedioic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butylated hydroxyanisole</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butylated hydroxyanisole</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butylated hydroxyanisole</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butylated hydroxytoluene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">butylated hydroxytoluene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">calcium-L-ascorbate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">carbonic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chlorobutanol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cholic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cholic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cholic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">d- alpha-tocopherol succinate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">delta-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">deoxycholic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">dodecyl beta-D-maltoside</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">gamma-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">glucose</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">hydroxyacetaldehyde</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inositol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">inositol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">isoleucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">isoleucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lactic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">leucine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">liquid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">lysine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium sulfate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">magnesium sulphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">maleic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">maleic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">maleic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">meso ribitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">monothioglycerol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyethylene</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyoxyethylene sorbitan monolaurate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyoxyethylene sorbitan monooleate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Polymers style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polysorbate 80</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Inorganic materials style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">potassium phosphate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">potassium phosphates</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">purification</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">rongalite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">scyllo-inosotol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium benzoate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium benzoate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium benzoate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium caprylate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium disulfite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium dithionite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium fluoride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium fluoride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium hydrogen sulphite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium lactate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium lactate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium lactate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium metabisulfite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium metabisulphite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium octanoate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium succinate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium succinate (anhydrous)</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sodium sulphite</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">strombine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">thimerosal</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">thimerosal</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">thioglycolic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">trans-butenedioic acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">trimethylamine N-oxide</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">xylitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">xylitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">xylitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">xylitol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">-tocopherol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">4</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Proteins style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Cell Wall Skeleton</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Sodium bicarbonate-14C</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">Vitamin E</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">[(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Anatomy style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">cell wall skeleton</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">chromatography analysis</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">emulsion</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">loading method</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">monophosphoryl lipid a</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">phenol</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">polyoxyethylene sorbitan monolaurate</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">protein solution</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Natural products style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">saponin</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical class style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">saponins</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical group style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">sucrose group</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Drugs style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vitamin E</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Nutrition style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vitamin E</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">vitamin E</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">3</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">ampul</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Methods style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">diafiltration</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">metastatic cancer</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Diseases style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">metastatic malignant neoplasm</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Substances style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">quillaja saponaria molina bark</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims,description</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">L-lysine hydrochloride</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">2</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Chemical compound style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">acetic acid;sulfuric acid</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">claims</span>
                        <span class="td nowrap style-scope patent-result">1</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    
                      <div style="background-color: rgba(129, 201, 144, 0.000)" class="tr layout horizontal conceptDomain Effects style-scope patent-result">
                        <span class="td flex style-scope patent-result">
                          <concept-mention class="style-scope patent-result">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                           <span class="style-scope patent-result">enhancing effect</span>
                          
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
                        </span>
                        <span class="td nowrap style-scope patent-result">
                          <template is="dom-if" class="style-scope patent-result"></template>
                        </span>
                        <span class="td nowrap style-scope patent-result">abstract,description</span>
                        <span class="td nowrap style-scope patent-result">12</span>
                        <span class="td nowrap style-scope patent-result">0.000</span>
                      </div>
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1457014813" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.1457014813" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=426630938" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>